Keyword Search Results for ""

. .

. .

. .

. .

Hillis, L. D., Borer, J., Braunwald, E., Chesebro, J. H., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Knatterud, G., Ludbrook, P., et al., High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial Journal of the American College of Cardiology. 1985;6(5):957-62. Abstract

Williams, D. O., Borer, J., Braunwald, E., Chesebro, J. H., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Knatterud, G., Ludbrook, P., et al., Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial Circulation. 1986;73(2):338-46. Abstract

Braunwald, E., Knatterud, G. L., Passamani, E. R., Robertson, T. L. Announcement of protocol change in thrombolysis in myocardial infarction trial Journal of the American College of Cardiology. 1987;9(2):467.

Braunwald, E., Knatterud, G. L., Passamani, E. R., Robertson, T. L. Announcement of protocol change in thrombolysis in myocardial infarction trial Journal of the American College of Cardiology. 1987;9(2):467.

Braunwald, E., Knatterud, G. L., Passamani, E., Robertson, T. L., Solomon, R. Update from the Thrombolysis in Myocardial Infarction Trial Journal of the American College of Cardiology. 1987;10(4):970.

Braunwald, E., Knatterud, G. L., Passamani, E., Robertson, T. L., Solomon, R. Update from the Thrombolysis in Myocardial Infarction Trial Journal of the American College of Cardiology. 1987;10(4):970.

Chesebro, J. H., Knatterud, G., Roberts, R., Borer, J., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Hillis, D., Ludbrook, P., et al., Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation. 1987;76(1):142-54. Abstract

Knatterud, G. L., Forman, S. A. Patient recruitment experience in the Thrombolysis in Myocardial Infarction Trial Controlled clinical trials. 1987;8(4, Supplement 1):86S-93S. Abstract

Knatterud, G. L., Forman, S. A. Patient recruitment experience in the Thrombolysis in Myocardial Infarction Trial Controlled clinical trials. 1987;8(4, Supplement 1):86S-93S. Abstract

Knatterud, G. L., Forman, S. A. Patient recruitment experience in the Thrombolysis in Myocardial Infarction Trial Controlled clinical trials. 1987;8(4, Supplement 1):86S-93S. Abstract

Knatterud, G. L., Forman, S. A. Patient recruitment experience in the Thrombolysis in Myocardial Infarction Trial Controlled clinical trials. 1987;8(4, Supplement 1):86S-93S. Abstract

Owen, J., Friedman, K. D., Grossman, B. A., Wilkins, C., Berke, A. D., Powers, E. R. Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator Journal of clinical investigation. 1987;79(6):1642-7. Abstract

Passamani, E., Hodges, M., Herman, M., Grose, R., Chaitman, B., Rogers, W., Forman, S., Terrin, M., Knatterud, G., Robertson, T., et al., The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty Journal of the American College of Cardiology. 1987;10(5 Suppl 2):51B-64B. Abstract

Sheehan, F. H., Braunwald, E., Canner, P., Dodge, H. T., Gore, J., Van Natta, P., Passamani, E. R., Williams, D. O., Zaret, B. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial Circulation. 1987;75(4):817-29. Abstract

Williams, D. O., Ruocco, N. A., Forman, S. Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: a report from the Thrombolysis in Myocardial Infarction (TIMI) Trial Journal of the American College of Cardiology. 1987;10(5 Suppl B):45B-50B. Abstract

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group JAMA. 1988;260:2849-58. Abstract

Dalen, J. E., Gore, J. M., Braunwald, E., Borer, J., Goldberg, R. J., Passamani, E. R., Forman, S., Knatterud, G. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial American Journal of Cardiology. 1988;62(4):179-85. Abstract

Eisenberg, P. R., Sobel, B. E., Jaffe, A. S. Characterization in vivo of the fibrin specificity of activators of the fibrinolytic system Circulation. 1988;78(3):592-7. Abstract

Eisenberg, P. R., Sobel, B. E., Jaffe, A. S. Characterization in vivo of the fibrin specificity of activators of the fibrinolytic system Circulation. 1988;78(3):592-7. Abstract

Eisenberg, P. R., Sobel, B. E., Jaffe, A. S. Characterization in vivo of the fibrin specificity of activators of the fibrinolytic system Circulation. 1988;78(3):592-7. Abstract

Eisenberg, P. R., Sobel, B. E., Jaffe, A. S. Characterization in vivo of the fibrin specificity of activators of the fibrinolytic system Circulation. 1988;78(3):592-7. Abstract

Held, A. C., Gore, J. M., Paraskos, J., Pape, L. A., Ball, S. P., Corrao, J. M., Alpert, J. S. Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction American Journal of Cardiology. 1988;62(4):310-1.

Held, A. C., Gore, J. M., Paraskos, J., Pape, L. A., Ball, S. P., Corrao, J. M., Alpert, J. S. Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction American Journal of Cardiology. 1988;62(4):310-1.

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. The TIMI Study Group. N Engl J Med. 1989;320:618-27. Abstract

Chaitman, B. R., Thompson, B., Wittry, M. D., Stump, D., Hamilton, W. P., Hillis, L. D., Dwyer, J. G., Solomon, R. E., Knatterud, G. L. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators Journal of the American College of Cardiology. 1989;14(5):1159-65. Abstract

Gibbons, R. J., Verani, M. S., Behrenbeck, T., Pellikka, P. A., O'Connor, M. K., Mahmarian, J. J., Chesebro, J. H., Wackers, F. J. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction Circulation. 1989;80(5):1277-86. Abstract

Gore, J. M., Corrao, J. M., Goldberg, R. J., Ball, S. P., Weiner, B. H., Aghababian, R. V., Dalen, J. E. Feasibility and safety of emergency interhospital transport of patients during early hours of acute myocardial infarction Archives of internal medicine. 1989;149(2):353-5. Abstract

Gore, J. M., Corrao, J. M., Goldberg, R. J., Ball, S. P., Weiner, B. H., Aghababian, R. V., Dalen, J. E. Feasibility and safety of emergency interhospital transport of patients during early hours of acute myocardial infarction Archives of internal medicine. 1989;149(2):353-5. Abstract

Ong, L., Coromilas, J., Zimmerman, J. M., Green, S., Padmanabhan, V., Reiser, P., Bigger, J. T., Jr., Morrison, J. A physiologically based model of creatine kinase-MB release in reperfusion of acute myocardial infarction American Journal of Cardiology. 1989;64(1):5-Nov. Abstract

Rogers, W. J., Bourge, R. C., Papapietro, S. E., Wackers, F. J., Zaret, B. L., Forman, S., Dodge, H. T., Robertson, T. L., Passamani, E. R., Braunwald, E., et al., Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study American journal of cardiology. 1989;63(9):503-12. Abstract

Rogers, W. J., Bourge, R. C., Papapietro, S. E., Wackers, F. J., Zaret, B. L., Forman, S., Dodge, H. T., Robertson, T. L., Passamani, E. R., Braunwald, E., et al., Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study American journal of cardiology. 1989;63(9):503-12. Abstract

Sharkey, S. W., Bruneete, D. D., Ruiz, E., Hession, W. T., Wysham, D. G., Goldenberg, I. F., Hodges, M. An analysis of time delays preceding thrombolysis for acute myocardial infarction JAMA. 1989;262(22):3171-4. Abstract

Sharkey, S. W., Bruneete, D. D., Ruiz, E., Hession, W. T., Wysham, D. G., Goldenberg, I. F., Hodges, M. An analysis of time delays preceding thrombolysis for acute myocardial infarction JAMA. 1989;262(22):3171-4. Abstract

Wackers, F. J., Gibbons, R. J., Verani, M. S., Kayden, D. S., Pellikka, P. A., Behrenbeck, T., Mahmarian, J. J., Zaret, B. L. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy Journal of the American College of Cardiology. 1989;14(4):861-73. Abstract

Wackers, F. J., Gibbons, R. J., Verani, M. S., Kayden, D. S., Pellikka, P. A., Behrenbeck, T., Mahmarian, J. J., Zaret, B. L. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy Journal of the American College of Cardiology. 1989;14(4):861-73. Abstract

Wackers, F. J., Terrin, M. L., Kayden, D. S., Knatterud, G., Forman, S., Braunwald, E., Zaret, B. L. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial Journal of the American College of Cardiology. 1989;13(5):998-1005. Abstract

Baim, D. S., Braunwald, E., Feit, F., Knatterud, G. L., Passamani, E. R., Robertson, T. L., Rogers, W. J., Solomon, R. E., Williams, D. O. The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectives Journal of the American College of Cardiology. 1990;15(5):1188-92. Abstract

Baim, D. S., Braunwald, E., Feit, F., Knatterud, G. L., Passamani, E. R., Robertson, T. L., Rogers, W. J., Solomon, R. E., Williams, D. O. The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectives Journal of the American College of Cardiology. 1990;15(5):1188-92. Abstract

Chaitman, B. R., Thompson, B. W., Kern, M. J., Vandormael, M. G., Cohen, M. B., Ruocco, N. A., Solomon, R. E., Braunwald, E. Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators American heart journal. 1990;119(2 Pt 1):213-23. Abstract

Feit, F., Mueller, H. S., Braunwald, E., Ross, R., Hodges, M., Herman, M. V., Knatterud, G. L. Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group Journal of the American College of Cardiology. 1990;16(7):1529-34. Abstract

Gertz, S. D., Kalan, J. M., Kragel, A. H., Roberts, W. C., Braunwald, E. Cardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator American Journal of Cardiology. 1990;65(15):953-61. Abstract

Hillis, L. D., Forman, S., Braunwald, E. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators Journal of the American College of Cardiology. 1990;16(2):313-5. Abstract

Johnson, L. L., Seldin, D. W., Keller, A. M., Wall, R. M., Bhatia, K., Bingham, C. O., 3rd, Tresgallo, M. E. Dual isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk Circulation. 1990;81(1):37-45. Abstract

Johnson, L. L., Seldin, D. W., Keller, A. M., Wall, R. M., Bhatia, K., Bingham, C. O., 3rd, Tresgallo, M. E. Dual isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk Circulation. 1990;81(1):37-45. Abstract

Johnson, L. L., Seldin, D. W., Keller, A. M., Wall, R. M., Bhatia, K., Bingham, C. O., 3rd, Tresgallo, M. E. Dual isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk Circulation. 1990;81(1):37-45. Abstract

Kayden, D. S., Wackers, F. J., Zaret, B. L. Silent left ventricular dysfunction during routine activity after thrombolytic therapy for acute myocardial infarction Journal of the American College of Cardiology. 1990;15(7):1500-7. Abstract

Kayden, D. S., Wackers, F. J., Zaret, B. L. Silent left ventricular dysfunction during routine activity after thrombolytic therapy for acute myocardial infarction Journal of the American College of Cardiology. 1990;15(7):1500-7. Abstract

Lawler, C. M., Bovill, E. G., Stump, D. C., Collen, D. J., Mann, K. G., Tracy, R. P. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction Blood. 1990;76(7):1341-8. Abstract

Rogers, W. J., Baim, D. S., Gore, J. M., Brown, B. G., Roberts, R., Williams, D. O., Chesebro, J. H., Babb, J. D., Sheehan, F. H., Wackers, F. J., et al., Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial Circulation. 1990;81(5):1457-76. Abstract

Bovill, E. G., Terrin, M. L., Stump, D. C., Berke, A. D., Frederick, M., Collen, D., Feit, F., Gore, J. M., Hillis, L. D., Lambrew, C. T., et al., Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial Annals of internal medicine. 1991;115(4):256-65. Abstract

Gore, J. M., Sloan, M., Price, T. R., Randall, A. M., Bovill, E., Collen, D., Forman, S., Knatterud, G. L., Sopko, G., Terrin, M. L. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial Circulation. 1991;83(2):448-59. Abstract

Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, Bolli R. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation. 1991;83:739-46. Abstract

Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, Bolli R. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation. 1991;83:739-46. Abstract

Ockene, I. S., Miner, J., Shannon, T. A., Gore, J. M., Weiner, B. H., Ball, S. P. The consent process in the Thrombolysis in Myocardial Infarction (TIMI--phase I) trial Clinical research. 1991;39(1):13-7.

Ockene, I. S., Miner, J., Shannon, T. A., Gore, J. M., Weiner, B. H., Ball, S. P. The consent process in the Thrombolysis in Myocardial Infarction (TIMI--phase I) trial Clinical research. 1991;39(1):13-7.

Ockene, I. S., Miner, J., Shannon, T. A., Gore, J. M., Weiner, B. H., Ball, S. P. The consent process in the Thrombolysis in Myocardial Infarction (TIMI--phase I) trial Clinical research. 1991;39(1):13-7.

Ockene, I. S., Miner, J., Shannon, T. A., Gore, J. M., Weiner, B. H., Ball, S. P. The consent process in the Thrombolysis in Myocardial Infarction (TIMI--phase I) trial Clinical research. 1991;39(1):13-7.

Roberts R, Rogers WJ, Mueller HS, Lambrew CT, Diver DJ, Smith HC, Willerson JT, Knatterud GL, Forman S, Passamani E, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation. 1991;83:422-37. Abstract

Rogers, W. J., Babb, J. D., Baim, D. S., Chesebro, J. H., Gore, J. M., Roberts, R., Williams, D. O., Frederick, M., Passamani, E. R., Braunwald, E. Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators Journal of the American College of Cardiology. 1991;17(5):1007-16. Abstract

Zaret, Barry L., Wackers, Frans J., Terrin, Michael, Ross, Richard, Knatterud, Genell, Braunwald, Eugene Does left ventricular ejection fraction following thrombolytic therapy have the same prognostic impact described in the prethrombolytic era? Results of the TIMI II trail Journal of the American College of Cardiology. 1991;17(2, Supplement 1):A214.

Baim, D. S., Diver, D. J., Feit, F., Greenberg, M. A., Holmes, D. R., Weiner, B. H., Williams, D. O., Schweiger, M. J., Brown, B. G., Frederick, M. M., et al., Coronary angioplasty performed within the Thrombolysis in Myocardial Infarction II study Circulation. 1992;85(1):93-105. Abstract

Baim, D. S., Diver, D. J., Feit, F., Greenberg, M. A., Holmes, D. R., Weiner, B. H., Williams, D. O., Schweiger, M. J., Brown, B. G., Frederick, M. M., et al., Coronary angioplasty performed within the Thrombolysis in Myocardial Infarction II study Circulation. 1992;85(1):93-105. Abstract

Berger, P. B., Ruocco, N. A., Jr., Ryan, T. J., Frederick, M. M., Jacobs, A. K., Faxon, D. P. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II Journal of the American College of Cardiology. 1992;20(3):533-40. Abstract

Braunwald, E., Cannon, C. P., McCabe, C. H. An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point Circulation. 1992;86(2):683-7.

Braunwald, E., Cannon, C. P., McCabe, C. H. An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point Circulation. 1992;86(2):683-7.

Braunwald, E., Knatterud, G., Passamani, E. The rt-PA versus streptokinase. Controversy--II Journal of the American College of Cardiology. 1992;19(5):1116-9.

Braunwald, E., Knatterud, G., Passamani, E. The rt-PA versus streptokinase. Controversy--II Journal of the American College of Cardiology. 1992;19(5):1116-9.

Kleiman, N. S., Terrin, M., Mueller, H., Chaitman, B., Roberts, R., Knatterud, G. L., Solomon, R., McMahon, R. P., Braunwald, E. Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study Journal of the American College of Cardiology. 1992;19(6):1129-35. Abstract

Lehmann, K. G., Francis, C. K., Dodge, H. T. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group Annals of internal medicine. 1992;117(1):7-Oct. Abstract

Lehmann, K. G., Francis, C. K., Dodge, H. T. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group Annals of internal medicine. 1992;117(1):7-Oct. Abstract

Lehmann, K. G., Francis, C. K., Dodge, H. T. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group Annals of internal medicine. 1992;117(1):7-Oct. Abstract

Mueller, H. S., Cohen, L. S., Braunwald, E., Forman, S., Feit, F., Ross, A., Schweiger, M., Cabin, H., Davison, R., Miller, D., et al., Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II Circulation. 1992;85(4):1254-64. Abstract

Ruocco, N. A., Jr., Bergelson, B. A., Jacobs, A. K., Frederick, M. M., Faxon, D. P., Ryan, T. J. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II) Journal of the American College of Cardiology. 1992;20(7):1445-51. Abstract

Tofler, G. H., Muller, J. E., Stone, P. H., Forman, S., Solomon, R. E., Knatterud, G. L., Braunwald, E. Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group Journal of the American College of Cardiology. 1992;20(5):1049-55. Abstract

Williams, D. O., Braunwald, E., Knatterud, G., Babb, J., Bresnahan, J., Greenberg, M. A., Raizner, A., Wasserman, A., Robertson, T., Ross, R. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial Circulation. 1992;85(2):533-42. Abstract

Zaret, B. L., Wackers, F. J., Terrin, M. L., Ross, R., Weiss, M., Slater, J., Morrison, J., Bourge, R. C., Passamani, E., Knatterud, G., et al., Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II Study American journal of cardiology. 1992;69(1):9-Jan. Abstract

Zaret, B. L., Wackers, F. J., Terrin, M. L., Ross, R., Weiss, M., Slater, J., Morrison, J., Bourge, R. C., Passamani, E., Knatterud, G., et al., Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II Study American journal of cardiology. 1992;69(1):9-Jan. Abstract

Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation. 1993;87:38-52. Abstract

Berger, P. B., Ruocco, N. A., Jr., Ryan, T. J., Jacobs, A. K., Zaret, B. L., Wackers, F. J., Frederick, M. M., Faxon, D. P. Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research Group American journal of cardiology. 1993;71(13):1148-52. Abstract

Berger, P. B., Ruocco, N. A., Ryan, T. J., Frederick, M. M., Podrid, P. J. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial Journal of the American College of Cardiology. 1993;22(7):1773-9. Abstract

Braunwald, E., Cannon, C. P., McCabe, C. H. Use of composite endpoints in thrombolysis trials of acute myocardial infarction American journal of cardiology. 1993;72(19):G3-G12. Abstract

Braunwald, E., Cannon, C. P., McCabe, C. H. Use of composite endpoints in thrombolysis trials of acute myocardial infarction American journal of cardiology. 1993;72(19):G3-G12. Abstract

Braunwald, E., Cannon, C. P., McCabe, C. H. Use of composite endpoints in thrombolysis trials of acute myocardial infarction American journal of cardiology. 1993;72(19):G3-G12. Abstract

Lehmann, K. G., Francis, C. K., Sheehan, F. H., Dodge, H. T. Effect of thrombolysis on acute mitral regurgitation during evolving myocardial infarction. Experience from the Thrombolysis in Myocardial Infarction (TIMI) Trial Journal of the American College of Cardiology. 1993;22(3):714-9. Abstract

Simoons, M. L., Maggioni, A. P., Knatterud, G., Leimberger, J. D., de Jaegere, P., van Domburg, R., Boersma, E., Franzosi, M. G., Califf, R., Schroder, R., et al., Individual risk assessment for intracranial haemorrhage during thrombolytic therapy Lancet. 1993;342(8886-8887):1523-8. Abstract

Taylor, H. A., Chaitman, B. R., Rogers, W. J., Kern, M. J., Terrin, M. L., Aguirre, F. V., Sopko, G., McMahon, R., Ross, R. N., Bovill, E. C. Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial Circulation. 1993;88(4 Pt 1):1484-94. Abstract

Terrin, M. L., Williams, D. O., Kleiman, N. S., Willerson, J., Mueller, H. S., Desvigne-Nickens, P., Forman, S. A., Knatterud, G. L., Braunwald, E. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial Journal of the American College of Cardiology. 1993;22(7):1763-72. Abstract

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Circulation. 1994;89:1545-56. Abstract

Aguirre, F. V., McMahon, R. P., Mueller, H., Kleiman, N. S., Kern, M. J., Desvigne-Nickens, P., Hamilton, W. P., Chaitman, B. R. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators Circulation. 1994;90(1):78-86. Abstract

Aguirre, F. V., McMahon, R. P., Mueller, H., Kleiman, N. S., Kern, M. J., Desvigne-Nickens, P., Hamilton, W. P., Chaitman, B. R. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators Circulation. 1994;90(1):78-86. Abstract

Antman, E. M. Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial Circulation. 1994;90:1624-30. Abstract

Becker, R. C., Bovill, E. G., Corrao, J. M., Ball, S. P., Ault, K., Mann, K., Tracy, R. P. Platelet Activation Determined by Flow Cytometry Persists Despite Antithrombotic Therapy in Patients with Unstable Angina and Non-Q-Wave Myocardial Infarction Journal of thrombosis and thrombolysis. 1994;1(1):95-100. Abstract

Becker, R. C., Bovill, E. G., Corrao, J. M., Ball, S. P., Ault, K., Mann, K., Tracy, R. P. Platelet Activation Determined by Flow Cytometry Persists Despite Antithrombotic Therapy in Patients with Unstable Angina and Non-Q-Wave Myocardial Infarction Journal of thrombosis and thrombolysis. 1994;1(1):95-100. Abstract

Becker, R. C., Cannon, C. P. Hirudin: Its Biology and Clinical Use J Thromb Thrombolysis. 1994;1(1):16-Jul. Abstract

Becker, R. C., Cannon, C. P. Hirudin: Its Biology and Clinical Use J Thromb Thrombolysis. 1994;1(1):16-Jul. Abstract

Becker, R. C., Terrin, M., Ross, R., Knatterud, G. L., Desvigne-Nickens, P., Gore, J. M., Braunwald, E. Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators Annals of internal medicine. 1994;120(8):638-45. Abstract

Becker, R. C., Tracy, R. P., Bovill, E. G., Corrao, J. M., Baker, S., Ball, S. P., Mann, K. G. Surface 12-Lead Electrocardiographic Findings and Plasma Markers of Thrombin Activity and Generation in Patients with Myocardial Ischemia at Rest Journal of thrombosis and thrombolysis. 1994;1(1):101-107. Abstract

Becker, R. C., Tracy, R. P., Bovill, E. G., Mann, K. G., Ault, K. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group Coronary artery disease. 1994;5(4):339-45. Abstract

Becker, R. C., Tracy, R. P., Bovill, E. G., Mann, K. G., Ault, K. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group Coronary artery disease. 1994;5(4):339-45. Abstract

Becker, R. C., Tracy, R. P., Bovill, E. G., Mann, K. G., Ault, K. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group Coronary artery disease. 1994;5(4):339-45. Abstract

Cannon CP, McCabe CH, Henry TD, Schweiger MJ, Gibson RS, Mueller HS, Becker RC, Kleiman NS, Haugland JM, Anderson JL, et al. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. J Am Coll Cardiol. 1994;23:993-1003. Abstract

Cannon, C. P., Antman, E. M., Walls, R., Braunwald, E. Time as an Adjunctive Agent to Thrombolytic Therapy J Thromb Thrombolysis. 1994;1(1):27-34. Abstract

Cannon, C. P., McCabe, C. H., Diver, D. J., Herson, S., Greene, R. M., Shah, P. K., Sequeira, R. F., Leya, F., Kirshenbaum, J. M., Magorien, R. D., et al., Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial J Am Coll Cardiol. 1994;24:1602-10. Abstract

Cox, D. A., Rogers, W. J., Aguirre, F. V., Forman, S., Solomon, R., Zaret, B. L. Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators American journal of cardiology. 1994;73(11):729-36. Abstract

Aguirre, F. V., Younis, L. T., Chaitman, B. R., Ross, A. M., McMahon, R. P., Kern, M. J., Berger, P. B., Sopko, G., Rogers, W. J., Shaw, L., et al., Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study Circulation. 1995;91(10):2541-8. Abstract

Anderson, H. V., Cannon, C. P., Stone, P. H., Williams, D. O., McCabe, C. H., Knatterud, G. L., Thompson, B., Willerson, J. T., Braunwald, E. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction Journal of the American College of Cardiology. 1995;26(7):1643-50. Abstract

Boisjolie, C. R., Sharkey, S. W., Cannon, C. P., Brunette, D., Haugland, J. M., Thatcher, J. L., Henry, T. D. Impact of a thrombolysis research trial on time to treatment for acute myocardial infarction in the emergency department American journal of cardiology. 1995;76(5):396-8. Abstract

Boisjolie, C. R., Sharkey, S. W., Cannon, C. P., Brunette, D., Haugland, J. M., Thatcher, J. L., Henry, T. D. Impact of a thrombolysis research trial on time to treatment for acute myocardial infarction in the emergency department American journal of cardiology. 1995;76(5):396-8. Abstract

Cannon, C. P. Hirudin in Acute Myocardial Infarction J Thromb Thrombolysis. 1995;1(3):259-267. Abstract

Cannon, C. P. Hirudin in Acute Myocardial Infarction J Thromb Thrombolysis. 1995;1(3):259-267. Abstract

Cannon, C. P., Braunwald, E. Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty J Am Coll Cardiol. 1995;25(7 Suppl):30S-37S. Abstract

Cannon, C. P., Braunwald, E. Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty J Am Coll Cardiol. 1995;25(7 Suppl):30S-37S. Abstract

Cannon, C. P., Thompson, B., McCabe, C. H., Mueller, H. S., Kirshenbaum, J. M., Herson, S., Nasmith, J. B., Chaitman, B. R., Braunwald, E. Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials American journal of cardiology. 1995;75(15):977-81. Abstract

Fuchs J, Cannon CP. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial. Circulation. 1995;92:727-33. Abstract

Gersh, B. J., Chesebro, J. H., Braunwald, E., Lambrew, C., Passamani, E., Solomon, R. E., Ross, A. M., Ross, R., Terrin, M. L., Knatterud, G. L. Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II) Journal of the American College of Cardiology. 1995;25(2):395-402. Abstract

Kloner, R. A., Shook, T., Przyklenk, K., Davis, V. G., Junio, L., Matthews, R. V., Burstein, S., Gibson, M., Poole, W. K., Cannon, C. P., et al., Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation. 1995;91(1):37-45. Abstract

Kloner, R. A., Shook, T., Przyklenk, K., Davis, V. G., Junio, L., Matthews, R. V., Burstein, S., Gibson, M., Poole, W. K., Cannon, C. P., et al., Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation. 1995;91(1):37-45. Abstract

Lee, LV. Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial Am J Cardiol. 1995;75:7-13. Abstract

McKendall, G. R., Forman, S., Sopko, G., Braunwald, E., Williams, D. O. Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Thrombolysis in Myocardial Infarction Investigators American Journal of Cardiology. 1995;76(16):1108-11. Abstract

McKendall, G. R., Forman, S., Sopko, G., Braunwald, E., Williams, D. O. Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Thrombolysis in Myocardial Infarction Investigators American Journal of Cardiology. 1995;76(16):1108-11. Abstract

Mueller, Hiltrud S., Forman, Sandra A., Menegus, Mark A., Cohen, Lawrence S., Knatterud, Genell L., Braunwald, Eugene Prognostic significance of nonfatal reinfarction during 3-year follow-up: Results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial Journal of the American College of Cardiology. 1995;26(4):900-907.

Sloan, M. A., Price, T. R., Petito, C. K., Randall, A. M., Solomon, R. E., Terrin, M. L., Gore, J., Collen, D., Kleiman, N., Feit, F., et al., Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience Neurology. 1995;45(4):649-58. Abstract

Zahger, D., Cercek, B., Cannon, C. P., Jordan, M., Davis, V., Braunwald, E., Shah, P. K. How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial) American journal of cardiology. 1995;75(4):232-6. Abstract

Zahger, D., Cercek, B., Cannon, C. P., Jordan, M., Shah, P. K. Thrombolytic Therapy for Acute Myocardial Infarction in Patients with Prior Coronary Bypass Surgery: Results from the Thrombolysis in Myocardial Infarction (TIMI) 4 Trial Journal of thrombosis and thrombolysis. 1995;2(1):45-50. Abstract

Zaret, B. L., Wackers, F. J., Terrin, M. L., Forman, S. A., Williams, D. O., Knatterud, G. L., Braunwald, E. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group Journal of the American College of Cardiology. 1995;26(1):73-9. Abstract

Antman, E. M. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial Circulation. 1996;94:911-21. Abstract

Antman, E. M., Braunwald, E. Trials and tribulations of thrombin inhibition European heart journal. 1996;17(7):971-3.

Antman, E. M., Braunwald, E. Trials and tribulations of thrombin inhibition European heart journal. 1996;17(7):971-3.

Antman, E. M., Tanasijevic, M. J., Thompson, B., Schactman, M., McCabe, C. H., Cannon, C. P., Fischer, G. A., Fung, A. Y., Thompson, C., Wybenga, D., Braunwald, E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes New England journal of medicine. 1996;335(18):1342-9. Abstract

Antman, E. M., Tanasijevic, M. J., Thompson, B., Schactman, M., McCabe, C. H., Cannon, C. P., Fischer, G. A., Fung, A. Y., Thompson, C., Wybenga, D., Braunwald, E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes New England journal of medicine. 1996;335(18):1342-9. Abstract

Becker, R. C., Cannon, C. P., Tracy, R. P., Thompson, B., Bovill, E. G., Desvigne-Nickens, P., Randall, A. M., Knatternud, G., Braunwald, E. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators American heart journal. 1996;131(3):421-33. Abstract

Kleiman, N. S., Anderson, H. V., Rogers, W. J., Theroux, P., Thompson, B., Stone, P. H. Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry) American journal of cardiology. 1996;77(4):227-31. Abstract

Kleiman, N. S., Anderson, H. V., Rogers, W. J., Theroux, P., Thompson, B., Stone, P. H. Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry) American journal of cardiology. 1996;77(4):227-31. Abstract

Stone PH, Thompson B, Anderson HV, Kronenberg MW, Gibson RS, Rogers WJ, Diver DJ, Théroux P, Warnica JW, Nasmith JB, Kells C, Kleiman N, McCabe CH, Schactman M, Knatterud GL, Braunwald E. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. J Am Med Assoc. 1996;275:1104-12. Abstract

Stone PH, Thompson B, Anderson HV, Kronenberg MW, Gibson RS, Rogers WJ, Diver DJ, Théroux P, Warnica JW, Nasmith JB, Kells C, Kleiman N, McCabe CH, Schactman M, Knatterud GL, Braunwald E. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. J Am Med Assoc. 1996;275:1104-12. Abstract

Stone PH, Thompson B, Anderson HV, Kronenberg MW, Gibson RS, Rogers WJ, Diver DJ, Théroux P, Warnica JW, Nasmith JB, Kells C, Kleiman N, McCabe CH, Schactman M, Knatterud GL, Braunwald E. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. J Am Med Assoc. 1996;275:1104-12. Abstract

Williams, D. O., Braunwald, E., Thompson, B., Sharaf, B. L., Buller, C. E., Knatterud, G. L. Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial Circulation. 1996;94(11):2749-55. Abstract

Williams, D. O., Braunwald, E., Thompson, B., Sharaf, B. L., Buller, C. E., Knatterud, G. L. Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial Circulation. 1996;94(11):2749-55. Abstract

Anderson, H. V., Gibson, R. S., Stone, P. H., Cannon, C. P., Aguirre, F., Thompson, B., Knatterud, G. L., Braunwald, E. Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry) American journal of cardiology. 1997;79(11):1441-6. Abstract

Anderson, H. V., Gibson, R. S., Stone, P. H., Cannon, C. P., Aguirre, F., Thompson, B., Knatterud, G. L., Braunwald, E. Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry) American journal of cardiology. 1997;79(11):1441-6. Abstract

Anderson, H. V., Gibson, R. S., Stone, P. H., Cannon, C. P., Aguirre, F., Thompson, B., Knatterud, G. L., Braunwald, E. Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry) American journal of cardiology. 1997;79(11):1441-6. Abstract

Antman, E. M. Another chapter of the antithrombin story has been written European heart journal. 1997;18(9):1365-7.

Antman, E. M. Another chapter of the antithrombin story has been written European heart journal. 1997;18(9):1365-7.

Cannon CP, McCabe CH, Gibson CM, Ghali M, Sequeira RF, McKendall GR, Breed J, Modi NB, Fox NL, Tracy RP, Love TW, Braunwald E. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. Circulation. 1997;95:351-6. Abstract

Cannon, C. P., McCabe, C. H., Stone, P. H., Schactman, M., Thompson, B., Theroux, P., Gibson, R. S., Feldman, T., Kleiman, N. S., Tofler, G. H., Muller, J. E., Chaitman, B. R., Braunwald, E. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB) American journal of cardiology. 1997;79(3):253-8. Abstract

Cannon, C. P., McCabe, C. H., Stone, P. H., Schactman, M., Thompson, B., Theroux, P., Gibson, R. S., Feldman, T., Kleiman, N. S., Tofler, G. H., Muller, J. E., Chaitman, B. R., Braunwald, E. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB) American journal of cardiology. 1997;79(3):253-8. Abstract

Cannon, C. P., McCabe, C. H., Stone, P. H., Schactman, M., Thompson, B., Theroux, P., Gibson, R. S., Feldman, T., Kleiman, N. S., Tofler, G. H., Muller, J. E., Chaitman, B. R., Braunwald, E. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB) American journal of cardiology. 1997;79(3):253-8. Abstract

Cannon, C. P., Sharis, P. J., Schweiger, M. J., McCabe, C. H., Diver, D. J., Shah, P. K., Sequeira, R. F., Greene, R. M., Perritt, R. L., Poole, W. K., Braunwald, E. Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction American journal of cardiology. 1997;80(6):696-9. Abstract

Gibson, C. M., Cannon, C. P., Greene, R. M., Sequeira, R. F., Margorien, R. D., Leya, F., Diver, D. J., Baim, D. S., Braunwald, E. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial American journal of cardiology. 1997;80(1):21-6. Abstract

Giugliano, R. P., Antman, E. M., Braunwald, E. Reexamination of the Thrombin Hypothesis: What We Have Learned from TIMI 9B and GUSTO IIb Journal of thrombosis and thrombolysis. 1997;4(4-Mar):321-323.

Giugliano, R. P., Antman, E. M., Braunwald, E. Reexamination of the Thrombin Hypothesis: What We Have Learned from TIMI 9B and GUSTO IIb Journal of thrombosis and thrombolysis. 1997;4(4-Mar):321-323.

Hochman, J. S., McCabe, C. H., Stone, P. H., Becker, R. C., Cannon, C. P., DeFeo-Fraulini, T., Thompson, B., Steingart, R., Knatterud, G., Braunwald, E. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction Journal of the American College of Cardiology. 1997;30(1):141-8. Abstract

Jain, D., Thompson, B., Wackers, F. J., Zaret, B. L. Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB Study Journal of the American College of Cardiology. 1997;30(2):421-9. Abstract

Sloan, M. A., Price, T. R., Terrin, M. L., Forman, S., Gore, J. M., Chaitman, B. R., Hodges, M., Mueller, H., Rogers, W. J., Knatterud, G. L., Braunwald, E. Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience Stroke. 1997;28(6):1107-14. Abstract

Tanasijevic, M. J., Cannon, C. P., Wybenga, D. R., Fischer, G. A., Grudzien, C., Gibson, C. M., Winkelman, J. W., Antman, E. M., Braunwald, E. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A American heart journal. 1997;134(4):622-30. Abstract

The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators. Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A. J Am Coll Cardiol. 1997;29:1474-82. Abstract

Antman, E. M. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators Am Heart J. 1998;135(6, Supplement 2):S353-60. Abstract

Borzak, S., Cannon, C. P., Kraft, P. L., Douthat, L., Becker, R. C., Palmeri, S. T., Henry, T., Hochman, J. S., Fuchs, J., Antman, E. M., McCabe, C., Braunwald, E. Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia American journal of cardiology. 1998;81(6):678-81. Abstract

Borzak, S., Cannon, C. P., Kraft, P. L., Douthat, L., Becker, R. C., Palmeri, S. T., Henry, T., Hochman, J. S., Fuchs, J., Antman, E. M., McCabe, C., Braunwald, E. Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia American journal of cardiology. 1998;81(6):678-81. Abstract

Callas, P. W., Tracy, R. P., Bovill, E. G., Cannon, C., Thompson, B., Mann, K. G. The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thromholysis in Myocardial Infarction Phase II (TIMI II) Trial Journal of thrombosis and thrombolysis. 1998;5(1):53-60. Abstract

Callas, P. W., Tracy, R. P., Bovill, E. G., Cannon, C., Thompson, B., Mann, K. G. The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thromholysis in Myocardial Infarction Phase II (TIMI II) Trial Journal of thrombosis and thrombolysis. 1998;5(1):53-60. Abstract

Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Steingart RM, Weaver WD, Van de Werf F, Braunwald E. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Circulation. 1998;98:2805-14. Abstract

Cannon CP, McCabe CH, Borzak S, Henry TD, Tischler MD, Mueller HS, Feldman R, Palmeri ST, Ault K, Hamilton SA, Rothman JM, Novotny WF, Braunwald E. Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Circulation. 1998;97:340-9. Abstract

Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Robertson, D. H., Gormley, G. J., Braunwald, E. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction Am J Cardiol. 1998;82(6):731-6. Abstract

Goel, M., Dodge Jr, J. T., Rizzo, M., McLean, C., Ryan, K. A., Daley, W. L., Cannon, C. P., Gibson, C. M. The Open Artery Hypothesis: Past, Present, and Future J Thromb Thrombolysis. 1998;5(2):101-112. Abstract

Goel, M., Dodge Jr, J. T., Rizzo, M., McLean, C., Ryan, K. A., Daley, W. L., Cannon, C. P., Gibson, C. M. The Open Artery Hypothesis: Past, Present, and Future J Thromb Thrombolysis. 1998;5(2):101-112. Abstract

Kloner, R. A., Przyklenk, K., Shook, T., Cannon, C. P. Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial Journal of thrombosis and thrombolysis. 1998;6(2):89-92. Abstract

Kloner, R. A., Shook, T., Antman, E. M., Cannon, C. P., Przyklenk, K., Yoo, K., McCabe, C. H., Braunwald, E. Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B Circulation. 1998;97(11):1042-5. Abstract

Kloner, R. A., Shook, T., Antman, E. M., Cannon, C. P., Przyklenk, K., Yoo, K., McCabe, C. H., Braunwald, E. Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B Circulation. 1998;97(11):1042-5. Abstract

Modi, N. B., Eppler, S., Breed, J., Cannon, C. P., Braunwald, E., Love, T. W. Pharmacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarction Thrombosis and haemostasis. 1998;79(1):134-9. Abstract

Modi, N. B., Eppler, S., Breed, J., Cannon, C. P., Braunwald, E., Love, T. W. Pharmacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarction Thrombosis and haemostasis. 1998;79(1):134-9. Abstract

Sagarin, M. J., Cannon, C. P., Cermignani, M. S., Scirica, B. M., Walls, R. M. Delay in thrombolysis administration: causes of extended door-to-drug times and the asymptote effect J Emerg Med. 1998;16(4):557-65. Abstract

Tracy, R. P., Kleiman, N. S., Thompson, B., Cannon, C. P., Bovill, E. G., Brown, R. G., Collen, D., Mahan, E., Mann, K. G., Rogers, W. J., Sopko, G., Stump, D. C., Williams, D. O., Zaret, B. L. Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial American heart journal. 1998;135(1):29-37. Abstract

Tracy, R. P., Kleiman, N. S., Thompson, B., Cannon, C. P., Bovill, E. G., Brown, R. G., Collen, D., Mahan, E., Mann, K. G., Rogers, W. J., Sopko, G., Stump, D. C., Williams, D. O., Zaret, B. L. Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial American heart journal. 1998;135(1):29-37. Abstract

Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van de Werf F, Braunwald E. Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial. Circulation. 1999;99:2720-32. Abstract

Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald E. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial. Circulation. 1999;100:1593-601. Abstract

Antman, E. M., Cohen, M., Radley, D., McCabe, C., Rush, J., Premmereur, J., Braunwald, E. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis Circulation. 1999;100(15):1602-8. Abstract

Ault, K. A., Cannon, C. P., Mitchell, J., McCahan, J., Tracy, R. P., Novotny, W. F., Reimann, J. D., Braunwald, E. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction J Am Coll Cardiol. 1999;33(3):634-9. Abstract

Ault, K. A., Cannon, C. P., Mitchell, J., McCahan, J., Tracy, R. P., Novotny, W. F., Reimann, J. D., Braunwald, E. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction J Am Coll Cardiol. 1999;33(3):634-9. Abstract

Becker, R. C., Hochman, J. S., Cannon, C. P., Spencer, F. A., Ball, S. P., Rizzo, M. J., Antman, E. M. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study Journal of the American College of Cardiology. 1999;33(2):479-87. Abstract

Cannon, C. P., Johnson, E. B., Cermignani, M., Scirica, B. M., Sagarin, M. J., Walls, R. M. Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction Clin Cardiol. 1999;22(1):17-20. Abstract

Cannon, C. P., Johnson, E. B., Cermignani, M., Scirica, B. M., Sagarin, M. J., Walls, R. M. Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction Clin Cardiol. 1999;22(1):17-20. Abstract

Gibson, C. M., Murphy, S. A., Rizzo, M. J., Ryan, K. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Van de Werf, F., Braunwald, E. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation. 1999;99(15):1945-50. Abstract

Gibson, C. M., Ryan, K. A., Murphy, S. A., Mesley, R., Marble, S. J., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction J Am Coll Cardiol. 1999;34(4):974-82. Abstract

Gibson, C. M., Ryan, K. A., Murphy, S. A., Mesley, R., Marble, S. J., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction J Am Coll Cardiol. 1999;34(4):974-82. Abstract

Gurfinkel, E. P., Scirica, B. M., Bozovich, G., Macchia, A., Manos, E., Mautner, B. Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction Am J Cardiol. 1999;83(4):515-8. Abstract

Gurfinkel, E. P., Scirica, B. M., Bozovich, G., Macchia, A., Manos, E., Mautner, B. Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction Am J Cardiol. 1999;83(4):515-8. Abstract

Kizer, J. R., Cannon, C. P., McCabe, C. H., Mueller, H. S., Schweiger, M. J., Davis, V. G., Perritt, R., Antman, E. M. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction American heart journal. 1999;137(1):79-92. Abstract

Kizer, J. R., Cannon, C. P., McCabe, C. H., Mueller, H. S., Schweiger, M. J., Davis, V. G., Perritt, R., Antman, E. M. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction American heart journal. 1999;137(1):79-92. Abstract

Scirica, B. M., Moliterno, D. J., Every, N. R., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Arnold, A., Sapp, S. K., Booth, J. E., Ferguson, J. J., Cannon, C. P. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators Am J Cardiol. 1999;84(10):1145-50. Abstract

Scirica, B. M., Moliterno, D. J., Every, N. R., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Arnold, A., Sapp, S. K., Booth, J. E., Ferguson, J. J., Cannon, C. P. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators Am J Cardiol. 1999;84(10):1145-50. Abstract

Scirica, B. M., Moliterno, D. J., Every, N. R., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Arnold, A., Sapp, S. K., Booth, J. E., Ferguson, J. J., Cannon, C. P. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators Am J Cardiol. 1999;84(10):1145-50. Abstract

Scirica, B. M., Moliterno, D. J., Every, N. R., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Arnold, A., Sapp, S. K., Booth, J. E., Ferguson, J. J., Cannon, C. P. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators Am J Cardiol. 1999;84(10):1145-50. Abstract

Scirica, B. M., Moliterno, D. J., Every, N. R., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Sapp, S. K., Booth, J. E., Ferguson, J. J., Cannon, C. P. Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry Am Heart J. 1999;138(6 Pt 1):1065-72. Abstract

Scirica, B. M., Moliterno, D. J., Every, N. R., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Sapp, S. K., Booth, J. E., Ferguson, J. J., Cannon, C. P. Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry Am Heart J. 1999;138(6 Pt 1):1065-72. Abstract

Scirica, B. M., Moliterno, D. J., Every, N. R., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Sapp, S. K., Booth, J. E., Ferguson, J. J., Cannon, C. P. Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry Am Heart J. 1999;138(6 Pt 1):1065-72. Abstract

Stone, P. H., Thompson, B., Zaret, B. L., Chaitman, B., Gibson, R. S., Schweiger, M. J., Steingart, R., Kirshenbaum, J., Thompson, C., Fung, A., McCabe, C. H., Knatterud, G. L., Braunwald, E. Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study European heart journal. 1999;20(15):1084-93. Abstract

Stone, P. H., Thompson, B., Zaret, B. L., Chaitman, B., Gibson, R. S., Schweiger, M. J., Steingart, R., Kirshenbaum, J., Thompson, C., Fung, A., McCabe, C. H., Knatterud, G. L., Braunwald, E. Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study European heart journal. 1999;20(15):1084-93. Abstract

Tanasijevic, M. J., Cannon, C. P., Antman, E. M. The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease Clinical cardiology. 1999;22(1):13-6. Abstract

Tanasijevic, M. J., Cannon, C. P., Antman, E. M. The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease Clinical cardiology. 1999;22(1):13-6. Abstract

Van de Werf, F., Cannon, C. P., Luyten, A., Houbracken, K., McCabe, C. H., Berioli, S., Bluhmki, E., Sarelin, H., Wang-Clow, F., Fox, N. L., Braunwald, E. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators Am Heart J. 1999;137(5):786-91. Abstract

Weintraub, W. S., Culler, S. D., Kosinski, A., Becker, E. R., Mahoney, E., Burnette, J., Spertus, J. A., Feeny, D., Cohen, D. J., Krumholz, H., Ellis, S. G., Demopoulos, L., Robertson, D., Boccuzzi, S. J., Barr, E., Cannon, C. P. Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial Am J Cardiol. 1999;83(3):317-22. Abstract

Weintraub, W. S., Culler, S. D., Kosinski, A., Becker, E. R., Mahoney, E., Burnette, J., Spertus, J. A., Feeny, D., Cohen, D. J., Krumholz, H., Ellis, S. G., Demopoulos, L., Robertson, D., Boccuzzi, S. J., Barr, E., Cannon, C. P. Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial Am J Cardiol. 1999;83(3):317-22. Abstract

Antman, E. M., Cohen, M., Bernink, P. J., McCabe, C. H., Horacek, T., Papuchis, G., Mautner, B., Corbalan, R., Radley, D., Braunwald, E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making JAMA. 2000;284(7):835-42. Abstract

Antman, E. M., Cohen, M., Bernink, P. J., McCabe, C. H., Horacek, T., Papuchis, G., Mautner, B., Corbalan, R., Radley, D., Braunwald, E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making JAMA. 2000;284(7):835-42. Abstract

Antman, E. M., Gibson, C. M., de Lemos, J. A., Giugliano, R. P., McCabe, C. H., Coussement, P., Menown, I., Nienaber, C. A., Rehders, T. C., Frey, M. J., Van der Wieken, R., Andresen, D., Scherer, J., Anderson, K., Van de Werf, F., Braunwald, E. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators Eur Heart J. 2000;21(23):1944-53. Abstract

Barron, H. V., Cannon, C. P., Murphy, S. A., Braunwald, E., Gibson, C. M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy Circulation. 2000;102(19):2329-34. Abstract

Barron, H. V., Cannon, C. P., Murphy, S. A., Braunwald, E., Gibson, C. M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy Circulation. 2000;102(19):2329-34. Abstract

Bozovich, G. E., Gurfinkel, E. P., Antman, E. M., McCabe, C. H., Mautner, B. Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time Am Heart J. 2000;140(4):637-42. Abstract

Bozovich, G. E., Gurfinkel, E. P., Antman, E. M., McCabe, C. H., Mautner, B. Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time Am Heart J. 2000;140(4):637-42. Abstract

Cannon CP, McCabe CH, Wilcox RG, Langer A, Caspi A, Berink P, Lopez-Sendon J, Toman J, Charlesworth A, Anders RJ, Alexander JC, Skene A, Braunwald E. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation. 2000;102:149-56. Abstract

Cannon, C. P. Bridging the gap with new strategies in acute ST elevation myocardial infarction: bolus thrombolysis, glycoprotein IIb/IIIa inhibitors, combination therapy, percutaneous coronary intervention, and "facilitated" PCI J Thromb Thrombolysis. 2000;9(3):235-41. Abstract

Cannon, C. P. Learning from the recently completed oral glycoprotein IIb/IIIa receptor antagonist trials Clin Cardiol. 2000;23 Suppl 6(NA):VI-14-7. Abstract

Cohen, M., Antman, E. M., Gurfinkel, E., Turpie, A. G., Furst, J., Bigonzi, F., Radley, D. Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction Am J Cardiol. 2000;86(5):553-6, A9. Abstract

Coulter, S. A., Cannon, C. P., Ault, K. A., Antman, E. M., Van de Werf, F., Adgey, A. A., Gibson, C. M., Giugliano, R. P., Mascelli, M. A., Scherer, J., Barnathan, E. S., Braunwald, E., Kleiman, N. S. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14 Circulation. 2000;101(23):2690-5. Abstract

Coulter, S. A., Cannon, C. P., Ault, K. A., Antman, E. M., Van de Werf, F., Adgey, A. A., Gibson, C. M., Giugliano, R. P., Mascelli, M. A., Scherer, J., Barnathan, E. S., Braunwald, E., Kleiman, N. S. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14 Circulation. 2000;101(23):2690-5. Abstract

Giugliano RP, McCabe CH, Sequeira RF, Frey MJ, Henry TD, Piana RN, Tamby JF, Jensen BK, Nicolas SB, Jennings LK, Wise RJ, Braunwald E. First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trials. Am Heart J. 2000;140:81-93. Abstract

Holmes, M. B., Sobel, B. E., Cannon, C. P., Schneider, D. J. Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial Infarction Am J Cardiol. 2000;85(4):491-3, A10. Abstract

Modi, N. B., Fox, N. L., Clow, F. W., Tanswell, P., Cannon, C. P., Van de Werf, F., Braunwald, E. Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction J Clin Pharmacol. 2000;40(5):508-15. Abstract

Modi, N. B., Fox, N. L., Clow, F. W., Tanswell, P., Cannon, C. P., Van de Werf, F., Braunwald, E. Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction J Clin Pharmacol. 2000;40(5):508-15. Abstract

Morrow, D. A., Antman, E. M., Charlesworth, A., Cairns, R., Murphy, S. A., de Lemos, J. A., Giugliano, R. P., McCabe, C. H., Braunwald, E. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation Circulation. 2000;102(17):2031-7. Abstract

Morrow, D. A., Antman, E. M., Charlesworth, A., Cairns, R., Murphy, S. A., de Lemos, J. A., Giugliano, R. P., McCabe, C. H., Braunwald, E. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation Circulation. 2000;102(17):2031-7. Abstract

Morrow, D. A., Antman, E. M., Charlesworth, A., Cairns, R., Murphy, S. A., de Lemos, J. A., Giugliano, R. P., McCabe, C. H., Braunwald, E. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation Circulation. 2000;102(17):2031-7. Abstract

Morrow, D. A., Rifai, N., Tanasijevic, M. J., Wybenga, D. R., de Lemos, J. A., Antman, E. M. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy Clin Chem. 2000;46(4):453-60. Abstract

Morrow, D. A., Rifai, N., Tanasijevic, M. J., Wybenga, D. R., de Lemos, J. A., Antman, E. M. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy Clin Chem. 2000;46(4):453-60. Abstract

The InTIMI-II Investigators. Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J. 2000;21:2005-13. Abstract

de Lemos, J. A., Antman, E. M., Giugliano, R. P., Morrow, D. A., McCabe, C. H., Charlesworth, A., Schroder, R., Braunwald, E. Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram Am Heart J. 2000;140(3):373-8. Abstract

de Lemos, J. A., Antman, E. M., Giugliano, R. P., Morrow, D. A., McCabe, C. H., Cutler, S. S., Charlesworth, A., Schroder, R., Braunwald, E. Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II Am J Cardiol. 2000;86(11):1235-7, A5. Abstract

Blazing, M. A., De Lemos, J. A., Dyke, C. K., Califf, R. M., Bilheimer, D., Braunwald, E. The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy Am Heart J. 2001;142(2):211-7.

Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-87. Abstract

Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-87. Abstract

Cannon, C. P., McCabe, C. H., Wilcox, R. G., Bentley, J. H., Braunwald, E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators Am J Cardiol. 2001;87(5):636-9, A10. Abstract

Cannon, C. P., McCabe, C. H., Wilcox, R. G., Bentley, J. H., Braunwald, E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators Am J Cardiol. 2001;87(5):636-9, A10. Abstract

Cannon, C. P., McCabe, C. H., Wilcox, R. G., Bentley, J. H., Braunwald, E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators Am J Cardiol. 2001;87(5):636-9, A10. Abstract

Cohen, M., Antman, E. M., Gurfinkel, E. P., Radley, D. Enoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups J Thromb Thrombolysis. 2001;12(3):199-206. Abstract

Gibson, C. M., Marble, S. J. Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA) Clin Cardiol. 2001;24(9):577-84. Abstract

Gibson, C. M., Marble, S. J. Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA) Clin Cardiol. 2001;24(9):577-84. Abstract

Giugliano, R. P., Llevadot, J., Wilcox, R. G., Gurfinkel, E. P., McCabe, C. H., Charlesworth, A., Thompson, S. L., Antman, E. M., Braunwald, E. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II Eur Heart J. 2001;22(18):1702-15. Abstract

Giugliano, R. P., McCabe, C. H., Antman, E. M., Cannon, C. P., Van de Werf, F., Wilcox, R. G., Braunwald, E. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage Am Heart J. 2001;141(5):742-50. Abstract

Henry, T. D., Satran, D., Knox, L. L., Iacarella, C. L., Laxson, D. D., Antman, E. M. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin? Am Heart J. 2001;142(4):590-3. Abstract

Henry, T. D., Satran, D., Knox, L. L., Iacarella, C. L., Laxson, D. D., Antman, E. M. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin? Am Heart J. 2001;142(4):590-3. Abstract

Holper, E. M., Antman, E. M., McCabe, C. H., Premmereur, J., Gurfinkel, E., Bernink, P. J., Turpie, A. G., Bayes de Luna, A., Lablanche, J. M., Fox, K. M., Salein, D., Radley, D. R., Braunwald, E. A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction Am J Cardiol. 2001;87(8):1008-10; A5.

Holper, E. M., Antman, E. M., McCabe, C. H., Premmereur, J., Gurfinkel, E., Bernink, P. J., Turpie, A. G., Bayes de Luna, A., Lablanche, J. M., Fox, K. M., Salein, D., Radley, D. R., Braunwald, E. A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction Am J Cardiol. 2001;87(8):1008-10; A5.

Holper, E. M., Antman, E. M., McCabe, C. H., Premmereur, J., Gurfinkel, E., Bernink, P. J., Turpie, A. G., Bayes de Luna, A., Lablanche, J. M., Fox, K. M., Salein, D., Radley, D. R., Braunwald, E. A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction Am J Cardiol. 2001;87(8):1008-10; A5.

Kloner, R. A., Das, S., Poole, W. K., Perrit, R., Muller, J., Cannon, C. P., Braunwald, E. Seasonal variation of myocardial infarct size American journal of cardiology. 2001;88(9):1021-4.

Kloner, R. A., Das, S., Poole, W. K., Perrit, R., Muller, J., Cannon, C. P., Braunwald, E. Seasonal variation of myocardial infarct size American journal of cardiology. 2001;88(9):1021-4.

Kloner, R. A., Das, S., Poole, W. K., Perrit, R., Muller, J., Cannon, C. P., Braunwald, E. Seasonal variation of myocardial infarct size American journal of cardiology. 2001;88(9):1021-4.

Kloner, R. A., Das, S., Poole, W. K., Perrit, R., Muller, J., Cannon, C. P., Braunwald, E. Seasonal variation of myocardial infarct size American journal of cardiology. 2001;88(9):1021-4.

Llevadot, J., Giugliano, R. P., Antman, E. M., Wilcox, R. G., Gurfinkel, E. P., Henry, T., McCabe, C. H., Charlesworth, A., Thompson, S., Nicolau, J. C., Tebbe, U., Sadowski, Z., Braunwald, E. Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction Eur Heart J. 2001;22(22):2104-15. Abstract

Morrow, D. A., Antman, E. M., Giugliano, R. P., Cairns, R., Charlesworth, A., Murphy, S. A., de Lemos, J. A., McCabe, C. H., Braunwald, E. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy Lancet. 2001;358(9293):1571-5. Abstract

Morrow, D. A., Antman, E. M., Giugliano, R. P., Cairns, R., Charlesworth, A., Murphy, S. A., de Lemos, J. A., McCabe, C. H., Braunwald, E. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy Lancet. 2001;358(9293):1571-5. Abstract

Morrow, D. A., Antman, E. M., Giugliano, R. P., Cairns, R., Charlesworth, A., Murphy, S. A., de Lemos, J. A., McCabe, C. H., Braunwald, E. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy Lancet. 2001;358(9293):1571-5. Abstract

Morrow, D. A., Antman, E. M., Parsons, L., de Lemos, J. A., Cannon, C. P., Giugliano, R. P., McCabe, C. H., Barron, H. V., Braunwald, E. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3 JAMA. 2001;286(11):1356-9. Abstract

Morrow, D. A., Antman, E. M., Parsons, L., de Lemos, J. A., Cannon, C. P., Giugliano, R. P., McCabe, C. H., Barron, H. V., Braunwald, E. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3 JAMA. 2001;286(11):1356-9. Abstract

Morrow, D. A., Antman, E. M., Parsons, L., de Lemos, J. A., Cannon, C. P., Giugliano, R. P., McCabe, C. H., Barron, H. V., Braunwald, E. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3 JAMA. 2001;286(11):1356-9. Abstract

Morrow, D. A., Cannon, C. P., Rifai, N., Frey, M. J., Vicari, R., Lakkis, N., Robertson, D. H., Hille, D. A., DeLucca, P. T., DiBattiste, P. M., Demopoulos, L. A., Weintraub, W. S., Braunwald, E. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial JAMA. 2001;286(19):2405-12. Abstract

O'Connor, F. F., Shields, D. C., Fitzgerald, A., Cannon, C. P., Braunwald, E., Fitzgerald, D. J. Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes Blood. 2001;98(12):3256-60. Abstract

Santopinto, J., Gurfinkel, E. P., Torres, V., Marcos, E., Bozovich, G. E., Mautner, B., McCabe, C. H., Antman, E. M. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin Am Heart J. 2001;141(4):566-72. Abstract

Schweiger, M. J., Cannon, C. P., Murphy, S. A., Gibson, C. M., Cook, J. R., Giugliano, R. P., Changezi, H. U., Antman, E. M., Braunwald, E. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience) Am J Cardiol. 2001;88(8):831-6. Abstract

Solomon, D. H., Stone, P. H., Glynn, R. J., Ganz, D. A., Gibson, C. M., Tracy, R., Avorn, J. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy Journal of the American College of Cardiology. 2001;38(4):969-76. Abstract

Solomon, D. H., Stone, P. H., Glynn, R. J., Ganz, D. A., Gibson, C. M., Tracy, R., Avorn, J. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy Journal of the American College of Cardiology. 2001;38(4):969-76. Abstract

Srinivas, V. S., Cannon, C. P., Gibson, C. M., Antman, E. M., Greenberg, M. A., Tanasijevic, M. J., Murphy, S., de Lemos, J. A., Sokol, S., Braunwald, E., Mueller, H. S. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy Am Heart J. 2001;142(1):29-36. Abstract

de Lemos, J. A., Gibson, C. M., Antman, E. M., Murphy, S. A., Morrow, D. A., Schuhwerk, K. C., Schweiger, M., Coussement, P., Van de Werf, F., Braunwald, E. Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial Am Heart J. 2001;141(4):592-8. Abstract

de Lemos, J. A., Morrow, D. A., Bentley, J. H., Omland, T., Sabatine, M. S., McCabe, C. H., Hall, C., Cannon, C. P., Braunwald, E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med. 2001;345(14):1014-21. Abstract

de Lemos, J. A., Morrow, D. A., Gibson, C. M., Murphy, S. A., Rifai, N., Tanasijevic, M., Giugliano, R. P., Schuhwerk, K. C., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy Am J Cardiol. 2001;88(4):353-8. Abstract

Angeja, B. G., Kermgard, S., Chen, M. S., McKay, M., Murphy, S. A., Antman, E. M., Cannon, C. P., Braunwald, E., Gibson, C. M. The smoker's paradox: insights from the angiographic substudies of the TIMI trials J Thromb Thrombolysis. 2002;13(3):133-9. Abstract

Angeja, B. G., Kermgard, S., Chen, M. S., McKay, M., Murphy, S. A., Antman, E. M., Cannon, C. P., Braunwald, E., Gibson, C. M. The smoker's paradox: insights from the angiographic substudies of the TIMI trials J Thromb Thrombolysis. 2002;13(3):133-9. Abstract

Angeja, B. G., de Lemos, J., Murphy, S. A., Marble, S. J., Antman, E. M., Cannon, C. P., Braunwald, E., Gibson, C. M. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy Am Heart J. 2002;144(4):649-56. Abstract

Angeja, B. G., de Lemos, J., Murphy, S. A., Marble, S. J., Antman, E. M., Cannon, C. P., Braunwald, E., Gibson, C. M. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy Am Heart J. 2002;144(4):649-56. Abstract

Antman EM, Louwerenburg HW, Baars HF, Wesdorp JC, Hamer B, Bassand JP, Bigonzi F, Pisapia G, Gibson CM, Heidbuchel H, Braunwald E, Van de Werf F. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial Circulation. 2002;105:1642-9.

Antman EM, Louwerenburg HW, Baars HF, Wesdorp JC, Hamer B, Bassand JP, Bigonzi F, Pisapia G, Gibson CM, Heidbuchel H, Braunwald E, Van de Werf F. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial Circulation. 2002;105:1642-9.

Antman EM, McCabe CH, Braunwald E. Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction. Am Heart J. 2002;143:229-34. Abstract

Antman, E. M., Cohen, M., McCabe, C., Goodman, S. G., Murphy, S. A., Braunwald, E. Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE Eur Heart J. 2002;23(4):308-14. Abstract

Bahit, M. C., Murphy, S. A., Gibson, C. M., Cannon, C. P. Critical pathway for acute ST-segment elevation myocardial infarction: estimating its potential impact in the TIMI 9 Registry Critical pathways in cardiology. 2002;1(2):107-12. Abstract

Bahit, M. C., Murphy, S. A., Gibson, C. M., Cannon, C. P. Critical pathway for acute ST-segment elevation myocardial infarction: estimating its potential impact in the TIMI 9 Registry Critical pathways in cardiology. 2002;1(2):107-12. Abstract

Bahit, M. C., Murphy, S. A., Gibson, C. M., Cannon, C. P. Critical pathway for acute ST-segment elevation myocardial infarction: estimating its potential impact in the TIMI 9 Registry Critical pathways in cardiology. 2002;1(2):107-12. Abstract

Becker, R. C., Spencer, F. A., Gibson, M., Rush, J. E., Sanderink, G., Murphy, S. A., Ball, S. P., Antman, E. M. Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes Am Heart J. 2002;143(5):753-9. Abstract

Becker, R. C., Spencer, F. A., Gibson, M., Rush, J. E., Sanderink, G., Murphy, S. A., Ball, S. P., Antman, E. M. Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes Am Heart J. 2002;143(5):753-9. Abstract

Brassard, J. A., Curtis, B. R., Cooper, R. A., Ferguson, J., Komocsar, W., Ehardt, M., Kupfer, S., Maurath, C., Swabb, E., Cannon, C. P., Aster, R. H. Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology Thromb Haemost. 2002;88(6):892-7. Abstract

Brassard, J. A., Curtis, B. R., Cooper, R. A., Ferguson, J., Komocsar, W., Ehardt, M., Kupfer, S., Maurath, C., Swabb, E., Cannon, C. P., Aster, R. H. Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology Thromb Haemost. 2002;88(6):892-7. Abstract

Brener, S. J., Murphy, S. A., Gibson, C. M., DiBattiste, P. M., Demopoulos, L. A., Cannon, C. P. Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes Am J Cardiol. 2002;90(6):631-3.

Cannon CP, Bahit MC, Haugland JM, Henry TD, Schweiger MJ, McKendall GR, Shah PK, Murphy S, Gibson CM, McCabe CH, Antman EM, Braunwald E. Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry Crit Pathw Cardiol. 2002;1:44-52. Abstract

Cannon CP, Bahit MC, Haugland JM, Henry TD, Schweiger MJ, McKendall GR, Shah PK, Murphy S, Gibson CM, McCabe CH, Antman EM, Braunwald E. Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry Crit Pathw Cardiol. 2002;1:44-52. Abstract

Cannon CP, Bahit MC, Haugland JM, Henry TD, Schweiger MJ, McKendall GR, Shah PK, Murphy S, Gibson CM, McCabe CH, Antman EM, Braunwald E. Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry Crit Pathw Cardiol. 2002;1:44-52. Abstract

Cannon, C. P., McCabe, C. H., Belder, R., Breen, J., Braunwald, E. Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial Am J Cardiol. 2002;89(7):860-1.

Cannon, C. P., McCabe, C. H., Belder, R., Breen, J., Braunwald, E. Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial Am J Cardiol. 2002;89(7):860-1.

Cohen, M., Antman, E. M., Murphy, S. A., Radley, D. Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes Am Heart J. 2002;143(1):63-9. Abstract

Cooper, H. A., de Lemos, J. A., Morrow, D. A., Sabatine, M. S., Murphy, S. A., McCabe, C. H., Gibson, C. M., Antman, E. M., Braunwald, E. Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration Am Heart J. 2002;144(5):790-5. Abstract

Cooper, H. A., de Lemos, J. A., Morrow, D. A., Sabatine, M. S., Murphy, S. A., McCabe, C. H., Gibson, C. M., Antman, E. M., Braunwald, E. Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration Am Heart J. 2002;144(5):790-5. Abstract

Deakin, C. D., Sado, D. M., Petley, G. W., Clewlow, F. Determining the optimal paddle force for external defibrillation American journal of cardiology. 2002;90(7):812-3.

Deakin, C. D., Sado, D. M., Petley, G. W., Clewlow, F. Determining the optimal paddle force for external defibrillation American journal of cardiology. 2002;90(7):812-3.

Deakin, C. D., Sado, D. M., Petley, G. W., Clewlow, F. Determining the optimal paddle force for external defibrillation American journal of cardiology. 2002;90(7):812-3.

Fox, K. A., Antman, E. M., Cohen, M., Bigonzi, F. Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention Am J Cardiol. 2002;90(5):477-82. Abstract

Gibson, C. M., Chen, M., Angeja, B. G., Murphy, S. A., Marble, S. J., Barron, H. V., Cannon, C. P. Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending artery J Thromb Thrombolysis. 2002;13(1):12-Sep. Abstract

Glaser, R., Herrmann, H. C., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., Cannon, C. P., Braunwald, E. Benefit of an early invasive management strategy in women with acute coronary syndromes JAMA. 2002;288(24):3124-9.

Glaser, R., Herrmann, H. C., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., Cannon, C. P., Braunwald, E. Benefit of an early invasive management strategy in women with acute coronary syndromes JAMA. 2002;288(24):3124-9.

Januzzi, J. L., Cannon, C. P., DiBattiste, P. M., Murphy, S., Weintraub, W., Braunwald, E. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial) Am J Cardiol. 2002;90(11):1246-9.

Januzzi, J. L., Cannon, C. P., DiBattiste, P. M., Murphy, S., Weintraub, W., Braunwald, E. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial) Am J Cardiol. 2002;90(11):1246-9.

Kleiman, N. S., Lakkis, N., Cannon, C. P., Murphy, S. A., DiBattiste, P. M., Demopoulos, L. A., Weintraub, W. S., Braunwald, E. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes J Am Coll Cardiol. 2002;40(6):1044-50. Abstract

Kleiman, N. S., Lakkis, N., Cannon, C. P., Murphy, S. A., DiBattiste, P. M., Demopoulos, L. A., Weintraub, W. S., Braunwald, E. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes J Am Coll Cardiol. 2002;40(6):1044-50. Abstract

Kloner, R. A., Poole, K., Shook, T., Przyklenk, K., Perritt, K., Cannon, C. P. Comparison of acute myocardial infarct size in patients > or =65 years versus < 65 years in the prethrombolytic period versus the thrombolytic period American journal of cardiology. 2002;89(11):1291-3.

Kloner, R. A., Poole, K., Shook, T., Przyklenk, K., Perritt, K., Cannon, C. P. Comparison of acute myocardial infarct size in patients > or =65 years versus < 65 years in the prethrombolytic period versus the thrombolytic period American journal of cardiology. 2002;89(11):1291-3.

Lakkis, N., Tsyboulev, V., Gibson, C. M., Murphy, S. A., Weintraub, W. S., DiBattiste, P. M., Cannon, C. P. Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudy Crit Pathw Cardiol. 2002;1(4):232-7.

Lakkis, N., Tsyboulev, V., Gibson, C. M., Murphy, S. A., Weintraub, W. S., DiBattiste, P. M., Cannon, C. P. Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudy Crit Pathw Cardiol. 2002;1(4):232-7.

Mahoney, E. M., Jurkovitz, C. T., Chu, H., Becker, E. R., Culler, S., Kosinski, A. S., Robertson, D. H., Alexander, C., Nag, S., Cook, J. R., Demopoulos, L. A., DiBattiste, P. M., Cannon, C. P., Weintraub, W. S. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction JAMA. 2002;288(15):1851-8. Abstract

Mahoney, E. M., Jurkovitz, C. T., Chu, H., Becker, E. R., Culler, S., Kosinski, A. S., Robertson, D. H., Alexander, C., Nag, S., Cook, J. R., Demopoulos, L. A., DiBattiste, P. M., Cannon, C. P., Weintraub, W. S. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction JAMA. 2002;288(15):1851-8. Abstract

Mahoney, E. M., Jurkovitz, C. T., Chu, H., Becker, E. R., Culler, S., Kosinski, A. S., Robertson, D. H., Alexander, C., Nag, S., Cook, J. R., Demopoulos, L. A., DiBattiste, P. M., Cannon, C. P., Weintraub, W. S. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction JAMA. 2002;288(15):1851-8. Abstract

Morrow, D. A., Antman, E. M., Snapinn, S. M., McCabe, C. H., Theroux, P., Braunwald, E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS Eur Heart J. 2002;23(3):223-9. Abstract

Murphy, S. A., Chen, C., Cannon, C. P., Antman, E. M., Gibson, C. M. Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction Am J Cardiol. 2002;90(7):766-70.

Murphy, S. A., Chen, C., Cannon, C. P., Antman, E. M., Gibson, C. M. Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction Am J Cardiol. 2002;90(7):766-70.

Murphy, S. A., Gibson, C. M., Van de Werf, F., McCabe, C. H., Cannon, C. P. Comparison of errors in estimating weight and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I) Am J Cardiol. 2002;90(1):51-4.

Murphy, S. A., Gibson, C. M., Van de Werf, F., McCabe, C. H., Cannon, C. P. Comparison of errors in estimating weight and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I) Am J Cardiol. 2002;90(1):51-4.

NA, NA Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data Lancet. 2002;359(9303):294-302. Abstract

Omland, T., de Lemos, J. A., Morrow, D. A., Antman, E. M., Cannon, C. P., Hall, C., Braunwald, E. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes Am J Cardiol. 2002;89(4):463-5.

Omland, T., de Lemos, J. A., Morrow, D. A., Antman, E. M., Cannon, C. P., Hall, C., Braunwald, E. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes Am J Cardiol. 2002;89(4):463-5.

Sabatine, M. S., McCabe, C. H., Morrow, D. A., Giugliano, R. P., de Lemos, J. A., Cohen, M., Antman, E. M., Braunwald, E. Identification of patients at high risk for death and cardiac ischemic events after hospital discharge Am Heart J. 2002;143(6):966-70. Abstract

Sabatine, M. S., McCabe, C. H., Morrow, D. A., Giugliano, R. P., de Lemos, J. A., Cohen, M., Antman, E. M., Braunwald, E. Identification of patients at high risk for death and cardiac ischemic events after hospital discharge Am Heart J. 2002;143(6):966-70. Abstract

Sabatine, M. S., McCabe, C. H., Morrow, D. A., Giugliano, R. P., de Lemos, J. A., Cohen, M., Antman, E. M., Braunwald, E. Identification of patients at high risk for death and cardiac ischemic events after hospital discharge Am Heart J. 2002;143(6):966-70. Abstract

Sabatine, M. S., Morrow, D. A., Cannon, C. P., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., McCabe, C. H., Braunwald, E., Gibson, C. M. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy J Am Coll Cardiol. 2002;40(10):1761-8.

Sabatine, M. S., Morrow, D. A., Cannon, C. P., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., McCabe, C. H., Braunwald, E., Gibson, C. M. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy J Am Coll Cardiol. 2002;40(10):1761-8.

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C., Antman, E. M., Cannon, C. P., Braunwald, E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation. 2002;105(15):1760-3. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C., Antman, E. M., Cannon, C. P., Braunwald, E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation. 2002;105(15):1760-3. Abstract

Scirica, B. M., Cannon, C. P., Antman, E. M., Murphy, S. A., Morrow, D. A., Sabatine, M. S., McCabe, C. H., Gibson, C. M., Braunwald, E. Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry American journal of cardiology. 2002;90(3):303-5.

Scirica, B. M., Cannon, C. P., Antman, E. M., Murphy, S. A., Morrow, D. A., Sabatine, M. S., McCabe, C. H., Gibson, C. M., Braunwald, E. Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry American journal of cardiology. 2002;90(3):303-5.

Scirica, B. M., Cannon, C. P., Antman, E. M., Murphy, S. A., Morrow, D. A., Sabatine, M. S., McCabe, C. H., Gibson, C. M., Braunwald, E. Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry American journal of cardiology. 2002;90(3):303-5.

Scirica, B. M., Cannon, C. P., Gibson, C. M., Murphy, S. A., Moliterno, D. J., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Sapp, S. K., Booth, J. E., Ferguson, J. J., Braunwald, E. Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries Critical pathways in cardiology. 2002;1(3):150-8. Abstract

Scirica, B. M., Cannon, C. P., Gibson, C. M., Murphy, S. A., Moliterno, D. J., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Sapp, S. K., Booth, J. E., Ferguson, J. J., Braunwald, E. Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries Critical pathways in cardiology. 2002;1(3):150-8. Abstract

Scirica, B. M., Cannon, C. P., Gibson, C. M., Murphy, S. A., Moliterno, D. J., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Sapp, S. K., Booth, J. E., Ferguson, J. J., Braunwald, E. Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries Critical pathways in cardiology. 2002;1(3):150-8. Abstract

Scirica, B. M., Cannon, C. P., McCabe, C. H., Murphy, S. A., Anderson, H. V., Rogers, W. J., Stone, P. H., Braunwald, E., Thrombolysis in Myocardial Ischemia, I. I. I. Registry Investigators Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification Am J Cardiol. 2002;90(8):821-6. Abstract

Scirica, B. M., Cannon, C. P., McCabe, C. H., Murphy, S. A., Anderson, H. V., Rogers, W. J., Stone, P. H., Braunwald, E., Thrombolysis in Myocardial Ischemia, I. I. I. Registry Investigators Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification Am J Cardiol. 2002;90(8):821-6. Abstract

Scirica, B. M., Cannon, C. P., McCabe, C. H., Murphy, S. A., Anderson, H. V., Rogers, W. J., Stone, P. H., Braunwald, E., Thrombolysis in Myocardial Ischemia, I. I. I. Registry Investigators Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification Am J Cardiol. 2002;90(8):821-6. Abstract

Sharis, P. J., Cannon, C. P., Rogers, W. J., McCabe, C., Murphy, S., Gibson, C. M., Stone, P. H., Braunwald, E. Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III Registry) American journal of cardiology. 2002;90(10):1154-6.

Sharis, P. J., Cannon, C. P., Rogers, W. J., McCabe, C., Murphy, S., Gibson, C. M., Stone, P. H., Braunwald, E. Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III Registry) American journal of cardiology. 2002;90(10):1154-6.

Sharis, P. J., Cannon, C. P., Rogers, W. J., McCabe, C., Murphy, S., Gibson, C. M., Stone, P. H., Braunwald, E. Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III Registry) American journal of cardiology. 2002;90(10):1154-6.

Shields, D. C., Fitzgerald, A. P., O'Neill, P. A., Muckian, C., Kenny, D., Moran, B., Cannon, C. P., Byrne, C. E., Fitzgerald, D. J. The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists Pharmacogenomics J. 2002;2(3):182-90. Abstract

Solomon, Daniel H., Ganz, David A., Avorn, Jerry, Glynn, Robert J., Knight, Eric L., Gibson, C. Michael, Stone, Peter H. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy Journal of Clinical Epidemiology. 2002;55(2):121-128.

Solomon, Daniel H., Ganz, David A., Avorn, Jerry, Glynn, Robert J., Knight, Eric L., Gibson, C. Michael, Stone, Peter H. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy Journal of Clinical Epidemiology. 2002;55(2):121-128.

Solomon, Daniel H., Ganz, David A., Avorn, Jerry, Glynn, Robert J., Knight, Eric L., Gibson, C. Michael, Stone, Peter H. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy Journal of Clinical Epidemiology. 2002;55(2):121-128.

Weber, J. E., Hollander, J. E., Murphy, S. A., Braunwald, E., Gibson, C. M. Quantitative comparison of coronary artery flow and myocardial perfusion in patients with acute myocardial infarction in the presence and absence of recent cocaine use J Thromb Thrombolysis. 2002;14(3):239-45. Abstract

Weber, J. E., Hollander, J. E., Murphy, S. A., Braunwald, E., Gibson, C. M. Quantitative comparison of coronary artery flow and myocardial perfusion in patients with acute myocardial infarction in the presence and absence of recent cocaine use J Thromb Thrombolysis. 2002;14(3):239-45. Abstract

Wong, G. C., Morrow, D. A., Murphy, S., Kraimer, N., Pai, R., James, D., Robertson, D. H., Demopoulos, L. A., DiBattiste, P., Cannon, C. P., Gibson, C. M. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction Circulation. 2002;106(2):202-7.

Bahit, M. C., Cannon, C. P., Antman, E. M., Murphy, S. A., Gibson, C. M., McCabe, C. H., Braunwald, E. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry American heart journal. 2003;145(1):109-17. Abstract

Bahit, M. C., Cannon, C. P., Antman, E. M., Murphy, S. A., Gibson, C. M., McCabe, C. H., Braunwald, E. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry American heart journal. 2003;145(1):109-17. Abstract

Bahit, M. C., Cannon, C. P., Antman, E. M., Murphy, S. A., Gibson, C. M., McCabe, C. H., Braunwald, E. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry American heart journal. 2003;145(1):109-17. Abstract

Braunwald, E. Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction Circulation. 2003;108(16 Suppl 1):III28-37. Abstract

Braunwald, E. Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction Circulation. 2003;108(16 Suppl 1):III28-37. Abstract

Braunwald, E. Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction Circulation. 2003;108(16 Suppl 1):III28-37. Abstract

Cannon, C. P. PROVE-IT TIMI 22 Study: potential effects on critical pathways for acute coronary syndrome Crit Pathw Cardiol. 2003;2(3):188-96.

Cannon, C. P. PROVE-IT TIMI 22 Study: potential effects on critical pathways for acute coronary syndrome Crit Pathw Cardiol. 2003;2(3):188-96.

Cannon, C. P. PROVE-IT TIMI 22 Study: potential effects on critical pathways for acute coronary syndrome Crit Pathw Cardiol. 2003;2(3):188-96.

Cannon, C. P. Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial J Am Coll Cardiol. 2003;41(4 Suppl S):43S-48S. Abstract

Cannon, C. P. The next step in cardiovascular protection Atheroscler Suppl. 2003;4(5):9-Mar. Abstract

Christenson, R. H., Leino, E. V., Giugliano, R. P., Bahr, R. D. Usefulness of prodromal unstable angina pectoris in predicting better survival and smaller infarct size in acute myocardial infarction (The InTIME-II Prodromal Symptoms Substudy) Am J Cardiol. 2003;92(5):598-600. Abstract

Cotter, G., Cannon, C. P., McCabe, C. H., Michowitz, Y., Kaluski, E., Charlesworth, A., Milo, O., Bentley, J., Blatt, A., Krakover, R., Zimlichman, R., Reisin, L., Marmor, A., Lewis, B., Vered, Z., Caspi, A., Braunwald, E. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study Am Heart J. 2003;145(4):622-7. Abstract

Cotter, G., Cannon, C. P., McCabe, C. H., Michowitz, Y., Kaluski, E., Charlesworth, A., Milo, O., Bentley, J., Blatt, A., Krakover, R., Zimlichman, R., Reisin, L., Marmor, A., Lewis, B., Vered, Z., Caspi, A., Braunwald, E. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study Am Heart J. 2003;145(4):622-7. Abstract

Gibson, C. M., Karha, J., Murphy, S. A., James, D., Morrow, D. A., Cannon, C. P., Giugliano, R. P., Antman, E. M., Braunwald, E. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials J Am Coll Cardiol. 2003;42(1):16-Jul. Abstract

Gibson, C. M., Pinto, D. S., Murphy, S. A., Morrow, D. A., Hobbach, H. P., Wiviott, S. D., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Timi Study Group Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality J Am Coll Cardiol. 2003;42(9):1535-43. Abstract

Januzzi, J. L., Jr., Sabatine, M. S., Wan, Y., Servoss, S. J., DiBattiste, P. M., Jang, Ik, Theroux, P. Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy Am J Cardiol. 2003;91(4):457-61.

Januzzi, J. L., Jr., Sabatine, M. S., Wan, Y., Servoss, S. J., DiBattiste, P. M., Jang, Ik, Theroux, P. Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy Am J Cardiol. 2003;91(4):457-61.

Karha, J., Murphy, S. A., Kirtane, A. J., de Lemos, J. A., Aroesty, J. M., Cannon, C. P., Antman, E. M., Braunwald, E., Gibson, C. M. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction Am J Cardiol. 2003;92(8):913-8. Abstract

Morrow, D. A., Rifai, N., Sabatine, M. S., Ayanian, S., Murphy, S. A., de Lemos, J. A., Braunwald, E., Cannon, C. P. Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes Clin Chem. 2003;49(8):1396-8.

Morrow, D. A., Rifai, N., Sabatine, M. S., Ayanian, S., Murphy, S. A., de Lemos, J. A., Braunwald, E., Cannon, C. P. Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes Clin Chem. 2003;49(8):1396-8.

Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., McCabe, C. H., Gibson, C. M., Cannon, C. P., Braunwald, E. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 J Am Coll Cardiol. 2003;41(8):1264-72.

Murphy, S. A., Dauterman, K., de Lemos, J. A., Kermgard, S., Antman, E. M., Braunwald, E., Gibson, C. M. Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial Am Heart J. 2003;146(1):42-7. Abstract

Murphy, S. A., Dauterman, K., de Lemos, J. A., Kermgard, S., Antman, E. M., Braunwald, E., Gibson, C. M. Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial Am Heart J. 2003;146(1):42-7. Abstract

Pinto, D. S., Lorenz, D. P., Murphy, S. A., Marble, S. J., DiBattiste, P. M., Demopoulos, L. A., Cannon, C. P., Gibson, C. M. Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy) Am J Cardiol. 2003;91(8):976-8, A4.

Serrano, C. V., Jr., Nicolau, J. C., Venturinelli, M., Baracioli, L. M., Anders, R. J., Cannon, C. P., Ramires, J. A. Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromes Cardiovasc Drugs Ther. 2003;17(2):129-32. Abstract

Spinler, S. A., Inverso, S. M., Cohen, M., Goodman, S. G., Stringer, K. A., Antman, E. M. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies Am Heart J. 2003;146(1):33-41. Abstract

Varo, N., de Lemos, J. A., Libby, P., Morrow, D. A., Murphy, S. A., Nuzzo, R., Gibson, C. M., Cannon, C. P., Braunwald, E., Schonbeck, U. Soluble CD40L: risk prediction after acute coronary syndromes Circulation. 2003;108(9):1049-52. Abstract

Varo, N., de Lemos, J. A., Libby, P., Morrow, D. A., Murphy, S. A., Nuzzo, R., Gibson, C. M., Cannon, C. P., Braunwald, E., Schonbeck, U. Soluble CD40L: risk prediction after acute coronary syndromes Circulation. 2003;108(9):1049-52. Abstract

Varo, N., de Lemos, J. A., Libby, P., Morrow, D. A., Murphy, S. A., Nuzzo, R., Gibson, C. M., Cannon, C. P., Braunwald, E., Schonbeck, U. Soluble CD40L: risk prediction after acute coronary syndromes Circulation. 2003;108(9):1049-52. Abstract

Wong, G. C., Frisch, D., Murphy, S. A., Sabatine, M. S., Pai, R., James, D., Kraimer, N., Katsiyiannis, P. T., Marble, S. J., DiBattiste, P. M., Demopoulos, L. A., Gourlay, S. G., Barron, H. V., Cannon, C. P., Gibson, C. M. Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction Am J Cardiol. 2003;91(10):1163-7.

de Lemos, J. A., Morrow, D. A., Sabatine, M. S., Murphy, S. A., Gibson, C. M., Antman, E. M., McCabe, C. H., Cannon, C. P., Braunwald, E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes Circulation. 2003;107(5):690-5. Abstract

de Lemos, J. A., Morrow, D. A., Sabatine, M. S., Murphy, S. A., Gibson, C. M., Antman, E. M., McCabe, C. H., Cannon, C. P., Braunwald, E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes Circulation. 2003;107(5):690-5. Abstract

Bach, R. G., Cannon, C. P., Weintraub, W. S., DiBattiste, P. M., Demopoulos, L. A., Anderson, H. V., DeLucca, P. T., Mahoney, E. M., Murphy, S. A., Braunwald, E. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes Ann Intern Med. 2004;141(3):186-95.

Bach, R. G., Cannon, C. P., Weintraub, W. S., DiBattiste, P. M., Demopoulos, L. A., Anderson, H. V., DeLucca, P. T., Mahoney, E. M., Murphy, S. A., Braunwald, E. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes Ann Intern Med. 2004;141(3):186-95.

Blazing MA, de Lemos JA, White HD, Fox KA, Verheugt FW, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA. 2004;292:55-64.

Blazing MA, de Lemos JA, White HD, Fox KA, Verheugt FW, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA. 2004;292:55-64.

Byrne, C. E., Fitzgerald, A., Cannon, C. P., Fitzgerald, D. J., Shields, D. C. Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes BMC Med Genet. 2004;5(NA):13. Abstract

Byrne, C. E., Fitzgerald, A., Cannon, C. P., Fitzgerald, D. J., Shields, D. C. Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes BMC Med Genet. 2004;5(NA):13. Abstract

Byrne, C. E., Fitzgerald, A., Cannon, C. P., Fitzgerald, D. J., Shields, D. C. Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes BMC Med Genet. 2004;5(NA):13. Abstract

Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-504.

Cannon, C. P. Utilization of guidelines and computer-based technology to achieve optimal care in atherothrombotic vascular disease J Thromb Thrombolysis. 2004;17(1):45-9. Abstract

Cannon, C. P. Utilization of guidelines and computer-based technology to achieve optimal care in atherothrombotic vascular disease J Thromb Thrombolysis. 2004;17(1):45-9. Abstract

Cannon, C. P. Utilization of guidelines and computer-based technology to achieve optimal care in atherothrombotic vascular disease J Thromb Thrombolysis. 2004;17(1):45-9. Abstract

Gibson, C. M., Dumaine, R. L., Gelfand, E. V., Murphy, S. A., Morrow, D. A., Wiviott, S. D., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Timi Study Group Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials Eur Heart J. 2004;25(22):1998-2005. Abstract

Gibson, C. M., Dumaine, R. L., Gelfand, E. V., Murphy, S. A., Morrow, D. A., Wiviott, S. D., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Timi Study Group Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials Eur Heart J. 2004;25(22):1998-2005. Abstract

Gibson, C. M., Karha, J., Giugliano, R. P., Roe, M. T., Murphy, S. A., Harrington, R. A., Green, C. L., Schweiger, M. J., Miklin, J. S., Baran, K. W., Palmeri, S., Braunwald, E., Krucoff, M. W. Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction Am Heart J. 2004;147(5):847-52.

Gibson, C. M., Karha, J., Murphy, S. A., de Lemos, J. A., Morrow, D. A., Giugliano, R. P., Roe, M. T., Harrington, R. A., Cannon, C. P., Antman, E. M., Califf, R. M., Braunwald, E. Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction J Am Coll Cardiol. 2004;43(7):1170-6. Abstract

Gibson, C. M., Karha, J., Murphy, S. A., de Lemos, J. A., Morrow, D. A., Giugliano, R. P., Roe, M. T., Harrington, R. A., Cannon, C. P., Antman, E. M., Califf, R. M., Braunwald, E. Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction J Am Coll Cardiol. 2004;43(7):1170-6. Abstract

Gibson, C. M., Karha, J., Murphy, S. A., de Lemos, J. A., Morrow, D. A., Giugliano, R. P., Roe, M. T., Harrington, R. A., Cannon, C. P., Antman, E. M., Califf, R. M., Braunwald, E. Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction J Am Coll Cardiol. 2004;43(7):1170-6. Abstract

Gibson, C. M., Karha, J., Murphy, S. A., de Lemos, J. A., Morrow, D. A., Giugliano, R. P., Roe, M. T., Harrington, R. A., Cannon, C. P., Antman, E. M., Califf, R. M., Braunwald, E. Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction J Am Coll Cardiol. 2004;43(7):1170-6. Abstract

Gibson, C. M., Murphy, S. A., Morrow, D. A., Aroesty, J. M., Gibbons, R. J., Gourlay, S. G., Barron, H. V., Giugliano, R. P., Antman, E. M., Braunwald, E. Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction American Heart Journal. 2004;148(2):336-340. Abstract

Gibson, C. M., Singh, K. P., Murphy, S. A., DiBattiste, P. M., Demopoulos, L. A., Cannon, C. P., Braunwald, E. Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy) Am J Cardiol. 2004;94(4):492-4. Abstract

Giugliano, R. P., Sabatine, M. S., Gibson, C. M., Roe, M. T., Harrington, R. A., Murphy, S. A., Morrow, D. A., Antman, E. M., Braunwald, E. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion Am J Cardiol. 2004;93(11):1362-7, A5-6. Abstract

Giugliano, R. P., Sabatine, M. S., Gibson, C. M., Roe, M. T., Harrington, R. A., Murphy, S. A., Morrow, D. A., Antman, E. M., Braunwald, E. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion Am J Cardiol. 2004;93(11):1362-7, A5-6. Abstract

Herrmann, H. C., Murphy, S. A., Dibattiste, P. M., Delucca, P. T., Demopoulos, L. A., Gibson, C. M., Cannon, C. P. Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy Crit Pathw Cardiol. 2004;3(2):95-100.

Herrmann, H. C., Murphy, S. A., Dibattiste, P. M., Delucca, P. T., Demopoulos, L. A., Gibson, C. M., Cannon, C. P. Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy Crit Pathw Cardiol. 2004;3(2):95-100.

Karha, J., Gibson, C. M., Murphy, S. A., Dibattiste, P. M., Cannon, C. P. Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarction Am J Cardiol. 2004;94(12):1537-9. Abstract

Karmpaliotis, D., Turakhia, M. P., Kirtane, A. J., Murphy, S. A., Kosmidou, I., Morrow, D. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Gibson, C. M. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction Am J Cardiol. 2004;94(9):1113-7. Abstract

Kirtane, A. J., Bui, A., Murphy, S. A., Karmpaliotis, D., Kosmidou, I., Boundy, K., Rahman, A., Pinto, D. S., Aroesty, J. M., Giugliano, R. P., Cannon, C. P., Antman, E. M., Gibson, C. M. Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction J Thromb Thrombolysis. 2004;17(3):177-84. Abstract

Kovar, D., Cannon, C. P., Bentley, J. H., Charlesworth, A., Rogers, W. J. Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? Clin Cardiol. 2004;27(2):80-6. Abstract

Kovar, D., Cannon, C. P., Bentley, J. H., Charlesworth, A., Rogers, W. J. Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? Clin Cardiol. 2004;27(2):80-6. Abstract

Kovar, D., Cannon, C. P., Bentley, J. H., Charlesworth, A., Rogers, W. J. Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? Clin Cardiol. 2004;27(2):80-6. Abstract

McCullough, P. A., Gibson, C. M., Dibattiste, P. M., Demopoulos, L. A., Murphy, S. A., Weintraub, W. S., Neumann, F. J., Khanal, S., Cannon, C. P. Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial J Interv Cardiol. 2004;17(2):81-6.

McCullough, P. A., Gibson, C. M., Dibattiste, P. M., Demopoulos, L. A., Murphy, S. A., Weintraub, W. S., Neumann, F. J., Khanal, S., Cannon, C. P. Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial J Interv Cardiol. 2004;17(2):81-6.

Morrow, D. A., Antman, E. M., Murphy, S. A., Assmann, S. F., Giugliano, R. P., Cannon, C. P., Michael Gibson, C., McCabe, C. H., Barron, H. V., Van De Werf, F., Braunwald, E. The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies Eur Heart J. 2004;25(13):1139-45. Abstract

Morrow, D. A., Antman, E. M., Murphy, S. A., Assmann, S. F., Giugliano, R. P., Cannon, C. P., Michael Gibson, C., McCabe, C. H., Barron, H. V., Van De Werf, F., Braunwald, E. The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies Eur Heart J. 2004;25(13):1139-45. Abstract

Morrow, D. A., Sabatine, M. S., Antman, E. M., Cannon, C. P., Braunwald, E., Theroux, P. Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS) Am J Cardiol. 2004;94(6):774-6. Abstract

Petersen, J. L., Mahaffey, K. W., Hasselblad, V., Antman, E. M., Cohen, M., Goodman, S. G., Langer, A., Blazing, M. A., Le-Moigne-Amrani, A., de Lemos, J. A., Nessel, C. C., Harrington, R. A., Ferguson, J. J., Braunwald, E., Califf, R. M. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview JAMA. 2004;292(1):89-96. Abstract

Petersen, J. L., Mahaffey, K. W., Hasselblad, V., Antman, E. M., Cohen, M., Goodman, S. G., Langer, A., Blazing, M. A., Le-Moigne-Amrani, A., de Lemos, J. A., Nessel, C. C., Harrington, R. A., Ferguson, J. J., Braunwald, E., Califf, R. M. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview JAMA. 2004;292(1):89-96. Abstract

Ray, K. K., Cannon, C. P. Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology Curr Opin Lipidol. 2004;15(6):637-43. Abstract

Roe, M. T., Green, C. L., Giugliano, R. P., Gibson, C. M., Baran, K., Greenberg, M., Palmeri, S. T., Crater, S., Trollinger, K., Hannan, K., Harrington, R. A., Krucoff, M. W. Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;43(4):549-56.

Sabatine, M. S., Morrow, D. A., Giugliano, R. P., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., Weintraub, W. S., McCabe, C. H., Antman, E. M., Cannon, C. P., Braunwald, E. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction - A Comparison of the Thrombolysis in Myocardial Infarction (TIMI) IIIB Trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 Trial Circulation. 2004;109(7):874-880. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Omland, T., Desai, M. Y., Tanasijevic, M., Hall, C., McCabe, C. H., Braunwald, E. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia J Am Coll Cardiol. 2004;44(10):1988-95. Abstract

Sadanandan, S., Cannon, C. P., Gibson, C. M., Murphy, S. A., DiBattiste, P. M., Braunwald, E. A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(4):799-803. Abstract

Sadanandan, S., Cannon, C. P., Gibson, C. M., Murphy, S. A., DiBattiste, P. M., Braunwald, E. A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(4):799-803. Abstract

Sadanandan, S., Cannon, C. P., Gibson, C. M., Murphy, S. A., DiBattiste, P. M., Braunwald, E. A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(4):799-803. Abstract

Shimpo, M., Morrow, D. A., Weinberg, E. O., Sabatine, M. S., Murphy, S. A., Antman, E. M., Lee, R. T. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction Circulation. 2004;109(18):2186-90. Abstract

Wiviott, S. D., Cannon, C. P., Morrow, D. A., Murphy, S. A., Gibson, C. M., McCabe, C. H., Sabatine, M. S., Rifai, N., Giugliano, R. P., DiBattiste, P. M., Demopoulos, L. A., Antman, E. M., Braunwald, E. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy Circulation. 2004;109(5):580-6.

Wiviott, S. D., Morrow, D. A., Frederick, P. D., Giugliano, R. P., Gibson, C. M., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(4):783-9. Abstract

Wylie, J. V., Murphy, S. A., Morrow, D. A., de Lemos, J. A., Antman, E. M., Cannon, C. P. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 Am Heart J. 2004;148(1):173-80. Abstract

Wylie, J. V., Murphy, S. A., Morrow, D. A., de Lemos, J. A., Antman, E. M., Cannon, C. P. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 Am Heart J. 2004;148(1):173-80. Abstract

de Lemos, J. A., Blazing, M. A., Wiviott, S. D., Brady, W. E., White, H. D., Fox, K. A., Palmisano, J., Ramsey, K. E., Bilheimer, D. W., Lewis, E. F., Pfeffer, M., Califf, R. M., Braunwald, E. Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial Eur Heart J. 2004;25(19):1688-94.

de Lemos, J. A., Blazing, M. A., Wiviott, S. D., Brady, W. E., White, H. D., Fox, K. A., Palmisano, J., Ramsey, K. E., Bilheimer, D. W., Lewis, E. F., Pfeffer, M., Califf, R. M., Braunwald, E. Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial Eur Heart J. 2004;25(19):1688-94.

de Lemos, J. A., Blazing, M. A., Wiviott, S. D., Lewis, E. F., Fox, K. A., White, H. D., Rouleau, J. L., Pedersen, T. R., Gardner, L. H., Mukherjee, R., Ramsey, K. E., Palmisano, J., Bilheimer, D. W., Pfeffer, M. A., Califf, R. M., Braunwald, E. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA. 2004;292(11):1307-16.

ADVANCE MI Investigators Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial Am Heart J. 2005;150(1):116-22.

Antman, E. M., Morrow, D. A., McCabe, C. H., Jiang, F., White, H. D., Fox, K. A., Sharma, D., Chew, P., Braunwald, E. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) Am Heart J. 2005;149(2):217-26.

Antman, E. M., Morrow, D. A., McCabe, C. H., Jiang, F., White, H. D., Fox, K. A., Sharma, D., Chew, P., Braunwald, E. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) Am Heart J. 2005;149(2):217-26.

Antman, E. M., Morrow, D. A., McCabe, C. H., Jiang, F., White, H. D., Fox, K. A., Sharma, D., Chew, P., Braunwald, E. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) Am Heart J. 2005;149(2):217-26.

Cannon, C. P., Braunwald, E., McCabe, C. H., Grayston, J. T., Muhlestein, B., Giugliano, R. P., Cairns, R., Skene, A. M. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome N Engl J Med. 2005;352(16):1646-54.

Cannon, C. P., Braunwald, E., McCabe, C. H., Grayston, J. T., Muhlestein, B., Giugliano, R. P., Cairns, R., Skene, A. M. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome N Engl J Med. 2005;352(16):1646-54.

Cannon, C. P., Braunwald, E., McCabe, C. H., Grayston, J. T., Muhlestein, B., Giugliano, R. P., Cairns, R., Skene, A. M. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome N Engl J Med. 2005;352(16):1646-54.

Cantor, W. J., Goodman, S. G., Cannon, C. P., Murphy, S. A., Charlesworth, A., Braunwauld, E., Langer, A. Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial Am Heart J. 2005;149(2):275-83. Abstract

Cantor, W. J., Goodman, S. G., Cannon, C. P., Murphy, S. A., Charlesworth, A., Braunwauld, E., Langer, A. Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial Am Heart J. 2005;149(2):275-83. Abstract

Dokainish, H., Pillai, M., Murphy, S. A., DiBattiste, P. M., Schweiger, M. J., Lotfi, A., Morrow, D. A., Cannon, C. P., Braunwald, E., Lakkis, N. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy J Am Coll Cardiol. 2005;45(1):19-24.

Dokainish, H., Pillai, M., Murphy, S. A., DiBattiste, P. M., Schweiger, M. J., Lotfi, A., Morrow, D. A., Cannon, C. P., Braunwald, E., Lakkis, N. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy J Am Coll Cardiol. 2005;45(1):19-24.

Dupuis, J., Tardif, J. C., Rouleau, J. L., Ricci, J., Arnold, M., Lonn, E., Roux, R., Title, L. M., Amyot, R., Bonafede, N., Woo, A., Cannon, C. P. Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial) Am J Cardiol. 2005;96(9):1207-13. Abstract

Dupuis, J., Tardif, J. C., Rouleau, J. L., Ricci, J., Arnold, M., Lonn, E., Roux, R., Title, L. M., Amyot, R., Bonafede, N., Woo, A., Cannon, C. P. Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial) Am J Cardiol. 2005;96(9):1207-13. Abstract

Ferguson, J. J. Clopidogrel plus aspirin in patients with acute myocardial infarction treated with fibrinolytic therapy--CLARITY-TIMI 28 Future Cardiol. 2005;1(5):605-10. Abstract

Ferguson, J. J. Clopidogrel plus aspirin in patients with acute myocardial infarction treated with fibrinolytic therapy--CLARITY-TIMI 28 Future Cardiol. 2005;1(5):605-10. Abstract

Giugliano, R. P., Newby, L. K., Harrington, R. A., Gibson, C. M., Van de Werf, F., Armstrong, P., Montalescot, G., Gilbert, J., Strony, J. T., Califf, R. M., Braunwald, E. The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale Am Heart J. 2005;149(6):994-1002. Abstract

Gomberg-Maitland, M., Murphy, S. A., Moliterno, D. J., Cannon, C. P. Are we appropriately triaging patients with unstable angina? Am Heart J. 2005;149(4):613-8. Abstract

Gomberg-Maitland, M., Murphy, S. A., Moliterno, D. J., Cannon, C. P. Are we appropriately triaging patients with unstable angina? Am Heart J. 2005;149(4):613-8. Abstract

Gomberg-Maitland, M., Murphy, S. A., Moliterno, D. J., Cannon, C. P. Are we appropriately triaging patients with unstable angina? Am Heart J. 2005;149(4):613-8. Abstract

Gurjeva, O. S., Bukhman, G., Murphy, S., Cannon, C. P. Treatment and outcomes of eastern Europeans with coronary syndromes in OPUS-TIMI 16 Int J Cardiol. 2005;100(1):101-7. Abstract

Gurjeva, O. S., Bukhman, G., Murphy, S., Cannon, C. P. Treatment and outcomes of eastern Europeans with coronary syndromes in OPUS-TIMI 16 Int J Cardiol. 2005;100(1):101-7. Abstract

Gurjeva, O. S., Bukhman, G., Murphy, S., Cannon, C. P. Treatment and outcomes of eastern Europeans with coronary syndromes in OPUS-TIMI 16 Int J Cardiol. 2005;100(1):101-7. Abstract

Januzzi, J. L., Jr., Buros, J., Cannon, C. P. Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trial Clin Cardiol. 2005;28(5):238-42.

Januzzi, J. L., Jr., Buros, J., Cannon, C. P. Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trial Clin Cardiol. 2005;28(5):238-42.

Kirtane, A. J., Kosmidou, I., Karmpaliotis, D., Murphy, S. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Gibson, C. M. Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy Am J Cardiol. 2005;95(3):337-42. Abstract

Kirtane, A. J., Leder, D. M., Waikar, S. S., Chertow, G. M., Ray, K. K., Pinto, D. S., Karmpaliotis, D., Burger, A. J., Murphy, S. A., Cannon, C. P., Braunwald, E., Gibson, C. M. Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates J Am Coll Cardiol. 2005;45(11):1781-6. Abstract

Kirtane, A. J., Leder, D. M., Waikar, S. S., Chertow, G. M., Ray, K. K., Pinto, D. S., Karmpaliotis, D., Burger, A. J., Murphy, S. A., Cannon, C. P., Braunwald, E., Gibson, C. M. Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates J Am Coll Cardiol. 2005;45(11):1781-6. Abstract

Ly, H. Q., Kirtane, A. J., Buros, J., Giugliano, R. P., Popma, J. J., Antman, E. M., Harrington, R. A., Ohman, E. M., Gibson, C. M. Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction Am J Cardiol. 2005;95(3):383-6. Abstract

Ly, H. Q., Kirtane, A. J., Buros, J., Giugliano, R. P., Popma, J. J., Antman, E. M., Harrington, R. A., Ohman, E. M., Gibson, C. M. Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction Am J Cardiol. 2005;95(3):383-6. Abstract

Mega, J. L., Morrow, D. A., Sabatine, M. S., Zhao, X. Q., Snapinn, S. M., DiBattiste, P. M., Gibson, C. M., Antman, E. M., Braunwald, E., Theroux, P. Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial Am Heart J. 2005;149(5):846-50. Abstract

Mega, J. L., Morrow, D. A., Sabatine, M. S., Zhao, X. Q., Snapinn, S. M., DiBattiste, P. M., Gibson, C. M., Antman, E. M., Braunwald, E., Theroux, P. Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial Am Heart J. 2005;149(5):846-50. Abstract

Moghbeli, N., Kirtane, A. J., Ray, K. K., Murphy, S. A., Gibson, C. M., Braunwald, E., Cannon, C. P. C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial) Am J Cardiol. 2005;96(5):635-8.

Moghbeli, N., Kirtane, A. J., Ray, K. K., Murphy, S. A., Gibson, C. M., Braunwald, E., Cannon, C. P. C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial) Am J Cardiol. 2005;96(5):635-8.

Morrow, D. A., Murphy, S. A., McCabe, C. H., Mackman, N., Wong, H. C., Antman, E. M. Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial Eur Heart J. 2005;26(7):682-8.

Morrow, D. A., Murphy, S. A., McCabe, C. H., Mackman, N., Wong, H. C., Antman, E. M. Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial Eur Heart J. 2005;26(7):682-8.

Morrow, D. A., Murphy, S. A., McCabe, C. H., Mackman, N., Wong, H. C., Antman, E. M. Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial Eur Heart J. 2005;26(7):682-8.

Morrow, D. A., de Lemos, J. A., Blazing, M. A., Sabatine, M. S., Murphy, S. A., Jarolim, P., White, H. D., Fox, K. A., Califf, R. M., Braunwald, E. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease JAMA. 2005;294(22):2866-71.

Morrow, D. A., de Lemos, J. A., Blazing, M. A., Sabatine, M. S., Murphy, S. A., Jarolim, P., White, H. D., Fox, K. A., Califf, R. M., Braunwald, E. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease JAMA. 2005;294(22):2866-71.

O'Donoghue, M., Chen, A., Baggish, A. L., Anwaruddin, S., Krauser, D. G., Tung, R., Januzzi, J. L. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study J Card Fail. 2005;11(5 Suppl):S9-14. Abstract

O'Donoghue, M., Chen, A., Baggish, A. L., Anwaruddin, S., Krauser, D. G., Tung, R., Januzzi, J. L. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study J Card Fail. 2005;11(5 Suppl):S9-14. Abstract

Ohman, E. M., Van de Werf, F., Antman, E. M., Califf, R. M., de Lemos, J. A., Gibson, C. M., Oliverio, R. L., Harrelson, L., McCabe, C., DiBattiste, P., Braunwald, E. Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial Am Heart J. 2005;150(1):79-88.

Ohman, E. M., Van de Werf, F., Antman, E. M., Califf, R. M., de Lemos, J. A., Gibson, C. M., Oliverio, R. L., Harrelson, L., McCabe, C., DiBattiste, P., Braunwald, E. Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial Am Heart J. 2005;150(1):79-88.

Pinto, D. S., Skolnick, A. H., Kirtane, A. J., Murphy, S. A., Barron, H. V., Giugliano, R. P., Cannon, C. P., Braunwald, E., Gibson, C. M. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction J Am Coll Cardiol. 2005;46(1):178-80.

Pinto, D. S., Skolnick, A. H., Kirtane, A. J., Murphy, S. A., Barron, H. V., Giugliano, R. P., Cannon, C. P., Braunwald, E., Gibson, C. M. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction J Am Coll Cardiol. 2005;46(1):178-80.

Pinto, D. S., Skolnick, A. H., Kirtane, A. J., Murphy, S. A., Barron, H. V., Giugliano, R. P., Cannon, C. P., Braunwald, E., Gibson, C. M. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction J Am Coll Cardiol. 2005;46(1):178-80.

Ranade, K., Kirchgessner, T. G., Iakoubova, O. A., Devlin, J. J., DelMonte, T., Vishnupad, P., Hui, L., Tsuchihashi, Z., Sacks, F. M., Sabatine, M. S., Braunwald, E., White, T. J., Shaw, P. M., Dracopoli, N. C. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke Stroke. 2005;36(11):2346-50. Abstract

Ranade, K., Kirchgessner, T. G., Iakoubova, O. A., Devlin, J. J., DelMonte, T., Vishnupad, P., Hui, L., Tsuchihashi, Z., Sacks, F. M., Sabatine, M. S., Braunwald, E., White, T. J., Shaw, P. M., Dracopoli, N. C. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke Stroke. 2005;36(11):2346-50. Abstract

Ray, K. K., Cannon, C. P. Early time to benefit with intensive statin treatment: could it be the pleiotropic effects? Am J Cardiol. 2005;96(5A):54F-60F. Abstract

Ray, K. K., Cannon, C. P. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes J Am Coll Cardiol. 2005;46(8):1425-33. Abstract

Ray, K. K., Cannon, C. P., Cairns, R., Morrow, D. A., Rifai, N., Kirtane, A. J., McCabe, C. H., Skene, A. M., Gibson, C. M., Ridker, P. M., Braunwald, E. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial J Am Coll Cardiol. 2005;46(8):1417-24.

Ray, K. K., Cannon, C. P., Cairns, R., Morrow, D. A., Rifai, N., Kirtane, A. J., McCabe, C. H., Skene, A. M., Gibson, C. M., Ridker, P. M., Braunwald, E. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial J Am Coll Cardiol. 2005;46(8):1417-24.

Ray, K. K., Cannon, C. P., McCabe, C. H., Cairns, R., Tonkin, A. M., Sacks, F. M., Jackson, G., Braunwald, E. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial J Am Coll Cardiol. 2005;46(8):1405-10.

Ray, K. K., Cannon, C. P., McCabe, C. H., Cairns, R., Tonkin, A. M., Sacks, F. M., Jackson, G., Braunwald, E. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial J Am Coll Cardiol. 2005;46(8):1405-10.

Ray, K. K., Morrow, D. A., Gibson, C. M., Murphy, S., Antman, E. M., Braunwald, E. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy Eur Heart J. 2005;26(5):440-6.

Ray, K. K., Morrow, D. A., Gibson, C. M., Murphy, S., Antman, E. M., Braunwald, E. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy Eur Heart J. 2005;26(5):440-6.

Reid, I. R., Tonkin, A., Cannon, C. P. Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial--secondary analysis of a randomized controlled trial Bone. 2005;37(2):190-1.

Reid, I. R., Tonkin, A., Cannon, C. P. Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial--secondary analysis of a randomized controlled trial Bone. 2005;37(2):190-1.

Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., Braunwald, E. C-reactive protein levels and outcomes after statin therapy N Engl J Med. 2005;352(1):20-8.

Ridker, P. M., Morrow, D. A., Rose, L. M., Rifai, N., Cannon, C. P., Braunwald, E. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial J Am Coll Cardiol. 2005;45(10):1644-8.

Sabatine, M. S., Blake, G. J., Drazner, M. H., Morrow, D. A., Scirica, B. M., Murphy, S. A., McCabe, C. H., Weintraub, W. S., Gibson, C. M., Cannon, C. P. Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment Circulation. 2005;111(10):1217-24.

Sabatine, M. S., Blake, G. J., Drazner, M. H., Morrow, D. A., Scirica, B. M., Murphy, S. A., McCabe, C. H., Weintraub, W. S., Gibson, C. M., Cannon, C. P. Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment Circulation. 2005;111(10):1217-24.

Sabatine, M. S., Cannon, C. P., Gibson, C. M., Lopez-Sendon, J. L., Montalescot, G., Theroux, P., Claeys, M. J., Cools, F., Hill, K. A., Skene, A. M., McCabe, C. H., Braunwald, E. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med. 2005;352(12):1179-89.

Sabatine, M. S., Cannon, C. P., Gibson, C. M., Lopez-Sendon, J. L., Montalescot, G., Theroux, P., Lewis, B. S., Murphy, S. A., McCabe, C. H., Braunwald, E. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study JAMA. 2005;294(10):1224-32.

Sabatine, M. S., Liu, E., Morrow, D. A., Heller, E., McCarroll, R., Wiegand, R., Berriz, G. F., Roth, F. P., Gerszten, R. E. Metabolomic identification of novel biomarkers of myocardial ischemia Circulation. 2005;112(25):3868-75. Abstract

Sabatine, M. S., Liu, E., Morrow, D. A., Heller, E., McCarroll, R., Wiegand, R., Berriz, G. F., Roth, F. P., Gerszten, R. E. Metabolomic identification of novel biomarkers of myocardial ischemia Circulation. 2005;112(25):3868-75. Abstract

Sabatine, M. S., McCabe, C. H., Gibson, C. M., Cannon, C. P. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial Am Heart J. 2005;149(2):227-33.

Sabatine, M. S., Morrow, D. A., Giugliano, R. P., Burton, P. B., Murphy, S. A., McCabe, C. H., Gibson, C. M., Braunwald, E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation. 2005;111(16):2042-9. Abstract

Sabatine, M. S., Morrow, D. A., Giugliano, R. P., Burton, P. B., Murphy, S. A., McCabe, C. H., Gibson, C. M., Braunwald, E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation. 2005;111(16):2042-9. Abstract

Scirica, B. M., Cannon, C. P. Treatment of elevated cholesterol Circulation. 2005;111(21):e360-3.

Scirica, B. M., Cannon, C. P. Treatment of elevated cholesterol Circulation. 2005;111(21):e360-3.

Scirica, B. M., Cannon, C. P. Treatment of elevated cholesterol Circulation. 2005;111(21):e360-3.

Smith, C. S., Cannon, C. P., McCabe, C. H., Murphy, S. A., Bentley, J., Braunwald, E. Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial Am Heart J. 2005;149(3):444-50. Abstract

Steinberg, B. A., Braganza, A. J., Eminowicz, G., Dibattiste, P. M., Flaker, G. C., Murphy, S. A., Cannon, C. P. Are statins being underdosed in clinical practice? Data from TACTICS-TIMI 18 Crit Pathw Cardiol. 2005;4(4):169-73. Abstract

Wiviott, S. D., Antman, E. M., Winters, K. J., Weerakkody, G., Murphy, S. A., Behounek, B. D., Carney, R. J., Lazzam, C., McKay, R. G., McCabe, C. H., Braunwald, E. Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial Circulation. 2005;111(25):3366-73.

Wiviott, S. D., Antman, E. M., Winters, K. J., Weerakkody, G., Murphy, S. A., Behounek, B. D., Carney, R. J., Lazzam, C., McKay, R. G., McCabe, C. H., Braunwald, E. Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial Circulation. 2005;111(25):3366-73.

Wiviott, S. D., Antman, E. M., Winters, K. J., Weerakkody, G., Murphy, S. A., Behounek, B. D., Carney, R. J., Lazzam, C., McKay, R. G., McCabe, C. H., Braunwald, E. Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial Circulation. 2005;111(25):3366-73.

Wiviott, S. D., Cannon, C. P., Morrow, D. A., Ray, K. K., Pfeffer, M. A., Braunwald, E. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy J Am Coll Cardiol. 2005;46(8):1411-6.

Wiviott, S. D., Cannon, C. P., Morrow, D. A., Ray, K. K., Pfeffer, M. A., Braunwald, E. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy J Am Coll Cardiol. 2005;46(8):1411-6.

Ahmed, S., Antman, E. M., Murphy, S. A., Giugliano, R. P., Cannon, C. P., White, H., Morrow, D. A., Braunwald, E. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials) J Thromb Thrombolysis. 2006;21(2):119-29. Abstract

Ahmed, S., Antman, E. M., Murphy, S. A., Giugliano, R. P., Cannon, C. P., White, H., Morrow, D. A., Braunwald, E. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials) J Thromb Thrombolysis. 2006;21(2):119-29. Abstract

Ahmed, S., Cannon, C. P., Murphy, S. A., Braunwald, E. Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial Eur Heart J. 2006;27(19):2323-9.

Antman, E. M., Morrow, D. A., McCabe, C. H., Murphy, S. A., Ruda, M., Sadowski, Z., Budaj, A., Lopez-Sendon, J. L., Guneri, S., Jiang, F., White, H. D., Fox, K. A., Braunwald, E. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction N Engl J Med. 2006;354(14):1477-88.

Antman, E. M., Morrow, D. A., McCabe, C. H., Murphy, S. A., Ruda, M., Sadowski, Z., Budaj, A., Lopez-Sendon, J. L., Guneri, S., Jiang, F., White, H. D., Fox, K. A., Braunwald, E. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction N Engl J Med. 2006;354(14):1477-88.

Atar, S., Cannon, C. P., Murphy, S. A., Rosanio, S., Uretsky, B. F., Birnbaum, Y. Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial Am Heart J. 2006;151(5):976 e1-6. Abstract

Bhadriraju, S., Ray, K. K., DeFranco, A. C., Barber, K., Bhadriraju, P., Murphy, S. A., Morrow, D. A., McCabe, C. H., Gibson, C. M., Cannon, C. P., Braunwald, E. Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial Am J Cardiol. 2006;97(11):1573-7. Abstract

Cannon, C. P. Evolving management of ST-segment elevation myocardial infarction: update on recent data Am J Cardiol. 2006;98(12A):10Q-21Q. Abstract

Cannon, C. P. Evolving management of ST-segment elevation myocardial infarction: update on recent data Am J Cardiol. 2006;98(12A):10Q-21Q. Abstract

Cannon, C. P. Evolving management of ST-segment elevation myocardial infarction: update on recent data Am J Cardiol. 2006;98(12A):10Q-21Q. Abstract

Cannon, C. P., Curtis, S. P., Bolognese, J. A., Laine, L. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis Am Heart J. 2006;152(2):237-45. Abstract

Cannon, C. P., Curtis, S. P., Bolognese, J. A., Laine, L. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis Am Heart J. 2006;152(2):237-45. Abstract

Cannon, C. P., Curtis, S. P., Bolognese, J. A., Laine, L. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis Am Heart J. 2006;152(2):237-45. Abstract

Cannon, C. P., McLean, D. S. Critical pathways using platelet testing to potentially optimize the use of oral antiplatelet therapy Am J Cardiol. 2006;98(10A):33N-38N. Abstract

Cannon, C. P., McLean, D. S. Critical pathways using platelet testing to potentially optimize the use of oral antiplatelet therapy Am J Cardiol. 2006;98(10A):33N-38N. Abstract

Cannon, C. P., Steinberg, B. A., Murphy, S. A., Mega, J. L., Braunwald, E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy J Am Coll Cardiol. 2006;48(3):438-45. Abstract

Cannon, C. P., Steinberg, B. A., Murphy, S. A., Mega, J. L., Braunwald, E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy J Am Coll Cardiol. 2006;48(3):438-45. Abstract

Charytan, D., Mauri, L., Agarwal, A., Servoss, S., Scirica, B., Kuntz, R. E. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients Am Heart J. 2006;152(3):558-64. Abstract

Charytan, D., Mauri, L., Agarwal, A., Servoss, S., Scirica, B., Kuntz, R. E. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients Am Heart J. 2006;152(3):558-64. Abstract

Dumaine, R., Gibson, C. M., Murphy, S. A., Southard, M., Ly, H. Q., McCabe, C. H., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome J Clin Hypertens (Greenwich). 2006;8(5):315-22. Abstract

Dumaine, R., Gibson, C. M., Murphy, S. A., Southard, M., Ly, H. Q., McCabe, C. H., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome J Clin Hypertens (Greenwich). 2006;8(5):315-22. Abstract

Gibson, C. M., Karmpaliotis, D., Kosmidou, I., Murphy, S. A., Kirtane, A. J., Budiu, D., Ray, K. K., Herrmann, H. C., Lakkis, N., Kovach, R., French, W., Blankenship, J., Lui, H. H., Palabrica, T., Jennings, L. K., Cohen, D. J., Morrow, D. A. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome Am J Cardiol. 2006;97(10):1473-7.

Gibson, C. M., Kirtane, A. J., Morrow, D. A., Palabrica, T. M., Murphy, S. A., Stone, P. H., Scirica, B. M., Jennings, L. K., Herrmann, H. C., Cohen, D. J., McCabe, C. H., Braunwald, E. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30) Am Heart J. 2006;152(4):756-61.

Gibson, C. M., Kirtane, A. J., Murphy, S. A., Rohrbeck, S., Menon, V., Lins, J., Kazziha, S., Rokos, I., Shammas, N. W., Palabrica, T. M., Fish, P., McCabe, C. H., Braunwald, E. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial Am Heart J. 2006;152(4):668-75. Abstract

Gibson, C. M., Ly, H. Q., Murphy, S. A., Ciaglo, L. N., Southard, M. C., Stein, E. B., Buros, J. L., Sabatine, M. S., Cannon, C. P. Usefulness of clopidogrel in abolishing the increased risk of reinfarction associated with higher platelet counts in patients with ST-elevation myocardial infarction (results from CLARITY-TIMI 28) Am J Cardiol. 2006;98(6):761-3.

Gibson, C. M., Morrow, D. A., Murphy, S. A., Palabrica, T. M., Jennings, L. K., Stone, P. H., Lui, H. H., Bulle, T., Lakkis, N., Kovach, R., Cohen, D. J., Fish, P., McCabe, C. H., Braunwald, E. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial J Am Coll Cardiol. 2006;47(12):2364-73.

Gibson, C. M., Morrow, D. A., Murphy, S. A., Palabrica, T. M., Jennings, L. K., Stone, P. H., Lui, H. H., Bulle, T., Lakkis, N., Kovach, R., Cohen, D. J., Fish, P., McCabe, C. H., Braunwald, E. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial J Am Coll Cardiol. 2006;47(12):2364-73.

Gibson, C. M., Zorkun, C., Molhoek, P., Zmudka, K., Greenberg, M., Mueller, H., Wesdorp, J., Louwerenburg, H., Niederman, A., Westenburg, J., Bikkina, M., Batty, J., de Winter, J., Murphy, S. A., McCabe, C. H. Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial J Thromb Thrombolysis. 2006;22(1):13-21.

Gibson, C. M., Zorkun, C., Molhoek, P., Zmudka, K., Greenberg, M., Mueller, H., Wesdorp, J., Louwerenburg, H., Niederman, A., Westenburg, J., Bikkina, M., Batty, J., de Winter, J., Murphy, S. A., McCabe, C. H. Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial J Thromb Thrombolysis. 2006;22(1):13-21.

Januzzi, J. L., Jr., Newby, L. K., Murphy, S. A., Pieper, K., Antman, E. M., Morrow, D. A., Sabatine, M. S., Ohman, E. M., Cannon, C. P., Braunwald, E. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies Am Heart J. 2006;151(2):360-6. Abstract

Januzzi, J. L., Jr., Newby, L. K., Murphy, S. A., Pieper, K., Antman, E. M., Morrow, D. A., Sabatine, M. S., Ohman, E. M., Cannon, C. P., Braunwald, E. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies Am Heart J. 2006;151(2):360-6. Abstract

Kirtane, A. J., Piazza, G., Murphy, S. A., Budiu, D., Morrow, D. A., Cohen, D. J., Peterson, E., Lakkis, N., Herrmann, H. C., Palabrica, T. M., Gibson, C. M. Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial J Am Coll Cardiol. 2006;47(12):2374-9.

Kugelmass, A. D., Sadanandan, S., Lakkis, N., Dibattiste, P. M., Robertson, D. H., Demopoulos, L. A., Gibson, C. M., Weintraub, W. S., Murphy, S. A., Cannon, C. P. Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18 Crit Pathw Cardiol. 2006;5(3):167-72.

Kugelmass, A. D., Sadanandan, S., Lakkis, N., Dibattiste, P. M., Robertson, D. H., Demopoulos, L. A., Gibson, C. M., Weintraub, W. S., Murphy, S. A., Cannon, C. P. Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18 Crit Pathw Cardiol. 2006;5(3):167-72.

Ly, H. Q., Kirtane, A. J., Murphy, S. A., Buros, J., Cannon, C. P., Braunwald, E., Gibson, C. M. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials) Am J Cardiol. 2006;98(1):5-Jan. Abstract

Ly, H. Q., Kirtane, A. J., Murphy, S. A., Buros, J., Cannon, C. P., Braunwald, E., Gibson, C. M. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials) Am J Cardiol. 2006;98(1):5-Jan. Abstract

Morrow, D. A., Scirica, B. M., Karwatowska-Prokopczuk, E., Skene, A., McCabe, C. H., Braunwald, E. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial Am Heart J. 2006;151(6):1186 e1-9. Abstract

Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Wiviott, S. D., Blazing, M. A., Shui, A., Rifai, N., Califf, R. M., Braunwald, E. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial Circulation. 2006;114(4):281-8.

Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Wiviott, S. D., Blazing, M. A., Shui, A., Rifai, N., Califf, R. M., Braunwald, E. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial Circulation. 2006;114(4):281-8.

O'Donoghue, M., Morrow, D. A., Sabatine, M. S., Murphy, S. A., McCabe, C. H., Cannon, C. P., Braunwald, E. Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial Circulation. 2006;113(14):1745-52.

O'Donoghue, M., de Lemos, J. A., Morrow, D. A., Murphy, S. A., Buros, J. L., Cannon, C. P., Sabatine, M. S. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes Circulation. 2006;114(6):550-7. Abstract

Pinto, D. S., Kirtane, A. J., Nallamothu, B. K., Murphy, S. A., Cohen, D. J., Laham, R. J., Cutlip, D. E., Bates, E. R., Frederick, P. D., Miller, D. P., Carrozza, J. P., Jr., Antman, E. M., Cannon, C. P., Gibson, C. M. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy Circulation. 2006;114(19):2019-25. Abstract

Pinto, D. S., Kirtane, A. J., Nallamothu, B. K., Murphy, S. A., Cohen, D. J., Laham, R. J., Cutlip, D. E., Bates, E. R., Frederick, P. D., Miller, D. P., Carrozza, J. P., Jr., Antman, E. M., Cannon, C. P., Gibson, C. M. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy Circulation. 2006;114(19):2019-25. Abstract

Ray, K. K., Bach, R. G., Cannon, C. P., Cairns, R., Kirtane, A. J., Wiviott, S. D., McCabe, C. H., Braunwald, E., Gibson, C. M. Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS Eur Heart J. 2006;27(19):2310-6.

Ray, K. K., Bach, R. G., Cannon, C. P., Cairns, R., Kirtane, A. J., Wiviott, S. D., McCabe, C. H., Braunwald, E., Gibson, C. M. Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS Eur Heart J. 2006;27(19):2310-6.

Sabatine, M. S., Morrow, D. A., McCabe, C. H., Antman, E. M., Gibson, C. M., Cannon, C. P. Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction Am Heart J. 2006;151(1):25-31.

Scirica, B. M., Cannon, C. P., Cooper, R., Aster, R. H., Brassard, J., McCabe, C. H., Charlesworth, A., Skene, A. M., Braunwald, E. Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial J Thromb Thrombolysis. 2006;22(2):95-102. Abstract

Scirica, B. M., Cannon, C. P., Cooper, R., Aster, R. H., Brassard, J., McCabe, C. H., Charlesworth, A., Skene, A. M., Braunwald, E. Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial J Thromb Thrombolysis. 2006;22(2):95-102. Abstract

Scirica, B. M., Morrow, D. A., Cannon, C. P., Ray, K. K., Sabatine, M. S., Jarolim, P., Shui, A., McCabe, C. H., Braunwald, E. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study J Am Coll Cardiol. 2006;47(11):2326-31.

Smith, E. E., Cannon, C. P., Murphy, S., Feske, S. K., Schwamm, L. H. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study Am Heart J. 2006;151(2):338-44. Abstract

Smith, E. E., Cannon, C. P., Murphy, S., Feske, S. K., Schwamm, L. H. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study Am Heart J. 2006;151(2):338-44. Abstract

Smith, E. E., Cannon, C. P., Murphy, S., Feske, S. K., Schwamm, L. H. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study Am Heart J. 2006;151(2):338-44. Abstract

Wallace, T. W., Abdullah, S. M., Drazner, M. H., Das, S. R., Khera, A., McGuire, D. K., Wians, F., Sabatine, M. S., Morrow, D. A., de Lemos, J. A. Prevalence and determinants of troponin T elevation in the general population Circulation. 2006;113(16):1958-65. Abstract

Wallace, T. W., Abdullah, S. M., Drazner, M. H., Das, S. R., Khera, A., McGuire, D. K., Wians, F., Sabatine, M. S., Morrow, D. A., de Lemos, J. A. Prevalence and determinants of troponin T elevation in the general population Circulation. 2006;113(16):1958-65. Abstract

Wallace, T. W., Abdullah, S. M., Drazner, M. H., Das, S. R., Khera, A., McGuire, D. K., Wians, F., Sabatine, M. S., Morrow, D. A., de Lemos, J. A. Prevalence and determinants of troponin T elevation in the general population Circulation. 2006;113(16):1958-65. Abstract

Wiviott, S. D., Antman, E. M., Gibson, C. M., Montalescot, G., Riesmeyer, J., Weerakkody, G., Winters, K. J., Warmke, J. W., McCabe, C. H., Braunwald, E. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) Am Heart J. 2006;152(4):627-35. Abstract

Wiviott, S. D., Cannon, C. P. Update on lipid-lowering therapy and LDL-cholesterol targets Nat Clin Pract Cardiovasc Med. 2006;3(8):424-36. Abstract

Wiviott, S. D., Cannon, C. P. Update on lipid-lowering therapy and LDL-cholesterol targets Nat Clin Pract Cardiovasc Med. 2006;3(8):424-36. Abstract

Wiviott, S. D., Cannon, C. P. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy Curr Opin Lipidol. 2006;17(6):626-30. Abstract

Wiviott, S. D., Cannon, C. P. Update on lipid-lowering therapy and LDL-cholesterol targets Nat Clin Pract Cardiovasc Med. 2006;3(8):424-36. Abstract

Wiviott, S. D., Morrow, D. A., Frederick, P. D., Antman, E. M., Braunwald, E., National Registry of Myocardial, Infarction Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction J Am Coll Cardiol. 2006;47(8):1553-8. Abstract

Wiviott, S. D., Morrow, D. A., Frederick, P. D., Antman, E. M., Braunwald, E., National Registry of Myocardial, Infarction Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction J Am Coll Cardiol. 2006;47(8):1553-8. Abstract

Wiviott, S. D., Morrow, D. A., Frederick, P. D., Antman, E. M., Braunwald, E., National Registry of Myocardial, Infarction Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction J Am Coll Cardiol. 2006;47(8):1553-8. Abstract

Wiviott, S. D., de Lemos, J. A., Cannon, C. P., Blazing, M., Murphy, S. A., McCabe, C. H., Califf, R., Braunwald, E. A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22 Circulation. 2006;113(11):1406-14. Abstract

de Lemos, J. A., Wiviott, S. D., Murphy, S. A., Blazing, M. A., Lewis, E. F., Califf, R. M., Pfeffer, M. A., Braunwald, E. Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial Am J Cardiol. 2006;98(6):739-42.

Bonaca, M. P., Wiviott, S. D., Sabatine, M. S., Buros, J., Murphy, S. A., Scirica, B. M., Rifai, N., Antman, E. M., Morrow, D. A. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial) Am J Cardiol. 2007;99(3):344-8.

Bonaca, M. P., Wiviott, S. D., Sabatine, M. S., Buros, J., Murphy, S. A., Scirica, B. M., Rifai, N., Antman, E. M., Morrow, D. A. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial) Am J Cardiol. 2007;99(3):344-8.

Bonaca, M. P., Wiviott, S. D., Sabatine, M. S., Buros, J., Murphy, S. A., Scirica, B. M., Rifai, N., Antman, E. M., Morrow, D. A. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial) Am J Cardiol. 2007;99(3):344-8.

Brandt, J. T., Payne, C. D., Wiviott, S. D., Weerakkody, G., Farid, N. A., Small, D. S., Jakubowski, J. A., Naganuma, H., Winters, K. J. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation Am Heart J. 2007;153(1):66 e9-16. Abstract

Brandt, J. T., Payne, C. D., Wiviott, S. D., Weerakkody, G., Farid, N. A., Small, D. S., Jakubowski, J. A., Naganuma, H., Winters, K. J. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation Am Heart J. 2007;153(1):66 e9-16. Abstract

Brandt, J. T., Payne, C. D., Wiviott, S. D., Weerakkody, G., Farid, N. A., Small, D. S., Jakubowski, J. A., Naganuma, H., Winters, K. J. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation Am Heart J. 2007;153(1):66 e9-16. Abstract

Cannon, C. P. Clopidogrel: who, when, and how? Rev Cardiovasc Med. 2007;8 Suppl 3(NA):S27-34. Abstract

Cannon, C. P. Clopidogrel: who, when, and how? Rev Cardiovasc Med. 2007;8 Suppl 3(NA):S27-34. Abstract

Cannon, C. P., Husted, S., Harrington, R. A., Scirica, B. M., Emanuelsson, H., Peters, G., Storey, R. F. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial J Am Coll Cardiol. 2007;50(19):1844-51. Abstract

Donahoe, S. M., Stewart, G. C., McCabe, C. H., Mohanavelu, S., Murphy, S. A., Cannon, C. P., Antman, E. M. Diabetes and mortality following acute coronary syndromes JAMA. 2007;298(7):765-75. Abstract

Donahoe, S. M., Stewart, G. C., McCabe, C. H., Mohanavelu, S., Murphy, S. A., Cannon, C. P., Antman, E. M. Diabetes and mortality following acute coronary syndromes JAMA. 2007;298(7):765-75. Abstract

Fox, K. A., Antman, E. M., Montalescot, G., Agewall, S., SomaRaju, B., Verheugt, F. W., Lopez-Sendon, J., Hod, H., Murphy, S. A., Braunwald, E. The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial J Am Coll Cardiol. 2007;49(23):2249-55.

Fox, K. A., Antman, E. M., Montalescot, G., Agewall, S., SomaRaju, B., Verheugt, F. W., Lopez-Sendon, J., Hod, H., Murphy, S. A., Braunwald, E. The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial J Am Coll Cardiol. 2007;49(23):2249-55.

Fox, K. A., Antman, E. M., Montalescot, G., Agewall, S., SomaRaju, B., Verheugt, F. W., Lopez-Sendon, J., Hod, H., Murphy, S. A., Braunwald, E. The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial J Am Coll Cardiol. 2007;49(23):2249-55.

Gibson, C. M., Buros, J., Ciaglo, L. N., Southard, M. C., Takao, S., Harrigan, C., Filopei, J., Lew, M., Marble, S. J., Murphy, S. A., Cohen, M. G. Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction Am J Cardiol. 2007;100(1):13-7. Abstract

Gibson, C. M., Murphy, S. A., Montalescot, G., Morrow, D. A., Ardissino, D., Cohen, M., Gulba, D. C., Kracoff, O. H., Lewis, B. S., Roguin, N., Antman, E. M., Braunwald, E. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial J Am Coll Cardiol. 2007;49(23):2238-46.

Gibson, C. M., Murphy, S. A., Montalescot, G., Morrow, D. A., Ardissino, D., Cohen, M., Gulba, D. C., Kracoff, O. H., Lewis, B. S., Roguin, N., Antman, E. M., Braunwald, E. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial J Am Coll Cardiol. 2007;49(23):2238-46.

Giraldez, R. R., Nicolau, J. C., Corbalan, R., Gurfinkel, E. P., Juarez, U., Lopez-Sendon, J., Parkhomenko, A., Molhoek, P., Mohanavelu, S., Morrow, D. A., Antman, E. M. Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis Eur Heart J. 2007;28(13):1566-73.

Giraldez, R. R., Nicolau, J. C., Corbalan, R., Gurfinkel, E. P., Juarez, U., Lopez-Sendon, J., Parkhomenko, A., Molhoek, P., Mohanavelu, S., Morrow, D. A., Antman, E. M. Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis Eur Heart J. 2007;28(13):1566-73.

Giugliano, R. P., Wiviott, S. D., Stone, P. H., Simon, D. I., Schweiger, M. J., Bouchard, A., Leesar, M. A., Goulder, M. A., Deitcher, S. R., McCabe, C. H., Braunwald, E. Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial J Am Coll Cardiol. 2007;49(25):2398-407. Abstract

Januzzi, J. L., Jr., Peacock, W. F., Maisel, A. S., Chae, C. U., Jesse, R. L., Baggish, A. L., O'Donoghue, M., Sakhuja, R., Chen, A. A., van Kimmenade, R. R., Lewandrowski, K. B., Lloyd-Jones, D. M., Wu, A. H. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study J Am Coll Cardiol. 2007;50(7):607-13. Abstract

Karmpaliotis, D., Kirtane, A. J., Ruisi, C. P., Polonsky, T., Malhotra, A., Talmor, D., Kosmidou, I., Jarolim, P., de Lemos, J. A., Sabatine, M. S., Gibson, C. M., Morrow, D. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema Chest. 2007;131(4):964-71. Abstract

Karmpaliotis, D., Kirtane, A. J., Ruisi, C. P., Polonsky, T., Malhotra, A., Talmor, D., Kosmidou, I., Jarolim, P., de Lemos, J. A., Sabatine, M. S., Gibson, C. M., Morrow, D. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema Chest. 2007;131(4):964-71. Abstract

Karmpaliotis, D., Kirtane, A. J., Ruisi, C. P., Polonsky, T., Malhotra, A., Talmor, D., Kosmidou, I., Jarolim, P., de Lemos, J. A., Sabatine, M. S., Gibson, C. M., Morrow, D. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema Chest. 2007;131(4):964-71. Abstract

Matheny, M. E., Morrow, D. A., Ohno-Machado, L., Cannon, C. P., Resnic, F. S. Validating an automated outcomes surveillance application using data from a terminated randomized, controlled trial (OPUS [TIMI-16]) AMIA Annu Symp Proc. 2007;NA(NA):1043. Abstract

McLean, D. S., Sabatine, M. S., Guo, W., McCabe, C. H., Cannon, C. P. Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28 J Thromb Thrombolysis. 2007;24(2):85-91.

Mega, J. L., Morrow, D. A., Ostor, E., Dorobantu, M., Qin, J., Antman, E. M., Braunwald, E. Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction Circulation. 2007;115(22):2822-2828. Abstract

Morello, A., Lloyd-Jones, D. M., Chae, C. U., van Kimmenade, R. R., Chen, A. C., Baggish, A. L., O'Donoghue, M., Lee-Lewandrowski, E., Januzzi, J. L., Jr. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study Am Heart J. 2007;153(1):90-7. Abstract

Morello, A., Lloyd-Jones, D. M., Chae, C. U., van Kimmenade, R. R., Chen, A. C., Baggish, A. L., O'Donoghue, M., Lee-Lewandrowski, E., Januzzi, J. L., Jr. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study Am Heart J. 2007;153(1):90-7. Abstract

Morrow, D. A., Antman, E. M., Murphy, S. A., Qin, J., Ruda, M., Guneri, S., Jacob, A. J., Budaj, A., Braunwald, E. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial Am Heart J. 2007;154(6):1078-84, 1084 e1.

Morrow, D. A., Antman, E. M., Murphy, S. A., Qin, J., Ruda, M., Guneri, S., Jacob, A. J., Budaj, A., Braunwald, E. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial Am Heart J. 2007;154(6):1078-84, 1084 e1.

Morrow, D. A., Antman, E. M., Murphy, S. A., Qin, J., Ruda, M., Guneri, S., Jacob, A. J., Budaj, A., Braunwald, E. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial Am Heart J. 2007;154(6):1078-84, 1084 e1.

Morrow, D. A., Scirica, B. M., Karwatowska-Prokopczuk, E., Murphy, S. A., Budaj, A., Varshavsky, S., Wolff, A. A., Skene, A., McCabe, C. H., Braunwald, E. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA. 2007;297(16):1775-83. Abstract

Morrow, D. A., Scirica, B. M., Karwatowska-Prokopczuk, E., Murphy, S. A., Budaj, A., Varshavsky, S., Wolff, A. A., Skene, A., McCabe, C. H., Braunwald, E. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA. 2007;297(16):1775-83. Abstract

Murphy, S. A., Cannon, C. P., Wiviott, S. D., de Lemos, J. A., Blazing, M. A., McCabe, C. H., Califf, R. M., Braunwald, E. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials) Am J Cardiol. 2007;100(7):1047-51. Abstract

Murphy, S. A., Cannon, C. P., Wiviott, S. D., de Lemos, J. A., Blazing, M. A., McCabe, C. H., Califf, R. M., Braunwald, E. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials) Am J Cardiol. 2007;100(7):1047-51. Abstract

Murphy, S. A., Gibson, C. M., Morrow, D. A., Van de Werf, F., Menown, I. B., Goodman, S. G., Mahaffey, K. W., Cohen, M., McCabe, C. H., Antman, E. M., Braunwald, E. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis Eur Heart J. 2007;28(17):2077-86. Abstract

Murphy, S. A., Gibson, C. M., Morrow, D. A., Van de Werf, F., Menown, I. B., Goodman, S. G., Mahaffey, K. W., Cohen, M., McCabe, C. H., Antman, E. M., Braunwald, E. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis Eur Heart J. 2007;28(17):2077-86. Abstract

O'Donoghue, M., Kenney, P., Oestreicher, E., Anwaruddin, S., Baggish, A. L., Krauser, D. G., Chen, A., Tung, R., Cameron, R., Januzzi, J. L., Jr. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study) Am J Cardiol. 2007;100(9):1336-40. Abstract

O'Donoghue, M., Kenney, P., Oestreicher, E., Anwaruddin, S., Baggish, A. L., Krauser, D. G., Chen, A., Tung, R., Cameron, R., Januzzi, J. L., Jr. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study) Am J Cardiol. 2007;100(9):1336-40. Abstract

Ray, K. K., Cannon, C. P., Morrow, D. A., Kirtane, A. J., Buros, J., Rifai, N., McCabe, C. H., Gibson, C. M., Braunwald, E. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18 Eur Heart J. 2007;28(7):806-13. Abstract

Ray, K. K., Morrow, D. A., Sabatine, M. S., Shui, A., Rifai, N., Cannon, C. P., Braunwald, E. Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome Circulation. 2007;115(24):3071-8.

Ray, K. K., Morrow, D. A., Sabatine, M. S., Shui, A., Rifai, N., Cannon, C. P., Braunwald, E. Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome Circulation. 2007;115(24):3071-8.

Rich, J. D., Maraganore, J. M., Young, E., Lidon, R. M., Adelman, B., Bourdon, P., Charenkavanich, S., Hirsh, J., Theroux, P., Cannon, C. P. Heparin resistance in acute coronary syndromes J Thromb Thrombolysis. 2007;23(2):93-100. Abstract

Rich, J. D., Maraganore, J. M., Young, E., Lidon, R. M., Adelman, B., Bourdon, P., Charenkavanich, S., Hirsh, J., Theroux, P., Cannon, C. P. Heparin resistance in acute coronary syndromes J Thromb Thrombolysis. 2007;23(2):93-100. Abstract

Rich, J. D., Maraganore, J. M., Young, E., Lidon, R. M., Adelman, B., Bourdon, P., Charenkavanich, S., Hirsh, J., Theroux, P., Cannon, C. P. Heparin resistance in acute coronary syndromes J Thromb Thrombolysis. 2007;23(2):93-100. Abstract

Ruff, C. T., Wiviott, S. D., Morrow, D. A., Mohanavelu, S., Murphy, S. A., Antman, E. M., Braunwald, E. TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction American Journal of Medicine. 2007;120(11):993-8. Abstract

Sabatine, M. S., Morrow, D. A., Dalby, A., Pfisterer, M., Duris, T., Lopez-Sendon, J., Murphy, S. A., Gao, R., Antman, E. M., Braunwald, E. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel J Am Coll Cardiol. 2007;49(23):2256-63.

Sabatine, M. S., Morrow, D. A., Dalby, A., Pfisterer, M., Duris, T., Lopez-Sendon, J., Murphy, S. A., Gao, R., Antman, E. M., Braunwald, E. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel J Am Coll Cardiol. 2007;49(23):2256-63.

Sabatine, M. S., Morrow, D. A., Dalby, A., Pfisterer, M., Duris, T., Lopez-Sendon, J., Murphy, S. A., Gao, R., Antman, E. M., Braunwald, E. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel J Am Coll Cardiol. 2007;49(23):2256-63.

Sabatine, M. S., Morrow, D. A., Jablonski, K. A., Rice, M. M., Warnica, J. W., Domanski, M. J., Hsia, J., Gersh, B. J., Rifai, N., Ridker, P. M., Pfeffer, M. A., Braunwald, E., Peace Investigators Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease Circulation. 2007;115(12):1528-36. Abstract

Sabatine, M. S., Morrow, D. A., O'Donoghue, M., Jablonksi, K. A., Rice, M. M., Solomon, S., Rosenberg, Y., Domanski, M. J., Hsia, J. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease Arterioscler Thromb Vasc Biol. 2007;27(11):2463-9. Abstract

Schreiner, G. C., Laine, L., Murphy, S. A., Cannon, C. P. Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed Crit Pathw Cardiol. 2007;6(4):169-72. Abstract

Schreiner, G. C., Laine, L., Murphy, S. A., Cannon, C. P. Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed Crit Pathw Cardiol. 2007;6(4):169-72. Abstract

Schreiner, G. C., Laine, L., Murphy, S. A., Cannon, C. P. Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed Crit Pathw Cardiol. 2007;6(4):169-72. Abstract

Scirica, B. M., Morrow, D. A., Cannon, C. P., de Lemos, J. A., Murphy, S., Sabatine, M. S., Wiviott, S. D., Rifai, N., McCabe, C. H., Braunwald, E., Thrombolysis in Myocardial Infarction Study, Group Clinical application of C-reactive protein across the spectrum of acute coronary syndromes Clin Chem. 2007;53(10):1800-7. Abstract

Scirica, B. M., Morrow, D. A., Cannon, C. P., de Lemos, J. A., Murphy, S., Sabatine, M. S., Wiviott, S. D., Rifai, N., McCabe, C. H., Braunwald, E., Thrombolysis in Myocardial Infarction Study, Group Clinical application of C-reactive protein across the spectrum of acute coronary syndromes Clin Chem. 2007;53(10):1800-7. Abstract

Scirica, B. M., Morrow, D. A., Cannon, C. P., de Lemos, J. A., Murphy, S., Sabatine, M. S., Wiviott, S. D., Rifai, N., McCabe, C. H., Braunwald, E., Thrombolysis in Myocardial Infarction Study, Group Clinical application of C-reactive protein across the spectrum of acute coronary syndromes Clin Chem. 2007;53(10):1800-7. Abstract

Scirica, B. M., Morrow, D. A., Hod, H., Murphy, S. A., Belardinelli, L., Hedgepeth, C. M., Molhoek, P., Verheugt, F. W., Gersh, B. J., McCabe, C. H., Braunwald, E. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation. 2007;116(15):1647-52. Abstract

Scirica, B. M., Morrow, D. A., Sadowski, Z., Ruda, M., Nicolau, J. C., Giugliano, R. P., Wiviott, S. D., Sabatine, M. S., Shui, A., Antman, E. M., Braunwald, E. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study Eur Heart J. 2007;28(17):2070-6.

Scirica, B. M., Morrow, D. A., Sadowski, Z., Ruda, M., Nicolau, J. C., Giugliano, R. P., Wiviott, S. D., Sabatine, M. S., Shui, A., Antman, E. M., Braunwald, E. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study Eur Heart J. 2007;28(17):2070-6.

Steinberg, B. A., Moghbeli, N., Buros, J., Ruda, M., Parkhomenko, A., Raju, B. S., Garcia-Castillo, A., Janion, M., Nicolau, J. C., Fox, K. A., Morrow, D. A., Gibson, C. M., Antman, E. M. Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial Am Heart J. 2007;154(1):54-61.

Steinberg, B. A., Moghbeli, N., Buros, J., Ruda, M., Parkhomenko, A., Raju, B. S., Garcia-Castillo, A., Janion, M., Nicolau, J. C., Fox, K. A., Morrow, D. A., Gibson, C. M., Antman, E. M. Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial Am Heart J. 2007;154(1):54-61.

Steinberg, B. A., Moghbeli, N., Buros, J., Ruda, M., Parkhomenko, A., Raju, B. S., Garcia-Castillo, A., Janion, M., Nicolau, J. C., Fox, K. A., Morrow, D. A., Gibson, C. M., Antman, E. M. Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial Am Heart J. 2007;154(1):54-61.

Steinberg, B. A., Steg, P. G., Bhatt, D. L., Fonarow, G. C., Zeymer, U., Cannon, C. P. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry) Am J Cardiol. 2007;99(9):1212-5. Abstract

Steinberg, B. A., Steg, P. G., Bhatt, D. L., Fonarow, G. C., Zeymer, U., Cannon, C. P. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry) Am J Cardiol. 2007;99(9):1212-5. Abstract

Storey, R. F., Husted, S., Harrington, R. A., Heptinstall, S., Wilcox, R. G., Peters, G., Wickens, M., Emanuelsson, H., Gurbel, P., Grande, P., Cannon, C. P. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes J Am Coll Cardiol. 2007;50(19):1852-6. Abstract

Storey, R. F., Husted, S., Harrington, R. A., Heptinstall, S., Wilcox, R. G., Peters, G., Wickens, M., Emanuelsson, H., Gurbel, P., Grande, P., Cannon, C. P. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes J Am Coll Cardiol. 2007;50(19):1852-6. Abstract

White, H. D., Braunwald, E., Murphy, S. A., Jacob, A. J., Gotcheva, N., Polonetsky, L., Antman, E. M. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25 Eur Heart J. 2007;28(9):1066-71.

White, H. D., Braunwald, E., Murphy, S. A., Jacob, A. J., Gotcheva, N., Polonetsky, L., Antman, E. M. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25 Eur Heart J. 2007;28(9):1066-71.

White, H. D., Braunwald, E., Murphy, S. A., Jacob, A. J., Gotcheva, N., Polonetsky, L., Antman, E. M. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25 Eur Heart J. 2007;28(9):1066-71.

Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F. J., Ardissino, D., De Servi, S., Murphy, S. A., Riesmeyer, J., Weerakkody, G., Gibson, C. M., Antman, E. M. Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med. 2007;357(20):2001-15. Abstract

Wiviott, S. D., Trenk, D., Frelinger, A. L., O'Donoghue, M., Neumann, F. J., Michelson, A. D., Angiolillo, D. J., Hod, H., Montalescot, G., Miller, D. L., Jakubowski, J. A., Cairns, R., Murphy, S. A., McCabe, C. H., Antman, E. M., Braunwald, E. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial Circulation. 2007;116(25):2923-32. Abstract

Wiviott, S. D., Trenk, D., Frelinger, A. L., O'Donoghue, M., Neumann, F. J., Michelson, A. D., Angiolillo, D. J., Hod, H., Montalescot, G., Miller, D. L., Jakubowski, J. A., Cairns, R., Murphy, S. A., McCabe, C. H., Antman, E. M., Braunwald, E. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial Circulation. 2007;116(25):2923-32. Abstract

Wiviott, S. D., Trenk, D., Frelinger, A. L., O'Donoghue, M., Neumann, F. J., Michelson, A. D., Angiolillo, D. J., Hod, H., Montalescot, G., Miller, D. L., Jakubowski, J. A., Cairns, R., Murphy, S. A., McCabe, C. H., Antman, E. M., Braunwald, E. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial Circulation. 2007;116(25):2923-32. Abstract

Yeh, R. W., Wiviott, S. D., Giugliano, R. P., Morrow, D. A., Shui, A., Qin, J., Scirica, B., Bradner, J. E., Jang, I. K., Gibson, C. M., Antman, E. M. Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes Am J Cardiol. 2007;100(12):1734-8. Abstract

de Lemos, J. A., Morrow, D. A., Blazing, M. A., Jarolim, P., Wiviott, S. D., Sabatine, M. S., Califf, R. M., Braunwald, E. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial J Am Coll Cardiol. 2007;50(22):2117-24. Abstract

Ahmed, S., Cannon, C. P., Giugliano, R. P., Murphy, S. A., Morrow, D. A., Antman, E. M., Braunwald, E., Gibson, C. M. The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes Int J Cardiol. 2008;131(1):105-12. Abstract

Ahmed, S., Cannon, C. P., Giugliano, R. P., Murphy, S. A., Morrow, D. A., Antman, E. M., Braunwald, E., Gibson, C. M. The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes Int J Cardiol. 2008;131(1):105-12. Abstract

Antman, E. M., Wiviott, S. D., Murphy, S. A., Voitk, J., Hasin, Y., Widimsky, P., Chandna, H., Macias, W., McCabe, C. H., Braunwald, E. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis J Am Coll Cardiol. 2008;51(21):2028-33. Abstract

Arnold, S. V., Morrow, D. A., Wang, K., Lei, Y., Mahoney, E. M., Scirica, B. M., Braunwald, E., Cohen, D. J. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial Circ Cardiovasc Qual Outcomes. 2008;1(2):107-15. Abstract

Arnold, S. V., Morrow, D. A., Wang, K., Lei, Y., Mahoney, E. M., Scirica, B. M., Braunwald, E., Cohen, D. J. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial Circ Cardiovasc Qual Outcomes. 2008;1(2):107-15. Abstract

Arnold, S. V., Morrow, D. A., Wang, K., Lei, Y., Mahoney, E. M., Scirica, B. M., Braunwald, E., Cohen, D. J. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial Circ Cardiovasc Qual Outcomes. 2008;1(2):107-15. Abstract

Braunwald, E., Angiolillo, D., Bates, E., Berger, P. B., Bhatt, D., Cannon, C. P., Furman, M. I., Gurbel, P., Michelson, A. D., Peterson, E., Wiviott, S. Antiplatelet therapy and platelet function testing Clin Cardiol. 2008;31(3 Suppl 1):I36.

Braunwald, E., Angiolillo, D., Bates, E., Berger, P. B., Bhatt, D., Cannon, C. P., Furman, M. I., Gurbel, P., Michelson, A. D., Peterson, E., Wiviott, S. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes Clin Cardiol. 2008;31(3 Suppl 1):I2-9. Abstract

Braunwald, E., Angiolillo, D., Bates, E., Berger, P. B., Bhatt, D., Cannon, C. P., Furman, M. I., Gurbel, P., Michelson, A. D., Peterson, E., Wiviott, S. Antiplatelet therapy and platelet function testing Clin Cardiol. 2008;31(3 Suppl 1):I36.

Braunwald, E., Angiolillo, D., Bates, E., Berger, P. B., Bhatt, D., Cannon, C. P., Furman, M. I., Gurbel, P., Michelson, A. D., Peterson, E., Wiviott, S. Investigating the mechanisms of hyporesponse to antiplatelet approaches Clin Cardiol. 2008;31(3 Suppl 1):I21-7. Abstract

Braunwald, E., Angiolillo, D., Bates, E., Berger, P. B., Bhatt, D., Cannon, C. P., Furman, M. I., Gurbel, P., Michelson, A. D., Peterson, E., Wiviott, S. Antiplatelet therapy and platelet function testing Clin Cardiol. 2008;31(3 Suppl 1):I36.

Braunwald, E., Angiolillo, D., Bates, E., Berger, P. B., Bhatt, D., Cannon, C. P., Furman, M. I., Gurbel, P., Michelson, A. D., Peterson, E., Wiviott, S. Investigating the mechanisms of hyporesponse to antiplatelet approaches Clin Cardiol. 2008;31(3 Suppl 1):I21-7. Abstract

Braunwald, E., Angiolillo, D., Bates, E., Berger, P. B., Bhatt, D., Cannon, C. P., Furman, M. I., Gurbel, P., Michelson, A. D., Peterson, E., Wiviott, S. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes Clin Cardiol. 2008;31(3 Suppl 1):I2-9. Abstract

Braunwald, E., Angiolillo, D., Bates, E., Berger, P. B., Bhatt, D., Cannon, C. P., Furman, M. I., Gurbel, P., Michelson, A. D., Peterson, E., Wiviott, S. Investigating the mechanisms of hyporesponse to antiplatelet approaches Clin Cardiol. 2008;31(3 Suppl 1):I21-7. Abstract

Brilakis, E. S., de Lemos, J. A., Cannon, C. P., Wiviott, S. D., Murphy, S. A., Morrow, D. A., Sabatine, M. S., Banerjee, S., Blazing, M. A., Califf, R. M., Braunwald, E. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials) Am J Cardiol. 2008;102(5):552-8. Abstract

Cannon CP, Giugliano RP, Blazing MA, Harrington RA, Peterson JL, Sisk CM, Strony J, Musliner TA, McCabe CH, Veltri E, Braunwald E, Califf RM. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J. 2008;156:826-32. Abstract

Cannon, C. P. Cardiovascular disease and modifiable cardiometabolic risk factors Clin Cornerstone. 2008;9(2):24-38; discussion 39-41. Abstract

Cannon, C. P. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) ST-segment elevation myocardial infarction critical pathway toolkit Crit Pathw Cardiol. 2008;7(4):223-31. Abstract

Cannon, C. P. Cardiovascular disease and modifiable cardiometabolic risk factors Clin Cornerstone. 2008;9(2):24-38; discussion 39-41. Abstract

Cannon, C. P. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) ST-segment elevation myocardial infarction critical pathway toolkit Crit Pathw Cardiol. 2008;7(4):223-31. Abstract

Cannon, C. P. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) unstable angina/non-ST elevation myocardial infarction critical pathway toolkit Crit Pathw Cardiol. 2008;7(1):43-81. Abstract

Cannon, C. P. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) unstable angina/non-ST elevation myocardial infarction critical pathway toolkit Crit Pathw Cardiol. 2008;7(1):43-81. Abstract

Cannon, C. P. Combination therapy in the management of mixed dyslipidaemia J Intern Med. 2008;263(4):353-65. Abstract

Cannon, C. P. Cardiovascular disease and modifiable cardiometabolic risk factors Clin Cornerstone. 2008;9(2):24-38; discussion 39-41. Abstract

Cannon, C. P. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) ST-segment elevation myocardial infarction critical pathway toolkit Crit Pathw Cardiol. 2008;7(4):223-31. Abstract

Cannon, C. P. Combination therapy in the management of mixed dyslipidaemia J Intern Med. 2008;263(4):353-65. Abstract

Cannon, C. P. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) unstable angina/non-ST elevation myocardial infarction critical pathway toolkit Crit Pathw Cardiol. 2008;7(1):43-81. Abstract

Cannon, C. P., Greenberg, B. H. Risk stratification and prognostic factors in the post-myocardial infarction patient Am J Cardiol. 2008;102(5A):13G-20G. Abstract

Cannon, C. P., Greenberg, B. H. Risk stratification and prognostic factors in the post-myocardial infarction patient Am J Cardiol. 2008;102(5A):13G-20G. Abstract

Gibson, C. M., Murphy, S. A., Pride, Y. B., Kirtane, A. J., Aroesty, J. M., Stein, E. B., Ciaglo, L. N., Southard, M. C., Sabatine, M. S., Cannon, C. P., Braunwald, E. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study Am Heart J. 2008;155(1):133-9.

Gibson, C. M., Pride, Y. B., Buros, J. L., Lord, E., Shui, A., Murphy, S. A., Pinto, D. S., Zimetbaum, P. J., Sabatine, M. S., Cannon, C. P., Josephson, M. E. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction J Am Coll Cardiol. 2008;51(5):546-51.

Giraldez, R. R., Giugliano, R. P., Mohanavelu, S., Murphy, S. A., McCabe, C. H., Cannon, C. P., Braunwald, E. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis J Am Coll Cardiol. 2008;52(11):914-20.

Giraldez, R. R., Giugliano, R. P., Mohanavelu, S., Murphy, S. A., McCabe, C. H., Cannon, C. P., Braunwald, E. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis J Am Coll Cardiol. 2008;52(11):914-20.

Green, S. M., Martinez-Rumayor, A., Gregory, S. A., Baggish, A. L., O'Donoghue, M. L., Green, J. A., Lewandrowski, K. B., Januzzi, J. L., Jr. Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea Arch Intern Med. 2008;168(7):741-8. Abstract

Green, S. M., Martinez-Rumayor, A., Gregory, S. A., Baggish, A. L., O'Donoghue, M. L., Green, J. A., Lewandrowski, K. B., Januzzi, J. L., Jr. Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea Arch Intern Med. 2008;168(7):741-8. Abstract

Green, S. M., Martinez-Rumayor, A., Gregory, S. A., Baggish, A. L., O'Donoghue, M. L., Green, J. A., Lewandrowski, K. B., Januzzi, J. L., Jr. Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea Arch Intern Med. 2008;168(7):741-8. Abstract

Hsia, J., Jablonski, K. A., Rice, M. M., Sabatine, M. S., Zabalgoitia, M., Maggioni, A., Cuddy, T. E., Domanski, M. J., Geller, N. L., Flaker, G., Solomon, S., Omland, T., Rouleau, J. L., Peace Investigators Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function Am J Cardiol. 2008;101(4):457-61. Abstract

Iakoubova, O. A., Sabatine, M. S., Rowland, C. M., Tong, C. H., Catanese, J. J., Ranade, K., Simonsen, K. L., Kirchgessner, T. G., Cannon, C. P., Devlin, J. J., Braunwald, E. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study J Am Coll Cardiol. 2008;51(4):449-55.

Iakoubova, O. A., Tong, C. H., Rowland, C. M., Kirchgessner, T. G., Young, B. A., Arellano, A. R., Shiffman, D., Sabatine, M. S., Campos, H., Packard, C. J., Pfeffer, M. A., White, T. J., Braunwald, E., Shepherd, J., Devlin, J. J., Sacks, F. M. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials J Am Coll Cardiol. 2008;51(4):435-43. Abstract

Lotfi, A., Schweiger, M. J., Giugliano, G. R., Murphy, S. A., Cannon, C. P. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis Am Heart J. 2008;155(5):954-8.

Lotfi, A., Schweiger, M. J., Giugliano, G. R., Murphy, S. A., Cannon, C. P. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis Am Heart J. 2008;155(5):954-8.

McLean, D. S., Ravid, S., Blazing, M., Gersh, B., Shui, A., Cannon, C. P. Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials Am Heart J. 2008;155(2):298-302. Abstract

McLean, D. S., Ravid, S., Blazing, M., Gersh, B., Shui, A., Cannon, C. P. Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials Am Heart J. 2008;155(2):298-302. Abstract

Mega, J. L., Morrow, D. A., de Lemos, J. A., Mohanavelu, S., Cannon, C. P., Sabatine, M. S. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes J Am Coll Cardiol. 2008;51(25):2422-9. Abstract

Miller, M., Cannon, C. P., Murphy, S. A., Qin, J., Ray, K. K., Braunwald, E. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial J Am Coll Cardiol. 2008;51(7):724-30.

Miller, M., Cannon, C. P., Murphy, S. A., Qin, J., Ray, K. K., Braunwald, E. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial J Am Coll Cardiol. 2008;51(7):724-30.

Morrow, D. A., Sabatine, M. S., Brennan, M. L., de Lemos, J. A., Murphy, S. A., Ruff, C. T., Rifai, N., Cannon, C. P., Hazen, S. L. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 Eur Heart J. 2008;29(9):1096-102.

Murphy, S. A., Antman, E. M., Wiviott, S. D., Weerakkody, G., Morocutti, G., Huber, K., Lopez-Sendon, J., McCabe, C. H., Braunwald, E. Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial Eur Heart J. 2008;29(20):2473-9. Abstract

Murphy, S. A., Antman, E. M., Wiviott, S. D., Weerakkody, G., Morocutti, G., Huber, K., Lopez-Sendon, J., McCabe, C. H., Braunwald, E. Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial Eur Heart J. 2008;29(20):2473-9. Abstract

O'Donoghue, M., Boden, W. E., Braunwald, E., Cannon, C. P., Clayton, T. C., de Winter, R. J., Fox, K. A., Lagerqvist, B., McCullough, P. A., Murphy, S. A., Spacek, R., Swahn, E., Wallentin, L., Windhausen, F., Sabatine, M. S. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis JAMA. 2008;300(1):71-80. Abstract

O'Donoghue, M., Boden, W. E., Braunwald, E., Cannon, C. P., Clayton, T. C., de Winter, R. J., Fox, K. A., Lagerqvist, B., McCullough, P. A., Murphy, S. A., Spacek, R., Swahn, E., Wallentin, L., Windhausen, F., Sabatine, M. S. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis JAMA. 2008;300(1):71-80. Abstract

Olenchock, B. A., Wiviott, S. D., Murphy, S. A., Cannon, C. P., Rifai, N., Braunwald, E., Morrow, D. A. Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16 J Thromb Thrombolysis. 2008;26(2):79-84. Abstract

Olenchock, B. A., Wiviott, S. D., Murphy, S. A., Cannon, C. P., Rifai, N., Braunwald, E., Morrow, D. A. Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16 J Thromb Thrombolysis. 2008;26(2):79-84. Abstract

Sabatine, M. S., Hamdalla, H. N., Mehta, S. R., Fox, K. A., Topol, E. J., Steinhubl, S. R., Cannon, C. P. Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use Am Heart J. 2008;155(5):910-7.

Sabatine, M. S., Ploughman, L., Simonsen, K. L., Iakoubova, O. A., Kirchgessner, T. G., Ranade, K., Tsuchihashi, Z., Zerba, K. E., Long, D. U., Tong, C. H., Packard, C. J., Pfeffer, M. A., Devlin, J. J., Shepherd, J., Campos, H., Sacks, F. M., Braunwald, E. Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy Arterioscler Thromb Vasc Biol. 2008;28(3):562-7. Abstract

Wiviott, S. D., Braunwald, E., Angiolillo, D. J., Meisel, S., Dalby, A. J., Verheugt, F. W., Goodman, S. G., Corbalan, R., Purdy, D. A., Murphy, S. A., McCabe, C. H., Antman, E. M. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38 Circulation. 2008;118(16):1626-36. Abstract

Wiviott, S. D., Braunwald, E., McCabe, C. H., Horvath, I., Keltai, M., Herrman, J. P., Van de Werf, F., Downey, W. E., Scirica, B. M., Murphy, S. A., Antman, E. M. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet. 2008;371(9621):1353-63. Abstract

Wiviott, S. D., Braunwald, E., Murphy, S. A., Antman, E. M. A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38 Am J Cardiol. 2008;101(9):1367-70.

Wiviott, S. D., Braunwald, E., Murphy, S. A., Antman, E. M. A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38 Am J Cardiol. 2008;101(9):1367-70.

Arnold, S. V., Morrow, D. A., Lei, Y., Cohen, D. J., Mahoney, E. M., Braunwald, E., Chan, P. S. Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial Circulation Cardiovascular quality and outcomes. 2009;2(4):344-53. Abstract

Arnold, S. V., Morrow, D. A., Lei, Y., Cohen, D. J., Mahoney, E. M., Braunwald, E., Chan, P. S. Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial Circulation Cardiovascular quality and outcomes. 2009;2(4):344-53. Abstract

Berger, J. S., Bhatt, D. L., Cannon, C. P., Chen, Z., Jiang, L., Jones, J. B., Mehta, S. R., Sabatine, M. S., Steinhubl, S. R., Topol, E. J., Berger, P. B. The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis J Am Coll Cardiol. 2009;54(21):1935-45. Abstract

Berger, J. S., Bhatt, D. L., Cannon, C. P., Chen, Z., Jiang, L., Jones, J. B., Mehta, S. R., Sabatine, M. S., Steinhubl, S. R., Topol, E. J., Berger, P. B. The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis J Am Coll Cardiol. 2009;54(21):1935-45. Abstract

Berger, J. S., Bhatt, D. L., Cannon, C. P., Chen, Z., Jiang, L., Jones, J. B., Mehta, S. R., Sabatine, M. S., Steinhubl, S. R., Topol, E. J., Berger, P. B. The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis J Am Coll Cardiol. 2009;54(21):1935-45. Abstract

Braunwald, E. [TIMI group study of thrombolysis in myocardial infarction] Ter Arkh. 2009;81(5):78-84. Abstract

Braunwald, E. [TIMI group study of thrombolysis in myocardial infarction] Ter Arkh. 2009;81(5):78-84. Abstract

Cannon, C. P., Dansky, H. M., Davidson, M., Gotto, A. M., Jr., Brinton, E. A., Gould, A. L., Stepanavage, M., Liu, S. X., Shah, S., Rubino, J., Gibbons, P., Hermanowski-Vosatka, A., Binkowitz, B., Mitchel, Y., Barter, P. Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib Am Heart J. 2009;158(4):513-519 e3. Abstract

Cheng, S., Morrow, D. A., Sloan, S., Antman, E. M., Sabatine, M. S. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction Circulation. 2009;119(9):1195-202.

Cheng, S., Morrow, D. A., Sloan, S., Antman, E. M., Sabatine, M. S. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction Circulation. 2009;119(9):1195-202.

Diercks, D. B., Kontos, M. C., Chen, A. Y., Pollack, C. V., Jr., Wiviott, S. D., Rumsfeld, J. S., Magid, D. J., Gibler, W. B., Cannon, C. P., Peterson, E. D., Roe, M. T. Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry J Am Coll Cardiol. 2009;53(2):161-6. Abstract

Diercks, D. B., Kontos, M. C., Chen, A. Y., Pollack, C. V., Jr., Wiviott, S. D., Rumsfeld, J. S., Magid, D. J., Gibler, W. B., Cannon, C. P., Peterson, E. D., Roe, M. T. Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry J Am Coll Cardiol. 2009;53(2):161-6. Abstract

Gibson, C. M., Mega, J. L., Jennings, L. K., Mohanavelu, S., Misselwitz, F., Plotnikov, A., Sun, X., Zolynas, R., Braunwald, E. Effect of Rivaroxaban on Markers of Coagulation in Patients With Acute Coronary Syndromes: An ATLAS ACS-TIMI 46 Substudy Circulation. 2009;120(18):S1035-S1035.

Gibson, C. M., Pride, Y. B., Aylward, P. E., Col, J. J., Goodman, S. G., Gulba, D., Bergovec, M., Kunadian, V., Zorkun, C., Buros, J. L., Murphy, S. A., Antman, E. M. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis J Thromb Thrombolysis. 2009;27(1):7-Nov.

Gibson, C. M., Pride, Y. B., Buros, J. L., Ciaglo, L. N., Morrow, D. A., Scirica, B. M., Stone, P. H. Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis) Am J Cardiol. 2009;104(1):36-40.

Gibson, C. M., Pride, Y. B., Hochberg, C. P., Sloan, S., Sabatine, M. S., Cannon, C. P. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy J Am Coll Cardiol. 2009;54(24):2290-5.

Gibson, C. M., Pride, Y. B., Hochberg, C. P., Sloan, S., Sabatine, M. S., Cannon, C. P. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy J Am Coll Cardiol. 2009;54(24):2290-5.

Giraldez, R. R., Sabatine, M. S., Morrow, D. A., Mohanavelu, S., McCabe, C. H., Antman, E. M., Braunwald, E. Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction American heart journal. 2009;157(3):517-24. Abstract

Giraldez, R. R., Sabatine, M. S., Morrow, D. A., Mohanavelu, S., McCabe, C. H., Antman, E. M., Braunwald, E. Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction American heart journal. 2009;157(3):517-24. Abstract

Giraldez, R. R., Wiviott, S. D., Nicolau, J. C., Mohanavelu, S., Morrow, D. A., Antman, E. M., Giugliano, R. P. Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis Drugs. 2009;69(11):1433-43. Abstract

Giugliano, R. P., White, J. A., Bode, C., Armstrong, P. W., Montalescot, G., Lewis, B. S., van 't Hof, A., Berdan, L. G., Lee, K. L., Strony, J. T., Hildemann, S., Veltri, E., Van de Werf, F., Braunwald, E., Harrington, R. A., Califf, R. M., Newby, L. K. Early versus delayed, provisional eptifibatide in acute coronary syndromes N Engl J Med. 2009;360(21):2176-90. Abstract

Husted, S., Harrington, R. A., Cannon, C. P., Storey, R. F., Mitchell, P., Emanuelsson, H. Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial Int J Clin Pract. 2009;63(4):667-70. Abstract

Keshishian, H., Addona, T., Burgess, M., Mani, D. R., Shi, X., Kuhn, E., Sabatine, M. S., Gerszten, R. E., Carr, S. A. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution Mol Cell Proteomics. 2009;8(10):2339-49. Abstract

Keshishian, H., Addona, T., Burgess, M., Mani, D. R., Shi, X., Kuhn, E., Sabatine, M. S., Gerszten, R. E., Carr, S. A. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution Mol Cell Proteomics. 2009;8(10):2339-49. Abstract

Keshishian, H., Addona, T., Burgess, M., Mani, D. R., Shi, X., Kuhn, E., Sabatine, M. S., Gerszten, R. E., Carr, S. A. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution Mol Cell Proteomics. 2009;8(10):2339-49. Abstract

Kuhn, E., Addona, T., Keshishian, H., Burgess, M., Mani, D. R., Lee, R. T., Sabatine, M. S., Gerszten, R. E., Carr, S. A. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry Clin Chem. 2009;55(6):1108-17. Abstract

Kuhn, E., Addona, T., Keshishian, H., Burgess, M., Mani, D. R., Lee, R. T., Sabatine, M. S., Gerszten, R. E., Carr, S. A. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry Clin Chem. 2009;55(6):1108-17. Abstract

Kuhn, E., Addona, T., Keshishian, H., Burgess, M., Mani, D. R., Lee, R. T., Sabatine, M. S., Gerszten, R. E., Carr, S. A. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry Clin Chem. 2009;55(6):1108-17. Abstract

Matheny, M. E., Morrow, D. A., Ohno-Machado, L., Cannon, C. P., Sabatine, M. S., Resnic, F. S. Validation of an automated safety surveillance system with prospective, randomized trial data Med Decis Making. 2009;29(2):247-56. Abstract

Matheny, M. E., Morrow, D. A., Ohno-Machado, L., Cannon, C. P., Sabatine, M. S., Resnic, F. S. Validation of an automated safety surveillance system with prospective, randomized trial data Med Decis Making. 2009;29(2):247-56. Abstract

Matheny, M. E., Morrow, D. A., Ohno-Machado, L., Cannon, C. P., Sabatine, M. S., Resnic, F. S. Validation of an automated safety surveillance system with prospective, randomized trial data Med Decis Making. 2009;29(2):247-56. Abstract

Matheny, M. E., Morrow, D. A., Ohno-Machado, L., Cannon, C. P., Sabatine, M. S., Resnic, F. S. Validation of an automated safety surveillance system with prospective, randomized trial data Med Decis Making. 2009;29(2):247-56. Abstract

Mega, J. L., Braunwald, E., Lee, M., Misselwitz, F., Mohanavelu, S., Notani, R., Peters, G., Gibson, C. M. Cessation of Rivaroxaban in Post-ACS Patients is Not Associated With Clinical Evidence of Rebound Hypercoagulability: An ATLAS ACS-TIMI 46 Substudy Circulation. 2009;120(18):S1002-S1002.

Mega, J. L., Braunwald, E., Mohanavelu, S., Burton, P., Poulter, R., Misselwitz, F., Hricak, V., Barnathan, E. S., Bordes, P., Witkowski, A., Markov, V., Oppenheimer, L., Gibson, C. M. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial Lancet. 2009;374(9683):29-38. Abstract

Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Hockett, R. D., Brandt, J. T., Walker, J. R., Antman, E. M., Macias, W., Braunwald, E., Sabatine, M. S. Cytochrome p-450 polymorphisms and response to clopidogrel New England journal of medicine. 2009;360(4):354-62. Abstract

Mega, J. L., Morrow, D. A., Brown, A., Cannon, C. P., Sabatine, M. S. Identification of genetic variants associated with response to statin therapy Arteriosclerosis, thrombosis, and vascular biology. 2009;29(9):1310-5. Abstract

Michelson, A. D., Frelinger, A. L., 3rd, Braunwald, E., Downey, W. E., Angiolillo, D. J., Xenopoulos, N. P., Jakubowski, J. A., Li, Y., Murphy, S. A., Qin, J., McCabe, C. H., Antman, E. M., Wiviott, S. D. Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial European heart journal. 2009;30(14):1753-63. Abstract

Michelson, A. D., Frelinger, A. L., 3rd, Braunwald, E., Downey, W. E., Angiolillo, D. J., Xenopoulos, N. P., Jakubowski, J. A., Li, Y., Murphy, S. A., Qin, J., McCabe, C. H., Antman, E. M., Wiviott, S. D. Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial European heart journal. 2009;30(14):1753-63. Abstract

Montalescot, G., Wiviott, S. D., Braunwald, E., Murphy, S. A., Gibson, C. M., McCabe, C. H., Antman, E. M. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet. 2009;373(9665):723-31. Abstract

Morrow DA, Scirica BM, Fox KA, Berman G, Strony J, Veltri E, Bonaca MP, Fish P, McCabe CH, Braunwald E. Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2˚P)-TIMI 50 trial. Am Heart J. 2009;158:335-341 e3. Abstract

Morrow DA, Scirica BM, Fox KA, Berman G, Strony J, Veltri E, Bonaca MP, Fish P, McCabe CH, Braunwald E. Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2˚P)-TIMI 50 trial. Am Heart J. 2009;158:335-341 e3. Abstract

Morrow, D. A., Brickman, C. M., Murphy, S. A., Baran, K., Krakover, R., Dauerman, H., Kumar, S., Slomowitz, N., Grip, L., McCabe, C. H., Salzman, A. L. A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial J Thromb Thrombolysis. 2009;27(4):359-64. Abstract

Morrow, D. A., Brickman, C. M., Murphy, S. A., Baran, K., Krakover, R., Dauerman, H., Kumar, S., Slomowitz, N., Grip, L., McCabe, C. H., Salzman, A. L. A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial J Thromb Thrombolysis. 2009;27(4):359-64. Abstract

Morrow, D. A., Brickman, C. M., Murphy, S. A., Baran, K., Krakover, R., Dauerman, H., Kumar, S., Slomowitz, N., Grip, L., McCabe, C. H., Salzman, A. L. A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial J Thromb Thrombolysis. 2009;27(4):359-64. Abstract

Morrow, D. A., Brickman, C. M., Murphy, S. A., Baran, K., Krakover, R., Dauerman, H., Kumar, S., Slomowitz, N., Grip, L., McCabe, C. H., Salzman, A. L. A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial J Thromb Thrombolysis. 2009;27(4):359-64. Abstract

Morrow, D. A., Scirica, B. M., Chaitman, B. R., McGuire, D. K., Murphy, S. A., Karwatowska-Prokopczuk, E., McCabe, C. H., Braunwald, E. Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial Circulation. 2009;119(15):2032-9. Abstract

Morrow, D. A., Wiviott, S. D., White, H. D., Nicolau, J. C., Bramucci, E., Murphy, S. A., Bonaca, M. P., Ruff, C. T., Scirica, B. M., McCabe, C. H., Antman, E. M., Braunwald, E. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction Circulation. 2009;119(21):2758-64. Abstract

Murphy, S. A., Cannon, C. P., Wiviott, S. D., McCabe, C. H., Braunwald, E. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial Journal of the American College of Cardiology. 2009;54(25):2358-62. Abstract

O'Donoghue, M. L., Braunwald, E., Antman, E. M., Murphy, S. A., Bates, E. R., Rozenman, Y., Michelson, A. D., Hautvast, R. W., Ver Lee, P. N., Close, S. L., Shen, L., Mega, J. L., Sabatine, M. S., Wiviott, S. D. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials Lancet. 2009;374(9694):989-97. Abstract

O'Donoghue, M. L., Braunwald, E., Antman, E. M., Murphy, S. A., Bates, E. R., Rozenman, Y., Michelson, A. D., Hautvast, R. W., Ver Lee, P. N., Close, S. L., Shen, L., Mega, J. L., Sabatine, M. S., Wiviott, S. D. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials Lancet. 2009;374(9694):989-97. Abstract

O'Donoghue, M. L., Braunwald, E., Antman, E. M., Murphy, S. A., Bates, E. R., Rozenman, Y., Michelson, A. D., Hautvast, R. W., Ver Lee, P. N., Close, S. L., Shen, L., Mega, J. L., Sabatine, M. S., Wiviott, S. D. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials Lancet. 2009;374(9694):989-97. Abstract

O'Donoghue, M., Antman, E. M., Braunwald, E., Murphy, S. A., Steg, P. G., Finkelstein, A., Penny, W. F., Fridrich, V., McCabe, C. H., Sabatine, M. S., Wiviott, S. D. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis Journal of the American College of Cardiology. 2009;54(8):678-85. Abstract

Olenchock, B. A., Fonarow, G. G., Pan, W., Hernandez, A., Cannon, C. P. Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes Am J Cardiol. 2009;103(3):295-300. Abstract

Olenchock, B. A., Fonarow, G. G., Pan, W., Hernandez, A., Cannon, C. P. Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes Am J Cardiol. 2009;103(3):295-300. Abstract

Omland, T., de Lemos, J. A., Sabatine, M. S., Christophi, C. A., Rice, M. M., Jablonski, K. A., Tjora, S., Domanski, M. J., Gersh, B. J., Rouleau, J. L., Pfeffer, M. A., Braunwald, E., Prevention of Events with Angiotensin Converting Enzyme Inhibition Trial, Investigators A sensitive cardiac troponin T assay in stable coronary artery disease N Engl J Med. 2009;361(26):2538-47. Abstract

Pride, Y. B., Appelbaum, E., Lord, E. E., Sloan, S., Cannon, C. P., Sabatine, M. S., Gibson, C. M. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction Am J Cardiol. 2009;104(4):475-9.

Pride, Y. B., Appelbaum, E., Lord, E. E., Sloan, S., Cannon, C. P., Sabatine, M. S., Gibson, C. M. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction Am J Cardiol. 2009;104(4):475-9.

Pride, Y. B., Wiviott, S. D., Buros, J. L., Zorkun, C., Tariq, M. U., Antman, E. M., Braunwald, E., Gibson, C. M. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy American heart journal. 2009;158(3):e21-6. Abstract

Sabatine, M. S., Antman, E. M., Widimsky, P., Ebrahim, I. O., Kiss, R. G., Saaiman, A., Polasek, R., Contant, C. F., McCabe, C. H., Braunwald, E. Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial Lancet. 2009;374(9692):787-95. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Jarolim, P., Braunwald, E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 European heart journal. 2009;30(2):162-9. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Jarolim, P., Braunwald, E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 European heart journal. 2009;30(2):162-9. Abstract

Scirica, B. M., Cannon, C. P., Sabatine, M. S., Jarolim, P., Sloane, S., Rifai, N., Braunwald, E., Morrow, D. A. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death Clin Chem. 2009;55(2):265-73.

Storey, R. F., Melissa Thornton, S., Lawrance, R., Husted, S., Wickens, M., Emanuelsson, H., Cannon, C. P., Heptinstall, S., Armstrong, M. Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3 Platelets. 2009;20(5):341-8. Abstract

Storey, R. F., Melissa Thornton, S., Lawrance, R., Husted, S., Wickens, M., Emanuelsson, H., Cannon, C. P., Heptinstall, S., Armstrong, M. Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3 Platelets. 2009;20(5):341-8. Abstract

Syed, Z., Scirica, B. M., Mohanavelu, S., Sung, P., Michelson, E. L., Cannon, C. P., Stone, P. H., Stultz, C. M., Guttag, J. V. Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphology Am J Cardiol. 2009;103(3):307-11. Abstract

Syed, Z., Scirica, B. M., Mohanavelu, S., Sung, P., Michelson, E. L., Cannon, C. P., Stone, P. H., Stultz, C. M., Guttag, J. V. Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphology Am J Cardiol. 2009;103(3):307-11. Abstract

Syed, Z., Scirica, B. M., Mohanavelu, S., Sung, P., Michelson, E. L., Cannon, C. P., Stone, P. H., Stultz, C. M., Guttag, J. V. Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphology Am J Cardiol. 2009;103(3):307-11. Abstract

Syed, Z., Scirica, B. M., Mohanavelu, S., Sung, P., Michelson, E. L., Cannon, C. P., Stone, P. H., Stultz, C. M., Guttag, J. V. Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphology Am J Cardiol. 2009;103(3):307-11. Abstract

Syed, Z., Sung, P., Scirica, B. M., Morrow, D. A., Stultz, C. M., Guttag, J. V. Spectral energy of ECG morphologic differences to predict death Cardiovasc Eng. 2009;9(1):18-26. Abstract

Syed, Z., Sung, P., Scirica, B. M., Morrow, D. A., Stultz, C. M., Guttag, J. V. Spectral energy of ECG morphologic differences to predict death Cardiovasc Eng. 2009;9(1):18-26. Abstract

Syed, Z., Sung, P., Scirica, B. M., Morrow, D. A., Stultz, C. M., Guttag, J. V. Spectral energy of ECG morphologic differences to predict death Cardiovasc Eng. 2009;9(1):18-26. Abstract

Thomas, D., Giugliano, R. P. ExTRACT-TIMI 25 in perspective: key lessons regarding enoxaparin as an adjunct to fibrinolytic therapy J Thromb Thrombolysis. 2009;27(1):10-Jan. Abstract

Truong, Q. A., Cannon, C. P., Zakai, N. A., Rogers, I. S., Giugliano, R. P., Wiviott, S. D., McCabe, C. H., Morrow, D. A., Braunwald, E. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial Am Heart J. 2009;157(4):673-9 e1. Abstract

Truong, Q. A., Cannon, C. P., Zakai, N. A., Rogers, I. S., Giugliano, R. P., Wiviott, S. D., McCabe, C. H., Morrow, D. A., Braunwald, E. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial Am Heart J. 2009;157(4):673-9 e1. Abstract

Tung, P., Wiviott, S. D., Cannon, C. P., Murphy, S. A., McCabe, C. H., Gibson, C. M. Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study) Am J Cardiol. 2009;103(8):1056-60.

Tung, P., Wiviott, S. D., Cannon, C. P., Murphy, S. A., McCabe, C. H., Gibson, C. M. Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study) Am J Cardiol. 2009;103(8):1056-60.

Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., Mahaffey, K. W., Scirica, B. M., Skene, A., Steg, P. G., Storey, R. F., Harrington, R. A., Plato Investigators, Freij, A., Thorsen, M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med. 2009;361(11):1045-57. Abstract

Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., Mahaffey, K. W., Scirica, B. M., Skene, A., Steg, P. G., Storey, R. F., Harrington, R. A., Plato Investigators, Freij, A., Thorsen, M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med. 2009;361(11):1045-57. Abstract

Wilson, S. R., Sabatine, M. S., Braunwald, E., Sloan, S., Murphy, S. A., Morrow, D. A. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial American heart journal. 2009;158(3):386-91. Abstract

Wilson, S. R., Scirica, B. M., Braunwald, E., Murphy, S. A., Karwatowska-Prokopczuk, E., Buros, J. L., Chaitman, B. R., Morrow, D. A. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial Journal of the American College of Cardiology. 2009;53(17):1510-6. Abstract

Wrishko, R. E., Ernest, C. S., 2nd, Small, D. S., Li, Y. G., Weerakkody, G. J., Riesmeyer, J. R., Macias, W. L., Rohatagi, S., Salazar, D. E., Antman, E. M., Wiviott, S. D., Braunwald, E., Ni, L. Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38 Journal of clinical pharmacology. 2009;49(8):984-98. Abstract

Wrishko, R. E., Ernest, C. S., 2nd, Small, D. S., Li, Y. G., Weerakkody, G. J., Riesmeyer, J. R., Macias, W. L., Rohatagi, S., Salazar, D. E., Antman, E. M., Wiviott, S. D., Braunwald, E., Ni, L. Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38 Journal of clinical pharmacology. 2009;49(8):984-98. Abstract

Wrishko, R. E., Ernest, C. S., 2nd, Small, D. S., Li, Y. G., Weerakkody, G. J., Riesmeyer, J. R., Macias, W. L., Rohatagi, S., Salazar, D. E., Antman, E. M., Wiviott, S. D., Braunwald, E., Ni, L. Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38 Journal of clinical pharmacology. 2009;49(8):984-98. Abstract

Acharjee, S., Cannon, C. P. Office-based global cardiometabolic risk assessment: a simple tool incorporating nontraditional markers Crit Pathw Cardiol. 2010;9(3):156-9. Abstract

Acharjee, S., Cannon, C. P. Office-based global cardiometabolic risk assessment: a simple tool incorporating nontraditional markers Crit Pathw Cardiol. 2010;9(3):156-9. Abstract

Acharjee, S., Cannon, C. P. Office-based global cardiometabolic risk assessment: a simple tool incorporating nontraditional markers Crit Pathw Cardiol. 2010;9(3):156-9. Abstract

Acharjee, S., Qin, J., Murphy, S. A., McCabe, C., Cannon, C. P. Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial) Am J Cardiol. 2010;105(5):619-23. Abstract

Acharjee, S., Qin, J., Murphy, S. A., McCabe, C., Cannon, C. P. Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial) Am J Cardiol. 2010;105(5):619-23. Abstract

Acharjee, S., Qin, J., Murphy, S. A., McCabe, C., Cannon, C. P. Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial) Am J Cardiol. 2010;105(5):619-23. Abstract

Acharjee, S., Qin, J., Murphy, S. A., McCabe, C., Cannon, C. P. Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial) Am J Cardiol. 2010;105(5):619-23. Abstract

Bangalore, S., Qin, J., Sloan, S., Murphy, S. A., Cannon, C. P. What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial Circulation. 2010;122(21):2142-51. Abstract

Bhatt, D. L., Cryer, B. L., Contant, C. F., Cohen, M., Lanas, A., Schnitzer, T. J., Shook, T. L., Lapuerta, P., Goldsmith, M. A., Laine, L., Scirica, B. M., Murphy, S. A., Cannon, C. P., Cogent Investigators Clopidogrel with or without omeprazole in coronary artery disease N Engl J Med. 2010;363(20):1909-17. Abstract

Bonaca, M., Scirica, B., Sabatine, M., Dalby, A., Spinar, J., Murphy, S. A., Jarolim, P., Braunwald, E., Morrow, D. A. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I J Am Coll Cardiol. 2010;55(19):2118-24. Abstract

Califf, R. M., Lokhnygina, Y., Cannon, C. P., Stepanavage, M. E., McCabe, C. H., Musliner, T. A., Pasternak, R. C., Blazing, M. A., Giugliano, R. P., Harrington, R. A., Braunwald, E. An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design Am Heart J. 2010;159(5):705-9.

Califf, R. M., Lokhnygina, Y., Cannon, C. P., Stepanavage, M. E., McCabe, C. H., Musliner, T. A., Pasternak, R. C., Blazing, M. A., Giugliano, R. P., Harrington, R. A., Braunwald, E. An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design Am Heart J. 2010;159(5):705-9.

Cannon CP, Harrington RA, James S, Ardissino D, Becker RC, Emanuelsson H, Husted S, Katus H, Keltai M, Khurmi NS, Kontny F, Lewis BS, Steg PG, Storey RF, Wojdyla D, Wallentin L. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet. 2010;375:283-93. Abstract

Cannon, C. P., Rhee, K. E., Califf, R. M., Boden, W. E., Hirsch, A. T., Alberts, M. J., Cable, G., Shao, M., Ohman, E. M., Steg, P. G., Eagle, K. A., Bhatt, D. L. Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry) Am J Cardiol. 2010;105(4):445-52. Abstract

Cannon, C. P., Rhee, K. E., Califf, R. M., Boden, W. E., Hirsch, A. T., Alberts, M. J., Cable, G., Shao, M., Ohman, E. M., Steg, P. G., Eagle, K. A., Bhatt, D. L. Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry) Am J Cardiol. 2010;105(4):445-52. Abstract

Cannon, C. P., Rhee, K. E., Califf, R. M., Boden, W. E., Hirsch, A. T., Alberts, M. J., Cable, G., Shao, M., Ohman, E. M., Steg, P. G., Eagle, K. A., Bhatt, D. L. Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry) Am J Cardiol. 2010;105(4):445-52. Abstract

Cannon, C. P., Shah, S., Dansky, H. M., Davidson, M., Brinton, E. A., Gotto, A. M., Stepanavage, M., Liu, S. X., Gibbons, P., Ashraf, T. B., Zafarino, J., Mitchel, Y., Barter, P. Safety of anacetrapib in patients with or at high risk for coronary heart disease N Engl J Med. 2010;363(25):2406-15. Abstract

Chisholm, J. W., Goldfine, A. B., Dhalla, A. K., Braunwald, E., Morrow, D. A., Karwatowska-Prokopczuk, E., Belardinelli, L. Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome Diabetes care. 2010;33(6):1163-8. Abstract

Chisholm, J. W., Goldfine, A. B., Dhalla, A. K., Braunwald, E., Morrow, D. A., Karwatowska-Prokopczuk, E., Belardinelli, L. Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome Diabetes care. 2010;33(6):1163-8. Abstract

Diercks, D. B., Owen, K. P., Kontos, M. C., Blomkalns, A., Chen, A. Y., Miller, C., Wiviott, S., Peterson, E. D. Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG) Am Heart J. 2010;160(1):80-87 e3. Abstract

Diercks, D. B., Owen, K. P., Kontos, M. C., Blomkalns, A., Chen, A. Y., Miller, C., Wiviott, S., Peterson, E. D. Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG) Am Heart J. 2010;160(1):80-87 e3. Abstract

Diercks, D. B., Owen, K. P., Kontos, M. C., Blomkalns, A., Chen, A. Y., Miller, C., Wiviott, S., Peterson, E. D. Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG) Am Heart J. 2010;160(1):80-87 e3. Abstract

Forman, D. E., Chen, A. Y., Wiviott, S. D., Wang, T. Y., Magid, D. J., Alexander, K. P. Comparison of outcomes in patients aged <75, 75 to 84, and ≥ 85 years with ST-elevation myocardial infarction (from the ACTION Registry-GWTG) Am J Cardiol. 2010;106(10):1382-8. Abstract

Forman, D. E., Chen, A. Y., Wiviott, S. D., Wang, T. Y., Magid, D. J., Alexander, K. P. Comparison of outcomes in patients aged <75, 75 to 84, and ≥ 85 years with ST-elevation myocardial infarction (from the ACTION Registry-GWTG) Am J Cardiol. 2010;106(10):1382-8. Abstract

Fox, C. S., Muntner, P., Chen, A. Y., Alexander, K. P., Roe, M. T., Cannon, C. P., Saucedo, J. F., Kontos, M. C., Wiviott, S. D., Acute Coronary, Treatment, Intervention Outcomes Network, registry Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry Circulation. 2010;121(3):357-65. Abstract

Fox, C. S., Muntner, P., Chen, A. Y., Alexander, K. P., Roe, M. T., Cannon, C. P., Saucedo, J. F., Kontos, M. C., Wiviott, S. D., Acute Coronary, Treatment, Intervention Outcomes Network, registry Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry Circulation. 2010;121(3):357-65. Abstract

Gibler, K. B., Huskamp, H. A., Sabatine, M. S., Murphy, S. A., Cohen, D. J., Cannon, C. P. Cost-effectiveness analysis of short-term clopidogrel therapy for ST elevation myocardial infarction Crit Pathw Cardiol. 2010;9(1):14-8. Abstract

Gibler, K. B., Huskamp, H. A., Sabatine, M. S., Murphy, S. A., Cohen, D. J., Cannon, C. P. Cost-effectiveness analysis of short-term clopidogrel therapy for ST elevation myocardial infarction Crit Pathw Cardiol. 2010;9(1):14-8. Abstract

Giugliano, R. P., Giraldez, R. R., Morrow, D. A., Antman, E. M., Gibson, C. M., Mohanavelu, S., Murphy, S. A., McCabe, C. H., Braunwald, E. Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial Eur Heart J. 2010;31(17):2103-10. Abstract

Husted, S., Storey, R. F., Harrington, R. A., Emanuelsson, H., Cannon, C. P. Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel Clin Cardiol. 2010;33(4):206-12. Abstract

James S, Angiolillo DJ, Cornel JH, Erlinge D, Husted S, Kontny F, Maya J, Nicolau JC, Spinar J, Storey RF, Stevens SR, Wallentin L; PLATO Study Group. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial. Euro Heart J. 2010;31:3006-3016. Abstract

Kadakia, M. B., Desai, N. R., Alexander, K. P., Chen, A. Y., Foody, J. M., Cannon, C. P., Wiviott, S. D., Scirica, B. M., National Cardiovascular Data, Registry Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines) JACC Cardiovasc Interv. 2010;3(11):1166-77. Abstract

Khera, A. V., Wolfe, M. L., Cannon, C. P., Qin, J., Rader, D. J. On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study) Am J Cardiol. 2010;106(4):451-6. Abstract

Kontos, M. C., de Lemos, J. A., Ou, F. S., Wiviott, S. D., Foody, J. M., Newby, L. K., Chen, A., Roe, M. T. Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry Am Heart J. 2010;160(5):819-25. Abstract

Kontos, M. C., de Lemos, J. A., Ou, F. S., Wiviott, S. D., Foody, J. M., Newby, L. K., Chen, A., Roe, M. T. Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry Am Heart J. 2010;160(5):819-25. Abstract

Lewis, G. D., Farrell, L., Wood, M. J., Martinovic, M., Arany, Z., Rowe, G. C., Souza, A., Cheng, S., McCabe, E. L., Yang, E., Shi, X., Deo, R., Roth, F. P., Asnani, A., Rhee, E. P., Systrom, D. M., Semigran, M. J., Vasan, R. S., Carr, S. A., Wang, T. J., Sabatine, M. S., Clish, C. B., Gerszten, R. E. Metabolic signatures of exercise in human plasma Sci Transl Med. 2010;2(33):33ra37. Abstract

Lewis, G. D., Farrell, L., Wood, M. J., Martinovic, M., Arany, Z., Rowe, G. C., Souza, A., Cheng, S., McCabe, E. L., Yang, E., Shi, X., Deo, R., Roth, F. P., Asnani, A., Rhee, E. P., Systrom, D. M., Semigran, M. J., Vasan, R. S., Carr, S. A., Wang, T. J., Sabatine, M. S., Clish, C. B., Gerszten, R. E. Metabolic signatures of exercise in human plasma Sci Transl Med. 2010;2(33):33ra37. Abstract

Lewis, G. D., Farrell, L., Wood, M. J., Martinovic, M., Arany, Z., Rowe, G. C., Souza, A., Cheng, S., McCabe, E. L., Yang, E., Shi, X., Deo, R., Roth, F. P., Asnani, A., Rhee, E. P., Systrom, D. M., Semigran, M. J., Vasan, R. S., Carr, S. A., Wang, T. J., Sabatine, M. S., Clish, C. B., Gerszten, R. E. Metabolic signatures of exercise in human plasma Sci Transl Med. 2010;2(33):33ra37. Abstract

Lopes, R. D., Peterson, E. D., Chen, A. Y., Roe, M. T., Wang, T. Y., Ohman, E. M., Magid, D. J., Ho, P. M., Wiviott, S. D., Scirica, B. M., Alexander, K. P. Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry JACC Cardiovasc Interv. 2010;3(6):669-77. Abstract

Lopes, R. D., Peterson, E. D., Chen, A. Y., Roe, M. T., Wang, T. Y., Ohman, E. M., Magid, D. J., Ho, P. M., Wiviott, S. D., Scirica, B. M., Alexander, K. P. Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry JACC Cardiovasc Interv. 2010;3(6):669-77. Abstract

Mahoney, E. M., Wang, K., Arnold, S. V., Proskorovsky, I., Wiviott, S., Antman, E., Braunwald, E., Cohen, D. J. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38 Circulation. 2010;121(1):71-9. Abstract

Mahoney, E. M., Wang, K., Arnold, S. V., Proskorovsky, I., Wiviott, S., Antman, E., Braunwald, E., Cohen, D. J. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38 Circulation. 2010;121(1):71-9. Abstract

Mauri, L., Kereiakes, D. J., Normand, S. L., Wiviott, S. D., Cohen, D. J., Holmes, D. R., Bangalore, S., Cutlip, D. E., Pencina, M., Massaro, J. M. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions Am Heart J. 2010;160(6):1035-41, 1041 e1. Abstract

Mauri, L., Kereiakes, D. J., Normand, S. L., Wiviott, S. D., Cohen, D. J., Holmes, D. R., Bangalore, S., Cutlip, D. E., Pencina, M., Massaro, J. M. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions Am Heart J. 2010;160(6):1035-41, 1041 e1. Abstract

Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Walker, J. R., Simon, T., Antman, E. M., Braunwald, E., Sabatine, M. S. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis Lancet. 2010;376(9749):1312-9. Abstract

Mega, J. L., Hochman, J. S., Scirica, B. M., Murphy, S. A., Sloan, S., McCabe, C. H., Merlini, P., Morrow, D. A. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) Circulation. 2010;121(16):1809-17. Abstract

Mega, J. L., Simon, T., Collet, J. P., Anderson, J. L., Antman, E. M., Bliden, K., Cannon, C. P., Danchin, N., Giusti, B., Gurbel, P., Horne, B. D., Hulot, J. S., Kastrati, A., Montalescot, G., Neumann, F. J., Shen, L., Sibbing, D., Steg, P. G., Trenk, D., Wiviott, S. D., Sabatine, M. S. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis JAMA. 2010;304(16):1821-30. Abstract

Mega, J. L., Simon, T., Collet, J. P., Anderson, J. L., Antman, E. M., Bliden, K., Cannon, C. P., Danchin, N., Giusti, B., Gurbel, P., Horne, B. D., Hulot, J. S., Kastrati, A., Montalescot, G., Neumann, F. J., Shen, L., Sibbing, D., Steg, P. G., Trenk, D., Wiviott, S. D., Sabatine, M. S. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis JAMA. 2010;304(16):1821-30. Abstract

Melloni, Chiara, James, Stefan K., White, Jennifer A., Giugliano, Robert P., Harrington, Robert A., Huber, Kurt, Armstrong, Paul W., Califf, Robert M., Van de Werf, Frans, Montalescot, Gilles, Newby, L. Kristin Safety and Efficacy of Adjusted-Dose Eptifibatide in Patients with Acute Coronary Syndromes and Reduced Renal Function J Am Coll Cardiol. 2010;55(10s1):A102.E957-A102.E957.

Morrow, D. A., Antman, E. M., Fox, K. A., White, H. D., Giugliano, R., Murphy, S. A., McCabe, C. H., Braunwald, E. One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial European heart journal. 2010;31(17):2097-102. Abstract

O'Donoghue, M., Braunwald, E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol. 2010;7(1):13-20. Abstract

O'Donoghue, M., Braunwald, E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol. 2010;7(1):13-20. Abstract

Ray, K. K., Nazer, B., Cairns, R., Michael Gibson, C., Cannon, C. P. Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes J Thromb Thrombolysis. 2010;30(1):3-Oct. Abstract

Ray, K. K., Nazer, B., Cairns, R., Michael Gibson, C., Cannon, C. P. Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes J Thromb Thrombolysis. 2010;30(1):3-Oct. Abstract

Ruff, C. T., Braunwald, E. Will warfarin ever be replaced? J Cardiovasc Pharmacol Ther. 2010;15(3):210-9. Abstract

Ruff, C. T., Braunwald, E. Will warfarin ever be replaced? J Cardiovasc Pharmacol Ther. 2010;15(3):210-9. Abstract

Ruff, C. T., Giugliano, R. P., Antman, E. M., Crugnale, S. E., Bocanegra, T., Mercuri, M., Hanyok, J., Patel, I., Shi, M., Salazar, D., McCabe, C. H., Braunwald, E. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48) Am Heart J. 2010;160(4):635-41. Abstract

Scirica, B. M. Acute Coronary Syndrome Emerging Tools for Diagnosis and Risk Assessment J Am Coll Cardiol. 2010;55(14):1403-1415. Abstract

Scirica, B. M. Acute Coronary Syndrome Emerging Tools for Diagnosis and Risk Assessment J Am Coll Cardiol. 2010;55(14):1403-1415. Abstract

Scirica, B. M. Acute Coronary Syndrome Emerging Tools for Diagnosis and Risk Assessment J Am Coll Cardiol. 2010;55(14):1403-1415. Abstract

Scirica, B. M. Acute Coronary Syndrome Emerging Tools for Diagnosis and Risk Assessment J Am Coll Cardiol. 2010;55(14):1403-1415. Abstract

Scirica, B. M., Braunwald, E., Belardinelli, L., Hedgepeth, C. M., Spinar, J., Wang, W., Qin, J., Karwatowska-Prokopczuk, E., Verheugt, F. W., Morrow, D. A. Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation. 2010;122(5):455-62. Abstract

Scirica, B. M., Braunwald, E., Belardinelli, L., Hedgepeth, C. M., Spinar, J., Wang, W., Qin, J., Karwatowska-Prokopczuk, E., Verheugt, F. W., Morrow, D. A. Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation. 2010;122(5):455-62. Abstract

Sherwood, M. W., Morrow, D. A., Scirica, B. M., Jiang, S. T., Bode, C., Rifai, N., Gerszten, R. E., Gibson, C. M., Cannon, C. P., Braunwald, E., Sabatine, M. S. Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: Analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY) - Thrombolysis in Myocardial Infarction (TIMI) 28 American Heart Journal. 2010;159(6):964-U3. Abstract

Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, Emanuelsson H, Finkelstein A, Husted S, Katus H, Kilhamn J, Olofsson S, Storey RF, Weaver WD, Wallentin L; PLATO Study Group. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis. Circulation. 2010;122:2131-2141. Abstract

Tam, L. M., Fonarow, G. C., Bhatt, D. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Schwamm, L. H., Giugliano, R. P. Achievement of Secondary Prevention Performance Measures in Patients with Coronary Artery Disease in Teaching and Non-Teaching Hospitals: Results from the Get With The Guidelines CAD Program Circulation. 2010;122(21):NA.

Tam, L. M., Fonarow, G. C., Bhatt, D. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Schwamm, L. H., Giugliano, R. P. Achievement of Secondary Prevention Performance Measures in Patients with Coronary Artery Disease in Teaching and Non-Teaching Hospitals: Results from the Get With The Guidelines CAD Program Circulation. 2010;122(21):NA.

Tam, L. M., Fonarow, G. C., Bhatt, D. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Schwamm, L. H., Giugliano, R. P. Achievement of Secondary Prevention Performance Measures in Patients with Coronary Artery Disease in Teaching and Non-Teaching Hospitals: Results from the Get With The Guidelines CAD Program Circulation. 2010;122(21):NA.

Tanguay, Jean-François, Newby, L. Kristin, Hochman, Judith, Westerhout, Cynthia M., Califf, Robert M., Gibson, C. Michael, Giugliano, Robert P., Harrington, Robert A., Van de Werf, Frans, Armstrong, Paul W. SEX DIFFERENCES IN HIGH-RISK ACUTE CORONARY SYNDROMES: INSIGHTS FROM EARLY-ACS J Am Coll Cardiol. 2010;55(10s1):A120.E1122-A120.E1122.

Wang, Tracy, White, Jennifer A., Giugliano, Robert P., Tricoci, Pierluigi, Harrington, Robert A., Montalescot, Gilles, Zeymer, Uwe, Van de Werf, Frans, Armstrong, Paul W., Braunwald, Eugene, Califf, Robert M., Newby, L. Kristin UPFRONT CLOPIDOGREL USE AND THE EFFICACY AND SAFETY OF EARLY EPTIFIBATIDE USE IN PATIENTS WITH ACUTE CORONARY SYNDROME: AN ANALYSIS FROM THE EARLY VERSUS DELAYED PROVISIONAL EPTIFIBATIDE IN ACUTE CORONARY SYNDROMES (EARLY ACS) TRIAL Journal of the American College of Cardiology. 2010;55(10, Supplement):A47.E451.

Wilson, Sean R., Wiviott, Stephen D., Antman, Elliott M., Giugliano, Robert P., Murphy, Sabina A., Sloan, Sarah, Braunwald, Eugene, Morrow, David A. APPLICATION OF THE TIMI RISK SCORE, A SIMPLE BEDSIDE TOOL, FOR TIMING OF DISCHARGE AFTER FIBRINOLYSIS OR PRIMARY ANGIOPLASTY FOR ST-ELEVATION MI IN THE EXTRACT-TIMI 25 AND TRITON-TIMI 38 TRIALS Journal of the American College of Cardiology. 2010;55(10, Supplement):A125.E1173.

Wiviott, S. D., Antman, E. M., Braunwald, E. Mortality in the TRITON trial: update from the FDA prasugrel action package Am J Cardiol. 2010;106(2):293-4.

Wiviott, S. D., Antman, E. M., Braunwald, E. Prasugrel Circulation. 2010;122(4):394-403.

Wiviott, S. D., Antman, E. M., Braunwald, E. Mortality in the TRITON trial: update from the FDA prasugrel action package Am J Cardiol. 2010;106(2):293-4.

Wiviott, S. D., Antman, E. M., Braunwald, E. Mortality in the TRITON trial: update from the FDA prasugrel action package Am J Cardiol. 2010;106(2):293-4.

Wiviott, S. D., Antman, E. M., Braunwald, E. Prasugrel Circulation. 2010;122(4):394-403.

Wiviott, S. D., Antman, E. M., Braunwald, E. Prasugrel Circulation. 2010;122(4):394-403.

Wiviott, S. D., Mega, J. L. Another step on the road to tailored antiplatelet therapy J Am Coll Cardiol. 2010;56(20):1637-8.

Wiviott, S. D., Mega, J. L. Another step on the road to tailored antiplatelet therapy J Am Coll Cardiol. 2010;56(20):1637-8.

Wiviott, S. D., Mega, J. L. Another step on the road to tailored antiplatelet therapy J Am Coll Cardiol. 2010;56(20):1637-8.

Abtahian, F., Olenchock, B., Ou, F. S., Kontos, M. C., Saucedo, J. F., Scirica, B. M., Desai, N., Peterson, E., Roe, M., Cannon, C. P., Wiviott, S. D. Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry) Am J Cardiol. 2011;107(10):1441-6. Abstract

Ahmed, S., Michael Gibson, C., Cannon, C. P., Murphy, S. A., Sabatine, M. S. Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis J Thromb Thrombolysis. 2011;31(4):493-500. Abstract

Bonaca, M. P., Morrow, D. A., Braunwald, E., Cannon, C. P., Jiang, S., Breher, S., Sabatine, M. S., Kempf, T., Wallentin, L., Wollert, K. C. Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22 Arteriosclerosis, thrombosis, and vascular biology. 2011;31(1):203-10. Abstract

Bonaca, M. P., Ruff, C. T., Grandin, E. W., Murphy, S. A., Jarolim, P., Conrad, M. J., Vora, A., Sabatine, M. S., Braunwald, E., Morrow, D. A. Evaluation of the Diagnostic Performance of an Investigational Ultra-Sensitive Assay for CARDIAC TROPONIN I Journal of the American College of Cardiology. 2011;57(14):E1018-E1018.

Bonaca, Marc P., Braunwald, Eugene, Murphy, Sabina A., Miller, Debra, Herrman, Jp R., Gottlieb, Shmuel, Menozzi, Alberto, McCabe, Carolyn H., Antman, Elliot M., Wiviott, Stephen W. LONG-TERM THIENOPYRIDINE THERAPY AND OUTCOMES IN PATIENTS WITH ACS TREATED WITH CORONARY STENTING: THE PRIMARY RESULTS OF THE TIMI-38 CORONARY STENT REGISTRY Journal of the American College of Cardiology. 2011;57(14, Supplement):E906.

Braunwald, E. Clinical efforts to reduce myocardial infarct size--the next step J Cardiovasc Pharmacol Ther. 2011;16(4-Mar):349-53. Abstract

Braunwald, E. Clinical efforts to reduce myocardial infarct size--the next step J Cardiovasc Pharmacol Ther. 2011;16(4-Mar):349-53. Abstract

Britton, K. A., Aggarwal, V., Chen, A. Y., Alexander, K. P., Amsterdam, E., Fraulo, E., Muntner, P., Thomas, L., McGuire, D. K., Wiviott, S. D., Roe, M. T., Schubart, U. K., Fox, C. S. No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction Am Heart J. 2011;161(4):657-663 e1. Abstract

Britton, K. A., Aggarwal, V., Chen, A. Y., Alexander, K. P., Amsterdam, E., Fraulo, E., Muntner, P., Thomas, L., McGuire, D. K., Wiviott, S. D., Roe, M. T., Schubart, U. K., Fox, C. S. No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction Am Heart J. 2011;161(4):657-663 e1. Abstract

Don, C. W., Roe, M. T., Li, S., Fraulo, E., Pomerantsev, E., Palacios, I., Wiviott, S. D. Temporal trends and practice variations in clopidogrel loading doses in patients with non-ST-segment elevation myocardial infarction, from the National Cardiovascular Data Registry Am Heart J. 2011;161(4):689-97. Abstract

Don, C. W., Roe, M. T., Li, S., Fraulo, E., Pomerantsev, E., Palacios, I., Wiviott, S. D. Temporal trends and practice variations in clopidogrel loading doses in patients with non-ST-segment elevation myocardial infarction, from the National Cardiovascular Data Registry Am Heart J. 2011;161(4):689-97. Abstract

Frelinger, A. L., 3rd, Michelson, A. D., Wiviott, S. D., Trenk, D., Neumann, F. J., Miller, D. L., Jakubowski, J. A., Costigan, T. M., McCabe, C. H., Antman, E. M., Braunwald, E. Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44 Thrombosis and haemostasis. 2011;106(2):219-26. Abstract

Frelinger, A. L., 3rd, Michelson, A. D., Wiviott, S. D., Trenk, D., Neumann, F. J., Miller, D. L., Jakubowski, J. A., Costigan, T. M., McCabe, C. H., Antman, E. M., Braunwald, E. Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44 Thrombosis and haemostasis. 2011;106(2):219-26. Abstract

Gibson, C. M., Mega, J. L., Burton, P., Goto, S., Verheugt, F., Bode, C., Plotnikov, A., Sun, X., Cook-Bruns, N., Braunwald, E. Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome American heart journal. 2011;161(5):815-821 e6. Abstract

Hanna, E. B., Chen, A. Y., Roe, M. T., Wiviott, S. D., Fox, C. S., Saucedo, J. F. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention JACC Cardiovasc Interv. 2011;4(9):1002-8. Abstract

Hanna, E. B., Chen, A. Y., Roe, M. T., Wiviott, S. D., Fox, C. S., Saucedo, J. F. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention JACC Cardiovasc Interv. 2011;4(9):1002-8. Abstract

Hanna, E. B., Chen, A. Y., Roe, M. T., Wiviott, S. D., Fox, C. S., Saucedo, J. F. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention JACC Cardiovasc Interv. 2011;4(9):1002-8. Abstract

Held C, Asenblad N, Bassand JP, Becker RC, Cannon CP, Claeys MJ, Harrington RA, Horrow J, Husted S, James SK, Mahaffey KW, Nicolau JC, Scirica BM, Storey RF, Vintila M, Ycas J, Wallentin L. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol. 2011;57:672-84. Abstract

Held C, Asenblad N, Bassand JP, Becker RC, Cannon CP, Claeys MJ, Harrington RA, Horrow J, Husted S, James SK, Mahaffey KW, Nicolau JC, Scirica BM, Storey RF, Vintila M, Ycas J, Wallentin L. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol. 2011;57:672-84. Abstract

Hochholzer, W., Trenk, D., Mega, J. L., Morath, T., Stratz, C., Valina, C. M., O'Donoghue, M. L., Bernlochner, I., Contant, C. F., Guo, J., Sabatine, M. S., Schomig, A., Neumann, F. J., Kastrati, A., Wiviott, S. D., Sibbing, D. Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy Am Heart J. 2011;162(3):518-26 e5. Abstract

Hochholzer, W., Trenk, D., Mega, J. L., Morath, T., Stratz, C., Valina, C. M., O'Donoghue, M. L., Bernlochner, I., Contant, C. F., Guo, J., Sabatine, M. S., Schomig, A., Neumann, F. J., Kastrati, A., Wiviott, S. D., Sibbing, D. Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy Am Heart J. 2011;162(3):518-26 e5. Abstract

Hochholzer, W., Trenk, D., Mega, J. L., Morath, T., Stratz, C., Valina, C. M., O'Donoghue, M. L., Bernlochner, I., Contant, C. F., Guo, J., Sabatine, M. S., Schomig, A., Neumann, F. J., Kastrati, A., Wiviott, S. D., Sibbing, D. Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy Am Heart J. 2011;162(3):518-26 e5. Abstract

Hochholzer, W., Wiviott, S. D., Antman, E. M., Contant, C. F., Guo, J., Giugliano, R. P., Dalby, A. J., Montalescot, G., Braunwald, E. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38) Circulation. 2011;123(23):2681-9. Abstract

Hochholzer, W., Wiviott, S. D., Antman, E. M., Contant, C. F., Guo, J., Giugliano, R. P., Dalby, A. J., Montalescot, G., Braunwald, E. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38) Circulation. 2011;123(23):2681-9. Abstract

Hochholzer, W., Wiviott, S. D., Antman, E. M., Contant, C. F., Guo, J., Giugliano, R. P., Dalby, A. J., Montalescot, G., Braunwald, E. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38) Circulation. 2011;123(23):2681-9. Abstract

Hochholzer, W., Wiviott, S. D., Antman, E. M., Contant, C. F., Guo, J., Giugliano, R. P., Dalby, A. J., Montalescot, G., Braunwald, E. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38) Circulation. 2011;123(23):2681-9. Abstract

James SK, Roe MT, Cannon CP, Cornel JH, Horrow J, Husted S, Katus H, Morais J, Steg PG, Storey RF, Stevens S, Wallentin L, Harrington RA; PLATO Study Group. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial. Brit Med J. 2011;342:d3527. Abstract

Kadakia, M. B., Fox, C. S., Scirica, B. M., Murphy, S. A., Bonaca, M. P., Morrow, D. A. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial Heart. 2011;97(21):1782-7. Abstract

Kadakia, M. B., Fox, C. S., Scirica, B. M., Murphy, S. A., Bonaca, M. P., Morrow, D. A. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial Heart. 2011;97(21):1782-7. Abstract

Kohli, P., Cannon, C. P. Statins and safety: can we finally be reassured? Lancet. 2011;378(9808):1980-1.

Kohli, P., Cannon, C. P. Statins and safety: can we finally be reassured? Lancet. 2011;378(9808):1980-1.

Kohli, P., Cannon, C. P. Statins and safety: can we finally be reassured? Lancet. 2011;378(9808):1980-1.

Mathews, R., Peterson, E. D., Li, S., Roe, M. T., Glickman, S. W., Wiviott, S. D., Saucedo, J. F., Antman, E. M., Jacobs, A. K., Wang, T. Y. Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines Circulation. 2011;124(2):154-63. Abstract

Mathews, R., Peterson, E. D., Li, S., Roe, M. T., Glickman, S. W., Wiviott, S. D., Saucedo, J. F., Antman, E. M., Jacobs, A. K., Wang, T. Y. Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines Circulation. 2011;124(2):154-63. Abstract

Mathews, R., Peterson, E. D., Li, S., Roe, M. T., Glickman, S. W., Wiviott, S. D., Saucedo, J. F., Antman, E. M., Jacobs, A. K., Wang, T. Y. Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines Circulation. 2011;124(2):154-63. Abstract

Mega, J. L., Hochholzer, W., Frelinger, A. L., Kluk, M. J., Isserman, S., Rogers, W. J., Angiolillo, D. J., Kereiakes, D. J., Ruff, C. T., Berg, D. D., Cyr, J., Scirica, B. M., Grip, L., Mesa, R. A., Mattimore, J. F., Longtine, J. A., Michelson, A. D., Sabatine, M. S. ELEVATE-TIMI 56: Escalating Clopidogrel by Involving a Genetic Strategy-TIMI 56 Circulation. 2011;124(21):2371-2372. Abstract

Mega, Jessica L, Close, Sandra L, Wiviott, Stephen D, Man, Michael, Duvvuru, Suman, Walker, Joseph, Sundseth, Scott S, Macias, William L, Antman, Elliott M, Braunwald, Eugene, Sabatine, Marc S Abstract 11255: PON1 Q192R (rs662) Genetic Variant and Response to Clopidogrel and Prasugrel Circulation. 2011;124(21 Supplement):A11255.

Mehran, R., Rao, S. V., Bhatt, D. L., Gibson, C. M., Caixeta, A., Eikelboom, J., Kaul, S., Wiviott, S. D., Menon, V., Nikolsky, E., Serebruany, V., Valgimigli, M., Vranckx, P., Taggart, D., Sabik, J. F., Cutlip, D. E., Krucoff, M. W., Ohman, E. M., Steg, P. G., White, H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation. 2011;123(23):2736-47.

Mehran, R., Rao, S. V., Bhatt, D. L., Gibson, C. M., Caixeta, A., Eikelboom, J., Kaul, S., Wiviott, S. D., Menon, V., Nikolsky, E., Serebruany, V., Valgimigli, M., Vranckx, P., Taggart, D., Sabik, J. F., Cutlip, D. E., Krucoff, M. W., Ohman, E. M., Steg, P. G., White, H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation. 2011;123(23):2736-47.

Mehran, R., Rao, S. V., Bhatt, D. L., Gibson, C. M., Caixeta, A., Eikelboom, J., Kaul, S., Wiviott, S. D., Menon, V., Nikolsky, E., Serebruany, V., Valgimigli, M., Vranckx, P., Taggart, D., Sabik, J. F., Cutlip, D. E., Krucoff, M. W., Ohman, E. M., Steg, P. G., White, H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation. 2011;123(23):2736-47.

Melloni, C., James, S. K., White, J. A., Giugliano, R. P., Harrington, R. A., Huber, K., Tricoci, P., Armstrong, P. W., Van de Werf, F., Montalescot, G., Califf, R. M., Newby, L. K., Early ACS Investigators Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function. Am Heart J. 2011;162(5):884-892. Abstract

Melloni, C., Roe, M. T., Chen, A. Y., Wang, T. Y., Wiviott, S. D., Ho, P. M., Peterson, E. D., Alexander, K. P. Use of early clopidogrel by reperfusion strategy among patients presenting with ST-segment elevation myocardial infarction Circ Cardiovasc Qual Outcomes. 2011;4(6):603-9. Abstract

O'Donoghue ML, Braunwald E, White HD, Serruys P, Steg PG, Hochman J, Maggioni AP, Bode C, Weaver D, Johnson JL, Cicconetti G, Lukas MA, Tarka E, Cannon CP. Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome. Am Heart J. 2011;162:613-619. Abstract

O'Donoghue ML, Braunwald E, White HD, Serruys P, Steg PG, Hochman J, Maggioni AP, Bode C, Weaver D, Johnson JL, Cicconetti G, Lukas MA, Tarka E, Cannon CP. Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome. Am Heart J. 2011;162:613-619. Abstract

O'Donoghue, M. L., Bhatt, D. L., Wiviott, S. D., Goodman, S. G., Fitzgerald, D. J., Angiolillo, D. J., Goto, S., Montalescot, G., Zeymer, U., Aylward, P. E., Guetta, V., Dudek, D., Ziecina, R., Contant, C. F., Flather, M. D., Lancelot-Acs Investigators Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin-Acute Coronary Syndromes Trial Circulation. 2011;123(17):1843-53. Abstract

O'Donoghue, M. L., Mallat, Z., Morrow, D. A., Benessiano, J., Sloan, S., Omland, T., Solomon, S. D., Braunwald, E., Tedgui, A., Sabatine, M. S. Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease Clinical chemistry. 2011;57(9):1311-7. Abstract

O'Donoghue, M. L., Mallat, Z., Morrow, D. A., Benessiano, J., Sloan, S., Omland, T., Solomon, S. D., Braunwald, E., Tedgui, A., Sabatine, M. S. Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease Clinical chemistry. 2011;57(9):1311-7. Abstract

Preiss, D., Seshasai, S. R., Welsh, P., Murphy, S. A., Ho, J. E., Waters, D. D., DeMicco, D. A., Barter, P., Cannon, C. P., Sabatine, M. S., Braunwald, E., Kastelein, J. J., de Lemos, J. A., Blazing, M. A., Pedersen, T. R., Tikkanen, M. J., Sattar, N., Ray, K. K. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis JAMA. 2011;305(24):2556-64. Abstract

Ruff, C. T., Braunwald, E. The evolving epidemiology of acute coronary syndromes Nat Rev Cardiol. 2011;8(3):140-7. Abstract

Ruff, C. T., Braunwald, E. The evolving epidemiology of acute coronary syndromes Nat Rev Cardiol. 2011;8(3):140-7. Abstract

Ruff, C. T., Braunwald, E. The evolving epidemiology of acute coronary syndromes Nat Rev Cardiol. 2011;8(3):140-7. Abstract

Ruff, C. T., Morrow, D. A., Jarolim, P., Ren, F., Contant, C. F., Kaur, A., Curtis, S. P., Laine, L., Cannon, C. P., Brune, K. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs J Rheumatol. 2011;38(6):1071-8. Abstract

Ruff, Christian T., Goodman, Shaun, Hod, Hanoch, Bode, Christoph, Widimsky, Petr, Kiss, Robert G., Contant, Charles F., Crugnale, Sharon E., Moryusef, Angele, Steg, Gabriel, Antman, Elliott M., Sabatine, Marc S. Evaluation of the Efficacy and Safety of Otamixaban vs. Unfractionated Heparin+Eptifibatide in Elderly Patients with Non-St-Elevation Acute Coronary Syndromes in the SEPIA ACS-TIMI 42 Trial Journal of the American College of Cardiology. 2011;57(14, Supplement):E915.

Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Price, D. L., Chen, R., Udell, J., Raz, I. The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study American heart journal. 2011;162(5):818-825 e6. Abstract

Syed, Z., Stultz, C. M., Scirica, B. M., Guttag, J. V. Computationally generated cardiac biomarkers for risk stratification after acute coronary syndrome Sci Transl Med. 2011;3(102):102ra95. Abstract

Syed, Z., Stultz, C. M., Scirica, B. M., Guttag, J. V. Computationally generated cardiac biomarkers for risk stratification after acute coronary syndrome Sci Transl Med. 2011;3(102):102ra95. Abstract

Toleva O, Westerhout CM, Senaratne M, Bode C, Lindroos M, Ardissino D, Sulimov VA, Montalescot G, Newby LK, Giugliano RP, Van de Werf F, Armstrong PW Association of Hub and Spoke Practice Patterns with Coronary Interventino and Outcomes in Non ST Elevation Acute Coronary Syndromes (NSTE ACS): Insights from the Early Glycoprotein IIb/IIIa Inhibition in NSTE ACS (EARLY-ACS) Trial J Am Coll Cardiol. 2011;57(14):74.

Truong, Q. A., Murphy, S. A., McCabe, C. H., Armani, A., Cannon, C. P. Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22 Circ Cardiovasc Qual Outcomes. 2011;4(3):328-36. Abstract

Turer, A. T., Addo, T. A., Martin, J. L., Sabatine, M. S., Lewis, G. D., Gerszten, R. E., Keeley, E. C., Cigarroa, J. E., Lange, R. A., Hillis, L. D., de Lemos, J. A. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study J Am Coll Cardiol. 2011;57(24):2398-405. Abstract

Turer, A. T., Addo, T. A., Martin, J. L., Sabatine, M. S., Lewis, G. D., Gerszten, R. E., Keeley, E. C., Cigarroa, J. E., Lange, R. A., Hillis, L. D., de Lemos, J. A. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study J Am Coll Cardiol. 2011;57(24):2398-405. Abstract

Turer, A. T., Addo, T. A., Martin, J. L., Sabatine, M. S., Lewis, G. D., Gerszten, R. E., Keeley, E. C., Cigarroa, J. E., Lange, R. A., Hillis, L. D., de Lemos, J. A. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study J Am Coll Cardiol. 2011;57(24):2398-405. Abstract

Wiviott, S. D. ILLUMINATE sheds more light Circulation. 2011;124(5):536-7.

Wiviott, S. D. ILLUMINATE sheds more light Circulation. 2011;124(5):536-7.

Wiviott, S. D., Desai, N., Murphy, S. A., Musumeci, G., Ragosta, M., Antman, E. M., Braunwald, E. Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies Am J Cardiol. 2011;108(7):905-11. Abstract

Wiviott, S. D., Hochholzer, W. On-clopidogrel platelet reactivity: a target in sight? J Am Coll Cardiol. 2011;58(19):1955-7.

Wiviott, S. D., Hochholzer, W. On-clopidogrel platelet reactivity: a target in sight? J Am Coll Cardiol. 2011;58(19):1955-7.

Wiviott, S. D., Hochholzer, W. On-clopidogrel platelet reactivity: a target in sight? J Am Coll Cardiol. 2011;58(19):1955-7.

Bansilal, S., Farkouh, M. E., Hueb, W., Ogdie, M., Dangas, G., Lansky, A. J., Cohen, D. J., Magnuson, E. A., Ramanathan, K., Tanguay, J. F., Muratov, V., Sleeper, L. A., Domanski, M., Bertrand, M. E., Fuster, V. The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry Am Heart J. 2012;164(4):591-9. Abstract

Bansilal, S., Farkouh, M. E., Hueb, W., Ogdie, M., Dangas, G., Lansky, A. J., Cohen, D. J., Magnuson, E. A., Ramanathan, K., Tanguay, J. F., Muratov, V., Sleeper, L. A., Domanski, M., Bertrand, M. E., Fuster, V. The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry Am Heart J. 2012;164(4):591-9. Abstract

Bansilal, S., Farkouh, M. E., Hueb, W., Ogdie, M., Dangas, G., Lansky, A. J., Cohen, D. J., Magnuson, E. A., Ramanathan, K., Tanguay, J. F., Muratov, V., Sleeper, L. A., Domanski, M., Bertrand, M. E., Fuster, V. The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry Am Heart J. 2012;164(4):591-9. Abstract

Bohula May, Erin A, Bonaca, Marc P, Scirica, Benjamin M, Morais, Joao, Nieminen, Markku, Murphy, Sabina A, Braunwald, Eugene, Morrow, David A Abstract 19221: Rates of Arterial Revascularization in Patients Treated with Vorapaxar vs. Placebo in the TRA 2{degrees}P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A19221.

Bonaca, M. P., Wiviott, S. D., Braunwald, E., Murphy, S. A., Ruff, C. T., Antman, E. M., Morrow, D. A. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38) Circulation. 2012;125(4):577-83. Abstract

Bonaca, M. P., Wiviott, S. D., Braunwald, E., Murphy, S. A., Ruff, C. T., Antman, E. M., Morrow, D. A. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38) Circulation. 2012;125(4):577-83. Abstract

Bonaca, M. P., Wiviott, S. D., Braunwald, E., Murphy, S. A., Ruff, C. T., Antman, E. M., Morrow, D. A. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38) Circulation. 2012;125(4):577-83. Abstract

Bonaca, Marc P, Scirica, Benjamin M, Braunwald, Eugene, White, Harvey D, Aylward, Philip E, Grande, Peer, Murphy, Sabina A, Morrow, David A Abstract 18595: Efficacy of Vorapaxar is not Modified by Thienopyridine Therapy: Results from TRA 2{degrees}P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A18595.

Bonaca, Marc P, Scirica, Benjamin M, Braunwald, Eugene, White, Harvey D, Aylward, Philip E, Grande, Peer, Murphy, Sabina A, Morrow, David A Abstract 18595: Efficacy of Vorapaxar is not Modified by Thienopyridine Therapy: Results from TRA 2{degrees}P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A18595.

Bonaca, Marc P, Scirica, Benjamin M, Braunwald, Eugene, White, Harvey D, Aylward, Philip E, Grande, Peer, Murphy, Sabina A, Morrow, David A Abstract 18595: Efficacy of Vorapaxar is not Modified by Thienopyridine Therapy: Results from TRA 2{degrees}P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A18595.

Bonaca, Marc P, Scirica, Benjamin M, Braunwald, Eugene, White, Harvey D, Aylward, Philip E, Grande, Peer, Murphy, Sabina A, Morrow, David A Abstract 18595: Efficacy of Vorapaxar is not Modified by Thienopyridine Therapy: Results from TRA 2{degrees}P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A18595.

Bonaca, Marc P, Scirica, Benjamin M, Braunwald, Eugene, Wiviott, Stephen D, Goto, Shinya, Nilsen, Dennis, Bonarjee, Vernon, Murphy, Sabina A, Morrow, David A Abstract 19144: New Ischemic Stroke and Outcomes with Vorapaxar vs. Placebo: Results from TRA 2{degrees}P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A19144.

Braunwald, E. Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials European heart journal. 2012;33(4):430-2.

Braunwald, E. Unstable angina and non-ST elevation myocardial infarction Am J Respir Crit Care Med. 2012;185(9):924-32. Abstract

Braunwald, E. Unstable angina and non-ST elevation myocardial infarction Am J Respir Crit Care Med. 2012;185(9):924-32. Abstract

Braunwald, E. Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials European heart journal. 2012;33(4):430-2.

Braunwald, E. Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials European heart journal. 2012;33(4):430-2.

Braunwald, E., Sabatine, M. S. The Thrombolysis in Myocardial Infarction (TIMI) Study Group experience J Thorac Cardiovasc Surg. 2012;144(4):762-70. Abstract

Braunwald, E., Sabatine, M. S. The Thrombolysis in Myocardial Infarction (TIMI) Study Group experience J Thorac Cardiovasc Surg. 2012;144(4):762-70. Abstract

Braunwald, E., Sabatine, M. S. The Thrombolysis in Myocardial Infarction (TIMI) Study Group experience J Thorac Cardiovasc Surg. 2012;144(4):762-70. Abstract

Braunwald, E., Sabatine, M. S. The Thrombolysis in Myocardial Infarction (TIMI) Study Group experience J Thorac Cardiovasc Surg. 2012;144(4):762-70. Abstract

Cavender, Matthew A, Joynt, Karen E, Resnic, Frederick S, Parzynski, Craig S, Rumsfeld, John S, Moscucci, Mauro, Masoudi, Frederick A, Curtis, Jeptha P, Peterson, Eric D, Gurm, Hitinder S Abstract 16534: State Mandated Public Reporting of Percutaneous Coronary Intervention Outcomes is Associated with Better Outcomes: A report from the NCDR(R) Circulation. 2012;126(21 Supplement):A16534.

Cavender, Matthew A, Joynt, Karen E, Resnic, Frederick S, Parzynski, Craig S, Rumsfeld, John S, Moscucci, Mauro, Masoudi, Frederick A, Curtis, Jeptha P, Peterson, Eric D, Gurm, Hitinder S Abstract 16534: State Mandated Public Reporting of Percutaneous Coronary Intervention Outcomes is Associated with Better Outcomes: A report from the NCDR(R) Circulation. 2012;126(21 Supplement):A16534.

Cavender, Matthew A, Joynt, Karen E, Resnic, Frederick S, Parzynski, Craig S, Rumsfeld, John S, Moscucci, Mauro, Masoudi, Frederick A, Curtis, Jeptha P, Peterson, Eric D, Gurm, Hitinder S Abstract 16534: State Mandated Public Reporting of Percutaneous Coronary Intervention Outcomes is Associated with Better Outcomes: A report from the NCDR(R) Circulation. 2012;126(21 Supplement):A16534.

Cavender, Matthew A, Joynt, Karen E, Resnic, Frederick S, Parzynski, Craig S, Rumsfeld, John S, Moscucci, Mauro, Masoudi, Frederick A, Curtis, Jeptha P, Peterson, Eric D, Gurm, Hitinder S Abstract 16534: State Mandated Public Reporting of Percutaneous Coronary Intervention Outcomes is Associated with Better Outcomes: A report from the NCDR(R) Circulation. 2012;126(21 Supplement):A16534.

Chia, C. C., Rubinfeld, I., Scirica, B. M., McMillan, S., Gurm, H. S., Syed, Z. Looking beyond historical patient outcomes to improve clinical models Sci Transl Med. 2012;4(131):131ra49. Abstract

Chia, C. C., Rubinfeld, I., Scirica, B. M., McMillan, S., Gurm, H. S., Syed, Z. Looking beyond historical patient outcomes to improve clinical models Sci Transl Med. 2012;4(131):131ra49. Abstract

Chia, C. C., Rubinfeld, I., Scirica, B. M., McMillan, S., Gurm, H. S., Syed, Z. Looking beyond historical patient outcomes to improve clinical models Sci Transl Med. 2012;4(131):131ra49. Abstract

Chin, C. T., Wang, T. Y., Li, S., Wiviott, S. D., deLemos, J. A., Kontos, M. C., Peterson, E. D., Roe, M. T. Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines Clin Cardiol. 2012;35(7):424-9. Abstract

Chin, C. T., Wang, T. Y., Li, S., Wiviott, S. D., deLemos, J. A., Kontos, M. C., Peterson, E. D., Roe, M. T. Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines Clin Cardiol. 2012;35(7):424-9. Abstract

Deedwania, Prakash, Kotak, Kamal, Fonarow, Gregg, Cannon, Christopher, Laskey, Warren, Peacock, Frank, Pan, Wendy, Bhatt, Deepak Abstract 12341: Improvement in Adherence to Guideline Based Therapy in Diabetic Patients Admitted with Acute Coronary Syndrome: Findings from AHA Get With the Guidelines Program Circulation. 2012;126(21 Supplement):A12341.

Deedwania, Prakash, Kotak, Kamal, Fonarow, Gregg, Cannon, Christopher, Laskey, Warren, Peacock, Frank, Pan, Wendy, Bhatt, Deepak Abstract 12341: Improvement in Adherence to Guideline Based Therapy in Diabetic Patients Admitted with Acute Coronary Syndrome: Findings from AHA Get With the Guidelines Program Circulation. 2012;126(21 Supplement):A12341.

Deedwania, Prakash, Kotak, Kamal, Fonarow, Gregg, Cannon, Christopher, Laskey, Warren, Peacock, Frank, Pan, Wendy, Bhatt, Deepak Abstract 12341: Improvement in Adherence to Guideline Based Therapy in Diabetic Patients Admitted with Acute Coronary Syndrome: Findings from AHA Get With the Guidelines Program Circulation. 2012;126(21 Supplement):A12341.

Desai, Nihar R., Kohli, Payal, Giugliano, Robert P., Kim, Jae B., Mohanavelu, Satishkumar, Hoffman, Elaine, Liu, Thomas, Scott, Robert, Wasserman, Scott, Sabatine, Marc S. AMG 145, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9), Facilitates Achievement of NCEP LDL-Cholesterol Goals in High-Risk Patients Circulation. 2012;126(23):2791-2791.

Desai, Nihar R., Kohli, Payal, Giugliano, Robert P., Kim, Jae B., Mohanavelu, Satishkumar, Hoffman, Elaine, Liu, Thomas, Scott, Robert, Wasserman, Scott, Sabatine, Marc S. AMG 145, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9), Facilitates Achievement of NCEP LDL-Cholesterol Goals in High-Risk Patients Circulation. 2012;126(23):2791-2791.

Fox, C. S., Muntner, P., Chen, A. Y., Alexander, K. P., Roe, M. T., Wiviott, S. D. Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry Circulation. 2012;125(3):497-504. Abstract

Fox, C. S., Muntner, P., Chen, A. Y., Alexander, K. P., Roe, M. T., Wiviott, S. D. Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry Circulation. 2012;125(3):497-504. Abstract

Fox, C. S., Muntner, P., Chen, A. Y., Alexander, K. P., Roe, M. T., Wiviott, S. D. Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry Circulation. 2012;125(3):497-504. Abstract

Fox, C. S., Muntner, P., Chen, A. Y., Alexander, K. P., Roe, M. T., Wiviott, S. D. Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry Circulation. 2012;125(3):497-504. Abstract

Gibson, C. Michael, Levitan, Bennett, Murphy, Sabina A, Yuan, Zhong, Chakrabarti, Anjan, Lee, Michael, Mega, Jessica, Braunwald, Eugene Abstract 13152: A Net Clinical Outcome Analysis Comparing Fatal or Irreversible Ischemic and Bleeding Events in ATLAS ACS 2 - TIMI 51 Circulation. 2012;126(21 Supplement):A13152.

Giugliano RP, Desai NR, Kohli P, Rogers WJ, Somaratne R, Huang F, Liu T, Mohanavelu S, Hoffman EB, McDonald ST, Abrahamsen TE, Wasserman SM, Scott R, Sabatine MS. Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study. Lancet. 2012;380:2007-2017. Abstract

Giugliano RP, Desai NR, Kohli P, Rogers WJ, Somaratne R, Huang F, Liu T, Mohanavelu S, Hoffman EB, McDonald ST, Abrahamsen TE, Wasserman SM, Scott R, Sabatine MS. Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study. Lancet. 2012;380:2007-2017. Abstract

Giugliano, Robert P., Desai, Nihar R., Kohli, Payal, Somaratne, Ransi, Huang, Fannie, Mohanavelu, Satishkumar, McDonald, Shannon T., Abrahamsen, Timothy E., Wasserman, Scott M., Scott, Robert, Sabatine, Marc S. LAPLACE-TIMI 57 Primary Results Circulation. 2012;126(23):2790-2791.

Giugliano, Robert P., Desai, Nihar R., Kohli, Payal, Somaratne, Ransi, Huang, Fannie, Mohanavelu, Satishkumar, McDonald, Shannon T., Abrahamsen, Timothy E., Wasserman, Scott M., Scott, Robert, Sabatine, Marc S. LAPLACE-TIMI 57 Primary Results Circulation. 2012;126(23):2790-2791.

Grandin, E. W., Jarolim, P., Murphy, S. A., Ritterova, L., Cannon, C. P., Braunwald, E., Morrow, D. A. Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22 Clinical chemistry. 2012;58(1):267-73. Abstract

Hall, Hurst M, Enriquez, Jonathan R, de Lemos, James A, Desai, Nihar, Peng, S. Andrew, Alexander, Karen P, Roe, Matthew T, McGuire, Darren K, Wiviott, Stephen D, Das, Sandeep R Abstract 12693: Patterns of Discharge Aspirin Dosing in 213,344 U.S. Patients after Acute Myocardial Infarction: Results from the NCDR Circulation. 2012;126(21 Supplement):A12693.

Hall, Hurst M, Enriquez, Jonathan R, de Lemos, James A, Desai, Nihar, Peng, S. Andrew, Alexander, Karen P, Roe, Matthew T, McGuire, Darren K, Wiviott, Stephen D, Das, Sandeep R Abstract 12693: Patterns of Discharge Aspirin Dosing in 213,344 U.S. Patients after Acute Myocardial Infarction: Results from the NCDR Circulation. 2012;126(21 Supplement):A12693.

Hoffmann, U., Truong, Q. A., Fleg, J. L., Goehler, A., Gazelle, S., Wiviott, S., Lee, H., Udelson, J. E., Schoenfeld, D., Romicat,, II Design of the Rule Out Myocardial Ischemia/Infarction Using Computer Assisted Tomography: a multicenter randomized comparative effectiveness trial of cardiac computed tomography versus alternative triage strategies in patients with acute chest pain in the emergency department Am Heart J. 2012;163(3):330-8, 338 e1. Abstract

Hoffmann, U., Truong, Q. A., Fleg, J. L., Goehler, A., Gazelle, S., Wiviott, S., Lee, H., Udelson, J. E., Schoenfeld, D., Romicat,, II Design of the Rule Out Myocardial Ischemia/Infarction Using Computer Assisted Tomography: a multicenter randomized comparative effectiveness trial of cardiac computed tomography versus alternative triage strategies in patients with acute chest pain in the emergency department Am Heart J. 2012;163(3):330-8, 338 e1. Abstract

Hoffmann, U., Truong, Q. A., Schoenfeld, D. A., Chou, E. T., Woodard, P. K., Nagurney, J. T., Pope, J. H., Hauser, T. H., White, C. S., Weiner, S. G., Kalanjian, S., Mullins, M. E., Mikati, I., Peacock, W. F., Zakroysky, P., Hayden, D., Goehler, A., Lee, H., Gazelle, G. S., Wiviott, S. D., Fleg, J. L., Udelson, J. E., Romicat-Ii Investigators Coronary CT angiography versus standard evaluation in acute chest pain N Engl J Med. 2012;367(4):299-308. Abstract

Hoffmann, U., Truong, Q. A., Schoenfeld, D. A., Chou, E. T., Woodard, P. K., Nagurney, J. T., Pope, J. H., Hauser, T. H., White, C. S., Weiner, S. G., Kalanjian, S., Mullins, M. E., Mikati, I., Peacock, W. F., Zakroysky, P., Hayden, D., Goehler, A., Lee, H., Gazelle, G. S., Wiviott, S. D., Fleg, J. L., Udelson, J. E., Romicat-Ii Investigators Coronary CT angiography versus standard evaluation in acute chest pain N Engl J Med. 2012;367(4):299-308. Abstract

Hoffmann, U., Truong, Q. A., Schoenfeld, D. A., Chou, E. T., Woodard, P. K., Nagurney, J. T., Pope, J. H., Hauser, T. H., White, C. S., Weiner, S. G., Kalanjian, S., Mullins, M. E., Mikati, I., Peacock, W. F., Zakroysky, P., Hayden, D., Goehler, A., Lee, H., Gazelle, G. S., Wiviott, S. D., Fleg, J. L., Udelson, J. E., Romicat-Ii Investigators Coronary CT angiography versus standard evaluation in acute chest pain N Engl J Med. 2012;367(4):299-308. Abstract

Husted S, James S, Becker RC, Horrow J, Katus H, Storey RF, Cannon CP, Heras M, Lopes RD, Morais J, Mahaffey KW, Bach RG, Wojdyla D, Wallentin L; PLATO study group. Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes A Substudy From the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial. Circ Cardiovasc Qual Outcomes. 2012;5:680-688. Abstract

James SK, Storey RF, Khurmi NS, Husted S, Keltai M, Mahaffey KW, Maya J, Morais J, Lopes RD, Nicolau JC, Pais P, Raev D, Lopez-Sendon JL, Stevens SR, Becker RC; PLATO Study Group. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack. Circulation. 2012;125:2914-2921. Abstract

Kohli, P., Bonaca, M. P., Kakkar, R., Kudinova, A. Y., Scirica, B. M., Sabatine, M. S., Murphy, S. A., Braunwald, E., Lee, R. T., Morrow, D. A. Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial Clinical chemistry. 2012;58(1):257-66. Abstract

Kohli, P., Bonaca, M. P., Kakkar, R., Kudinova, A. Y., Scirica, B. M., Sabatine, M. S., Murphy, S. A., Braunwald, E., Lee, R. T., Morrow, D. A. Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial Clinical chemistry. 2012;58(1):257-66. Abstract

Kohli, P., Cannon, C. P. The importance of matching language to type of evidence: avoiding the pitfalls of reporting outcomes data Clin Cardiol. 2012;35(12):714-7. Abstract

Kohli, P., Cannon, C. P. The importance of matching language to type of evidence: avoiding the pitfalls of reporting outcomes data Clin Cardiol. 2012;35(12):714-7. Abstract

Kohli, P., Cannon, C. P. Triglycerides: how much credit do they deserve? Med Clin North Am. 2012;96(1):39-55. Abstract

Kohli, P., Cannon, C. P. The importance of matching language to type of evidence: avoiding the pitfalls of reporting outcomes data Clin Cardiol. 2012;35(12):714-7. Abstract

Kohli, P., Cannon, C. P. The importance of matching language to type of evidence: avoiding the pitfalls of reporting outcomes data Clin Cardiol. 2012;35(12):714-7. Abstract

Kohli, P., Desai, N. R., Giugliano, R. P., Kim, J. B., Somaratne, R., Huang, F., Knusel, B., McDonald, S., Abrahamsen, T., Wasserman, S. M., Scott, R., Sabatine, M. S. Design and rationale of the LAPLACE-TIMI 57 trial: a phase II, double-blind, placebo-controlled study of the efficacy and tolerability of a monoclonal antibody inhibitor of PCSK9 in subjects with hypercholesterolemia on background statin therapy Clin Cardiol. 2012;35(7):385-91. Abstract

Kohli, P., Desai, N. R., Giugliano, R. P., Kim, J. B., Somaratne, R., Huang, F., Knusel, B., McDonald, S., Abrahamsen, T., Wasserman, S. M., Scott, R., Sabatine, M. S. Design and rationale of the LAPLACE-TIMI 57 trial: a phase II, double-blind, placebo-controlled study of the efficacy and tolerability of a monoclonal antibody inhibitor of PCSK9 in subjects with hypercholesterolemia on background statin therapy Clin Cardiol. 2012;35(7):385-91. Abstract

Kohli, Payal, Desai, Nihar R, Giugliano, Robert P, O'Donoghue, Michelle L, Somaratne, Ransi, Hoffman, Elaine B, Huang, Fannie, Wasserman, Scott M, Scott, Robert, Sabatine, Marc S Abstract 17630: Reduction in Lipoprotein (a) with the PCSK9 Inhibitor AMG145 in Hypercholesterolemic Patients on Background Statin: Results from the LAPLACE-TIMI 57 Trial Circulation. 2012;126(21 Supplement):A17630. Abstract

Kohli, Payal, Desai, Nihar R, Giugliano, Robert P, O'Donoghue, Michelle L, Somaratne, Ransi, Hoffman, Elaine B, Huang, Fannie, Wasserman, Scott M, Scott, Robert, Sabatine, Marc S Abstract 17630: Reduction in Lipoprotein (a) with the PCSK9 Inhibitor AMG145 in Hypercholesterolemic Patients on Background Statin: Results from the LAPLACE-TIMI 57 Trial Circulation. 2012;126(21 Supplement):A17630. Abstract

Kohli, Payal, Laine, Loren, Kaur, Amarjot, Curtis, Sean, Cannon, Christopher P Abstract 19248: Atrial Fibrillation/Flutter Associated with Rheumatoid Arthritis vs. Osteoarthritis and the use of Etoricoxib vs. Diclofenac: Results from the MEDAL Program Circulation. 2012;126(21 Supplement):A19248.

Kohli, Payal, Laine, Loren, Kaur, Amarjot, Curtis, Sean, Cannon, Christopher P Abstract 19248: Atrial Fibrillation/Flutter Associated with Rheumatoid Arthritis vs. Osteoarthritis and the use of Etoricoxib vs. Diclofenac: Results from the MEDAL Program Circulation. 2012;126(21 Supplement):A19248.

Kohli, Payal, Laine, Loren, Kaur, Amarjot, Curtis, Sean, Cannon, Christopher P Abstract 19248: Atrial Fibrillation/Flutter Associated with Rheumatoid Arthritis vs. Osteoarthritis and the use of Etoricoxib vs. Diclofenac: Results from the MEDAL Program Circulation. 2012;126(21 Supplement):A19248.

Kulik, Alexander, Desai, Nihar R., Shrank, William H., Antman, Elliott M., Avorn, Jerry, Glynn, Robert J., Levin, Raisa, Choudhry, Niteesh K. Abstract 13548: Full Prescription Coverage versus Usual Prescription Coverage after Coronary Artery Bypass Graft Surgery for Recent Myocardial Infarction: Analysis from the MI FREEE Randomized Trial Circulation. 2012;126(21 Supplement):A13548.

Kulik, Alexander, Desai, Nihar R., Shrank, William H., Antman, Elliott M., Avorn, Jerry, Glynn, Robert J., Levin, Raisa, Choudhry, Niteesh K. Abstract 13548: Full Prescription Coverage versus Usual Prescription Coverage after Coronary Artery Bypass Graft Surgery for Recent Myocardial Infarction: Analysis from the MI FREEE Randomized Trial Circulation. 2012;126(21 Supplement):A13548.

Kulik, Alexander, Desai, Nihar R., Shrank, William H., Antman, Elliott M., Avorn, Jerry, Glynn, Robert J., Levin, Raisa, Choudhry, Niteesh K. Abstract 13548: Full Prescription Coverage versus Usual Prescription Coverage after Coronary Artery Bypass Graft Surgery for Recent Myocardial Infarction: Analysis from the MI FREEE Randomized Trial Circulation. 2012;126(21 Supplement):A13548.

Kumbhani, Dharam J., Bavry, Anthony A., Bhatt, Deepak L. Abstract 17864: Role of Aspiration and Mechanical Thrombectomy in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty: An Updated Meta-Analysis of Randomized Trials Circulation. 2012;126(21 Supplement):A17864.

Kumbhani, Dharam J., Bavry, Anthony A., Bhatt, Deepak L. Abstract 17864: Role of Aspiration and Mechanical Thrombectomy in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty: An Updated Meta-Analysis of Randomized Trials Circulation. 2012;126(21 Supplement):A17864.

Kumbhani, Dharam J., Fonarow, Gregg C., Cannon, Christopher P., Hernandez, Adrian F., Peterson, Eric D., Peacock, W. F., Laskey, Warren K., Grau-Sepulveda, Maria, Schwamm, Lee H., Bhatt, Deepak L. Abstract 17901: A Comparison of Temporal Trends in In-hospital Adherence to Secondary Prevention Measures Among Patients Undergoing Coronary Artery Bypass Graft Surgery, Percutaneous Coronary Intervention or No Intervention: Insights From the GWTG-CAD Circulation. 2012;126(21 Supplement):A17901.

Kumbhani, Dharam J., Fonarow, Gregg C., Cannon, Christopher P., Hernandez, Adrian F., Peterson, Eric D., Peacock, W. F., Laskey, Warren K., Grau-Sepulveda, Maria, Schwamm, Lee H., Bhatt, Deepak L. Abstract 17901: A Comparison of Temporal Trends in In-hospital Adherence to Secondary Prevention Measures Among Patients Undergoing Coronary Artery Bypass Graft Surgery, Percutaneous Coronary Intervention or No Intervention: Insights From the GWTG-CAD Circulation. 2012;126(21 Supplement):A17901.

Lopes, R. D., White, J. A., Tricoci, P., White, H. D., Armstrong, P. W., Braunwald, E., Giugliano, R. P., Harrington, R. A., Lewis, B. S., Brogan, G. X., Jr., Gibson, C. M., Califf, R. M., Newby, L. K. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: Insights from the EARLY ACS trial International journal of cardiology. 2012;NA(NA):NA. Abstract

Maddox, T. M., Ho, P. M., Tsai, T. T., Wang, T. Y., Li, S., Peng, S. A., Wiviott, S. D., Masoudi, F. A., Rumsfeld, J. S. Clopidogrel use and hospital quality in medically managed patients with non-ST-segment-elevation myocardial infarction Circ Cardiovasc Qual Outcomes. 2012;5(4):523-31. Abstract

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012;366:9-19. Abstract

Mega, Jessica L, Braunwald, Eugene, Wiviott, Stephen D, Murphy, Sabina, Plotnikov, Alexei, Gotcheva, Nina, Ruda, Mikhail, Gibson, C. Michael Abstract 16014: Evaluation of Cardiac Events in ATLAS ACS 2-TIMI 51 Circulation. 2012;126(21 Supplement):A16014.

Miller, Amy L., Holmes, DaJuanicia, Roe, Matthew T., Kontos, Michael C., Diercks, Deborah B., Amsterdam, Ezra, Bhatt, Deepak L., Wang, Tracy Y. Abstract 12552: Patient and Neighborhood Factors Associated with Presentation Delay in ST-Elevation Myocardial Infarction: Insights from the NCDR(R) Circulation. 2012;126(21 Supplement):A12552.

Miller, Amy L., Holmes, DaJuanicia, Roe, Matthew T., Kontos, Michael C., Diercks, Deborah B., Amsterdam, Ezra, Bhatt, Deepak L., Wang, Tracy Y. Abstract 12552: Patient and Neighborhood Factors Associated with Presentation Delay in ST-Elevation Myocardial Infarction: Insights from the NCDR(R) Circulation. 2012;126(21 Supplement):A12552.

Miller, Amy L., Holmes, DaJuanicia, Roe, Matthew T., Kontos, Michael C., Diercks, Deborah B., Amsterdam, Ezra, Bhatt, Deepak L., Wang, Tracy Y. Abstract 12552: Patient and Neighborhood Factors Associated with Presentation Delay in ST-Elevation Myocardial Infarction: Insights from the NCDR(R) Circulation. 2012;126(21 Supplement):A12552.

Mogabgab, O., Giugliano, R. P., Sabatine, M. S., Cannon, C. P., Mohanavelu, S., Wiviott, S. D., Antman, E. M., Braunwald, E. Circadian Variation in Patient Characteristics and Outcomes in ST-Segment Elevation Myocardial Infarction Chronobiology International. 2012;29(10):1390-1396. Abstract

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy, SA. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012;366:1404-13. Abstract

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy, SA. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012;366:1404-13. Abstract

Morrow, D. A., O'Donoghue, M. L. Galectin-3 in cardiovascular disease: a possible window into early myocardial fibrosis J Am Coll Cardiol. 2012;60(14):1257-8.

Morrow, D. A., O'Donoghue, M. L. Galectin-3 in cardiovascular disease: a possible window into early myocardial fibrosis J Am Coll Cardiol. 2012;60(14):1257-8.

Morrow, D. A., O'Donoghue, M. L. Galectin-3 in cardiovascular disease: a possible window into early myocardial fibrosis J Am Coll Cardiol. 2012;60(14):1257-8.

Moukarbel, G. V., Bhatt, D. L. Antiplatelet Therapy and Proton Pump Inhibition Clinician Update Circulation. 2012;125(2):375-380.

Moukarbel, G. V., Bhatt, D. L. Antiplatelet Therapy and Proton Pump Inhibition Clinician Update Circulation. 2012;125(2):375-380.

Moukarbel, G. V., Bhatt, D. L. Antiplatelet Therapy and Proton Pump Inhibition Clinician Update Circulation. 2012;125(2):375-380.

Naccarelli, Gerald, Bhatt, Deepak L., Camm, A. J., Le Heuzey, Jean-Yves, Lombardi, Federico, Tamargo, Juan, Bozzi, Sylvie, Marchese-Roland, Catherine, for the, Artemis Investigators Abstract 15918: Switching Patients with Atrial Fibrillation from Amiodarone to Dronedarone: Results of the ARTEMIS AF Studies Circulation. 2012;126(21 Supplement):A15918.

Naccarelli, Gerald, Bhatt, Deepak L., Camm, A. J., Le Heuzey, Jean-Yves, Lombardi, Federico, Tamargo, Juan, Bozzi, Sylvie, Marchese-Roland, Catherine, for the, Artemis Investigators Abstract 15918: Switching Patients with Atrial Fibrillation from Amiodarone to Dronedarone: Results of the ARTEMIS AF Studies Circulation. 2012;126(21 Supplement):A15918.

Naccarelli, Gerald, Bhatt, Deepak L., Camm, A. J., Le Heuzey, Jean-Yves, Lombardi, Federico, Tamargo, Juan, Bozzi, Sylvie, Marchese-Roland, Catherine, for the, Artemis Investigators Abstract 15918: Switching Patients with Atrial Fibrillation from Amiodarone to Dronedarone: Results of the ARTEMIS AF Studies Circulation. 2012;126(21 Supplement):A15918.

O'Donoghue, M. L., Bhatt, D. L., Flather, M. D., Goto, S., Angiolillo, D. J., Goodman, S. G., Zeymer, U., Aylward, P. E., Montalescot, G., Ziecina, R., Kobayashi, H., Ren, F., Wiviott, S. D. Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program J Thromb Thrombolysis. 2012;34(1):36-43. Abstract

O'Donoghue, M. L., Vaidya, A., Afsal, R., Alfredsson, J., Boden, W. E., Braunwald, E., Cannon, C. P., Clayton, T. C., de Winter, R. J., Fox, K. A., Lagerqvist, B., McCullough, P. A., Murphy, S. A., Spacek, R., Swahn, E., Windhausen, F., Sabatine, M. S. An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials Journal of the American College of Cardiology. 2012;60(2):106-11. Abstract

O'Donoghue, M. L., Vaidya, A., Afsal, R., Alfredsson, J., Boden, W. E., Braunwald, E., Cannon, C. P., Clayton, T. C., de Winter, R. J., Fox, K. A., Lagerqvist, B., McCullough, P. A., Murphy, S. A., Spacek, R., Swahn, E., Windhausen, F., Sabatine, M. S. An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials Journal of the American College of Cardiology. 2012;60(2):106-11. Abstract

O'Donoghue, M. L., Vaidya, A., Afsal, R., Alfredsson, J., Boden, W. E., Braunwald, E., Cannon, C. P., Clayton, T. C., de Winter, R. J., Fox, K. A., Lagerqvist, B., McCullough, P. A., Murphy, S. A., Spacek, R., Swahn, E., Windhausen, F., Sabatine, M. S. An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials Journal of the American College of Cardiology. 2012;60(2):106-11. Abstract

Piccini, J. P., White, J. A., Mehta, R. H., Lokhnygina, Y., Al-Khatib, S. M., Tricoci, P., Pollack, C. V., Jr., Montalescot, G., Van de Werf, F., Gibson, C. M., Giugliano, R. P., Califf, R. M., Harrington, R. A., Newby, L. K. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes Circulation. 2012;126(1):41-9. Abstract

Piccini, J. P., White, J. A., Mehta, R. H., Lokhnygina, Y., Al-Khatib, S. M., Tricoci, P., Pollack, C. V., Jr., Montalescot, G., Van de Werf, F., Gibson, C. M., Giugliano, R. P., Califf, R. M., Harrington, R. A., Newby, L. K. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes Circulation. 2012;126(1):41-9. Abstract

Pride, Yuri, Mohanavelu, Satishkumar, Mega, Jessica, Braunwald, Eugene, Gibson, C. Michael Abstract 9944: Temporal Relationship Between Major Hemorrhagic Events and Mortality among Patients with Recent Acute Coronary Syndrome: Insights from ATLAS ACS 2-TIMI 51 Circulation. 2012;126(21 Supplement):A9944.

Rasoul S, van't Hof A, Clare R, Atar D, James S, Tanguay J, Betriu A, Brogan G, Giugliano R, Newby LK Routine Early Eptifibatide, Infarct Size and Outcomes in Non-ST segment Elevation Acute Coronary Syndrome Patients with Elevated Troponins on Admission J Am Coll Cardiol. 2012;59(13):A121.

Roe, M. T., Armstrong, P. W., Fox, K. A., White, H. D., Prabhakaran, D., Goodman, S. G., Cornel, J. H., Bhatt, D. L., Clemmensen, P., Martinez, F., Ardissino, D., Nicolau, J. C., Boden, W. E., Gurbel, P. A., Ruzyllo, W., Dalby, A. J., McGuire, D. K., Leiva-Pons, J. L., Parkhomenko, A., Gottlieb, S., Topacio, G. O., Hamm, C., Pavlides, G., Goudev, A. R., Oto, A., Tseng, C. D., Merkely, B., Gasparovic, V., Corbalan, R., Cinteza, M., McLendon, R. C., Winters, K. J., Brown, E. B., Lokhnygina, Y., Aylward, P. E., Huber, K., Hochman, J. S., Ohman, E. M., Trilogy Acs Investigators Prasugrel versus clopidogrel for acute coronary syndromes without revascularization N Engl J Med. 2012;367(14):1297-309. Abstract

Roe, M. T., White, J. A., Kaul, P., Tricoci, P., Lokhnygina, Y., Miller, C. D., van't Hof, A. W., Montalescot, G., James, S. K., Saucedo, J., Ohman, E. M., Pollack, C. V., Jr., Hochman, J. S., Armstrong, P. W., Giugliano, R. P., Harrington, R. A., Van de Werf, F., Califf, R. M., Newby, L. K. Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial Circ Cardiovasc Qual Outcomes. 2012;5(2):205-13. Abstract

Roe, M. T., White, J. A., Kaul, P., Tricoci, P., Lokhnygina, Y., Miller, C. D., van't Hof, A. W., Montalescot, G., James, S. K., Saucedo, J., Ohman, E. M., Pollack, C. V., Jr., Hochman, J. S., Armstrong, P. W., Giugliano, R. P., Harrington, R. A., Van de Werf, F., Califf, R. M., Newby, L. K. Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial Circ Cardiovasc Qual Outcomes. 2012;5(2):205-13. Abstract

Roe, M. T., White, J. A., Kaul, P., Tricoci, P., Lokhnygina, Y., Miller, C. D., van't Hof, A. W., Montalescot, G., James, S. K., Saucedo, J., Ohman, E. M., Pollack, C. V., Jr., Hochman, J. S., Armstrong, P. W., Giugliano, R. P., Harrington, R. A., Van de Werf, F., Califf, R. M., Newby, L. K. Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial Circ Cardiovasc Qual Outcomes. 2012;5(2):205-13. Abstract

Roysland, R., Bonaca, M. P., Omland, T., Sabatine, M., Murphy, S. A., Scirica, B. M., Bjerre, M., Flyvbjerg, A., Braunwald, E., Morrow, D. A. Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes Heart. 2012;98(10):786-91. Abstract

Ruff, C. T., Giugliano, R. P., Antman, E. M., Murphy, S. A., Lotan, C., Heuer, H., Merkely, B., Baracioli, L., Schersten, F., Seabro-Gomes, R., Braunwald, E., Wiviott, S. D. Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world Int J Cardiol. 2012;155(3):424-9. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Omland, T., Sloan, S., Jarolim, P., Solomon, S. D., Pfeffer, M. A., Braunwald, E. Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease Circulation. 2012;125(2):233-40. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Omland, T., Sloan, S., Jarolim, P., Solomon, S. D., Pfeffer, M. A., Braunwald, E. Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease Circulation. 2012;125(2):233-40. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Omland, T., Sloan, S., Jarolim, P., Solomon, S. D., Pfeffer, M. A., Braunwald, E. Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease Circulation. 2012;125(2):233-40. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Omland, T., Sloan, S., Jarolim, P., Solomon, S. D., Pfeffer, M. A., Braunwald, E. Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease Circulation. 2012;125(2):233-40. Abstract

Sarma, Amy, Wiviott, Stephen D, Antman, Elliott, Mega, Jessica L, Murphy, Sabina A, Hoffman, Elaine, Sabatine, Marc S, O'Donoghue, Michelle L Abstract 17455: Pharmacodynamic Response to Clopidogrel in Men versus Women: Insights from the PRINCIPLE-TIMI 44 Trial Circulation. 2012;126(21 Supplement):A17455.

Scirica BM, Bonaca MP, Braunwald E, De Ferrari GM, Isaza D, Lewis BS, Mehrhof F, Merlini PA, Murphy SA, Sabatine MS, Tendera M, Van de Werf F, Wilcox R, Morrow DA. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2˚P-TIMI 50 trial Lancet. 2012;380:1317-24. Abstract

Scirica BM, Bonaca MP, Braunwald E, De Ferrari GM, Isaza D, Lewis BS, Mehrhof F, Merlini PA, Murphy SA, Sabatine MS, Tendera M, Van de Werf F, Wilcox R, Morrow DA. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2˚P-TIMI 50 trial Lancet. 2012;380:1317-24. Abstract

Scirica, Benjamin M, Bonaca, Marc P, Braunwald, Eugene, Betriu, Amadeo, Moliterno, David J, Corbalan, Ramon, Murphy, Sabina A, Morrow, David A Abstract 14508: Vorapaxar for Secondary Prevention after Myocardial Infarction According to Aspirin Dose - Insights from the TRA2{degrees}P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A14508.

Scirica, Benjamin M, Bonaca, Marc P, Braunwald, Eugene, Diehm, Curt H, Hankey, Graeme J, Moliterno, David J, Murphy, Sabina A, Morrow, David A Abstract 14419: Natural History of Atherothrombotic Events According to the Primary Diseased Vascular Bed - Insights from the TRA2P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A14419.

Shah, R. V., Holmes, D., Anderson, M., Wang, T. Y., Kontos, M. C., Wiviott, S. D., Scirica, B. M. Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry Circ Heart Fail. 2012;5(6):693-702. Abstract

Shah, R. V., Holmes, D., Anderson, M., Wang, T. Y., Kontos, M. C., Wiviott, S. D., Scirica, B. M. Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry Circ Heart Fail. 2012;5(6):693-702. Abstract

Steg, P. G., Mehta, S. R., Pollack, C. V., Jr., Bode, C., Gaudin, C., Fanouillere, K., Moryusef, A., Wiviott, S. D., Sabatine, M. S. Design and rationale of the treatment of acute coronary syndromes with otamixaban trial: a double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non-ST-segment elevation acute coronary syndromes with a planned early invasive strategy Am Heart J. 2012;164(6):817-24 e13. Abstract

Subherwal, S., Peterson, E. D., Chen, A. Y., Roe, M. T., Washam, J. B., Gage, B. F., Bach, R. G., Bhatt, D. L., Wiviott, S. D., Lopes, R. D., Alexander, K. P., Wang, T. Y. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry Circulation. 2012;125(11):1414-23. Abstract

Truong, Quynh A., Hayden, Douglas, Woodard, Pamela K., Kirby, Ruth, Chou, Eric T., Wiviott, Stephen D., Fleg, Jerome L., Schoenfeld, David A., Udelson, James E., Hoffmann, Udo Abstract 12596: Women Benefit Most from Early CCTA Compared to Standard ED Evaluation for Acute Chest Pain: The ROMICAT II Trial Circulation. 2012;126(21 Supplement):A12596.

Truong, Quynh A., Hayden, Douglas, Woodard, Pamela K., Kirby, Ruth, Chou, Eric T., Wiviott, Stephen D., Fleg, Jerome L., Schoenfeld, David A., Udelson, James E., Hoffmann, Udo Abstract 12596: Women Benefit Most from Early CCTA Compared to Standard ED Evaluation for Acute Chest Pain: The ROMICAT II Trial Circulation. 2012;126(21 Supplement):A12596.

Udell, J. A., Scirica, B. M., Braunwald, E., Raz, I., Steg, P. G., Davidson, J., Hirshberg, B., Bhatt, D. L. Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus Clin Cardiol. 2012;35(12):722-9. Abstract

Udell, J. A., Steg, P. G., Scirica, B. M., Smith, S. C., Jr., Ohman, E. M., Eagle, K. A., Goto, S., Cho, J. I., Bhatt, D. L., R. Eduction of Atherothrombosis for Continued Health Registry Investigators Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis Arch Intern Med. 2012;172(14):1086-95. Abstract

Udell, J. A., Steg, P. G., Scirica, B. M., Smith, S. C., Jr., Ohman, E. M., Eagle, K. A., Goto, S., Cho, J. I., Bhatt, D. L., R. Eduction of Atherothrombosis for Continued Health Registry Investigators Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis Arch Intern Med. 2012;172(14):1086-95. Abstract

Varenhorst C, Alström U, Scirica BM, Hogue CW, Åsenblad N, Storey RF, Steg PG, Horrow J, Mahaffey KW, Becker RC, James S, Cannon CP, Brandrup-Wognsen G, Wallentin L, Held C. Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol. 2012;60:1623-30. Abstract

Varenhorst C, Alström U, Scirica BM, Hogue CW, Åsenblad N, Storey RF, Steg PG, Horrow J, Mahaffey KW, Becker RC, James S, Cannon CP, Brandrup-Wognsen G, Wallentin L, Held C. Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol. 2012;60:1623-30. Abstract

Varenhorst C, Alström U, Scirica BM, Hogue CW, Åsenblad N, Storey RF, Steg PG, Horrow J, Mahaffey KW, Becker RC, James S, Cannon CP, Brandrup-Wognsen G, Wallentin L, Held C. Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol. 2012;60:1623-30. Abstract

Vavalle, J. P., Lopes, R. D., Chen, A. Y., Newby, L. K., Wang, T. Y., Shah, B. R., Ho, P. M., Wiviott, S. D., Peterson, E. D., Roe, M. T., Granger, C. B. Hospital length of stay in patients with non-ST-segment elevation myocardial infarction Am J Med. 2012;125(11):1085-94. Abstract

Vavalle, J. P., Lopes, R. D., Chen, A. Y., Newby, L. K., Wang, T. Y., Shah, B. R., Ho, P. M., Wiviott, S. D., Peterson, E. D., Roe, M. T., Granger, C. B. Hospital length of stay in patients with non-ST-segment elevation myocardial infarction Am J Med. 2012;125(11):1085-94. Abstract

Vora, A. N., Bonaca, M. P., Ruff, C. T., Jarolim, P., Murphy, S., Croce, K., Sabatine, M. S., Simon, D. I., Morrow, D. A. Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest pain J Thromb Thrombolysis. 2012;34(2):229-34. Abstract

Vora, A. N., Bonaca, M. P., Ruff, C. T., Jarolim, P., Murphy, S., Croce, K., Sabatine, M. S., Simon, D. I., Morrow, D. A. Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest pain J Thromb Thrombolysis. 2012;34(2):229-34. Abstract

Zeymer, Uwe, Clare, Robert, Schweiger, Marc, van't Hof, Arnoud, Hochman, Judith, James, Stefan, White, Harvey, Widimsky, Petr, Betriu, Amadeo, Bode, Christoph, Califf, Robert, Harrington, Robert, Giugliano, Robert, Gibson, C. Michael, Newby, L. Kristin FREQUENCY, CLINICAL AND ANGIOGRAPHIC CHARACTERISTICS, AND OUTCOMES OF HIGH-RISK NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES PATIENTS WITH LEFT CIRCUMFLEX CULPRIT LESIONS Journal of the American College of Cardiology. 2012;59(13, Supplement):E405.

Aday AW, Dell'orfano H, Hirning BA, Matta L, O'Brien MH, Scirica BM, Avery KR, Morrow DA. Evaluation of a clinical pathway for sedation and analgesia of mechanically ventilated patients in a cardiac intensive care unit (CICU): The Brigham and Women's Hospital Levine CICU sedation pathways. Eur Heart J Acute Cardiovasc Care. 2013;2:299-305. Abstract

Aday AW, Dell'orfano H, Hirning BA, Matta L, O'Brien MH, Scirica BM, Avery KR, Morrow DA. Evaluation of a clinical pathway for sedation and analgesia of mechanically ventilated patients in a cardiac intensive care unit (CICU): The Brigham and Women's Hospital Levine CICU sedation pathways. Eur Heart J Acute Cardiovasc Care. 2013;2:299-305. Abstract

Aday AW, Dell'orfano H, Hirning BA, Matta L, O'Brien MH, Scirica BM, Avery KR, Morrow DA. Evaluation of a clinical pathway for sedation and analgesia of mechanically ventilated patients in a cardiac intensive care unit (CICU): The Brigham and Women's Hospital Levine CICU sedation pathways. Eur Heart J Acute Cardiovasc Care. 2013;2:299-305. Abstract

Aday AW, Dell'orfano H, Hirning BA, Matta L, O'Brien MH, Scirica BM, Avery KR, Morrow DA. Evaluation of a clinical pathway for sedation and analgesia of mechanically ventilated patients in a cardiac intensive care unit (CICU): The Brigham and Women's Hospital Levine CICU sedation pathways. Eur Heart J Acute Cardiovasc Care. 2013;2:299-305. Abstract

Ademi, Z., Huq, M. M., Liew, D., Steg, P. G., Bhatt, D. L., Nelson, M., Reid, C. M., Reach Registry investigators The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry Cardiovasc Ther. 2013;31(6):370-6. Abstract

Ademi, Z., Huq, M. M., Liew, D., Steg, P. G., Bhatt, D. L., Nelson, M., Reid, C. M., Reach Registry investigators The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry Cardiovasc Ther. 2013;31(6):370-6. Abstract

Ademi, Z., Huq, M. M., Liew, D., Steg, P. G., Bhatt, D. L., Nelson, M., Reid, C. M., Reach Registry investigators The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry Cardiovasc Ther. 2013;31(6):370-6. Abstract

Ademi, Z., Huq, M. M., Liew, D., Steg, P. G., Bhatt, D. L., Nelson, M., Reid, C. M., Reach Registry investigators The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry Cardiovasc Ther. 2013;31(6):370-6. Abstract

Ademi, Z., Liew, D., Zomer, E., Gorelik, A., Hollingsworth, B., Steg, P. G., Bhatt, D. L., Reid, C. M. Outcomes and Excess Costs among Patients with Cardiovascular Disease Heart Lung Circ. 2013;22(9):724-30. Abstract

Ademi, Z., Liew, D., Zomer, E., Gorelik, A., Hollingsworth, B., Steg, P. G., Bhatt, D. L., Reid, C. M. Outcomes and Excess Costs among Patients with Cardiovascular Disease Heart Lung Circ. 2013;22(9):724-30. Abstract

Ademi, Z., Liew, D., Zomer, E., Gorelik, A., Hollingsworth, B., Steg, P. G., Bhatt, D. L., Reid, C. M. Outcomes and Excess Costs among Patients with Cardiovascular Disease Heart Lung Circ. 2013;22(9):724-30. Abstract

Agrawal, K., Bhatt, D. L. Antiplatelet therapy: Does prasugrel or ticagrelor suffice in patients with STEMI? Nat Rev Cardiol. 2013;10(3):121-2.

Agrawal, K., Bhatt, D. L. Antiplatelet therapy: Does prasugrel or ticagrelor suffice in patients with STEMI? Nat Rev Cardiol. 2013;10(3):121-2.

Amin, S. T., Morrow, D. A., Braunwald, E., Sloan, S., Contant, C., Murphy, S., Antman, E. M. Dynamic TIMI Risk Score for STEMI J Am Heart Assoc. 2013;2(1):e003269. Abstract

Amin, S. T., Morrow, D. A., Braunwald, E., Sloan, S., Contant, C., Murphy, S., Antman, E. M. Dynamic TIMI Risk Score for STEMI J Am Heart Assoc. 2013;2(1):e003269. Abstract

Anderson, M. L., Peterson, E. D., Peng, S. A., Wang, T. Y., Ohman, E. M., Bhatt, D. L., Saucedo, J. F., Roe, M. T. Differences in the Profile, Treatment, and Prognosis of Patients With Cardiogenic Shock by Myocardial Infarction Classification: A Report From NCDR Circ Cardiovasc Qual Outcomes. 2013;6(6):708-15. Abstract

Anderson, M. L., Peterson, E. D., Peng, S. A., Wang, T. Y., Ohman, E. M., Bhatt, D. L., Saucedo, J. F., Roe, M. T. Differences in the Profile, Treatment, and Prognosis of Patients With Cardiogenic Shock by Myocardial Infarction Classification: A Report From NCDR Circ Cardiovasc Qual Outcomes. 2013;6(6):708-15. Abstract

Bagai, A., White, J. A., Lokhnygina, Y., Giugliano, R. P., Van de Werf, F., Montalescot, G., Armstrong, P. W., Tricoci, P., Gibson, C. M., Califf, R. M., Harrington, R. A., Newby, L. K. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: An analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trial Am Heart J. 2013;166(3):466-473 e1. Abstract

Bangalore, S., Bhatt, D. L. Coronary intravascular ultrasound Circulation. 2013;127(25):e868-74.

Bangalore, S., Bhatt, D. L. Coronary intravascular ultrasound Circulation. 2013;127(25):e868-74.

Bangalore, S., Bhatt, D. L. Coronary intravascular ultrasound Circulation. 2013;127(25):e868-74.

Bansilal S, Bonaca MP, Sabatine MS. Ticagrelor for acute coronary syndromes. Expert Rev Cardiovasc Ther. 2013;11:1473-84. Abstract

Bansilal S, Bonaca MP, Sabatine MS. Ticagrelor for acute coronary syndromes. Expert Rev Cardiovasc Ther. 2013;11:1473-84. Abstract

Bansilal, S., Wiviott, S., Becker, R., Harrington, R., Himmelmann, A., Neely, B., Husted, S., Storey, R., Steg, P., Katus, H., James, S., Wallentin, L., Cannon, C., Timi Study Group The Efficacy and Safety of Ticagrelor as Compared to Clopidogrel, with and without a Glycoprotein iib/iiia Inhibitor in Patients with Acute Coronary Syndromes Undergoin Percutaneous Intervention: A PLATO (Study of Platelet Inhibition and Patient Outcomes) Analysis Journal of the American College of Cardiology. 2013;61(10):A460.

Bhatt, D. L., Stone, G. W., Mahaffey, K. W., Gibson, C. M., Steg, P. G., Hamm, C. W., Price, M. J., Leonardi, S., Gallup, D., Bramucci, E., Radke, P. W., Widimsky, P., Tousek, F., Tauth, J., Spriggs, D., McLaurin, B. T., Angiolillo, D. J., Genereux, P., Liu, T., Prats, J., Todd, M., Skerjanec, S., White, H. D., Harrington, R. A., Champion Phoenix Investigators Effect of platelet inhibition with cangrelor during PCI on ischemic events N Engl J Med. 2013;368(14):1303-13. Abstract

Bohula May, E. A., Bonaca, M. P., Jarolim, P., Antman, E. M., Braunwald, E., Giugliano, R. P., Newby, L. K., Sabatine, M. S., Morrow, D. A. Prognostic Performance of a High-Sensitivity Cardiac Troponin I Assay in Patients with Non-ST-Elevation Acute Coronary Syndrome Clin Chem. 2013;NA(NA):NA. Abstract

Bonaca MP, Ruff CT, Kosowsky J, Conrad MJ, Murphy SA, Sabatine MS, Jarolim P, Morrow DA. Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study. Eur Heart J Acute Cardiovasc Care. 2013;2:195-202. Abstract

Bonaca MP, Ruff CT, Kosowsky J, Conrad MJ, Murphy SA, Sabatine MS, Jarolim P, Morrow DA. Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study. Eur Heart J Acute Cardiovasc Care. 2013;2:195-202. Abstract

Bonaca MP, Ruff CT, Kosowsky J, Conrad MJ, Murphy SA, Sabatine MS, Jarolim P, Morrow DA. Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study. Eur Heart J Acute Cardiovasc Care. 2013;2:195-202. Abstract

Bonaca MP, Scirica BM, Creager MA, Olin J, Bounameaux H, Dellborg M, Lamp JM, Murphy SA, Braunwald E, Morrow DA Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA 2˚P-TIMI 50 Circulation. 2013;127:1522-9. Abstract

Bonaca, M. P., Beckman, J. Management of asymptomatic carotid artery stenosis Curr Treat Options Cardiovasc Med. 2013;15(2):252-63. Abstract

Bonaca, M. P., Beckman, J. Management of asymptomatic carotid artery stenosis Curr Treat Options Cardiovasc Med. 2013;15(2):252-63. Abstract

Bonaca, M., Creager, M. A., Olin, J., Scirica, B., Bohula May, E. A., Murphy, S., Braunwald, E. B., Morrow, D., Timi Study Group Vorapaxar Reduces Peripheral revascularization Regardless of the Number of Diseased Territories: Insights from the TRA 2P - TIMI 50 Trial Journal of the American College of Cardiology. 2013;61(10):A504.

Bonaca, Marc P, Scirica, Benjamin M, Braunwald, Eugene, Wiviott, Stephen D, Murphy, Sabina A, Morrow, David A Abstract 18928: Vorapaxar Reduces Coronary Stent Thrombosis: Results From the TRA2P-TIMI 50 Trial Circulation. 2013;128(22 Supplement):A18928.

Braunwald, E. Cardiovascular science: opportunities for translating research into improved care J Clin Invest. 2013;123(1):10-Jun. Abstract

Braunwald, E. Cardiovascular science: opportunities for translating research into improved care J Clin Invest. 2013;123(1):10-Jun. Abstract

Braunwald, E. Research Advances in Heart Failure: A Compendium Circ Res. 2013;NA(NA):NA. Abstract

Braunwald, E. Research Advances in Heart Failure: A Compendium Circ Res. 2013;NA(NA):NA. Abstract

Braunwald, E. Research Advances in Heart Failure: A Compendium Circ Res. 2013;NA(NA):NA. Abstract

Braunwald, E. Cardiovascular science: opportunities for translating research into improved care J Clin Invest. 2013;123(1):10-Jun. Abstract

Braunwald, E., Morrow, D. A. Unstable angina: is it time for a requiem? Circulation. 2013;127(24):2452-7.

Braunwald, E., Morrow, D. A. Unstable angina: is it time for a requiem? Circulation. 2013;127(24):2452-7.

Braunwald, E., Morrow, D. A. Unstable angina: is it time for a requiem? Circulation. 2013;127(24):2452-7.

Bui, A. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Yancy, C. W., Bhatt, D. L., Fonarow, G. C. Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation Am Heart J. 2013;165(4):567-574 e6. Abstract

Bui, A. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Yancy, C. W., Bhatt, D. L., Fonarow, G. C. Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation Am Heart J. 2013;165(4):567-574 e6. Abstract

Bui, A. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Yancy, C. W., Bhatt, D. L., Fonarow, G. C. Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation Am Heart J. 2013;165(4):567-574 e6. Abstract

Buyukkaya, E., Poyraz, F., Karakas, M. F., Kurt, M., Akcay, A. B., Akpinar, I., Motor, S., Turak, O., Ozturk, O. H., Sen, N., Akpek, M., Kaya, M. G., Gibson, C. M. Usefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Am J Cardiol. 2013;NA(NA):NA. Abstract

Cavender, M. A., Braunwald, E. B., Gibson, C. M., Wiviott, S., Murphy, S., Amuchastegui, A., Ophuis, A. J, van Hessen, M, Mega, J. L., Timi Study Group Rivaroxaban Reduces Spontaneous and Large Myocardial Infarctions: findings from the ATLAS ACS 2 - TIMI 51 Trial Journal of the American College of Cardiology. 2013;61(10):A1.

Cavender, M. A., Rajeswaran, J., Di Paola, L., Houghtaling, P., Kiernan, M. S., Rassi, A. N., Menon, V., Whitlow, P. W., Ellis, S. G., Shishehbor, M. H. Outcomes of Culprit Versus Multivessel PCI in Patients With Multivessel Coronary Artery Disease Presenting With ST-Elevation Myocardial Infarction Complicated by Shock J Invasive Cardiol. 2013;25(5):218-24. Abstract

Cavender, M. A., Rajeswaran, J., Di Paola, L., Houghtaling, P., Kiernan, M. S., Rassi, A. N., Menon, V., Whitlow, P. W., Ellis, S. G., Shishehbor, M. H. Outcomes of Culprit Versus Multivessel PCI in Patients With Multivessel Coronary Artery Disease Presenting With ST-Elevation Myocardial Infarction Complicated by Shock J Invasive Cardiol. 2013;25(5):218-24. Abstract

Cavender, M. A., Rassi, A. N., Fonarow, G. C., Cannon, C. P., Frank Peacock, W., Laskey, W. K., Hernandez, A. F., Peterson, E. D., Cox, M., Grau-Sepulveda, M., Schwamm, L. H., Bhatt, D. L. Relationship of Race/Ethnicity With Door-to-Balloon Time and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Findings From Get With the Guidelines-Coronary Artery Disease Clin Cardiol. 2013;NA(NA):NA. Abstract

Cavender, M. A., Rassi, A. N., Fonarow, G. C., Cannon, C. P., Frank Peacock, W., Laskey, W. K., Hernandez, A. F., Peterson, E. D., Cox, M., Grau-Sepulveda, M., Schwamm, L. H., Bhatt, D. L. Relationship of Race/Ethnicity With Door-to-Balloon Time and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Findings From Get With the Guidelines-Coronary Artery Disease Clin Cardiol. 2013;NA(NA):NA. Abstract

Cavender, M. A., Rassi, A. N., Fonarow, G. C., Cannon, C. P., Frank Peacock, W., Laskey, W. K., Hernandez, A. F., Peterson, E. D., Cox, M., Grau-Sepulveda, M., Schwamm, L. H., Bhatt, D. L. Relationship of Race/Ethnicity With Door-to-Balloon Time and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Findings From Get With the Guidelines-Coronary Artery Disease Clin Cardiol. 2013;NA(NA):NA. Abstract

Cavender, Matthew A, Scirica, Benjamin M, Raz, Itamar, Steg, P. G, Hirshberg, Boaz, Davidson, Jaime, Im, KyungAh, Hoffman, Elaine, Braunwald, Eugene, Bhatt, Deepak L Abstract 17270: Outcomes of Patients With Type 2 Diabetes at High Risk of Cardiovascular Events Treated With Saxagliptin: Outcomes by Baseline HgbA1c Circulation. 2013;128(22 Supplement):A17270.

Cavender, Matthew A, Scirica, Benjamin, Bonaca, Marc P, Morais, Joao, Oude Ophius, Ton, Dalby, Tony, Murphy, Sabina, Braunwald, Eugene, Morrow, David Abstract 10398: Vorapaxar in Patients With Diabetes and Prior MI: Findings From the TRA 2P - TIMI 50 Trial Circulation. 2013;128(22 Supplement):A10398.

Celik, T., Kaya, M. G., Akpek, M., Yarlioglues, M., Sarli, B., Topsakal, R., Gibson, C. M. Does Serum Bilirubin Level on Admission Predict TIMI Flow Grade and In-Hospital MACE in Patients With STEMI Undergoing Primary PCI Angiology. 2013;NA(NA):NA. Abstract

Celik, T., Kaya, M. G., Akpek, M., Yarlioglues, M., Sarli, B., Topsakal, R., Gibson, C. M. Does Serum Bilirubin Level on Admission Predict TIMI Flow Grade and In-Hospital MACE in Patients With STEMI Undergoing Primary PCI Angiology. 2013;NA(NA):NA. Abstract

Chakrabarti, A. K., Feeney, K., Abueg, C., Brown, D. A., Czyz, E., Tendera, M., Janosi, A., Giugliano, R. P., Kloner, R. A., Weaver, W. D., Bode, C., Godlewski, J., Merkely, B., Gibson, C. M. Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction Am Heart J. 2013;165(4):509-514 e7. Abstract

Chan, P. S., Rao, S. V., Bhatt, D. L., Rumsfeld, J. S., Gurm, H. S., Nallamothu, B. K., Cavender, M. A., Kennedy, K., Spertus, J. A. Patient and Hospital Characteristics Associated with Inappropriate Percutaneous Coronary Interventions J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Chan, P. S., Rao, S. V., Bhatt, D. L., Rumsfeld, J. S., Gurm, H. S., Nallamothu, B. K., Cavender, M. A., Kennedy, K., Spertus, J. A. Patient and Hospital Characteristics Associated with Inappropriate Percutaneous Coronary Interventions J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Chan, P. S., Rao, S. V., Bhatt, D. L., Rumsfeld, J. S., Gurm, H. S., Nallamothu, B. K., Cavender, M. A., Kennedy, K., Spertus, J. A. Patient and Hospital Characteristics Associated with Inappropriate Percutaneous Coronary Interventions J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Chen, H. H., Abouezzeddine, O. F., Anstrom, K. J., Givertz, M. M., Bart, B. A., Felker, G. M., Hernandez, A. F., Lee, K. L., Braunwald, E., Redfield, M. M. Targeting the Kidney in Acute Heart Failure: Can Old Drugs Provide New Benefit?: Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial Circ Heart Fail. 2013;6(5):1087-94.

Chen, H. H., Abouezzeddine, O. F., Anstrom, K. J., Givertz, M. M., Bart, B. A., Felker, G. M., Hernandez, A. F., Lee, K. L., Braunwald, E., Redfield, M. M. Targeting the Kidney in Acute Heart Failure: Can Old Drugs Provide New Benefit?: Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial Circ Heart Fail. 2013;6(5):1087-94.

Chen, H. H., Abouezzeddine, O. F., Anstrom, K. J., Givertz, M. M., Bart, B. A., Felker, G. M., Hernandez, A. F., Lee, K. L., Braunwald, E., Redfield, M. M. Targeting the Kidney in Acute Heart Failure: Can Old Drugs Provide New Benefit?: Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial Circ Heart Fail. 2013;6(5):1087-94.

Clarke, J. C., Aragam, J. R., Bhatt, D. L., Brown, J. D., Ferrazzani, S., Pietro, D. A., Maron, B. A. An unusual cause of dyspnea diagnosed late in life: severe pulmonary hypertension resulting from isolated anomalous pulmonary venous connection Circ Cardiovasc Imaging. 2013;6(2):349-51.

Clarke, J. C., Aragam, J. R., Bhatt, D. L., Brown, J. D., Ferrazzani, S., Pietro, D. A., Maron, B. A. An unusual cause of dyspnea diagnosed late in life: severe pulmonary hypertension resulting from isolated anomalous pulmonary venous connection Circ Cardiovasc Imaging. 2013;6(2):349-51.

Clarke, J. C., Aragam, J. R., Bhatt, D. L., Brown, J. D., Ferrazzani, S., Pietro, D. A., Maron, B. A. An unusual cause of dyspnea diagnosed late in life: severe pulmonary hypertension resulting from isolated anomalous pulmonary venous connection Circ Cardiovasc Imaging. 2013;6(2):349-51.

Clarke, J. C., Aragam, J. R., Bhatt, D. L., Brown, J. D., Ferrazzani, S., Pietro, D. A., Maron, B. A. An unusual cause of dyspnea diagnosed late in life: severe pulmonary hypertension resulting from isolated anomalous pulmonary venous connection Circ Cardiovasc Imaging. 2013;6(2):349-51.

Cumbler, E., Wald, H., Bhatt, D. L., Cox, M., Xian, Y., Reeves, M., Smith, E. E., Schwamm, L., Fonarow, G. C. Quality of Care and Outcomes for In-Hospital Ischemic Stroke: Findings From the National Get With The Guidelines-Stroke Stroke. 2013;NA(NA):NA. Abstract

Cumbler, E., Wald, H., Bhatt, D. L., Cox, M., Xian, Y., Reeves, M., Smith, E. E., Schwamm, L., Fonarow, G. C. Quality of Care and Outcomes for In-Hospital Ischemic Stroke: Findings From the National Get With The Guidelines-Stroke Stroke. 2013;NA(NA):NA. Abstract

Cumbler, E., Wald, H., Bhatt, D. L., Cox, M., Xian, Y., Reeves, M., Smith, E. E., Schwamm, L., Fonarow, G. C. Quality of Care and Outcomes for In-Hospital Ischemic Stroke: Findings From the National Get With The Guidelines-Stroke Stroke. 2013;NA(NA):NA. Abstract

Curzen, N., Gurbel, P. A., Myat, A., Bhatt, D. L., Redwood, S. R. What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention? Lancet. 2013;382(9892):633-43. Abstract

Curzen, N., Gurbel, P. A., Myat, A., Bhatt, D. L., Redwood, S. R. What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention? Lancet. 2013;382(9892):633-43. Abstract

Curzen, N., Gurbel, P. A., Myat, A., Bhatt, D. L., Redwood, S. R. What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention? Lancet. 2013;382(9892):633-43. Abstract

Davidson, M., Liu, S. X., Barter, P., Brinton, E. A., Cannon, C. P., Gotto, A. M., Jr., Leary, E. T., Shah, S., Stepanavage, M., Mitchel, Y., Dansky, H. M. Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib J Lipid Res. 2013;54(2):467-72. Abstract

Davidson, M., Liu, S. X., Barter, P., Brinton, E. A., Cannon, C. P., Gotto, A. M., Jr., Leary, E. T., Shah, S., Stepanavage, M., Mitchel, Y., Dansky, H. M. Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib J Lipid Res. 2013;54(2):467-72. Abstract

De Luca, G., Van't Hof, A. W., Huber, K., Gibson, C. M., Bellandi, F., Arntz, H. R., Maioli, M., Noc, M., Zorman, S., Secco, G. G., Zeymer, U., Gabriel, H. M., Emre, A., Cutlip, D., Rakowski, T., Gyongyosi, M., Dudek, D. Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors Heart Vessels. 2013;NA(NA):NA. Abstract

De Luca, G., Van't Hof, A. W., Huber, K., Gibson, C. M., Bellandi, F., Arntz, H. R., Maioli, M., Noc, M., Zorman, S., Secco, G. G., Zeymer, U., Gabriel, H. M., Emre, A., Cutlip, D., Rakowski, T., Gyongyosi, M., Dudek, D. Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors Heart Vessels. 2013;NA(NA):NA. Abstract

De Luca, G., Van't Hof, A. W., Huber, K., Gibson, C. M., Bellandi, F., Arntz, H. R., Maioli, M., Noc, M., Zorman, S., Zeymer, U., Gabriel, H. M., Emre, A., Cutlip, D., Rakowski, T., Gyongyosi, M., Dudek, D., Egypt cooperation Impact of Hypertension on Distal Embolization, Myocardial Perfusion, and Mortality in Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty Am J Cardiol. 2013;112(8):1083-1086. Abstract

Desai, N. Variability in Response: Patterns in Prescribming Antiplatelet Therapy after CYP2C19 Genotyping among Patients with ACS and PCI Journal of the American College of Cardiology. 2013;61(10):A39.

Desai, N. R., Choudhry, N. K. Impediments to adherence to post myocardial infarction medications Curr Cardiol Rep. 2013;15(1):322. Abstract

Desai, N. R., Choudhry, N. K. Impediments to adherence to post myocardial infarction medications Curr Cardiol Rep. 2013;15(1):322. Abstract

Desai, N. R., Choudhry, N. K. Impediments to adherence to post myocardial infarction medications Curr Cardiol Rep. 2013;15(1):322. Abstract

Desai, N. R., Choudhry, N. K. Impediments to adherence to post myocardial infarction medications Curr Cardiol Rep. 2013;15(1):322. Abstract

Desai, N. R., Giugliano, R. P., Zhou, J., Kohli, P., Somaratne, R., Hoffman, E., Liu, T., Scott, R., Wasserman, S. M., Sabatine, M. S. AMG 145, A Monoclonal Antibody Against PCSK9, Facilitates Achievement of NCEP-ATP III LDL-C Goals Among High Risk Patients: An Analysis From the LAPLACE-TIMI 57 Trial J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Desai, N. R., Giugliano, R. P., Zhou, J., Kohli, P., Somaratne, R., Hoffman, E., Liu, T., Scott, R., Wasserman, S. M., Sabatine, M. S. AMG 145, A Monoclonal Antibody Against PCSK9, Facilitates Achievement of NCEP-ATP III LDL-C Goals Among High Risk Patients: An Analysis From the LAPLACE-TIMI 57 Trial J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Desai, N. R., Kohli, P., Giugliano, R. P., O'Donoghue, M. L., Somaratne, R., Zhou, J., Hoffman, E. B., Huang, F., Rogers, W. J., Wasserman, S. M., Scott, R., Sabatine, M. S. AMG145, a Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9, Significantly Reduces Lipoprotein(a) in Hypercholesterolemic Patients Receiving Statin Therapy: An Analysis From the LDL-C Assessment With Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined With Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 Trial Circulation. 2013;128(9):962-9. Abstract

Desai, N. R., Kohli, P., Giugliano, R. P., O'Donoghue, M. L., Somaratne, R., Zhou, J., Hoffman, E. B., Huang, F., Rogers, W. J., Wasserman, S. M., Scott, R., Sabatine, M. S. AMG145, a Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9, Significantly Reduces Lipoprotein(a) in Hypercholesterolemic Patients Receiving Statin Therapy: An Analysis From the LDL-C Assessment With Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined With Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 Trial Circulation. 2013;128(9):962-9. Abstract

Desai, N. R., Peterson, E. D., Chen, A. Y., Wiviott, S. D., Sabatine, M. S., Alexander, K. P., Roe, M. T., Shah, B. R. Balancing the risk of mortality and major bleeding in the treatment of NSTEMI patients - A report from the National Cardiovascular Data Registry Am Heart J. 2013;166(6):1043-1049 e1. Abstract

Desai, N. R., Peterson, E. D., Chen, A. Y., Wiviott, S. D., Sabatine, M. S., Alexander, K. P., Roe, M. T., Shah, B. R. Balancing the risk of mortality and major bleeding in the treatment of NSTEMI patients - A report from the National Cardiovascular Data Registry Am Heart J. 2013;166(6):1043-1049 e1. Abstract

Dogliotti, A., Paolasso, E., Giugliano, R. P. Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients Heart. 2013;NA(NA):NA. Abstract

Dogliotti, A., Paolasso, E., Giugliano, R. P. Novel Oral Anticoagulants in Atrial Fibrillation: A Meta-analysis of Large, Randomized, Controlled Trials vs Warfarin Clin Cardiol. 2013;36(2):61-7. Abstract

Ducrocq, G., Amarenco, P., Labreuche, J., Alberts, M. J., Mas, J. L., Ohman, E. M., Goto, S., Lavallee, P., Bhatt, D. L., Steg, P. G. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease Circulation. 2013;127(6):730-8. Abstract

Ducrocq, G., Amarenco, P., Labreuche, J., Alberts, M. J., Mas, J. L., Ohman, E. M., Goto, S., Lavallee, P., Bhatt, D. L., Steg, P. G. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease Circulation. 2013;127(6):730-8. Abstract

Feres, F., Costa, R. A., Abizaid, A., Leon, M. B., Marin-Neto, J. A., Botelho, R. V., King, S. B., 3rd, Negoita, M., Liu, M., de Paula, J. E., Mangione, J. A., Meireles, G. X., Castello, H. J., Jr., Nicolela, E. L., Jr., Perin, M. A., Devito, F. S., Labrunie, A., Salvadori, D., Jr., Gusmao, M., Staico, R., Costa, J. R., Jr., de Castro, J. P., Abizaid, A. S., Bhatt, D. L., for the, Optimize Trial Investigators Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents: The OPTIMIZE Randomized Trial JAMA. 2013;NA(NA):NA. Abstract

Ferreiro, J. L., Bhatt, D. L., Ueno, M., Bauer, D., Angiolillo, D. J. Impact of Smoking on Long-Term Outcomes in Patients with Atherosclerotic Vascular Disease Treated with Aspirin or Clopidogrel: Insights from the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) Trial J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Frelinger, A. L., 3rd, Bhatt, D. L., Lee, R. D., Mulford, D. J., Wu, J., Nudurupati, S., Nigam, A., Lampa, M., Brooks, J. K., Barnard, M. R., Michelson, A. D. Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function J Am Coll Cardiol. 2013;61(8):872-9. Abstract

Frelinger, A. L., 3rd, Bhatt, D. L., Lee, R. D., Mulford, D. J., Wu, J., Nudurupati, S., Nigam, A., Lampa, M., Brooks, J. K., Barnard, M. R., Michelson, A. D. Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function J Am Coll Cardiol. 2013;61(8):872-9. Abstract

Frelinger, A. L., 3rd, Bhatt, D. L., Lee, R. D., Mulford, D. J., Wu, J., Nudurupati, S., Nigam, A., Lampa, M., Brooks, J. K., Barnard, M. R., Michelson, A. D. Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function J Am Coll Cardiol. 2013;61(8):872-9. Abstract

Gibson, C. M., Chakrabarti, A. K., Mega, J., Bode, C., Bassand, J. P., Verheugt, F. W., Bhatt, D. L., Goto, S., Cohen, M., Mohanavelu, S., Burton, P., Stone, G., Braunwald, E., Atlas-Acs Timi Investigators Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51 J Am Coll Cardiol. 2013;62(4):286-90. Abstract

Giraldez, R. R., Clare, R. M., Lopes, R. D., Dalby, A. J., Prabhakaran, D., Brogan, G. X., Jr., Giugliano, R. P., James, S. K., Tanguay, J. F., Pollack, C. V., Jr., Harrington, R. A., Braunwald, E., Newby, L. K. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome Am Heart J. 2013;165(6):918-925 e2. Abstract

Giraldez, R. R., Clare, R. M., Lopes, R. D., Dalby, A. J., Prabhakaran, D., Brogan, G. X., Jr., Giugliano, R. P., James, S. K., Tanguay, J. F., Pollack, C. V., Jr., Harrington, R. A., Braunwald, E., Newby, L. K. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome Am Heart J. 2013;165(6):918-925 e2. Abstract

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093-104. Abstract

Givertz, M. M., Mann, D. L., Lee, K. L., Ibarra, J. C., Velazquez, E. J., Hernandez, A. F., Mascette, A. M., Braunwald, E. Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study Circ Heart Fail. 2013;6(4):862-8.

Givertz, M. M., Mann, D. L., Lee, K. L., Ibarra, J. C., Velazquez, E. J., Hernandez, A. F., Mascette, A. M., Braunwald, E. Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study Circ Heart Fail. 2013;6(4):862-8.

Givertz, M. M., Mann, D. L., Lee, K. L., Ibarra, J. C., Velazquez, E. J., Hernandez, A. F., Mascette, A. M., Braunwald, E. Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study Circ Heart Fail. 2013;6(4):862-8.

Gloy, V. L., Briel, M., Bhatt, D. L., Kashyap, S. R., Schauer, P. R., Mingrone, G., Bucher, H. C., Nordmann, A. J. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials BMJ. 2013;347(NA):f5934. Abstract

Gloy, V. L., Briel, M., Bhatt, D. L., Kashyap, S. R., Schauer, P. R., Mingrone, G., Bucher, H. C., Nordmann, A. J. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials BMJ. 2013;347(NA):f5934. Abstract

Gloy, V. L., Briel, M., Bhatt, D. L., Kashyap, S. R., Schauer, P. R., Mingrone, G., Bucher, H. C., Nordmann, A. J. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials BMJ. 2013;347(NA):f5934. Abstract

Goel, K., Pinto, D. S., Gibson, C. M. Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: A systematic review Am Heart J. 2013;165(4):451-67. Abstract

Goel, K., Pinto, D. S., Gibson, C. M. Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: A systematic review Am Heart J. 2013;165(4):451-67. Abstract

Golwala, H. B., Thadani, U., Liang, L., Stavrakis, S., Butler, J., Yancy, C. W., Bhatt, D. L., Hernandez, A. F., Fonarow, G. C. Use of hydralazine-isosorbide dinitrate combination in african american and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction J Am Heart Assoc. 2013;2(4):e000214. Abstract

Golwala, H. B., Thadani, U., Liang, L., Stavrakis, S., Butler, J., Yancy, C. W., Bhatt, D. L., Hernandez, A. F., Fonarow, G. C. Use of hydralazine-isosorbide dinitrate combination in african american and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction J Am Heart Assoc. 2013;2(4):e000214. Abstract

Golwala, H. B., Thadani, U., Liang, L., Stavrakis, S., Butler, J., Yancy, C. W., Bhatt, D. L., Hernandez, A. F., Fonarow, G. C. Use of hydralazine-isosorbide dinitrate combination in african american and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction J Am Heart Assoc. 2013;2(4):e000214. Abstract

Gotto, A. M., Jr., Cannon, C. P., Li, X. S., Vaidya, S., Kher, U., Brinton, E. A., Davidson, M., Moon, J. E., Shah, S., Dansky, H. M., Mitchel, Y., Barter, P., Define Investigators Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease Am J Cardiol. 2013;NA(NA):NA. Abstract

Gotto, A. M., Jr., Cannon, C. P., Li, X. S., Vaidya, S., Kher, U., Brinton, E. A., Davidson, M., Moon, J. E., Shah, S., Dansky, H. M., Mitchel, Y., Barter, P., Define Investigators Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease Am J Cardiol. 2013;NA(NA):NA. Abstract

Gotto, A. M., Jr., Cannon, C. P., Li, X. S., Vaidya, S., Kher, U., Brinton, E. A., Davidson, M., Moon, J. E., Shah, S., Dansky, H. M., Mitchel, Y., Barter, P., Define Investigators Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease Am J Cardiol. 2013;NA(NA):NA. Abstract

Goyal, Abhinav, Steg, Ph. Gabriel, Smith, Jr., Sidney C, Eagle, Kim A, Ohman, E. Magnus, Koplan, Jeffrey P, Hoffman, Elaine B, Im, KyungAh, Goto, Shinya, Wilson, Peter W, Bhatt, Deepak L Abstract 13411: Cigarette Smoking is Associated With a Greater Hazard for Adverse Outcomes in Women Compared With Men: Insights From the Global REACH Registry Circulation. 2013;128(22 Supplement):A13411.

Goyal, Abhinav, Steg, Ph. Gabriel, Smith, Jr., Sidney C, Eagle, Kim A, Ohman, E. Magnus, Koplan, Jeffrey P, Hoffman, Elaine B, Im, KyungAh, Goto, Shinya, Wilson, Peter W, Bhatt, Deepak L Abstract 13411: Cigarette Smoking is Associated With a Greater Hazard for Adverse Outcomes in Women Compared With Men: Insights From the Global REACH Registry Circulation. 2013;128(22 Supplement):A13411.

Goyal, Abhinav, Steg, Ph. Gabriel, Smith, Jr., Sidney C, Eagle, Kim A, Ohman, E. Magnus, Koplan, Jeffrey P, Hoffman, Elaine B, Im, KyungAh, Goto, Shinya, Wilson, Peter W, Bhatt, Deepak L Abstract 13411: Cigarette Smoking is Associated With a Greater Hazard for Adverse Outcomes in Women Compared With Men: Insights From the Global REACH Registry Circulation. 2013;128(22 Supplement):A13411.

Gupta, D. K., Shah, A. M., Giugliano, R. P., Ruff, C. T., Antman, E. M., Grip, L. T., Deenadayalu, N., Hoffman, E., Patel, I., Shi, M., Mercuri, M., Mitrovic, V., Braunwald, E., Solomon, S. D., for the Effective aNticoaGulation with factor x, A. next GEneration in A. F. Thrombolysis In Myocardial Infarction Echocardiographic Study Investigators Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48 Eur Heart J. 2013;NA(NA):NA. Abstract

Gupta, D.K., Shah, A., Giugliano, R., Ruff, C. T., Antman, E., Grip, L., Deenadayalu, N., Hoffman, Elaine P., Betcher, J., Patel, I., Shi, M., Braunwald, E., Solomon, S., ENGAGE AF-TIMI 48 Investigators Cardiac Structure and Function and CHADS2 Risk Score in Patients with Atrial Fibrillation: The Effective aNticoaGulation with factor xA next GEeration in AF-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) Journal of the American College of Cardiology. 2013;61(10):A237.

Gutierrez, A., Tsai, T. T., Stanislawski, M. A., Vidovich, M., Bryson, C. L., Bhatt, D. L., Grunwald, G. K., Rumsfeld, J., Rao, S. V. Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program Circ Cardiovasc Interv. 2013;6(4):336-46. Abstract

Gutierrez, A., Tsai, T. T., Stanislawski, M. A., Vidovich, M., Bryson, C. L., Bhatt, D. L., Grunwald, G. K., Rumsfeld, J., Rao, S. V. Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program Circ Cardiovasc Interv. 2013;6(4):336-46. Abstract

Gutierrez, A., Tsai, T. T., Stanislawski, M. A., Vidovich, M., Bryson, C. L., Bhatt, D. L., Grunwald, G. K., Rumsfeld, J., Rao, S. V. Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program Circ Cardiovasc Interv. 2013;6(4):336-46. Abstract

Gutierrez, A., Tsai, T. T., Stanislawski, M. A., Vidovich, M., Bryson, C. L., Bhatt, D. L., Grunwald, G. K., Rumsfeld, J., Rao, S. V. Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program Circ Cardiovasc Interv. 2013;6(4):336-46. Abstract

Hess, P. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Bhatt, D. L., Schwamm, L. H., Yancy, C. W., Fonarow, G. C., Al-Khatib, S. M., for the Get with The Guidelines Steering, Committee, Hospitals, Age Differences in the Use of Implantable Cardioverter-Defibrillators Among Older Patients Hospitalized with Heart Failure J Cardiovasc Electrophysiol. 2013;NA(NA):NA. Abstract

Hess, P. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Bhatt, D. L., Schwamm, L. H., Yancy, C. W., Fonarow, G. C., Al-Khatib, S. M., for the Get with The Guidelines Steering, Committee, Hospitals, Age Differences in the Use of Implantable Cardioverter-Defibrillators Among Older Patients Hospitalized with Heart Failure J Cardiovasc Electrophysiol. 2013;NA(NA):NA. Abstract

Hess, P. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Bhatt, D. L., Schwamm, L. H., Yancy, C. W., Fonarow, G. C., Al-Khatib, S. M., for the Get with The Guidelines Steering, Committee, Hospitals, Age Differences in the Use of Implantable Cardioverter-Defibrillators Among Older Patients Hospitalized with Heart Failure J Cardiovasc Electrophysiol. 2013;NA(NA):NA. Abstract

Hochholzer, W., Giugliano, R. P. Does it make sense to combine statins with other lipid-altering agents following AIM-HIGH, SHARP and ACCORD? Curr Atheroscler Rep. 2013;15(1):290. Abstract

Holmes, M. V., Simon, T., Exeter, H. J., Folkersen, L., Asselbergs, F. W., Guardiola, M., Cooper, J. A., Palmen, J., Hubacek, J. A., Carruthers, K. F., Horne, B. D., Brunisholz, K. D., Mega, J. L., van Iperen, E. P., Li, M., Leusink, M., Trompet, S., Verschuren, J. J., Hovingh, G. K., Dehghan, A., Nelson, C. P., Kotti, S., Danchin, N., Scholz, M., Haase, C. L., Rothenbacher, D., Swerdlow, D. I., Kuchenbaecker, K. B., Staines-Urias, E., Goel, A., Hooft, F. V., Gertow, K., de Faire, U., Panayiotou, A. G., Tremoli, E., Baldassarre, D., Veglia, F., Holdt, L. M., Beutner, F., Gansevoort, R. T., Navis, G. J., Leach, I. M., Breitling, L. P., Brenner, H., Dallmeier, D., Franco-Cereceda, A., Boer, J., Stephens, J. W., Hofker, M. H., Tedgui, A., Hofman, A., Uitterlinden, A. G., Adamkova, V., Pitha, J., Onland-Moret, N. C., Cramer, M. J., Nathoe, H. M., Spiering, W., Klungel, O. H., Kumari, M., Whincup, P. H., Morrow, D. A., Braund, P. S., Hall, A. S., Olsson, A. G., Doevendans, P. A., Trip, M. D., Tobin, M. D., Hamsten, A., Watkins, H., Koenig, W., Nicolaides, A. N., Teupser, D., Day, I. N., Carlquist, J. F., Gaunt, T. R., Ford, I., Sattar, N., Tsimikas, S., Schwartz, G. G., Lawlor, D. A., Morris, R. W., Sandhu, M. S., Poledne, R., Maitland-van der Zee, A. H., Khaw, K. T., Keating, B. J., van der Harst, P., Price, J. F., Mehta, S. R., Yusuf, S., Witteman, J. C., Franco, O. H., Jukema, J. W., de Knijff, P., Tybjaerg-Hansen, A., Rader, D. J., Farrall, M., Samani, J., Kivimaki, M., Fox, K. A., Humphries, S. E., Anderson, J. L., Boekholdt, S. M., Palmer, T. M., Eriksson, P., Pare, G., Hingorani, A. D., Sabatine, M. S., Mallat, Z., Casas, J. P., Talmud, P. J. Secretory Phospholipase A2-IIA and Cardiovascular Disease: a Mendelian randomization study J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Hsich, E. M., Grau-Sepulveda, M. V., Hernandez, A. F., Eapen, Z. J., Xian, Y., Schwamm, L. H., Bhatt, D. L., Fonarow, G. C. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: Findings from the Get With The Guideline-Heart Failure Registry Am Heart J. 2013;166(6):1063-1071 e3. Abstract

Hsich, E. M., Grau-Sepulveda, M. V., Hernandez, A. F., Eapen, Z. J., Xian, Y., Schwamm, L. H., Bhatt, D. L., Fonarow, G. C. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: Findings from the Get With The Guideline-Heart Failure Registry Am Heart J. 2013;166(6):1063-1071 e3. Abstract

Huo, Y., Choy, J. S., Wischgoll, T., Luo, T., Teague, S. D., Bhatt, D. L., Kassab, G. S. Computed tomography-based diagnosis of diffuse compensatory enlargement of coronary arteries using scaling power laws J R Soc Interface. 2013;10(81):NA. Abstract

Huo, Y., Choy, J. S., Wischgoll, T., Luo, T., Teague, S. D., Bhatt, D. L., Kassab, G. S. Computed tomography-based diagnosis of diffuse compensatory enlargement of coronary arteries using scaling power laws J R Soc Interface. 2013;10(81):NA. Abstract

Huo, Y., Choy, J. S., Wischgoll, T., Luo, T., Teague, S. D., Bhatt, D. L., Kassab, G. S. Computed tomography-based diagnosis of diffuse compensatory enlargement of coronary arteries using scaling power laws J R Soc Interface. 2013;10(81):NA. Abstract

Huo, Y., Wischgoll, T., Choy, J. S., Sola, S., Navia, J. L., Teague, S. D., Bhatt, D. L., Kassab, G. S. CT-based Diagnosis of Diffuse Coronary Artery Disease on the Basis of Scaling Power Laws Radiology. 2013;NA(NA):NA. Abstract

James SK, Pieper KS, Cannon CP, Storey RF, Becker RC, Steg PG, Wallentin L, Harrington RA; PLATO study group. Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials. Stroke. 2013;44:1477-9.

James SK, Pieper KS, Cannon CP, Storey RF, Becker RC, Steg PG, Wallentin L, Harrington RA; PLATO study group. Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials. Stroke. 2013;44:1477-9.

James, M. L., Grau-Sepulveda, M. V., Olson, D. M., Smith, E. E., Hernandez, A. F., Peterson, E. D., Schwamm, L. H., Bhatt, D. L., Fonarow, G. C. Insurance Status and Outcome after Intracerebral Hemorrhage: Findings from Get with The Guidelines-Stroke J Stroke Cerebrovasc Dis. 2013;NA(NA):NA. Abstract

James, M. L., Grau-Sepulveda, M. V., Olson, D. M., Smith, E. E., Hernandez, A. F., Peterson, E. D., Schwamm, L. H., Bhatt, D. L., Fonarow, G. C. Insurance Status and Outcome after Intracerebral Hemorrhage: Findings from Get with The Guidelines-Stroke J Stroke Cerebrovasc Dis. 2013;NA(NA):NA. Abstract

James, M. L., Grau-Sepulveda, M. V., Olson, D. M., Smith, E. E., Hernandez, A. F., Peterson, E. D., Schwamm, L. H., Bhatt, D. L., Fonarow, G. C. Insurance Status and Outcome after Intracerebral Hemorrhage: Findings from Get with The Guidelines-Stroke J Stroke Cerebrovasc Dis. 2013;NA(NA):NA. Abstract

Kashyap, S. R., Bhatt, D. L., Wolski, K., Watanabe, R. M., Abdul-Ghani, M., Abood, B., Pothier, C. E., Brethauer, S., Nissen, S., Gupta, M., Kirwan, J. P., Schauer, P. R. Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment Diabetes Care. 2013;NA(NA):NA. Abstract

Kashyap, S. R., Bhatt, D. L., Wolski, K., Watanabe, R. M., Abdul-Ghani, M., Abood, B., Pothier, C. E., Brethauer, S., Nissen, S., Gupta, M., Kirwan, J. P., Schauer, P. R. Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment Diabetes Care. 2013;NA(NA):NA. Abstract

Kashyap, S. R., Bhatt, D. L., Wolski, K., Watanabe, R. M., Abdul-Ghani, M., Abood, B., Pothier, C. E., Brethauer, S., Nissen, S., Gupta, M., Kirwan, J. P., Schauer, P. R. Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment Diabetes Care. 2013;NA(NA):NA. Abstract

Kaul, P., Tanguay, J. F., Newby, L. K., Hochman, J. S., Westerhout, C. M., Califf, R. M., Tricoci, P., Gibson, C. M., Giugliano, R. P., Harrington, R. A., Van de Werf, F., Armstrong, P. W. Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial Am Heart J. 2013;166(4):723-8. Abstract

Kaul, P., Tanguay, J. F., Newby, L. K., Hochman, J. S., Westerhout, C. M., Califf, R. M., Tricoci, P., Gibson, C. M., Giugliano, R. P., Harrington, R. A., Van de Werf, F., Armstrong, P. W. Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial Am Heart J. 2013;166(4):723-8. Abstract

Kaul, P., Tanguay, J. F., Newby, L. K., Hochman, J. S., Westerhout, C. M., Califf, R. M., Tricoci, P., Gibson, C. M., Giugliano, R. P., Harrington, R. A., Van de Werf, F., Armstrong, P. W. Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial Am Heart J. 2013;166(4):723-8. Abstract

Klutstein, M. W., Westerhout, C. M., Armstrong, P. W., Giugliano, R. P., Lewis, B. S., Gibson, C. M., Lutchmedial, S., Widimsky, P., Steg, P. G., Dalby, A., Zeymer, U., Van de Werf, F., Harrington, R. A., Newby, L. K., Rao, S. V. Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy Am Heart J. 2013;165(4):583-590 e1. Abstract

Kohli P, Wallentin L, Reyes E, Horrow J, Husted S, Angiolillo DJ, Ardissino D, Maurer G, Morais J, Nicolau JC, Oto A, Storey RF, James SK, Cannon CP. Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study. Circulation. 2013;127:673-80. Abstract

Kohli, P., Steg, P. G., Cannon, C. P., Smith, S. C., Jr., Eagle, K. A., Ohman, E. M., Alberts, M. J., Hoffman, E., Guo, J., Simon, T., Sorbets, E., Goto, S., Bhatt, D. L., Reach Registry Investigators NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease Am J Med. 2013;NA(NA):NA. Abstract

Kohli, P., Steg, P. G., Cannon, C. P., Smith, S. C., Jr., Eagle, K. A., Ohman, E. M., Alberts, M. J., Hoffman, E., Guo, J., Simon, T., Sorbets, E., Goto, S., Bhatt, D. L., Reach Registry Investigators NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease Am J Med. 2013;NA(NA):NA. Abstract

Kohli, P., Udell, J. A., Murphy, S. A., Cannon, C. P., Antman, E. M., Braunwald, E., Wiviott, S. D. Discharge Aspirin Dose and Clinical Outcomes in Patients with Acute Coronary Syndromes treated with Prasugrel vs. Clopidogrel: An Analysis from the TRITON-TIMI 38 Study J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Kohli, Payal, Giugliano, Robert P. Low-Density Lipoprotein Lowering in 2013 by Nonstatin Agents: The Discovery and Development of Promising Novel Targeted Therapies Journal of Cardiovascular Pharmacology and Therapeutics. 2013;18(3):199-210.

Kohli, Payal, Giugliano, Robert P. Low-Density Lipoprotein Lowering in 2013 by Nonstatin Agents: The Discovery and Development of Promising Novel Targeted Therapies Journal of Cardiovascular Pharmacology and Therapeutics. 2013;18(3):199-210.

Kohli, Payal, Giugliano, Robert P. Low-Density Lipoprotein Lowering in 2013 by Nonstatin Agents: The Discovery and Development of Promising Novel Targeted Therapies Journal of Cardiovascular Pharmacology and Therapeutics. 2013;18(3):199-210.

Koren, M. J., Giugliano, R. P., Raal, F. J., Sullivan, D., Bolognese, M., Langslet, G., Civeira, F., Somaratne, R., Nelson, P., Liu, T., Scott, R., Wasserman, S. M., Sabatine, M. S., for the, Osler Investigators Efficacy and Safety of Longer-Term Administration of Evolocumab (AMG 145) in Patients With Hypercholesterolemia: 52-Week Results From the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) Randomized Trial Circulation. 2013;NA(NA):NA. Abstract

Koren, M. J., Giugliano, R. P., Raal, F. J., Sullivan, D., Bolognese, M., Langslet, G., Civeira, F., Somaratne, R., Nelson, P., Liu, T., Scott, R., Wasserman, S. M., Sabatine, M. S., for the, Osler Investigators Efficacy and Safety of Longer-Term Administration of Evolocumab (AMG 145) in Patients With Hypercholesterolemia: 52-Week Results From the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) Randomized Trial Circulation. 2013;NA(NA):NA. Abstract

Kulik, A., Desai, N. R., Shrank, W. H., Antman, E. M., Glynn, R. J., Levin, R., Reisman, L., Brennan, T., Choudhry, N. K. Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery Bypass Graft Surgery: Analysis From the Post-Myocardial Infarction Free Rx Event and Economic Evaluation (FREEE) Randomized Trial Circulation. 2013;128(26 Suppl 1):S219-25. Abstract

Kulik, A., Desai, N. R., Shrank, W. H., Antman, E. M., Glynn, R. J., Levin, R., Reisman, L., Brennan, T., Choudhry, N. K. Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery Bypass Graft Surgery: Analysis From the Post-Myocardial Infarction Free Rx Event and Economic Evaluation (FREEE) Randomized Trial Circulation. 2013;128(26 Suppl 1):S219-25. Abstract

Kulik, A., Desai, N. R., Shrank, W. H., Antman, E. M., Glynn, R. J., Levin, R., Reisman, L., Brennan, T., Choudhry, N. K. Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery Bypass Graft Surgery: Analysis From the Post-Myocardial Infarction Free Rx Event and Economic Evaluation (FREEE) Randomized Trial Circulation. 2013;128(26 Suppl 1):S219-25. Abstract

Kumbhani, D. J., Bavry, A. A., Desai, M. Y., Bangalore, S., Bhatt, D. L. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: An updated meta-analysis of randomized trials J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Kumbhani, D. J., Steg, P. G., Cannon, C. P., Eagle, K. A., Smith, S. C., Jr., Hoffman, E., Goto, S., Ohman, E. M., Bhatt, D. L., R. Eduction of Atherothrombosis for Continued Health Registry Investigators Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis Am J Med. 2013;126(8):693-700 e1. Abstract

Kumbhani, D. J., Steg, P. G., Cannon, C. P., Eagle, K. A., Smith, S. C., Jr., Hoffman, E., Goto, S., Ohman, E. M., Bhatt, D. L., R. Eduction of Atherothrombosis for Continued Health Registry Investigators Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis Am J Med. 2013;126(8):693-700 e1. Abstract

Lee, D., Goodman, S. G., Fox, K. A., DeYoung, J. P., Lai, C. C., Bhatt, D. L., Huynh, T., Yan, R. T., Gallo, R., Steg, P. G., Yan, A. T. Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertension Am Heart J. 2013;166(4):716-22. Abstract

Lee, D., Goodman, S. G., Fox, K. A., DeYoung, J. P., Lai, C. C., Bhatt, D. L., Huynh, T., Yan, R. T., Gallo, R., Steg, P. G., Yan, A. T. Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertension Am Heart J. 2013;166(4):716-22. Abstract

Lee, D., Goodman, S. G., Fox, K. A., DeYoung, J. P., Lai, C. C., Bhatt, D. L., Huynh, T., Yan, R. T., Gallo, R., Steg, P. G., Yan, A. T. Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertension Am Heart J. 2013;166(4):716-22. Abstract

Leonardi, S., Truffa, A. A., Neely, M. L., Tricoci, P., White, H. D., Gibson, C. M., Wilson, M., Stone, G. W., Harrington, R. A., Bhatt, D. L., Mahaffey, K. W. A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial Heart. 2013;99(17):1282-7. Abstract

Leonardi, S., Truffa, A. A., Neely, M. L., Tricoci, P., White, H. D., Gibson, C. M., Wilson, M., Stone, G. W., Harrington, R. A., Bhatt, D. L., Mahaffey, K. W. A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial Heart. 2013;99(17):1282-7. Abstract

Lopes, R. D., White, J. A., Atar, D., Keltai, M., Kleiman, N. S., White, H. D., Widimsky, P., Zeymer, U., Giugliano, R. P., Tricoci, P., Braunwald, E., Bode, C., Ohman, E. M., Armstrong, P. W., Newby, L. K. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes Int J Cardiol. 2013;NA(NA):NA. Abstract

Lopes, R. D., White, J. A., Atar, D., Keltai, M., Kleiman, N. S., White, H. D., Widimsky, P., Zeymer, U., Giugliano, R. P., Tricoci, P., Braunwald, E., Bode, C., Ohman, E. M., Armstrong, P. W., Newby, L. K. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes Int J Cardiol. 2013;NA(NA):NA. Abstract

Lopes, R. D., White, J. A., Atar, D., Keltai, M., Kleiman, N. S., White, H. D., Widimsky, P., Zeymer, U., Giugliano, R. P., Tricoci, P., Braunwald, E., Bode, C., Ohman, E. M., Armstrong, P. W., Newby, L. K. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes Int J Cardiol. 2013;NA(NA):NA. Abstract

Lopes, R. D., White, J. A., Tricoci, P., White, H. D., Armstrong, P. W., Braunwald, E., Giugliano, R. P., Harrington, R. A., Lewis, B. S., Brogan, G. X., Jr., Gibson, C. M., Califf, R. M., Newby, L. K. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial Int J Cardiol. 2013;167(6):2580-7. Abstract

Maddox, T. M., Chan, P. S., Spertus, J. A., Tang, F., Jones, P., Ho, P. M., Bradley, S. M., Tsai, T. T., Bhatt, D. L., Peterson, P. N. Variation in CAD Secondary Prevention Prescription among Outpatient Cardiology Practices: Insights from the NCDR(R) J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Maddox, T. M., Chan, P. S., Spertus, J. A., Tang, F., Jones, P., Ho, P. M., Bradley, S. M., Tsai, T. T., Bhatt, D. L., Peterson, P. N. Variation in CAD Secondary Prevention Prescription among Outpatient Cardiology Practices: Insights from the NCDR(R) J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Maddox, T. M., Chan, P. S., Spertus, J. A., Tang, F., Jones, P., Ho, P. M., Bradley, S. M., Tsai, T. T., Bhatt, D. L., Peterson, P. N. Variation in CAD Secondary Prevention Prescription among Outpatient Cardiology Practices: Insights from the NCDR(R) J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Magnani, Giulia, Morrow, David A, Scirica, Benjamin M, Sabatine, Marc S, Murphy, Sabina A, Bonaca, Marc P Abstract 18728: Patterns of Antiplatelet Use in Patients With Stable Atherosclerosis: Insights From the Tra 2{degrees}P-timi 50 Trial Circulation. 2013;128(22 Supplement):A18728.

Maron, B. A., Choudhary, G., Khan, U. A., Jankowich, M. D., McChesney, H., Ferrazzani, S. J., Gaddam, S., Sharma, S., Opotowsky, A. R., Bhatt, D. L., Rocco, T. P., Aragam, J. R. Clinical Profile and Underdiagnosis of Pulmonary Hypertension in US Veteran Patients Circ Heart Fail. 2013;6(5):906-12. Abstract

Maron, B. A., Choudhary, G., Khan, U. A., Jankowich, M. D., McChesney, H., Ferrazzani, S. J., Gaddam, S., Sharma, S., Opotowsky, A. R., Bhatt, D. L., Rocco, T. P., Aragam, J. R. Clinical Profile and Underdiagnosis of Pulmonary Hypertension in US Veteran Patients Circ Heart Fail. 2013;6(5):906-12. Abstract

Maron, B. A., Choudhary, G., Khan, U. A., Jankowich, M. D., McChesney, H., Ferrazzani, S. J., Gaddam, S., Sharma, S., Opotowsky, A. R., Bhatt, D. L., Rocco, T. P., Aragam, J. R. Clinical Profile and Underdiagnosis of Pulmonary Hypertension in US Veteran Patients Circ Heart Fail. 2013;6(5):906-12. Abstract

Maron, B. A., Choudhary, G., Khan, U. A., Jankowich, M. D., McChesney, H., Ferrazzani, S. J., Gaddam, S., Sharma, S., Opotowsky, A. R., Bhatt, D. L., Rocco, T. P., Aragam, J. R. Clinical Profile and Underdiagnosis of Pulmonary Hypertension in US Veteran Patients Circ Heart Fail. 2013;6(5):906-12. Abstract

Martin, S. S., Blaha, M. J., Toth, P. P., Joshi, P. H., McEvoy, J. W., Ahmed, H. M., Elshazly, M. B., Swiger, K. J., Michos, E. D., Kwiterovich, P. O., Kulkarni, K. R., Chimera, J., Cannon, C. P., Blumenthal, R. S., Jones, S. R. Very Large Database of Lipids: Rationale and Design Clin Cardiol. 2013;NA(NA):NA. Abstract

Martin, S. S., Blaha, M. J., Toth, P. P., Joshi, P. H., McEvoy, J. W., Ahmed, H. M., Elshazly, M. B., Swiger, K. J., Michos, E. D., Kwiterovich, P. O., Kulkarni, K. R., Chimera, J., Cannon, C. P., Blumenthal, R. S., Jones, S. R. Very Large Database of Lipids: Rationale and Design Clin Cardiol. 2013;NA(NA):NA. Abstract

Martin, S. S., Blaha, M. J., Toth, P. P., Joshi, P. H., McEvoy, J. W., Ahmed, H. M., Elshazly, M. B., Swiger, K. J., Michos, E. D., Kwiterovich, P. O., Kulkarni, K. R., Chimera, J., Cannon, C. P., Blumenthal, R. S., Jones, S. R. Very Large Database of Lipids: Rationale and Design Clin Cardiol. 2013;NA(NA):NA. Abstract

Martinez, G., Rigotti, A., Acevedo, M., Navarrete, C., Rosales, J., Giugliano, R. P., Corbalan, R. Cholesterol Levels and the Association of Statins With In-Hospital Mortality of Myocardial Infarction Patients Insights From a Chilean Registry of Myocardial Infarction Clin Cardiol. 2013;NA(NA):NA. Abstract

Martinez, G., Rigotti, A., Acevedo, M., Navarrete, C., Rosales, J., Giugliano, R. P., Corbalan, R. Cholesterol Levels and the Association of Statins With In-Hospital Mortality of Myocardial Infarction Patients Insights From a Chilean Registry of Myocardial Infarction Clin Cardiol. 2013;NA(NA):NA. Abstract

Matteau, A., Bhatt, D. L. Recent advances in antithrombotic therapy after acute coronary syndrome CMAJ. 2013;NA(NA):NA.

Matteau, A., Bhatt, D. L. Recent advances in antithrombotic therapy after acute coronary syndrome CMAJ. 2013;NA(NA):NA.

Matteau, A., Bhatt, D. L. Recent advances in antithrombotic therapy after acute coronary syndrome CMAJ. 2013;NA(NA):NA.

Mega, J. L., Braunwald, E. B., Murphy, S., Plotnikov, A, Cook-Bruns, N, Aylward, P., Chopra, V., Gao, R., Nicolau, J., Gibson, C. M., Timi Study Group Rivaroxaban in the Settling of continued Dual Antiplatelet Therapy: Findings from the ATLAS ACS 2 - TIMI 51 Trial Journal of the American College of Cardiology. 2013;61(10):A1.

Mega, J. L., Braunwald, E., Murphy, S. A., Plotnikov, A., Burton, P., Kiss, R. G., Parkhomenko, A., Tendera, M., Widimsky, P., Gibson, C. M. Rivaroxaban in Patients Stabilized after a ST-Elevation Myocardial Infarction: Results from the ATLAS ACS 2-TIMI 51 Trial J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Mega, J. L., Braunwald, E., Wiviott, S. D., Murphy, S. A., Plotnikov, A., Gotcheva, N., Ruda, M., Gibson, C. M. Comparison of the Efficacy and Safety of Two Rivaroxaban Doses in Acute Coronary Syndrome (from ATLAS ACS 2-TIMI 51) Am J Cardiol. 2013;NA(NA):NA. Abstract

Messe, S. R., Pervez, M. A., Smith, E. E., Siddique, K. A., Hellkamp, A. S., Saver, J. L., Bhatt, D. L., Fonarow, G. C., Peterson, E. D., Schwamm, L. H. Lipid Profile, Lipid-lowering Medications, and Intracerebral Hemorrhage After tPA in Get With The Guidelines-Stroke Stroke. 2013;44(5):1354-9. Abstract

Mogabgab, O., Wiviott, S. D., Antman, E. M., Foody, J. M., Wang, T. Y., Sabatine, M. S., Cannon, C. P., Li, S., Giugliano, R. P. Relation Between Time of Symptom Onset of ST-Segment Elevation Myocardial Infarction and Patient Baseline Characteristics: From the National Cardiovascular Data Registry Clin Cardiol. 2013;36(4):222-7. Abstract

Mogabgab, O., Wiviott, S. D., Antman, E. M., Foody, J. M., Wang, T. Y., Sabatine, M. S., Cannon, C. P., Li, S., Giugliano, R. P. Relation Between Time of Symptom Onset of ST-Segment Elevation Myocardial Infarction and Patient Baseline Characteristics: From the National Cardiovascular Data Registry Clin Cardiol. 2013;36(4):222-7. Abstract

Mogabgab, O., Wiviott, S. D., Cannon, C. P., Sloan, S., Sabatine, M. S., Antman, E. M., Braunwald, E., Giugliano, R. P. Circadian Variation of Stent Thrombosis and the Effect of More Robust Platelet Inhibition: A Post Hoc Analysis of the TRITON-TIMI 38 Trial J Cardiovasc Pharmacol Ther. 2013;NA(NA):NA. Abstract

Mogabgab, O., Wiviott, S. D., Cannon, C. P., Sloan, S., Sabatine, M. S., Antman, E. M., Braunwald, E., Giugliano, R. P. Circadian Variation of Stent Thrombosis and the Effect of More Robust Platelet Inhibition: A Post Hoc Analysis of the TRITON-TIMI 38 Trial J Cardiovasc Pharmacol Ther. 2013;NA(NA):NA. Abstract

Mohareb, M., Goodman, S. G., Yan, R. T., Bhatt, D. L., Elbarouni, B., Deyoung, J. P., Gallo, R., Kornder, J. M., Welsh, R. C., Saposnik, G., Rose, B., Wong, G. C., Grondin, F. R., Yan, A. T., on behalf of the Canadian, Grace Grace Canrace investigators Treatment and outcomes of non-ST elevation acute coronary syndromes in relation to burden of pre-existing vascular disease Int J Cardiol. 2013;NA(NA):NA. Abstract

Mohareb, M., Goodman, S. G., Yan, R. T., Bhatt, D. L., Elbarouni, B., Deyoung, J. P., Gallo, R., Kornder, J. M., Welsh, R. C., Saposnik, G., Rose, B., Wong, G. C., Grondin, F. R., Yan, A. T., on behalf of the Canadian, Grace Grace Canrace investigators Treatment and outcomes of non-ST elevation acute coronary syndromes in relation to burden of pre-existing vascular disease Int J Cardiol. 2013;NA(NA):NA. Abstract

Morrow DA, Alberts MJ, Mohr JP, Ameriso SF, Bonaca MP, Goto S, Hankey GJ, Murphy SA, Scirica BM, Braunwald E. Efficacy and safety of vorapaxar in patients with prior ischemic stroke. Stroke. 2013;44:691-8. Abstract

Morrow, D. A., Bonaca, M. P. Real-world application of "delta" troponin: diagnostic and prognostic implications J Am Coll Cardiol. 2013;62(14):1239-41.

Morrow, D. A., Bonaca, M. P. Real-world application of "delta" troponin: diagnostic and prognostic implications J Am Coll Cardiol. 2013;62(14):1239-41.

Morrow, D. A., Bonaca, M. P. Real-world application of "delta" troponin: diagnostic and prognostic implications J Am Coll Cardiol. 2013;62(14):1239-41.

Mosenzon, O., Raz, I., Scirica, B. M., Hirshberg, B., Stahre, C. I., Steg, P. G., Davidson, J., Ohman, P., Price, D. L., Frederich, B., Udell, J. A., Braunwald, E., Bhatt, D. L. Baseline characteristics of patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR) - TIMI 53 Trial Diabetes Metab Res Rev. 2013;NA(NA):NA. Abstract

Motiwala, S. R., Sarma, A., Januzzi, J. L., O'Donoghue, M. L. Biomarkers in ACS and Heart Failure: Should Men and Women Be Interpreted Differently? Clin Chem. 2013;NA(NA):NA. Abstract

Motiwala, S. R., Sarma, A., Januzzi, J. L., O'Donoghue, M. L. Biomarkers in ACS and Heart Failure: Should Men and Women Be Interpreted Differently? Clin Chem. 2013;NA(NA):NA. Abstract

Murphy, S. A., Giugliano, R. P. Atrial fibrillation and prior MI: searching for balance in ischaemic and bleeding events in patients treated with fibrin-specific anticoagulants Eur Heart J. 2013;NA(NA):NA.

Murphy, S., Bohula May, Erin A., Bonaca, M. P., Scirica, B., Braunwald, E. B., Morrow, D., Brigham and Women's Hospital Procedural Bleeding with Vorapaxar versus Placebo in TRA 2P - TIMI 50 Trial Journal of the American College of Cardiology. 2013;61(10):A30.

Nerini, E., Grip, L., Camm, A. J., Giugliano, R. P. Atrial fibrillation and the 'other drug problem': reducing non-adherence with technology Eur Heart J. 2013;NA(NA):NA.

Nerini, E., Grip, L., Camm, A. J., Giugliano, R. P. Atrial fibrillation and the 'other drug problem': reducing non-adherence with technology Eur Heart J. 2013;NA(NA):NA.

Nicholls, S. J., Kastelein, J. J., Schwartz, G. G., Bash, D., Rosenson, R. S., Cavender, M. A., Brennan, D. M., Koenig, W., Jukema, J. W., Nambi, V., Wright, R. S., Menon, V., Lincoff, A. M., Nissen, S. E., for the, Vista-Investigators Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome: The VISTA-16 Randomized Clinical Trial JAMA. 2013;NA(NA):NA. Abstract

O'Donoghue, M., Morrow, D. A., Tsimikas, S., Sloan, S., Ren, A. F., Hoffman, E. B., Desai, N. P., Solomon, S. D., Domanski, M., Arai, K., Chiuve, S. E., Cannon, C. P., Sacks, F. M., Sabatine, M. S. Lipoprotein (a) For Risk Assessment in Patients with Established Coronary Artery Disease J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

O'Donoghue, Michelle L, Mega, Jessica L, Braunwald, Eugene, Nicolau, Jose C, Bhatt, Deepak L, Murphy, Sabina A, Gibson, C. Michael Abstract 11382: The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor: Insights From the ATLAS ACS 2-TIMI 51 Trial Circulation. 2013;128(22 Supplement):A11382.

Ojeifo, O., Wiviott, S. D., Antman, E. M., Murphy, S. A., Udell, J. A., Bates, E. R., Mega, J. L., Sabatine, M. S., O'Donoghue, M. L. Concomitant Administration of Clopidogrel With Statins or Calcium Channel Blockers: Insights From the TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38) Trial JACC Cardiovasc Interv. 2013;NA(NA):NA. Abstract

Peacock, W. F., Kontos, M. C., Amsterdam, E., Cannon, C. P., Diercks, D., Garvey, L., Graff, L. th, Holmes, D., Holmes, K. S., McCord, J., Newby, K., Roe, M., Dadkhah, S., Siler-Fisher, A., Ross, M. Impact of Society of Cardiovascular Patient Care accreditation on quality: an ACTION Registry(R)-Get With The Guidelines analysis Crit Pathw Cardiol. 2013;12(3):116-20. Abstract

Peacock, W. F., Kontos, M. C., Amsterdam, E., Cannon, C. P., Diercks, D., Garvey, L., Graff, L. th, Holmes, D., Holmes, K. S., McCord, J., Newby, K., Roe, M., Dadkhah, S., Siler-Fisher, A., Ross, M. Impact of Society of Cardiovascular Patient Care accreditation on quality: an ACTION Registry(R)-Get With The Guidelines analysis Crit Pathw Cardiol. 2013;12(3):116-20. Abstract

Peacock, W. F., Kontos, M. C., Amsterdam, E., Cannon, C. P., Diercks, D., Garvey, L., Graff, L. th, Holmes, D., Holmes, K. S., McCord, J., Newby, K., Roe, M., Dadkhah, S., Siler-Fisher, A., Ross, M. Impact of Society of Cardiovascular Patient Care accreditation on quality: an ACTION Registry(R)-Get With The Guidelines analysis Crit Pathw Cardiol. 2013;12(3):116-20. Abstract

Piccini, J. P., White, J. A., Mehta, R. H., Lokhnygina, Y., Al-Khatib, S. M., Tricoci, P., Califf, R. M., Harrington, R. A., Newby, L. K., Pollack, C. V., Jr., Montalescot, G., Van de Werf, F., Gibson, C. M., Giugliano, R. P. Response to letter regarding article, "sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment elevation acute coronary syndromes" Circulation. 2013;127(20):e634.

Piccini, J. P., White, J. A., Mehta, R. H., Lokhnygina, Y., Al-Khatib, S. M., Tricoci, P., Califf, R. M., Harrington, R. A., Newby, L. K., Pollack, C. V., Jr., Montalescot, G., Van de Werf, F., Gibson, C. M., Giugliano, R. P. Response to letter regarding article, "sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment elevation acute coronary syndromes" Circulation. 2013;127(20):e634.

Piccini, J. P., White, J. A., Mehta, R. H., Lokhnygina, Y., Al-Khatib, S. M., Tricoci, P., Califf, R. M., Harrington, R. A., Newby, L. K., Pollack, C. V., Jr., Montalescot, G., Van de Werf, F., Gibson, C. M., Giugliano, R. P. Response to letter regarding article, "sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment elevation acute coronary syndromes" Circulation. 2013;127(20):e634.

Pride, Y. B., Piccirillo, B. J., Gibson, C. M. Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction Am J Cardiol. 2013;111(6):914-8. Abstract

Pride, Y. B., Piccirillo, B. J., Gibson, C. M. Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction Am J Cardiol. 2013;111(6):914-8. Abstract

Qian, F., Fonarow, G. C., Smith, E. E., Xian, Y., Pan, W., Hannan, E. L., Shaw, B. A., Glance, L. G., Peterson, E. D., Eapen, Z. J., Hernandez, A. F., Schwamm, L. H., Bhatt, D. L. Racial and ethnic differences in outcomes in older patients with acute ischemic stroke Circ Cardiovasc Qual Outcomes. 2013;6(3):284-92. Abstract

Qian, F., Fonarow, G. C., Smith, E. E., Xian, Y., Pan, W., Hannan, E. L., Shaw, B. A., Glance, L. G., Peterson, E. D., Eapen, Z. J., Hernandez, A. F., Schwamm, L. H., Bhatt, D. L. Racial and ethnic differences in outcomes in older patients with acute ischemic stroke Circ Cardiovasc Qual Outcomes. 2013;6(3):284-92. Abstract

Qian, F., Fonarow, G. C., Smith, E. E., Xian, Y., Pan, W., Hannan, E. L., Shaw, B. A., Glance, L. G., Peterson, E. D., Eapen, Z. J., Hernandez, A. F., Schwamm, L. H., Bhatt, D. L. Racial and ethnic differences in outcomes in older patients with acute ischemic stroke Circ Cardiovasc Qual Outcomes. 2013;6(3):284-92. Abstract

Redfield, M. M., Chen, H. H., Borlaug, B. A., Semigran, M. J., Lee, K. L., Lewis, G., LeWinter, M. M., Rouleau, J. L., Bull, D. A., Mann, D. L., Deswal, A., Stevenson, L. W., Givertz, M. M., Ofili, E. O., O'Connor, C. M., Felker, G. M., Goldsmith, S. R., Bart, B. A., McNulty, S. E., Ibarra, J. C., Lin, G., Oh, J. K., Patel, M. R., Kim, R. J., Tracy, R. P., Velazquez, E. J., Anstrom, K. J., Hernandez, A. F., Mascette, A. M., Braunwald, E., Relax Trial Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA. 2013;309(12):1268-77. Abstract

Redfield, M. M., Chen, H. H., Borlaug, B. A., Semigran, M. J., Lee, K. L., Lewis, G., LeWinter, M. M., Rouleau, J. L., Bull, D. A., Mann, D. L., Deswal, A., Stevenson, L. W., Givertz, M. M., Ofili, E. O., O'Connor, C. M., Felker, G. M., Goldsmith, S. R., Bart, B. A., McNulty, S. E., Ibarra, J. C., Lin, G., Oh, J. K., Patel, M. R., Kim, R. J., Tracy, R. P., Velazquez, E. J., Anstrom, K. J., Hernandez, A. F., Mascette, A. M., Braunwald, E., Relax Trial Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA. 2013;309(12):1268-77. Abstract

Redfield, M. M., Chen, H. H., Borlaug, B. A., Semigran, M. J., Lee, K. L., Lewis, G., LeWinter, M. M., Rouleau, J. L., Bull, D. A., Mann, D. L., Deswal, A., Stevenson, L. W., Givertz, M. M., Ofili, E. O., O'Connor, C. M., Felker, G. M., Goldsmith, S. R., Bart, B. A., McNulty, S. E., Ibarra, J. C., Lin, G., Oh, J. K., Patel, M. R., Kim, R. J., Tracy, R. P., Velazquez, E. J., Anstrom, K. J., Hernandez, A. F., Mascette, A. M., Braunwald, E., Relax Trial Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA. 2013;309(12):1268-77. Abstract

Reed, G. W. Influence of Smoking on the Antiplatelet Effect of Clopidogrel Differs According to Dosing Stragegy: Insights from the GRAVITAS Trial Journal of the American College of Cardiology. 2013;61(10):A475.

Reed, G. W. Influence of Smoking on the Antiplatelet Effect of Clopidogrel Differs According to Dosing Stragegy: Insights from the GRAVITAS Trial Journal of the American College of Cardiology. 2013;61(10):A475.

Reed, G. W., Cannon, C. P. Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting Clin Cardiol. 2013;NA(NA):NA. Abstract

Reed, Grant W, Guo, Jianping, Hoffman, Elaine B, Maree, Andrew O, Shekar, Prem, Aranki, Sary, Rosenfield, Kenneth, Cannon, Christopher P Abstract 10331: Aspirin Responsiveness Testing Predicts Bleeding During Coronary Artery Bypass Grafting: The Verify Pre-Op - TIMI 45 Study Circulation. 2013;128(22 Supplement):A10331.

Reed, Grant W, Guo, Jianping, Hoffman, Elaine B, Maree, Andrew O, Shekar, Prem, Aranki, Sary, Rosenfield, Kenneth, Cannon, Christopher P Abstract 10331: Aspirin Responsiveness Testing Predicts Bleeding During Coronary Artery Bypass Grafting: The Verify Pre-Op - TIMI 45 Study Circulation. 2013;128(22 Supplement):A10331.

Rodes-Cabau, J., Dauerman, H. L., Cohen, M. G., Mehran, R., Small, E. M., Smyth, S. S., Costa, M. A., Mega, J. L., O'Donoghue, M. L., Ohman, E. M., Becker, R. C. Antithrombotic Treatment in Transcatheter Aortic Valve Implantation: Insights for Cerebrovascular and Bleeding Events J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Rodes-Cabau, J., Dauerman, H. L., Cohen, M. G., Mehran, R., Small, E. M., Smyth, S. S., Costa, M. A., Mega, J. L., O'Donoghue, M. L., Ohman, E. M., Becker, R. C. Antithrombotic Treatment in Transcatheter Aortic Valve Implantation: Insights for Cerebrovascular and Bleeding Events J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Rodes-Cabau, J., Dauerman, H. L., Cohen, M. G., Mehran, R., Small, E. M., Smyth, S. S., Costa, M. A., Mega, J. L., O'Donoghue, M. L., Ohman, E. M., Becker, R. C. Antithrombotic Treatment in Transcatheter Aortic Valve Implantation: Insights for Cerebrovascular and Bleeding Events J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Rodes-Cabau, J., Dauerman, H. L., Cohen, M. G., Mehran, R., Small, E. M., Smyth, S. S., Costa, M. A., Mega, J. L., O'Donoghue, M. L., Ohman, E. M., Becker, R. C. Antithrombotic Treatment in Transcatheter Aortic Valve Implantation: Insights for Cerebrovascular and Bleeding Events J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Rodriguez, F., Bhatt, D. L., Steg, P., Kumbhani, D. J., Umez-Eronini, A., Hoffman, E. P., Cannon, C. P. Predictors of Long-Term Adherence to Evidence-Based Cardiovascular Disease Medications in OUtpatients with Atherothrombotic Disease Journal of the American College of Cardiology. 2013;61(10):A377.

Rodriguez, F., Bhatt, D. L., Steg, P., Kumbhani, D. J., Umez-Eronini, A., Hoffman, E. P., Cannon, C. P. Predictors of Long-Term Adherence to Evidence-Based Cardiovascular Disease Medications in OUtpatients with Atherothrombotic Disease Journal of the American College of Cardiology. 2013;61(10):A377.

Rodriguez, F., Bhatt, D. L., Steg, P., Kumbhani, D. J., Umez-Eronini, A., Hoffman, E. P., Cannon, C. P. Predictors of Long-Term Adherence to Evidence-Based Cardiovascular Disease Medications in OUtpatients with Atherothrombotic Disease Journal of the American College of Cardiology. 2013;61(10):A377.

Rodriguez, F., Cannon, C. P., Steg, P. G., Kumbhani, D. J., Goto, S., Smith, S. C., Eagle, K. A., Ohman, E. M., Umez-Eronini, A. A., Hoffman, E., Bhatt, D. L., on Behalf of the, Reach Registry Investigators Predictors of Long-term Adherence to Evidence-based Cardiovascular Disease Medications in Outpatients With Stable Atherothrombotic Disease: Findings From the REACH Registry Clin Cardiol. 2013;NA(NA):NA. Abstract

Rodriguez, F., Cannon, C. P., Steg, P. G., Kumbhani, D. J., Goto, S., Smith, S. C., Eagle, K. A., Ohman, E. M., Umez-Eronini, A. A., Hoffman, E., Bhatt, D. L., on Behalf of the, Reach Registry Investigators Predictors of Long-term Adherence to Evidence-based Cardiovascular Disease Medications in Outpatients With Stable Atherothrombotic Disease: Findings From the REACH Registry Clin Cardiol. 2013;NA(NA):NA. Abstract

Rodriguez, F., Cannon, C. P., Steg, P. G., Kumbhani, D. J., Goto, S., Smith, S. C., Eagle, K. A., Ohman, E. M., Umez-Eronini, A. A., Hoffman, E., Bhatt, D. L., on Behalf of the, Reach Registry Investigators Predictors of Long-term Adherence to Evidence-based Cardiovascular Disease Medications in Outpatients With Stable Atherothrombotic Disease: Findings From the REACH Registry Clin Cardiol. 2013;NA(NA):NA. Abstract

Rose, J. J., Newby, L. K., Broderick, S., Chiswell, K., Van de Werf, F., Armstrong, P. W., Mahaffey, K. W., Harrington, R. A., Ohman, E. M., Giugliano, R. P., Goodman, S. G., White, H. D., Califf, R. M., Granger, C. B., Lopes, R. D. Left Bundle Branch Block in Non-ST-Segment Elevation Acute Coronary Syndromes: Incidence, Angiographic Characteristics, and Clinical Outcomes J Am Coll Cardiol. 2013;61(13):1461-3.

Ruff CT, Bonaca MP, Kosowsky JM, Conrad MJ, Murphy SA, Jarolim P, Donahoe SM, O'Donoghue ML, Morrow DA. Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. J Thromb Thrombolysis. 2013;36:361-367. Abstract

Ruff CT, Bonaca MP, Kosowsky JM, Conrad MJ, Murphy SA, Jarolim P, Donahoe SM, O'Donoghue ML, Morrow DA. Erratum to: Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. J Thromb Thrombolysis. 2013;36:368.

Ruff CT, Bonaca MP, Kosowsky JM, Conrad MJ, Murphy SA, Jarolim P, Donahoe SM, O'Donoghue ML, Morrow DA. Erratum to: Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. J Thromb Thrombolysis. 2013;36:368.

Ruff CT, Bonaca MP, Kosowsky JM, Conrad MJ, Murphy SA, Jarolim P, Donahoe SM, O'Donoghue ML, Morrow DA. Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. J Thromb Thrombolysis. 2013;36:361-367. Abstract

Ruff, C. T., Bonaca, M. P., Kosowsky, J. M., Conrad, M. J., Murphy, S. A., Jarolim, P., Donahoe, S. M., O'Donoghue, M. L., Morrow, D. A. Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study J Thromb Thrombolysis. 2013;NA(NA):NA. Abstract

Ruff, C. T., Bonaca, M. P., Kosowsky, J. M., Conrad, M. J., Murphy, S. A., Jarolim, P., Donahoe, S. M., O'Donoghue, M. L., Morrow, D. A. Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study J Thromb Thrombolysis. 2013;NA(NA):NA. Abstract

Ruff, C. T., Bonaca, M. P., Kosowsky, J. M., Conrad, M. J., Murphy, S. A., Jarolim, P., Donahoe, S. M., O'Donoghue, M. L., Morrow, D. A. Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study J Thromb Thrombolysis. 2013;NA(NA):NA. Abstract

Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., Yamashita, T., Antman, E. M. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet. 2013;NA(NA):NA. Abstract

Ruff, C. T., Moryusef, A, Umez-Eronini, A., Hoffman, Elain P., Gaudin, C., Antman, E., Sabatine, M., Timi Study Group Evaluation of the Efficacy and Safety of Otamixaban versus Unfractionated Heparin+Eptifibatide in Patients with Non-ST-Elevation Acute Coronary Syndromes by PCI in the SEPIA-ACS1 TIMI 42 Trial Journal of the American College of Cardiology. 2013;61(10):A25.

Schwamm, L. H., Ali, S. F., Reeves, M. J., Smith, E. E., Saver, J. L., Messe, S., Bhatt, D. L., Grau-Sepulveda, M. V., Peterson, E. D., Fonarow, G. C. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at get with the guidelines-stroke hospitals Circ Cardiovasc Qual Outcomes. 2013;6(5):543-9. Abstract

Schwamm, L. H., Ali, S. F., Reeves, M. J., Smith, E. E., Saver, J. L., Messe, S., Bhatt, D. L., Grau-Sepulveda, M. V., Peterson, E. D., Fonarow, G. C. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at get with the guidelines-stroke hospitals Circ Cardiovasc Qual Outcomes. 2013;6(5):543-9. Abstract

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus. N Engl J Med. 2013;369:1317-1326. Abstract

Scirica, B. M. Therapeutic hypothermia after cardiac arrest Circulation. 2013;127(2):244-50.

Scirica, B. M. Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus Circulation. 2013;127(9):965-7.

Scirica, B. M. Therapeutic hypothermia after cardiac arrest Circulation. 2013;127(2):244-50.

Scirica, B. M. Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus Circulation. 2013;127(9):965-7.

Scirica, B. M. Therapeutic hypothermia after cardiac arrest Circulation. 2013;127(2):244-50.

Scirica, B. M. Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus Circulation. 2013;127(9):965-7.

Scirica, B. M. Therapeutic hypothermia after cardiac arrest Circulation. 2013;127(2):244-50.

Scirica, B. M., Kadakia, M. B., de Lemos, J. A., Roe, M. T., Morrow, D. A., Li, S., Wiviott, S. D., Kontos, M. C., on behalf of the National Cardiovascular Data, Registry Association between Natriuretic Peptides and Mortality among Patients Admitted with Myocardial Infarction: A Report from the ACTION Registry(R)-GWTG Clin Chem. 2013;NA(NA):NA. Abstract

Scirica, Benjamin M, Raz, Itamar, Cavender, Matthew A, Steg, P. G, Hirshberg, Boaz, Davidson, Jaime, Im, KyungAh, Hoffman, Elaine, Braunwald, Eugene, Bhatt, Deepak L Abstract 17503: Outcomes of Patients With Type 2 Diabetes and Known Congestive Heart Failure Treated With Saxagliptin: Analyses of the SAVOR-TIMI 53 Study Circulation. 2013;128(22 Supplement):A17503.

Scott, S. A., Sangkuhl, K., Stein, C. M., Hulot, J. S., Mega, J. L., Roden, D. M., Klein, T. E., Sabatine, M. S., Johnson, J. A., Shuldiner, A. R. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy: 2013 Update Clin Pharmacol Ther. 2013;NA(NA):NA.

Scott, S. A., Sangkuhl, K., Stein, C. M., Hulot, J. S., Mega, J. L., Roden, D. M., Klein, T. E., Sabatine, M. S., Johnson, J. A., Shuldiner, A. R. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy: 2013 Update Clin Pharmacol Ther. 2013;NA(NA):NA.

Seif, F., Patel, S. R., Walia, H. K., Rueschman, M., Bhatt, D. L., Blumenthal, R. S., Quan, S. F., Gottlieb, D. J., Lewis, E. F., Patil, S. P., Punjabi, N. M., Babineau, D. C., Redline, S., Mehra, R. Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk J Hypertens. 2013;NA(NA):NA. Abstract

Seif, F., Patel, S. R., Walia, H. K., Rueschman, M., Bhatt, D. L., Blumenthal, R. S., Quan, S. F., Gottlieb, D. J., Lewis, E. F., Patil, S. P., Punjabi, N. M., Babineau, D. C., Redline, S., Mehra, R. Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk J Hypertens. 2013;NA(NA):NA. Abstract

Seif, F., Patel, S. R., Walia, H. K., Rueschman, M., Bhatt, D. L., Blumenthal, R. S., Quan, S. F., Gottlieb, D. J., Lewis, E. F., Patil, S. P., Punjabi, N. M., Babineau, D. C., Redline, S., Mehra, R. Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk J Hypertens. 2013;NA(NA):NA. Abstract

Sirimarco, G., Amarenco, P., Labreuche, J., Touboul, P. J., Alberts, M., Goto, S., Rother, J., Mas, J. L., Bhatt, D. L., Steg, P. G., Reach Registry Investigators Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis Stroke. 2013;44:373-9. Abstract

Sirimarco, G., Amarenco, P., Labreuche, J., Touboul, P. J., Alberts, M., Goto, S., Rother, J., Mas, J. L., Bhatt, D. L., Steg, P. G., Reach Registry Investigators Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis Stroke. 2013;44:373-9. Abstract

Smith, S. W., Diercks, D. B., Nagurney, J. T., Hollander, J. E., Miller, C. D., Schrock, J. W., Singer, A. J., Apple, F. S., McCullough, P. A., Ruff, C. T., Sesma, A., Jr., Peacock, W. F. Central versus local adjudication of myocardial infarction in a cardiac biomarker trial Am Heart J. 2013;165(3):273-279 e1. Abstract

Steen, D. L., Bhatt, D. L. Statin potency associated with incident diabetes in a real-world evaluation Evid Based Med. 2013;NA(NA):NA.

Steen, D. L., Bhatt, D. L. Statin potency associated with incident diabetes in a real-world evaluation Evid Based Med. 2013;NA(NA):NA.

Steen, Dylan L, Umez-Eronini, Amarachi A, Hoffman, Elaine B, Antman, Elliott M, Wiviott, Stephen D Abstract 17544: Utilization of Intensive Lipid-Lowering Therapy After an Acute Coronary Syndrome: Insights From the Triton-TIMI 38 Trial Circulation. 2013;128(22 Supplement):A17544.

Steen, Dylan L, Umez-Eronini, Amarachi A, Hoffman, Elaine B, Antman, Elliott M, Wiviott, Stephen D Abstract 17544: Utilization of Intensive Lipid-Lowering Therapy After an Acute Coronary Syndrome: Insights From the Triton-TIMI 38 Trial Circulation. 2013;128(22 Supplement):A17544.

Steen, Dylan L., Cannon, Christopher P., Lele, Suhas S., Rajapurkar, Mohan M., Mukhopadhyay, Banibrata, Scirica, Benjamin M., Murphy, Sabina A., Morrow, David A. Prognostic Evaluation of Catalytic Iron in Patients With Acute Coronary Syndromes Clinical Cardiology. 2013;NA(NA):n/a-n/a.

Steen, Dylan L., Cannon, Christopher P., Lele, Suhas S., Rajapurkar, Mohan M., Mukhopadhyay, Banibrata, Scirica, Benjamin M., Murphy, Sabina A., Morrow, David A. Prognostic Evaluation of Catalytic Iron in Patients With Acute Coronary Syndromes Clinical Cardiology. 2013;NA(NA):n/a-n/a.

Steg, P. G., Bhatt, D. L., Hamm, C. W., Stone, G. W., Gibson, C. M., Mahaffey, K. W., Leonardi, S., Liu, T., Skerjanec, S., Day, J. R., Iwaoka, R. S., Stuckey, T. D., Gogia, H. S., Gruberg, L., French, W. J., White, H. D., Harrington, R. A. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data Lancet. 2013;NA(NA):NA. Abstract

Steg, P. G., Mehta, S. R., Pollack, C. V., Jr., Bode, C., Cohen, M., French, W. J., Hoekstra, J., Rao, S. V., Ruzyllo, W., Ruiz-Nodar, J. M., Sabate, M., Widimsky, P., Kiss, R. G., Navarro Estrada, J. L., Hod, H., Kerkar, P., Guneri, S., Sezer, M., Ruda, M., Nicolau, J. C., Cavallini, C., Ebrahim, I., Petrov, I., Kim, J. H., Jeong, M. H., Ramos Lopez, G. A., Laanmets, P., Kovar, F., Gaudin, C., Fanouillere, K. C., Minini, P., Hoffman, E. B., Moryusef, A., Wiviott, S. D., Sabatine, M. S., T. A. O. Investigators Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial JAMA. 2013;310(11):1145-55. Abstract

Steinberg, B. A., Beckley, P. D., Deering, T. F., Clark, C. L., Amin, A. N., Bauer, K. A., Cryer, B., Mansour, M., Scheiman, J. M., Zenati, M. A., Newby, L. K., Peacock, W. F., Bhatt, D. L., for the Society of Cardiovascular Patient, Care Evaluation and Management of the Atrial Fibrillation Patient: A Report From the Society of Cardiovascular Patient Care Crit Pathw Cardiol. 2013;12(3):107-115. Abstract

Steinberg, B. A., Beckley, P. D., Deering, T. F., Clark, C. L., Amin, A. N., Bauer, K. A., Cryer, B., Mansour, M., Scheiman, J. M., Zenati, M. A., Newby, L. K., Peacock, W. F., Bhatt, D. L., for the Society of Cardiovascular Patient, Care Evaluation and Management of the Atrial Fibrillation Patient: A Report From the Society of Cardiovascular Patient Care Crit Pathw Cardiol. 2013;12(3):107-115. Abstract

Storey RF, James SK, Siegbahn A, Varenhorst C, Held C, Ycas J, Husted SE, Cannon CP, Becker RC, Steg PG, Åsenblad N, Wallentin L. Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study. Platelets. 2013;25:517-25. Abstract

Storey RF, James SK, Siegbahn A, Varenhorst C, Held C, Ycas J, Husted SE, Cannon CP, Becker RC, Steg PG, Åsenblad N, Wallentin L. Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study. Platelets. 2013;25:517-25. Abstract

Subherwal, S., Patel, M. R., Tang, F., Smolderen, K. G., Jones, W. S., Tsai, T. T., Ting, H. H., Bhatt, D. L., Spertus, J. A., Chan, P. S. Socioeconomic Disparities in Use of Cardioprotective Medications Among Patients with Peripheral Artery Disease-An Analysis of the American College of Cardiology's NCDR PINNACLE Registry(R) J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Subherwal, S., Patel, M. R., Tang, F., Smolderen, K. G., Jones, W. S., Tsai, T. T., Ting, H. H., Bhatt, D. L., Spertus, J. A., Chan, P. S. Socioeconomic Disparities in Use of Cardioprotective Medications Among Patients with Peripheral Artery Disease-An Analysis of the American College of Cardiology's NCDR PINNACLE Registry(R) J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Subherwal, S., Patel, M. R., Tang, F., Smolderen, K. G., Jones, W. S., Tsai, T. T., Ting, H. H., Bhatt, D. L., Spertus, J. A., Chan, P. S. Socioeconomic Disparities in Use of Cardioprotective Medications Among Patients with Peripheral Artery Disease-An Analysis of the American College of Cardiology's NCDR PINNACLE Registry(R) J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Svendsen, M. C., Akingba, A. G., Sinha, A. K., Chattin, B., Turner, A., Brass, M., Bhatt, D. L., Kassab, G. S. Conductance sizing balloon for measurement of peripheral artery minimal stent area J Vasc Surg. 2013;NA(NA):NA. Abstract

Svendsen, M. C., Akingba, A. G., Sinha, A. K., Chattin, B., Turner, A., Brass, M., Bhatt, D. L., Kassab, G. S. Conductance sizing balloon for measurement of peripheral artery minimal stent area J Vasc Surg. 2013;NA(NA):NA. Abstract

Tantry, U. S., Bonello, L., Aradi, D., Price, M. J., Jeong, Y. H., Angiolillo, D. J., Stone, G. W., Curzen, N., Geisler, T., Ten Berg, J., Kirtane, A., Siller-Matula, J., Mahla, E., Becker, R. C., Bhatt, D. L., Waksman, R., Rao, S. V., Alexopoulos, D., Marcucci, R., Reny, J. L., Trenk, D., Sibbing, D., Gurbel, P. A. Consensus and Update on the Definition of On-Treatment Platelet Reactivity to ADP Associated with Ischemia and Bleeding J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Thukkani, A. K., Bhatt, D. L. Renal denervation therapy for hypertension Circulation. 2013;128(20):2251-4.

Thukkani, A. K., Bhatt, D. L. Renal denervation therapy for hypertension Circulation. 2013;128(20):2251-4.

Thukkani, A. K., Bhatt, D. L. Renal denervation therapy for hypertension Circulation. 2013;128(20):2251-4.

Thukkani, A. K., Bhatt, D. L. Renal denervation therapy for hypertension Circulation. 2013;128(20):2251-4.

Truong, Q. A., Hayden, D. L., Woodard, P. K., Kirby, R., Chou, E. T., Nagurney, J. T., Wiviott, S. D., Fleg, J. L., Schoenfeld, D. A., Udelson, J. E., Hoffmann, U. Sex Differences in the Effectiveness of Early Coronary CT Angiography Compared to Standard Emergency Department Evaluation for Acute Chest Pain: The ROMICAT II Trial Circulation. 2013;NA(NA):NA. Abstract

Udell, J. A., Morrow, D. A., Braunwald, E., Swedberg, K., Bode, C., Rifai, N., Brunel, P. C., Prescott, M. F., Ren, F., Hoffman, E. B., Scirica, B. M. Inhibition of the Renin-Angiotensin System Reduces the Rise in Serum Aldosterone in Acute Coronary Syndrome Patients with Preserved Left Ventricular Function: Observations from the AVANT GARDE-TIMI 43 Trial Clin Chem. 2013;NA(NA):NA. Abstract

Udell, J. A., Steg, P. G., Scirica, B. M., Eagle, K. A., Ohman, E. M., Goto, S., Alsheikh-Ali, A. A., Porath, A., Corbalan, R., Umez-Eronini, A. A., Hoffman, E. B., Wilson, P. W., Bhatt, D. L., on Behalf of the Reduction of Atherothrombosis for Continued Health Registry, Investigators Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis Eur J Prev Cardiol. 2013;NA(NA):NA. Abstract

Udell, J. A., Steg, P. G., Scirica, B. M., Eagle, K. A., Ohman, E. M., Goto, S., Alsheikh-Ali, A. A., Porath, A., Corbalan, R., Umez-Eronini, A. A., Hoffman, E. B., Wilson, P. W., Bhatt, D. L., on Behalf of the Reduction of Atherothrombosis for Continued Health Registry, Investigators Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis Eur J Prev Cardiol. 2013;NA(NA):NA. Abstract

Udell, J. A., Steg, P. G., Scirica, B. M., Eagle, K. A., Ohman, E. M., Goto, S., Alsheikh-Ali, A. A., Porath, A., Corbalan, R., Umez-Eronini, A. A., Hoffman, E. B., Wilson, P. W., Bhatt, D. L., on Behalf of the Reduction of Atherothrombosis for Continued Health Registry, Investigators Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis Eur J Prev Cardiol. 2013;NA(NA):NA. Abstract

Udell, J. A., Zawi, R., Bhatt, D. L., Keshtkar-Jahromi, M., Gaughran, F., Phrommintikul, A., Ciszewski, A., Vakili, H., Hoffman, E. B., Farkouh, M. E., Cannon, C. P. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis JAMA. 2013;310(16):1711-20. Abstract

Udell, J. A., Zawi, R., Bhatt, D. L., Keshtkar-Jahromi, M., Gaughran, F., Phrommintikul, A., Ciszewski, A., Vakili, H., Hoffman, E. B., Farkouh, M. E., Cannon, C. P. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis JAMA. 2013;310(16):1711-20. Abstract

Udell, J. A., Zawi, R., Bhatt, D. L., Keshtkar-Jahromi, M., Gaughran, F., Phrommintikul, A., Ciszewski, A., Vakili, H., Hoffman, E. B., Farkouh, M. E., Cannon, C. P. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis JAMA. 2013;310(16):1711-20. Abstract

Udell, Jacob A, Bhatt, Deepak L, Hoffman, Elaine B, Cannon, Christopher P Abstract 10286: Benefit of High-Dose Atorvastatin in Patients With Acute Coronary Syndromes After Recent Influenza-like Illness: Results From the PROVE IT-TIMI 22 Trial Circulation. 2013;128(22 Supplement):A10286.

Wallentin L, Lindholm D, Siegbahn A, Wernroth L, Becker RC, Cannon CP, Cornel JH, Himmelmann A, Giannitsis E, Harrington RA, Held C, Husted S, Katus HA, Mahaffey KW, Steg PG, Storey RF, James SK; PLATO study group. Biomarkers in Relation to the Effects of Ticagrelor Compared with Clopidogrel in Non-ST-Elevation Acute Coronary Syndrome Patients Managed with or without In-Hospital Revascularization: A Substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation. 2013;129:293-303. Abstract

White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., Wilson, C., Cushman, W. C., Zannad, F. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes N Engl J Med. 2013;NA(NA):NA. Abstract

Wiviott, S. D., White, H. D., Ohman, E. M., Fox, K. A., Armstrong, P. W., Prabhakaran, D., Hafley, G., Lokhnygina, Y., Boden, W. E., Hamm, C., Clemmensen, P., Nicolau, J. C., Menozzi, A., Ruzyllo, W., Widimsky, P., Oto, A., Leiva-Pons, J., Pavlides, G., Winters, K. J., Roe, M. T., Bhatt, D. L. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial Lancet. 2013;382(9892):605-13. Abstract

Zakeri, R., Borlaug, B. A., McNulty, S., Mohammed, S. F., Lewis, G. D., Semigran, M. J., Deswal, A., Lewinter, M., Hernandez, A. F., Braunwald, E., Redfield, M. M. Impact of Atrial Fibrillation on Exercise Capacity in Heart Failure with Preserved Ejection Fraction: A RELAX Trial Ancillary Study Circ Heart Fail. 2013;NA(NA):NA. Abstract

Zakeri, R., Borlaug, B. A., McNulty, S., Mohammed, S. F., Lewis, G. D., Semigran, M. J., Deswal, A., Lewinter, M., Hernandez, A. F., Braunwald, E., Redfield, M. M. Impact of Atrial Fibrillation on Exercise Capacity in Heart Failure with Preserved Ejection Fraction: A RELAX Trial Ancillary Study Circ Heart Fail. 2013;NA(NA):NA. Abstract

Ademi, Z., Liew, D., Gorelik, A., Bohensky, M., Zomer, E., Hollingsworth, B., Steg, G., Bhatt, D. L., Reid, C. M. Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data Int J Cardiol. 2014;NA(NA):NA. Abstract

Ademi, Z., Liew, D., Gorelik, A., Bohensky, M., Zomer, E., Hollingsworth, B., Steg, G., Bhatt, D. L., Reid, C. M. Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data Int J Cardiol. 2014;NA(NA):NA. Abstract

Ademi, Z., Liew, D., Gorelik, A., Bohensky, M., Zomer, E., Hollingsworth, B., Steg, G., Bhatt, D. L., Reid, C. M. Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data Int J Cardiol. 2014;NA(NA):NA. Abstract

Bakris, G. L., Townsend, R. R., Liu, M., Cohen, S. A., D'Agostino, R., Flack, J. M., Kandzari, D. E., Katzen, B. T., Leon, M. B., Mauri, L., Negoita, M., O'Neill, W. W., Oparil, S., Rocha-Singh, K., Bhatt, D. L. Impact of Renal Denervation on 24-hour Ambulatory Blood Pressure: Results from SYMPLICITY HTN-3 J Am Coll Cardiol. 2014;NA(NA):NA. Abstract

Bakris, G. L., Townsend, R. R., Liu, M., Cohen, S. A., D'Agostino, R., Flack, J. M., Kandzari, D. E., Katzen, B. T., Leon, M. B., Mauri, L., Negoita, M., O'Neill, W. W., Oparil, S., Rocha-Singh, K., Bhatt, D. L. Impact of Renal Denervation on 24-hour Ambulatory Blood Pressure: Results from SYMPLICITY HTN-3 J Am Coll Cardiol. 2014;NA(NA):NA. Abstract

Bakris, G. L., Townsend, R. R., Liu, M., Cohen, S. A., D'Agostino, R., Flack, J. M., Kandzari, D. E., Katzen, B. T., Leon, M. B., Mauri, L., Negoita, M., O'Neill, W. W., Oparil, S., Rocha-Singh, K., Bhatt, D. L. Impact of Renal Denervation on 24-hour Ambulatory Blood Pressure: Results from SYMPLICITY HTN-3 J Am Coll Cardiol. 2014;NA(NA):NA. Abstract

Bakris, G. L., Townsend, R. R., Liu, M., Cohen, S. A., D'Agostino, R., Flack, J. M., Kandzari, D. E., Katzen, B. T., Leon, M. B., Mauri, L., Negoita, M., O'Neill, W. W., Oparil, S., Rocha-Singh, K., Bhatt, D. L. Impact of Renal Denervation on 24-hour Ambulatory Blood Pressure: Results from SYMPLICITY HTN-3 J Am Coll Cardiol. 2014;NA(NA):NA. Abstract

Bangalore, S., Schwamm, L., Smith, E. E., Singh, I. M., Liang, L., Fonarow, G. C., Bhatt, D. L., Get With the Guidelines-Stroke Steering, Committee, Investigators, Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack Am J Med. 2014;NA(NA):NA. Abstract

Bangalore, S., Schwamm, L., Smith, E. E., Singh, I. M., Liang, L., Fonarow, G. C., Bhatt, D. L., Get With the Guidelines-Stroke Steering, Committee, Investigators, Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack Am J Med. 2014;NA(NA):NA. Abstract

Bangalore, S., Schwamm, L., Smith, E. E., Singh, I. M., Liang, L., Fonarow, G. C., Bhatt, D. L., Get With the Guidelines-Stroke Steering, Committee, Investigators, Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack Am J Med. 2014;NA(NA):NA. Abstract

Bangalore, S., Schwamm, L., Smith, E. E., Singh, I. M., Liang, L., Fonarow, G. C., Bhatt, D. L., Get With the Guidelines-Stroke Steering, Committee, Investigators, Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack Am J Med. 2014;NA(NA):NA. Abstract

Bergmark, B., Giugliano, R. P. Perioperative management of target-specific oral anticoagulants Hosp Pract (1995). 2014;42(1):38-45. Abstract

Bergmark, B., Giugliano, R. P. Perioperative management of target-specific oral anticoagulants Hosp Pract (1995). 2014;42(1):38-45. Abstract

Bergmark, B., Giugliano, R. P. Perioperative management of target-specific oral anticoagulants Hosp Pract (1995). 2014;42(1):38-45. Abstract

Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., Cohen, S. A., Oparil, S., Rocha-Singh, K., Townsend, R. R., Bakris, G. L., Symplicity Htn- Investigators A controlled trial of renal denervation for resistant hypertension N Engl J Med. 2014;370(15):1393-401. Abstract

Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., Cohen, S. A., Oparil, S., Rocha-Singh, K., Townsend, R. R., Bakris, G. L., Symplicity Htn- Investigators A controlled trial of renal denervation for resistant hypertension N Engl J Med. 2014;370(15):1393-401. Abstract

Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., Cohen, S. A., Oparil, S., Rocha-Singh, K., Townsend, R. R., Bakris, G. L., Symplicity Htn- Investigators A controlled trial of renal denervation for resistant hypertension N Engl J Med. 2014;370(15):1393-401. Abstract

Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., Cohen, S. A., Oparil, S., Rocha-Singh, K., Townsend, R. R., Bakris, G. L., Symplicity Htn- Investigators A controlled trial of renal denervation for resistant hypertension N Engl J Med. 2014;370(15):1393-401. Abstract

Bonaca MP, Bhatt DL, Braunwald E, Cohen M, Steg PG, Storey RF, Held P, Jensen EC, Sabatine MS Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial. Am Heart J. 2014;167:437-444. Abstract

Bonaca MP, O'Malley RG, Murphy SA, Jarolim P, Conrad MJ, Braunwald E, Sabatine MS, Morrow DA Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36 Eur Heart J Acute Cardiovasc Care. 2014:Epub ahead of print. Abstract

Bonaca MP, O'Malley RG, Murphy SA, Jarolim P, Conrad MJ, Braunwald E, Sabatine MS, Morrow DA Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36 Eur Heart J Acute Cardiovasc Care. 2014:Epub ahead of print. Abstract

Bonaca MP, O'Malley RG, Murphy SA, Jarolim P, Conrad MJ, Braunwald E, Sabatine MS, Morrow DA Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36 Eur Heart J Acute Cardiovasc Care. 2014:Epub ahead of print. Abstract

Bonaca, M. P., Murphy, S. A., Miller, D., Herrman, J. P., Gottlieb, S., Keltai, M., Menozzi, A., Nicolau, J. C., Widimsky, P., Antman, E. M., Wiviott, S. D. Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry Clin Cardiol. 2014;NA(NA):NA. Abstract

Braunwald, E. Responsiveness to loop diuretics in heart failure Eur Heart J. 2014;NA(NA):NA.

Braunwald, E. Responsiveness to loop diuretics in heart failure Eur Heart J. 2014;NA(NA):NA.

Braunwald, E. Responsiveness to loop diuretics in heart failure Eur Heart J. 2014;NA(NA):NA.

Carreras, E. T., Mega, J. L. Dual antiplatelet therapy for heart disease Circulation. 2014;129(21):e506-8.

Carreras, E. T., Mega, J. L. Dual antiplatelet therapy for heart disease Circulation. 2014;129(21):e506-8.

Cavender, M. A., Rassi, A. N., Schwamm, L. H., Fonarow, G. C., Cannon, C. P., Peacock, W. F., Laskey, W. K., Hernandez, A. F., Peterson, E. D., Cox, M., Grau-Sepulveda, M., Bhatt, D. L. Authors' Reply Clin Cardiol. 2014;NA(NA):NA.

Cavender, M. A., Rassi, A. N., Schwamm, L. H., Fonarow, G. C., Cannon, C. P., Peacock, W. F., Laskey, W. K., Hernandez, A. F., Peterson, E. D., Cox, M., Grau-Sepulveda, M., Bhatt, D. L. Authors' Reply Clin Cardiol. 2014;NA(NA):NA.

Cavender, M. A., Rassi, A. N., Schwamm, L. H., Fonarow, G. C., Cannon, C. P., Peacock, W. F., Laskey, W. K., Hernandez, A. F., Peterson, E. D., Cox, M., Grau-Sepulveda, M., Bhatt, D. L. Authors' Reply Clin Cardiol. 2014;NA(NA):NA.

Cavender, M. A., Rassi, A. N., Schwamm, L. H., Fonarow, G. C., Cannon, C. P., Peacock, W. F., Laskey, W. K., Hernandez, A. F., Peterson, E. D., Cox, M., Grau-Sepulveda, M., Bhatt, D. L. Authors' Reply Clin Cardiol. 2014;NA(NA):NA.

Cavender, Matthew, Steg, Philippe, Smith, Sidney, Eagle, Kim, Ohman, Erik, Goto, Shinya, Kuder, Julia, Im, Kyungah, Bhatt, Deepak Cardiovascular Event Rates in Patients with Diabetes: Insights from the International Reach Registry Journal of the American College of Cardiology. 2014;63(12, Supplement):A1340.

Cavender, Matthew, Steg, Philippe, Smith, Sidney, Eagle, Kim, Ohman, Erik, Goto, Shinya, Kuder, Julia, Im, Kyungah, Bhatt, Deepak Cardiovascular Event Rates in Patients with Diabetes: Insights from the International Reach Registry Journal of the American College of Cardiology. 2014;63(12, Supplement):A1340.

Feres, F., Costa, R. A., Bhatt, D. L. Dual antiplatelet therapy after stent implantation--reply JAMA. 2014;311(14):1446-7.

Feres, F., Costa, R. A., Bhatt, D. L. Dual antiplatelet therapy after stent implantation--reply JAMA. 2014;311(14):1446-7.

Feres, F., Costa, R. A., Bhatt, D. L. Dual antiplatelet therapy after stent implantation--reply JAMA. 2014;311(14):1446-7.

Fonarow, G. C., Zhao, X., Smith, E. E., Saver, J. L., Reeves, M. J., Bhatt, D. L., Xian, Y., Hernandez, A. F., Peterson, E. D., Schwamm, L. H. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative JAMA. 2014;311(16):1632-40. Abstract

Fonarow, G. C., Zhao, X., Smith, E. E., Saver, J. L., Reeves, M. J., Bhatt, D. L., Xian, Y., Hernandez, A. F., Peterson, E. D., Schwamm, L. H. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative JAMA. 2014;311(16):1632-40. Abstract

Gonzalez-Quesada, C. J., Giugliano, R. P. Comparison of the Phase III Clinical Trial Designs of Novel Oral Anticoagulants Versus Warfarin for the Treatment of Nonvalvular Atrial Fibrillation: Implications for Clinical Practice Am J Cardiovasc Drugs. 2014;NA(NA):NA. Abstract

Gonzalez-Quesada, C. J., Giugliano, R. P. Erratum to: Comparison of the Phase III Clinical Trial Designs of Novel Oral Anticoagulants Versus Warfarin for the Treatment of Nonvalvular Atrial Fibrillation: Implications for Clinical Practice Am J Cardiovasc Drugs. 2014;NA(NA):NA.

Gotto, A. M., Jr., Kher, U., Chatterjee, M. S., Liu, Y., Li, X. S., Vaidya, S., Cannon, C. P., Brinton, E. A., Moon, J. E., Shah, S., Dansky, H. M., Mitchel, Y., Barter, P. Lipids, Safety Parameters, and Drug Concentrations After an Additional 2 Years of Treatment With Anacetrapib in the DEFINE Study J Cardiovasc Pharmacol Ther. 2014;NA(NA):NA. Abstract

Gotto, A. M., Jr., Kher, U., Chatterjee, M. S., Liu, Y., Li, X. S., Vaidya, S., Cannon, C. P., Brinton, E. A., Moon, J. E., Shah, S., Dansky, H. M., Mitchel, Y., Barter, P. Lipids, Safety Parameters, and Drug Concentrations After an Additional 2 Years of Treatment With Anacetrapib in the DEFINE Study J Cardiovasc Pharmacol Ther. 2014;NA(NA):NA. Abstract

Gutierrez, A., Bhatt, D. L. Balancing the risks of stent thrombosis and major bleeding during primary percutaneous coronary intervention Eur Heart J. 2014;NA(NA):NA.

Gutierrez, A., Bhatt, D. L. Balancing the risks of stent thrombosis and major bleeding during primary percutaneous coronary intervention Eur Heart J. 2014;NA(NA):NA.

Gutierrez, A., Bhatt, D. L. Balancing the risks of stent thrombosis and major bleeding during primary percutaneous coronary intervention Eur Heart J. 2014;NA(NA):NA.

Kidd, Stephen, Bonaca, Marc, Scirica, Benjamin, Murphy, Sabina, Braunwald, Eugene, Morrow, David UNIVERSAL CLASSIFICATION SYSTEM TYPE OF INCIDENT MYOCARDIAL INFARCTION IN PATIENTS WITH STABLE ATHEROSCLEROSIS: OBSERVATIONS FROM TRA 2°P-TIMI 50 Journal of the American College of Cardiology. 2014;63(12, Supplement):A1568.

Kumbhani, D. J., Bavry, A. A., Desai, M. Y., Bangalore, S., Byrne, R. A., Jneid, H., Bhatt, D. L. Aspiration thrombectomy in patients undergoing primary angioplasty: Totality of data to 2013 Catheter Cardiovasc Interv. 2014;NA(NA):NA. Abstract

Kumbhani, D. J., Steg, P. G., Cannon, C. P., Eagle, K. A., Smith, S. C., Jr., Goto, S., Ohman, E. M., Elbez, Y., Sritara, P., Baumgartner, I., Banerjee, S., Creager, M. A., Bhatt, D. L., on Behalf of the, Reach Registry Investigators Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry Eur Heart J. 2014;NA(NA):NA. Abstract

Lindholm D, Varenhorst C, Cannon CP, Harrington RA, Himmelmann A, Maya J, Husted S, Steg PG, Cornel JH, Storey RF, Stevens SR, Wallentin L, James SK. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J. 2014;35:2083-93. Abstract

Mahaffey KW, Held C, Wojdyla DM, James SK, Katus HA, Husted S, Steg PG, Cannon CP, Becker RC, Storey RF, Khurmi NS, Nicolau JC, Yu CM, Ardissino D, Budaj A, Morais J, Montgomery D, Himmelmann A, Harrington RA, Wallentin L; PLATO Investigators. Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the Platelet Inhibition and Patient Outcomes (PLATO) Trial. J Am Coll Cardiol. 2014;63:1493-9. Abstract

Mahaffey KW, Held C, Wojdyla DM, James SK, Katus HA, Husted S, Steg PG, Cannon CP, Becker RC, Storey RF, Khurmi NS, Nicolau JC, Yu CM, Ardissino D, Budaj A, Morais J, Montgomery D, Himmelmann A, Harrington RA, Wallentin L; PLATO Investigators. Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the Platelet Inhibition and Patient Outcomes (PLATO) Trial. J Am Coll Cardiol. 2014;63:1493-9. Abstract

Mahaffey KW, Held C, Wojdyla DM, James SK, Katus HA, Husted S, Steg PG, Cannon CP, Becker RC, Storey RF, Khurmi NS, Nicolau JC, Yu CM, Ardissino D, Budaj A, Morais J, Montgomery D, Himmelmann A, Harrington RA, Wallentin L; PLATO Investigators. Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the Platelet Inhibition and Patient Outcomes (PLATO) Trial. J Am Coll Cardiol. 2014;63:1493-9. Abstract

Mega, J. L., Giugliano, R. P. Genotype-Guided Dosing of Warfarin Clin Chem. 2014;NA(NA):NA.

Mohammed, S. F., Borlaug, B. A., McNulty, S., Lewis, G. D., Lin, G., Zakeri, R., Semigran, M. J., LeWinter, M., Hernandez, A. F., Braunwald, E., Redfield, M. M. Resting Ventricular-Vascular Function and Exercise Capacity in Heart Failure with Preserved Ejection Fraction: A RELAX Trial Ancillary Study Circ Heart Fail. 2014;NA(NA):NA. Abstract

Mohammed, S. F., Borlaug, B. A., McNulty, S., Lewis, G. D., Lin, G., Zakeri, R., Semigran, M. J., LeWinter, M., Hernandez, A. F., Braunwald, E., Redfield, M. M. Resting Ventricular-Vascular Function and Exercise Capacity in Heart Failure with Preserved Ejection Fraction: A RELAX Trial Ancillary Study Circ Heart Fail. 2014;NA(NA):NA. Abstract

Mohammed, S. F., Borlaug, B. A., McNulty, S., Lewis, G. D., Lin, G., Zakeri, R., Semigran, M. J., LeWinter, M., Hernandez, A. F., Braunwald, E., Redfield, M. M. Resting Ventricular-Vascular Function and Exercise Capacity in Heart Failure with Preserved Ejection Fraction: A RELAX Trial Ancillary Study Circ Heart Fail. 2014;NA(NA):NA. Abstract

O'Donoghue, M. L. Acute coronary syndromes: Targeting inflammation-what has the VISTA-16 trial taught us? Nat Rev Cardiol. 2014;11(3):130-2.

O'Donoghue, M. L. Acute coronary syndromes: Targeting inflammation-what has the VISTA-16 trial taught us? Nat Rev Cardiol. 2014;11(3):130-2.

O'Donoghue, M. L. Acute coronary syndromes: Targeting inflammation-what has the VISTA-16 trial taught us? Nat Rev Cardiol. 2014;11(3):130-2.

Patel, J. H., Gupta, R., Roe, M. T., Peng, S. A., Wiviott, S. D., Saucedo, J. F. Influence of Presenting Electrocardiographic Findings on the Treatment and Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction Am J Cardiol. 2014;113(2):256-61. Abstract

Patel, J. H., Gupta, R., Roe, M. T., Peng, S. A., Wiviott, S. D., Saucedo, J. F. Influence of Presenting Electrocardiographic Findings on the Treatment and Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction Am J Cardiol. 2014;113(2):256-61. Abstract

Plitt, A., Giugliano, R. P. Edoxaban or standard therapy with warfarin for stroke prevention in patients with atrial fibrillation? Future Cardiol. 2014;10(2):153-5.

Plitt, A., Giugliano, R. P. Edoxaban: Review of Pharmacology and Key Phase I to III Clinical Trials J Cardiovasc Pharmacol Ther. 2014;NA(NA):NA. Abstract

Plitt, A., Giugliano, R. P. Edoxaban: Review of Pharmacology and Key Phase I to III Clinical Trials J Cardiovasc Pharmacol Ther. 2014;NA(NA):NA. Abstract

Potier, L., Roussel, R., Labreuche, J., Marre, M., Cacoub, P., Rother, J., Wilson, P. W., Goto, S., Bhatt, D. L., Steg, P. G. Interaction between diabetes and a high ankle-brachial index on mortality risk Eur J Prev Cardiol. 2014;NA(NA):NA. Abstract

Potier, L., Roussel, R., Labreuche, J., Marre, M., Cacoub, P., Rother, J., Wilson, P. W., Goto, S., Bhatt, D. L., Steg, P. G. Interaction between diabetes and a high ankle-brachial index on mortality risk Eur J Prev Cardiol. 2014;NA(NA):NA. Abstract

Potier, L., Roussel, R., Labreuche, J., Marre, M., Cacoub, P., Rother, J., Wilson, P. W., Goto, S., Bhatt, D. L., Steg, P. G. Interaction between diabetes and a high ankle-brachial index on mortality risk Eur J Prev Cardiol. 2014;NA(NA):NA. Abstract

Potier, L., Roussel, R., Labreuche, J., Marre, M., Cacoub, P., Rother, J., Wilson, P. W., Goto, S., Bhatt, D. L., Steg, P. G. Interaction between diabetes and a high ankle-brachial index on mortality risk Eur J Prev Cardiol. 2014;NA(NA):NA. Abstract

Reddy, P., Giugliano, R. P. The Role of Rivaroxaban in Atrial Fibrillation and Acute Coronary Syndromes J Cardiovasc Pharmacol Ther. 2014;NA(NA):NA. Abstract

Reddy, P., Giugliano, R. P. The Role of Rivaroxaban in Atrial Fibrillation and Acute Coronary Syndromes J Cardiovasc Pharmacol Ther. 2014;NA(NA):NA. Abstract

Rhee, J. W., Wiviott, S. D., Scirica, B. M., Gibson, C. M., Murphy, S. A., Bonaca, M. P., Morrow, D. A., Mega, J. L. Clinical Features, Use of Evidence-Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non-ST-Elevation Acute Coronary Syndrome Clin Cardiol. 2014;NA(NA):NA. Abstract

Rhee, J. W., Wiviott, S. D., Scirica, B. M., Gibson, C. M., Murphy, S. A., Bonaca, M. P., Morrow, D. A., Mega, J. L. Clinical Features, Use of Evidence-Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non-ST-Elevation Acute Coronary Syndrome Clin Cardiol. 2014;NA(NA):NA. Abstract

Ruff, C. T., Bhatt, D. L., Steg, P. G., Gersh, B. J., Alberts, M. J., Hoffman, E. B., Ohman, E. M., Eagle, K. A., Lip, G. Y., Goto, S., Reach Registry Investigators Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry Int J Cardiol. 2014;170(3):413-8. Abstract

Ruff, C. T., Bhatt, D. L., Steg, P. G., Gersh, B. J., Alberts, M. J., Hoffman, E. B., Ohman, E. M., Eagle, K. A., Lip, G. Y., Goto, S., Reach Registry Investigators Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry Int J Cardiol. 2014;170(3):413-8. Abstract

Ruff, C. T., Bhatt, D. L., Steg, P. G., Gersh, B. J., Alberts, M. J., Hoffman, E. B., Ohman, E. M., Eagle, K. A., Lip, G. Y., Goto, S., Reach Registry Investigators Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry Int J Cardiol. 2014;170(3):413-8. Abstract

Ruff, Christian T., Giugliano, Robert, Braunwald, Eugene, Morrow, David, Murphy, Sabina, Deenadayalu, Naveen, Jarolim, Petr, Betcher, Joshua, Shi, Minggao, Brown, Karen S., Patel, Indravadan, Mercuri, Michele, Antman, Elliott RELATIONSHIP BETWEEN DOSE, ANTI-FACTOR XA ACTIVITY, AND OUTCOMES IN PATIENTS RANDOMIZED TO EDOXABAN IN THE ENGAGE AF-TIMI 48 TRIAL Journal of the American College of Cardiology. 2014;63(12, Supplement):A329.

Sarma, A., Cannon, C. P., de Lemos, J., Rouleau, J. L., Lewis, E. F., Guo, J., Mega, J. L., Sabatine, M. S., O'Donoghue, M. L. The Incidence of Kidney Injury for Patients Treated With a High-Potency Versus Moderate-Potency Statin Regimen After an Acute Coronary Syndrome J Am Heart Assoc. 2014;3(3):e000784. Abstract

Sarma, A., Cannon, C. P., de Lemos, J., Rouleau, J. L., Lewis, E. F., Guo, J., Mega, J. L., Sabatine, M. S., O'Donoghue, M. L. The Incidence of Kidney Injury for Patients Treated With a High-Potency Versus Moderate-Potency Statin Regimen After an Acute Coronary Syndrome J Am Heart Assoc. 2014;3(3):e000784. Abstract

Scirica, B. M. Evaluating the efficacy of mineralocorticoid receptor antagonism in patients with STEMI without heart failure Eur Heart J. 2014;NA(NA):NA.

Scirica, B. M. Evaluating the efficacy of mineralocorticoid receptor antagonism in patients with STEMI without heart failure Eur Heart J. 2014;NA(NA):NA.

Setoguchi, S., Warner Stevenson, L., Stewart, G. C., Bhatt, D. L., Epstein, A. E., Desai, M., Williams, L. A., Chen, C. Y. Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure BMJ. 2014;348(NA):g2866. Abstract

Setoguchi, S., Warner Stevenson, L., Stewart, G. C., Bhatt, D. L., Epstein, A. E., Desai, M., Williams, L. A., Chen, C. Y. Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure BMJ. 2014;348(NA):g2866. Abstract

Setoguchi, S., Warner Stevenson, L., Stewart, G. C., Bhatt, D. L., Epstein, A. E., Desai, M., Williams, L. A., Chen, C. Y. Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure BMJ. 2014;348(NA):g2866. Abstract

Sherwood, M. W., Wiviott, S. D., Peng, S. A., Roe, M. T., Delemos, J., Peterson, E. D., Wang, T. Y. Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry J Am Heart Assoc. 2014;3(2):e000849. Abstract

Stein, E. A., Giugliano, R. P., Koren, M. J., Raal, F. J., Roth, E. M., Weiss, R., Sullivan, D., Wasserman, S. M., Somaratne, R., Kim, J. B., Yang, J., Liu, T., Albizem, M., Scott, R., Sabatine, M. S., for the, Proficio Investigators Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials Eur Heart J. 2014;NA(NA):NA. Abstract

Stein, E. A., Giugliano, R. P., Koren, M. J., Raal, F. J., Roth, E. M., Weiss, R., Sullivan, D., Wasserman, S. M., Somaratne, R., Kim, J. B., Yang, J., Liu, T., Albizem, M., Scott, R., Sabatine, M. S., for the, Proficio Investigators Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials Eur Heart J. 2014;NA(NA):NA. Abstract

Sukul D, Bonaca MP, Ruff CT, Kosowsky J, Conrad M, Murphy SA, Sabatine MS, Jarolim P, Morrow DA. Diagnostic Performance of Copeptin in Patients With Acute Nontraumatic Chest Pain: BWH-TIMI ED Chest Pain Study. Clin Cardiol. 2014;37:227-32. Abstract

Sukul D, Bonaca MP, Ruff CT, Kosowsky J, Conrad M, Murphy SA, Sabatine MS, Jarolim P, Morrow DA. Diagnostic Performance of Copeptin in Patients With Acute Nontraumatic Chest Pain: BWH-TIMI ED Chest Pain Study. Clin Cardiol. 2014;37:227-32. Abstract

Sukul D, Bonaca MP, Ruff CT, Kosowsky J, Conrad M, Murphy SA, Sabatine MS, Jarolim P, Morrow DA. Diagnostic Performance of Copeptin in Patients With Acute Nontraumatic Chest Pain: BWH-TIMI ED Chest Pain Study. Clin Cardiol. 2014;37:227-32. Abstract

Sukul D, Bonaca MP, Ruff CT, Kosowsky J, Conrad M, Murphy SA, Sabatine MS, Jarolim P, Morrow DA. Diagnostic Performance of Copeptin in Patients With Acute Nontraumatic Chest Pain: BWH-TIMI ED Chest Pain Study. Clin Cardiol. 2014;37:227-32. Abstract

Timur, A. A., Murugesan, G., Zhang, L., Barnard, J., Bhatt, D. L., Kottke-Marchant, K. Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy Thromb Res. 2014;NA(NA):NA. Abstract

Timur, A. A., Murugesan, G., Zhang, L., Barnard, J., Bhatt, D. L., Kottke-Marchant, K. Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy Thromb Res. 2014;NA(NA):NA. Abstract

Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg PG, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im K, Umez-Eronini AA, He P, McGuire DK, Leiter LA, Raz I, Scirica BM Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial Diabetes Care. 2014;Epub ahead of print. Abstract

Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg PG, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im K, Umez-Eronini AA, He P, McGuire DK, Leiter LA, Raz I, Scirica BM Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial Diabetes Care. 2014;Epub ahead of print. Abstract

Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg PG, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im K, Umez-Eronini AA, He P, McGuire DK, Leiter LA, Raz I, Scirica BM Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial Diabetes Care. 2014;Epub ahead of print. Abstract

Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg PG, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im K, Umez-Eronini AA, He P, McGuire DK, Leiter LA, Raz I, Scirica BM Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial Diabetes Care. 2014;Epub ahead of print. Abstract

Udell, Jacob A., Scirica, Benjamin, Cavender, Matthew A., Mosenzon, Ofri, Steg, Philippe, Davidson, Jaime, Hirshberg, Boaz, Im, Kyungah, Raz, Itamar, Bhatt, Deepak Baseline Renal Function and Cardiovascular Risk in Patients Treated with Saxagliptin: Observations from the SAVOR-TIMI 53 TRIAL Journal of the American College of Cardiology. 2014;63(12, Supplement):A1523.

Vardi, M., Debidda, M., Bhatt, D. L., Mauri, L., Cannon, C. P. Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists Clin Cardiol. 2014;37(2):103-7. Abstract

Vardi, M., Debidda, M., Bhatt, D. L., Mauri, L., Cannon, C. P. Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists Clin Cardiol. 2014;37(2):103-7. Abstract

Xian, Y., Chen, A. Y., Thomas, L., Roe, M. T., Subherwal, S., Cannon, C. P., Pollack, C. V., Jr., Fonarow, G. C., Kosiborod, M., Peterson, E. D., Alexander, K. P. Sources of Hospital-Level Variation in Major Bleeding Among Patients With Non-ST-Segment Elevation Myocardial Infarction: A Report From the National Cardiovascular Data Registry (NCDR) Circ Cardiovasc Qual Outcomes. 2014;7(2):236-43. Abstract

Xian, Y., Chen, A. Y., Thomas, L., Roe, M. T., Subherwal, S., Cannon, C. P., Pollack, C. V., Jr., Fonarow, G. C., Kosiborod, M., Peterson, E. D., Alexander, K. P. Sources of Hospital-Level Variation in Major Bleeding Among Patients With Non-ST-Segment Elevation Myocardial Infarction: A Report From the National Cardiovascular Data Registry (NCDR) Circ Cardiovasc Qual Outcomes. 2014;7(2):236-43. Abstract

Xian, Y., Smith, E. E., Zhao, X., Peterson, E. D., Olson, D. M., Hernandez, A. F., Bhatt, D. L., Saver, J. L., Schwamm, L. H., Fonarow, G. C. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke Stroke. 2014;45(5):1387-95. Abstract

Xian, Y., Smith, E. E., Zhao, X., Peterson, E. D., Olson, D. M., Hernandez, A. F., Bhatt, D. L., Saver, J. L., Schwamm, L. H., Fonarow, G. C. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke Stroke. 2014;45(5):1387-95. Abstract

Xu, Haiyan, Yang, YueJin, Yang, Jingang, Li, Wei, Peterson, Eric, Roe, Matthew, Xian, Ying, Sabatine, Marc, Wiviott, Stephen THE CHINA ACUTE MYOCARDIAL INFARCTION REGISTRY: A NATIONAL REGISTRY-QUALITY IMPROVEMENT INTEGRATED PROGRAM IN CHINA Journal of the American College of Cardiology. 2014;63(12, Supplement):A174.

Xu, Haiyan, Yang, YueJin, Yang, Jingang, Li, Wei, Peterson, Eric, Roe, Matthew, Xian, Ying, Sabatine, Marc, Wiviott, Stephen THE CHINA ACUTE MYOCARDIAL INFARCTION REGISTRY: A NATIONAL REGISTRY-QUALITY IMPROVEMENT INTEGRATED PROGRAM IN CHINA Journal of the American College of Cardiology. 2014;63(12, Supplement):A174.

Xu, Haiyan, Yang, YueJin, Yang, Jingang, Li, Wei, Peterson, Eric, Roe, Matthew, Xian, Ying, Sabatine, Marc, Wiviott, Stephen THE CHINA ACUTE MYOCARDIAL INFARCTION REGISTRY: A NATIONAL REGISTRY-QUALITY IMPROVEMENT INTEGRATED PROGRAM IN CHINA Journal of the American College of Cardiology. 2014;63(12, Supplement):A174.

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction NEJM. 2015:Epub ahead of print. Abstract

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction NEJM. 2015:Epub ahead of print. Abstract

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction NEJM. 2015:Epub ahead of print. Abstract

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction NEJM. 2015:Epub ahead of print. Abstract

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med. 2015;Epub ahead of print. Abstract

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med. 2015;Epub ahead of print. Abstract

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med. 2015;Epub ahead of print. Abstract

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med. 2015;Epub ahead of print. Abstract

O'Donoghue ML, Glaser R, Aylward PE, Cavender MA, Crisp A, Fox KA, Laws I, Lopez-Sendon JL, Steg PG, Theroux P, Sabatine MS, Morrow DA. Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial. Am Heart J. 2015;169:622-630. Abstract

O'Donoghue ML, Glaser R, Aylward PE, Cavender MA, Crisp A, Fox KA, Laws I, Lopez-Sendon JL, Steg PG, Theroux P, Sabatine MS, Morrow DA. Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial. Am Heart J. 2015;169:622-630. Abstract

O'Donoghue ML, Glaser R, Aylward PE, Cavender MA, Crisp A, Fox KA, Laws I, Lopez-Sendon JL, Steg PG, Theroux P, Sabatine MS, Morrow DA. Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial. Am Heart J. 2015;169:622-630. Abstract

O'Donoghue ML, Glaser R, Aylward PE, Cavender MA, Crisp A, Fox KA, Laws I, Lopez-Sendon JL, Steg PG, Theroux P, Sabatine MS, Morrow DA. Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial. Am Heart J. 2015;169:622-630. Abstract

Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, Ballantyne CM, Somaratne R, Legg J, Wasserman SM, Scott R, Koren MJ, Stein EA. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events N Engl J Med. 2015;372:1500-9. Abstract

Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, Ballantyne CM, Somaratne R, Legg J, Wasserman SM, Scott R, Koren MJ, Stein EA. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events N Engl J Med. 2015;372:1500-9. Abstract

Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, Ballantyne CM, Somaratne R, Legg J, Wasserman SM, Scott R, Koren MJ, Stein EA. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events N Engl J Med. 2015;372:1500-9. Abstract

Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, Ballantyne CM, Somaratne R, Legg J, Wasserman SM, Scott R, Koren MJ, Stein EA. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events N Engl J Med. 2015;372:1500-9. Abstract

O’Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA,Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ, Lopez-Sendon JL, Ophuis TO, Parkhomenko A, Shannon JB, Spinar J, Tanguay JF, Ruda M, Steg PG, Theroux P, Wiviott SD, Laws I, Sabatine MS, Morrow DA. Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction J Am Med Assoc. 2016. Abstract

O’Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA,Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ, Lopez-Sendon JL, Ophuis TO, Parkhomenko A, Shannon JB, Spinar J, Tanguay JF, Ruda M, Steg PG, Theroux P, Wiviott SD, Laws I, Sabatine MS, Morrow DA. Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction J Am Med Assoc. 2016. Abstract

O’Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA,Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ, Lopez-Sendon JL, Ophuis TO, Parkhomenko A, Shannon JB, Spinar J, Tanguay JF, Ruda M, Steg PG, Theroux P, Wiviott SD, Laws I, Sabatine MS, Morrow DA. Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction J Am Med Assoc. 2016. Abstract

O’Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA,Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ, Lopez-Sendon JL, Ophuis TO, Parkhomenko A, Shannon JB, Spinar J, Tanguay JF, Ruda M, Steg PG, Theroux P, Wiviott SD, Laws I, Sabatine MS, Morrow DA. Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction J Am Med Assoc. 2016. Abstract

Desai, Nihar, Peterson, E., Chen, A., Wiviott, S., Sabatine, M., Alexander, K. P., Roe, M., Shah, B. Balancing the Risk of Mortality and Major Bleeding in the Treatment of NSTEMI Patients – A Report from the NCDR American Heart Journal. NA;NA(NA):NA.

Desai, Nihar, Peterson, E., Chen, A., Wiviott, S., Sabatine, M., Alexander, K. P., Roe, M., Shah, B. Balancing the Risk of Mortality and Major Bleeding in the Treatment of NSTEMI Patients – A Report from the NCDR American Heart Journal. NA;NA(NA):NA.